<!DOCTYPE html>

<html>

<head>
	<title>ESCMID</title>
	<style>
		.sessionid {
			background-color: red;
		}
		.title {
			background-color: blue; color: #ccc;
		}
		.start {
			background-color: green; color: #ccc;
		}
		.end {
			background-color: purple; color: #ccc;
		}
		.location {
			background-color: yellow; color: #333;
		}
		.presenter {
			background-color: orange;
		}
		.presenters {
			background-color: darkorange;
		}
	</style>
</head>
<body>

<p>ESCMID Global 2025 - Programme <br/></p><p>Friday, 11 April 2025</p><p> 

</p><p> 



<p class="sessionid">SP1</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 0</span>

</p><p class="header">Special Session</p><p><span class="title"> Antimicrobial   Stewardship   in   Different   Scenarios</span>
</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">EW001</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 2</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Surgical site infections: principles and practice in the era of multidrug resistance</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Gabriel Birgand (Nantes, France) Efthymia Giannitsioti (Athens, Greece)</p></td></tr>
<tr><td>

<p class="sessionid">W0001</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Evolving antimicrobial resistance: do we need a change in surgical antimicrobial prophylaxis? <span> </span>Camilla Rodrigues (Mumbai, India)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0002</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Role of decolonisation and bowel decontamination in regions of overwhelming multidrug resistance </p><span class="presenter">Prasannakumar Palanikumar (Vellore, India)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0003</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Screening for MDR GNR coloniSation: is there evidence for prophylaxis </p><span class="presenter">Elisabeth Presterl (Vienna, Austria)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0004</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Perioperative prophylaxis in special populations in the era of MDR </p><span class="presenter">Divyashree Shanthamurthy (Mumbai, India)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EW002</p></p></td><td><span class="start">08:30</span><span class="end">10:30</p></td><td><span class="location">Hall 3</span></td></tr>
<tr><td></td><td><p> 

</p><p>Educational Session</p></td><td></td></tr>
<tr><td><p class="title">Demystifying pharmacokinetics and population pharmacokinetics: a toolkit for non-experts</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Shampa Das (Liverpool, United Kingdom) João Paulo Telles (Sao Paulo, Brazil)</p></td></tr>
<tr><td>

<p class="sessionid">W0005</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Pharmacokinetics 101: navigating the basics for optimal dosing <span> </span>Linda Aulin (Leiden, Netherlands)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0006</p></p></td><td><p class="start">08:50</p></td><td><p class="title">The ABCs of population pharmacokinetic models </p><span class="presenter">Erwin Dreesen (Leuven, Belgium)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0007</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Looking into the crystal ball: exploring the fabulous world of PK-PD simulations </p><span class="presenter">Vincent Aranzana-Climent (Poitiers, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0008</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Decoding population pharmacokinetic papers: interpreting, comparing and discussing results </p><span class="presenter">Iris K. Minichmayr (Vienna, Austria)</span>
</p></td></tr></table><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG) <br/></p><p> 

</p><p> 



<p class="sessionid">EW003</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 5</span>

</p><p>Educational Session</p><table>
<tr><td><p class="title">Challenges in identification and relevance of slow-growing pathogens</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Kerrie Davies (Leeds, United Kingdom) Yann Dumont (Nancy, France)</p></td></tr>
<tr><td>

<p class="sessionid">W0009</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Sampling and culturing anaerobes <span> </span>Hugo Cruz (Porto, Portugal)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0010</p></p></td><td><p class="start">08:50</p></td><td><p class="title">I have an anaerobe: what is it and does it matter? </p><span class="presenter">Kathleen Boiten (Groningen, Netherlands)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0011</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Actinomyces in clinical samples: when is it worth the trouble? </p><span class="presenter">Eija Inkeri Könönen (Turku, Finland)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0012</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Nocardiosis: when to test and how to manage results? </p><span class="presenter">David Lebeaux (Paris, France)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Anaerobic Infections (ESGAI), ESCMID Study Group for Clostridioides difficile (ESGCD) <br/></p><p> 

</p><p> 



<p class="sessionid">EW004</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 6</span>

</p><p>Educational Session <br/></p><div><p>A hard nut to crack in HIV</p></div><p><p class="presenters"></p><p>

<p class="sessionid">W0013</p><span class="start">08:30</span><span class="title">Viral  reservoir: what a physician should know 
<span>Ivailo Alexiev (Sofia, Bulgaria)</span>
</p><p>

<p class="sessionid">W0014</p>  08:50    Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians 
<span>Jose Arribas (Madrid, Spain)</span>
</p><p>

<p class="sessionid">W0015</p><span class="start">09:10</span><span class="title">Chronic  vascular and pulmonary disease and HIV:</p><p>what can we do about it? 
<span>Susanne Dam Poulsen (Copenhagen, Denmark)</span>
</p><p>

<p class="sessionid">W0016</p><span class="start">09:30</span><span class="title">Opportunistic  infections: most common and most deadly 
<span>Milena Stevanovikj (Sopje, North Macedonia, Republic of)</span>
</p><p>Co-organised with: Euroguidelines in Central and Eastern Europe Network Group <br/></p><p> 

</p><p> 



<p class="sessionid">EW005</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 8</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Miriam José Álvarez-Martínez (Barcelona, Spain) Caroline Rönnberg (Stockholm, Sweden)</p></td></tr>
<tr><td>

<p class="sessionid">W0017</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Artificial Intelligence for the diagnosis of parasitic infections <span> </span>Bobbi Pritt (Rochester, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0018</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Histopathology of parasitic infections </p><span class="presenter">Richard Bradbury (Townsville, Australia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0019</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Molecular diagnosis vs. microscopy in the diagnosis of parasitic infections </p><span class="presenter">Sitara Sr Ajjampur (Vellore, India)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0020</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Paleoparasitology: what diagnostic tools? </p><span class="presenter">Ayman El- Badry (Cairo, Egypt)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) <br/></p><p> 

</p><p> 



<p class="sessionid">EW006</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 9</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Vaccine hesitancy: from issues to solutions through developing communication skills</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Monia Chemais (Soignies, Belgium) Petar Velikov (Sofia, Bulgaria)</p></td></tr>
<tr><td>

<p class="sessionid">W0021</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Vaccine hesitancy and its consequences <span> </span>Noni Macdonald (Halifax, Canada)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0022</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Why are patients and parents hesitant about vaccination? </p><span class="presenter">Eve Dube (Quebec City, Canada)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0023</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Using social media to deal with vaccine hesitancy </p><span class="presenter">Muge Cevik (St Andrews, United Kingdom)</span>
</p></td></tr></table><p>ESCMID Global 2025 - Programme</p><p>

<p class="sessionid">W0024</p><span class="start">09:30</span><span class="title">Strengthening  vaccine confidence in patients and parents 
<span class="presenters">Tba</span>
</p><p>Co-organised with: ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">SP2</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 0</span>

</p><p class="header">Special Session</p><p><span class="title"> Principles of systematic reviews (with and without meta-analysis)</span>
</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">ME007</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 2</span>

</p><p>Meet-the-Expert</p><p> 
<span> How  to  interpret  resistance  patterns  from  antibiograms</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0025</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Tommaso Giani (Florence, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">M0026</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Diaz Lorena (Santiago, Chile)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME008</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 3</span>

</p><p>Meet-the-Expert</p><p> 
<span> Children are not just small adults: interactive paediatric cases</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0027</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Julie Toubiana (Paris, France)</p></td></tr>
<tr><td>

<p class="sessionid">M0028</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Sanjay Patel (Winchester, United Kingdom)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME009</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 5</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to practise WHO Guidelines for the prevention of bloodstream infections and other intravascular catheter infections</p></div><p><table>
<tr><td>

<p class="sessionid">M0029</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Kushlani Jayatilleke (Battaramulla, Sri Lanka)</p></td></tr>
<tr><td>

<p class="sessionid">M0030</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Walter Zingg (Zurich, Switzerland)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME010</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 6</span>

</p><p>Meet-the-Expert <br/></p><div><p>Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional experience</p></div><p><table>
<tr><td>

<p class="sessionid">M0031</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Ecaterina Noroc (Chisinau, Moldova, Republic of)</p></td></tr>
<tr><td>

<p class="sessionid">M0032</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Fakhriddin Nizamov (Almaty, Kazakhstan)</p></td></tr></table><p>Co-organised with: Euroguidelines in Central and Eastern Europe Network Group, United Nations International Children's Emergency Fund (UNICEF) <br/></p><p> 

</p><p> 



<p class="sessionid">ME011</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 8</span>

</p><p>Meet-the-Expert</p><p> 
<span> Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0033</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Jaime Esteban (Madrid, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">M0034</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Philippe Morand (Paris, France)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Mycobacterial Infections (ESGMYC) <br/></p><p> 

</p><p> 



<p class="sessionid">ME012</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 9</span>

</p><p>Meet-the-Expert</p><p> 
<span> How to understand infectious disease risks in changing climates</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0035</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Kimberly Fornace (Singapore, Singapore)</p></td></tr>
<tr><td>

<p class="sessionid">M0036</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Rachel Lowe (Barcelona, Spain)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SP3</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 0</span>

</p><p class="header">Special Session</p><p><span class="title"> Top  five  mistakes  in  Infection  prevention  and  control</span>
</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">ME013</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 2</span>

</p><p>Meet-the-Expert</p><p> 
<span> Orthopaedic implant infections: new approaches for improved outcomes</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0037</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Marjan Wouthuyzen-Bakker (Groningen,</p></td></tr>
<tr><td>

<p class="sessionid">M0038</p></p></td><td><p class="start">13:42</p></td><td><p>Netherlands)</p><p>Trisha Peel (Melbourne, Australia)</p></td></tr></table><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Infectious Diseases of the Brain (ESGIB) <br/></p><p> 

</p><p> 



<p class="sessionid">ME014</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 3</span>

</p><p>Meet-the-Expert</p><p> 
<span> Timing of antimicrobials in sepsis and septic shock - the sooner the better?</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0039</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Laura Evans (Seattle, United States)</p></td></tr>
<tr><td>

<p class="sessionid">M0040</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Evangelos Giamarellos-Bourboulis (Athens, Greece)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) <br/></p><p> 

</p><p> 



<p class="sessionid">ME015</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 5</span>

</p><p>Meet-the-Expert</p><p> 
<span> PrEP  in  Europe:  Current  gaps  and  solutions</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0041</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Teymur Noori (Stockholm, Sweden)</p></td></tr>
<tr><td>

<p class="sessionid">M0042</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Milosz Parczewski (Szczecin, Poland)</p></td></tr></table><p>Co-organised with: European AIDS Clinical Society (EACS) <br/></p><p> 

</p><p> 



<p class="sessionid">ME016</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 6</span>

</p><p>Meet-the-Expert <br/></p><div><p>Short regimens for treating drug-susceptible and drug-resistant tuberculosis: Insights from guidelines</p></div><p><p>ESCMID Global 2025 - Programme</p><table>
<tr><td>

<p class="sessionid">M0043</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Daria Podlekareva (Copenhagen, Denmark)</p></td></tr>
<tr><td>

<p class="sessionid">M0044</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Raquel Duarte (Porto, Portugal)</p></td></tr></table><p>Co-organised with: European Respiratory Society (ERS) <br/></p><p> 

</p><p> 



<p class="sessionid">ME017</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 8</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to navigate Risk Communication in Public Health</p></div><p><table>
<tr><td>

<p class="sessionid">M0045</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Christina Rolfheim-Bye (Oslo, Norway)</p></td></tr>
<tr><td>

<p class="sessionid">M0046</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Marius Gilbert (Brussels, Belgium)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Public Health Microbiology (ESGPHM) <br/></p><p> 

</p><p> 



<p class="sessionid">ME018</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 9</span>

</p><p>Meet-the-Expert <br/></p><div><p>Do we need antiviral stewardship in immunocompromised hosts? role of cell- mediated immunity</p></div><p><table>
<tr><td><p>

<p class="sessionid">M0047</p> <p class="sessionid" style="background-color: red;">M0048</p></p></td><td><p>13:30</p><p>13:42</p></td><td><p>Michelle Yong (Melbourne, Australia)</p><p>Genovefa Papanicolaou (New York, United States)</p></td></tr>
<tr><td>

<p class="sessionid">SP4</p></p></td><td><p>14:45  
<span>-</span>
15:45</p><p>Special Session</p></td><td><p>Hall 0</p></td></tr></table><div><p>Science Slam - How to Communicate Science with Clarity</p></div><p><p> 

</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">ME019</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 2</span>

</p><p>Meet-the-Expert <br/></p><div><p>Healthcare-associated CNS infections</p></div><p><table>
<tr><td>

<p class="sessionid">M0049</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Diederik Van De Beek (Amsterdam, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">M0050</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Alexandra Mailles (Paris, France)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain (ESGIB) <br/></p><p> 

</p><p> 



<p class="sessionid">ME020</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 3</span>

</p><p>Meet-the-Expert <br/></p><div><p>Translation of gut microbiome data to clinical practice: a guide for clinicians</p></div><p><table>
<tr><td>

<p class="sessionid">M0051</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Aycan Gundogdu (Kayseri, Türkiye)</p></td></tr>
<tr><td>

<p class="sessionid">M0052</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Niranjan Nagarajan (Singapore, Singapore)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI) <br/></p><p> 

</p><p> 



<p class="sessionid">ME021</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 5</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to make sense out of guidelines and scientific evidence</p></div><p><table>
<tr><td>

<p class="sessionid">M0053</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Luigia Scudeller (Pavia, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">M0054</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Blin Nagavci (Gjakove, Kosovo)</p></td></tr></table><p>Co-organised with: ESCMID Guidelines Subcommittee <br/></p><p> 

</p><p> 



<p class="sessionid">ME022</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 6</span>

</p><p>Meet-the-Expert <br/></p><div><p>Multidisciplinary management of bone and joint infections: is there a recipe for success?</p></div><p><table>
<tr><td>

<p class="sessionid">M0055</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Natividad Benito (Barcelona, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">M0056</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Tiziana Ascione (Naples, Italy)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Lyme Borreliosis (ESGBOR) <br/></p><p> 

</p><p> 



<p class="sessionid">ME023</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 8</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to manage and prevent travellers' diarrhoea</p></div><p><table>
<tr><td>

<p class="sessionid">M0057</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Tinja Laaveri (Helsinki, Finland)</p></td></tr>
<tr><td>

<p class="sessionid">M0058</p></p></td><td><p class="start">14:57</p></td><td><p class="title">David Tribble (Bethesda, United States)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME024</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 9</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to diagnose and treat infectious complications in critically ill patients receiving ECMO support</p></div><p><table>
<tr><td>

<p class="sessionid">M0059</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Jordi Riera (Barcelona, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">M0060</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Giacomo Grasselli (Besana In Brianza, Italy)</p></td></tr></table><p>Co-organised with: European Extracorporeal Life Support Organization (EuroELSO) <br/></p><p> 

</p><p> 



<p class="sessionid">SP5</p></span>
<span class="start">16:15</span><span>-</span>
18:15 </span><span class="location">Hall 0</span>

</p><p>Special Session <br/></p><div><p>Multidisciplinary approach to early sepsis management</p></div><p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">EW025</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 2</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">AMR surveillance: current challenges and new perspectives</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Tomislav Mestrovic (Varazdin, Croatia)</p></td></tr>
<tr><td>

<p class="sessionid">W0061</p></p></td><td><p class="start">16:15</p></td><td><p class="title">The essentials of GRAM project: data sources, methodology and challenges in estimating AMR burden <span> </span>Authia Gray (Washington, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0062</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Networks for surveillance of AMR in animal pathogens </p><span class="presenter">Lucie Collineau (Lyon, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0063</p></p></td><td><p class="start">16:55</p></td><td><p class="title">Transition to genomic-based methodology for surveillance and outbreak detection to effectively combact AMR </p><span class="presenter">Camilla Wiuff Coia (Copenhagen, Denmark)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0064</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Implementing and running hospital-wide genomic surveillance of pathogens </p><span class="presenter">Alexander Mellmann</span>
</p></td></tr></table><p>ESCMID Global 2025 - Programme</p><p>(Münster, Germany)</p><p>Co-organised with: ESCMID Education Subcommittee, ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), ESCMID Study Group for Veterinary Microbiology (ESGVM) <br/></p><p> 

</p><p> 



<p class="sessionid">EW026</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 3</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">New insights into antifungal agents and resistance</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Anuradha Chowdhary (New Delhi, India) Jon Salmanton-Garcia (Cologne, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">W0065</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Emerging resistance in  <span> </span>Candida tropicalisSharon Chen (Sydney, Australia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0066</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Mechanisms of resistance in  </p><span class="presenter">Candida glabrataDavid Perlin (Nutley, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0067</p></p></td><td><p class="start">16:55</p></td><td><p class="title">Surveillance of resistance in  <span> </span>Aspergillus</span>
species <span> </span>Maiken Cavling Arendrup (Copenhagen, Denmark)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0068</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Environmental surveillance for antifungal resistance </p><span class="presenter">Eveline Snelders (Wageningen, Netherlands)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">EW027</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 5</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Going Viral! Phage Therapy Clinical rounds</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Gregory German (Maple, Canada) Ameneh Khatami (Sydney, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">W0069</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Clinical cases and lessons from the STAMP protocol <span> </span>Holly Sinclair (Nsw, Australia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0070</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Difficult cases treated with phages </p><span class="presenter">Ghady Haidar (Pittsburgh, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0071</p></p></td><td><p class="start">16:55</p></td><td><p class="title">Challenging osteoarticular cases treated with phages </p><span class="presenter">Tristan Ferry (Lyon, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0072</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Treating urinary tract infections with phages: dream or reality? </p><span class="presenter">Saima Aslam (San Diego, United States)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA) <br/></p><p> 

</p><p> 



<p class="sessionid">EW028</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 6</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Addressing infection challenges in immunocompromised patients: a case- based exploration</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Maddalena Giannella (Bologna, Italy) Asma Nasim (Karachi, Pakistan)</p></td></tr>
<tr><td>

<p class="sessionid">W0073</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Challenges in managing gastrointestinal infections in patients with primary immunodeficiency <span> </span>Effrossyni Gkrania-Klotsas (Cambridge, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0074</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Respiratory infections in patients receiving CAR-T cells or bispecific monoclonal antibodies </p><span class="presenter">Gemma Reynolds (Heidelberg, Australia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0075</p></p></td><td><p class="start">16:55</p></td><td><p class="title">Mycobacterial infections in patients with HIV infection </p><span class="presenter">Graeme Ayton Meintjes (Observatory, South Africa)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0076</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Breakthrough fungal infections in haematopoietic cancer and in stem cell transplantation </p><span class="presenter">Dimitrios P. Kontoyiannis (Houston, Tx, United States)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), International Immunocompromised Host Society (ICHS) <br/></p><p> 

</p><p> 



<p class="sessionid">EW029</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 8</span>

</p><p>Educational Session <br/></p><div><p>Impact of diabetes on infectious diseases: what should we know?</p></div><p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Mark G. J. De Boer (Leiden, Netherlands) Suzanne Van Asten (Nijmegen, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">W0077</p></p></td><td><p class="start">16:15</p></td><td><p class="title">The impact of diabetes and host-pathogen interaction and gut microbiome <span> </span>Reinout Van Crevel (Nijmegen, Netherlands)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0078</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Diabetes and invasive fungal infections </p><span class="presenter">Jochem Buil (Nijmegen, Netherlands)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0079</p></p></td><td><p class="start">16:55</p></td><td><p class="title">Viral infections and diabetes: is there a connection? </p><span class="presenter">Malin Flodström-Tullberg (Stockholm, Sweden)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0080</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Pathogenesis of diabetic wound infection </p><span class="presenter">Tba</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EW030</p></p></td><td><p>16:15  
<span>-</span>
18:15</p></td><td><p>Hall 9</p></td></tr>
<tr><td></td><td><p>Educational Session</p></td><td></td></tr>
<tr><td><p> 

</p><p>Primer on infection prevention and control: the crucial support by clinical microbiology</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Nico Tom Mutters (Bonn, Germany) Margreet C. Vos (Rotterdam, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">W0081</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Microbial fundamentals: building blocks of infection prevention and control <span> </span>Laurence Armand-Lefevre (Paris, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0082</p></p></td><td><p class="start">16:35</p></td><td><p class="title">Optimising environmental sampling in infection control: rational use of the microbiology laboratory </p><span class="presenter">John E. Coia (Esbjerg, Denmark)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0083</p></p></td><td><p class="start">16:55</p></td><td><p class="title">The crucial role of molecular typing in infection control </p><span class="presenter">Stefanie Kampmeier (Würzburg, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0084</p></p></td><td><p class="start">17:15</p></td><td><p class="title">How can we link diagnostic and antibiotic stewardship? </p><span class="presenter">Constantinos Tsioutis (Nicosia, Cyprus)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering Committee</p><p>Saturday, 12 April 2025</p><p> 

</p><p> 



<p class="sessionid">SY036</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 15<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> The quality of antibiotics used in the communities of LMICs</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Thi Thuy Nga Do (Ha Noi, Vietnam) Christina Obiero (Kilifi, Kenya)</p></td></tr>
<tr><td>

<p class="sessionid">S0105</p></p></td><td><p class="start">08:30</p></td><td><p class="title">The quality of antibiotics and their potential impact on patient outcome and AMR <span> </span>Paul Newton (Oxford, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0106</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Community antibiotic access and use in Sub-Sahara Africa </p><span class="presenter">Samuel Afari-Asiedu (Kintampo, Ghana)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0107</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Encountered challenges and reflections on conducting multi-country medicine quality studies </p><span class="presenter">Noudy Sengxeu (Vientiane Capital, Lao People's democratic republic)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0108</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Confusion in appearance of common used antibiotics in LMICs </p><span class="presenter">Heiman Wertheim (Nijmegen, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">SY031</p></p></td><td><p>08:30  
<span>-</span>
10:30</p></td><td><p>Hall 6</p></td></tr>
<tr><td></td><td><p> 

</p><p>2-hour Symposium</p></td><td></td></tr>
<tr><td><p> 
<span> To  screen  or  not  to  screen  prior  to  transplant?</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Laura Alicia Barcan (Buenos Aires, Argentina) Oscar Len (Barcelona, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">S0085</p></p></td><td><p class="start">08:30</p></td><td><p class="title">HHV-8 Screening <span> </span>Alessandra Mularoni (Palermo, Italy)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0086</p></p></td><td><p class="start">09:00</p></td><td><p class="title">TB screening and prevention in endemic regions </p><span class="presenter">Rubina Naqvi (Karachi, Pakistan)</span>
</p></td></tr></table><p>ESCMID Global 2025 - Programme</p><table>
<tr><td>

<p class="sessionid">S0087</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Screening for and prevention of chagas in immunocompromised hosts </p><span class="presenter">Marcelo Victor Radisic (Buenos Aires, Argentina)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0088</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Screening of lung donors for Molicutes </p><span class="presenter">Michael G Ison (Derwood (MD), United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EF003</p></p></td><td><p>08:30  
<span>-</span>
09:30</p></td><td><p>Arena 1</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><p> 

</p><p> 
<span> On  the  frontiers  of  vaccine  driven  prevention</span>
</p><p>Chair      Maria Ganczak (Zielona Gora, Poland) <br/></p>


<p class="sessionid">E0021</p><span class="title">Changes in dose interval can impact T cell responses but not antibody levels in individuals receiving the modified vaccinia Ankara Mpox vaccine 
<span>J. Parsons* (Liverpool, United Kingdom), K. Subramaniam, L. Turtle, S. Dobson, L. Goodwin, C. Jones, T. Jones, P. Shellman, A. Uriel, S. Jones, A. Otter, S. Laidlaw, M. Carroll</span>
</p>

<p class="sessionid">E0022</p><span class="title">A phase 1 study with an innovative approach for an HIV-1 prophylactic vaccine 
<span>P. Garbes* (Newark, United States), C. Chang, H. Wraight, R. Norton, S. Ouyang, S. Shen, H. Gao, D. Montefiori, J. Heptinstall,
 S. Sawant, G. Tomaras, J. Zhu, K. Braz Gomes, M. Giffear, K. Damjanoska, J. Li</span></p><p>

<p class="sessionid">E0023</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">C. Schwarz, E. Gonzalez, M. Skovdal, P. Zhang, B. Gessner, N. Aliabadi, E. Begier, T. Biering-Sørensen</p>

<p class="sessionid">E0024</p><span class="title">Six-month Immunogenicity of mRNA-1345 RSV Vaccine in Adults Aged ≥60 Years </span><span class="presenters">M. Desai* (Cambridge, United States), E. Comstock, L. Lan, A. Kapoor, F. She, C. Reuter, J. Goswami, F. Priddy, R. Das</span>
</p>

<p class="sessionid">E0025</p><span class="title">Comparative Immune Responses to Homologous and Heterologous SARS-CoV-2 Vaccination Using DNA and Protein Platforms 
<span>S. Prieto Martin Gil* (Madrid, Spain), S. Prieto Martín Gil, M. López Siles, J.A. Infantes Lorenzo, E. Lorente, D. Fousteris, B. Cano Castaño, A. Tajuelo, D. López, V. Mas Lloret, E. Gato,</span>
</p><p class="presenter">A. Pérez, M.J. Mcconnell</p>

<p class="sessionid">E0026</p><span class="title">Quantitative correlates of protection against SARS- CoV-2 variants using individual-level reconstructed antibody kinetics </span><span class="presenters">T. Russell* (London, United Kingdom), E.C. Wall, A.J. Kucharski, J. Hellewell, O. Hague, H. Townsley, J. Gahir, M. Shawe-Taylor, D. Greenwood, R. Harvey, M.Y. Wu, D.L. Bauer, E.J. Carr</span>
</p><p>

<p class="sessionid">E0027</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">A. Atti, J. Islam, S. Hopkins, N. Andrews, V. Hall</p>

<p class="sessionid">E0028</p><span class="title">Immunogenicity and safety of second COVID-19 booster and Influenza vaccination coadministration </span><span class="presenters">I. Wagenhäuser* (Würzburg, Germany), J. Reusch, J. Mees, A. Gabel, N. Petri, M. Krone</span>
</p>

<p class="sessionid">E0029</p><span class="title">The degree of immunization against the Measles virus of the infant population in Sibiu county, Romania 
<span>S. Cristea* (Sibiu, Romania), C. Grigore</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF004</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Pharmacology   from   bench   to   the   bedside</span>
</p><p>Chair      Alina Karoline Nussbaumer-Pröll (Wien, Österreich, Austria) <br/></p>

<p class="sessionid">E0030</p></p>
<span>Enterococcus faecalis</span>
impairs  
<span>Escherichia coli</span>
</p><p>response to antibiotics in a dual-species intracellular infection model 
<span>F. Van Bambeke* (Brussels, Belgium),</span>
</p><p class="presenter">G. Wang</p>

<p class="sessionid">E0031</p><span class="title">In vitro investigations of ceftazidime-avibactam and fosfomycin against carbapenemase-producing  </span><span class="presenters">Enterobacterales</span>
clinical isolates 
<span>M. Martens* (Hamburg, Germany), F.M. Docobo-Perez, C. Sauco Carballo, J. Rodriguez-Baño, S. Marchand, L. Keomany, I. Portillo-Calderon, M. Gianella, S. Ambretti, B. Secci, S.G. Wicha</span>
</p>

<p class="sessionid">E0032</p></p>
<span>In vivo</span>
activity and PK of the novel siderophore- cephalosporin AR-2126 in a lethal lung infection model in mice infected with a carbapenem-resistant  
<span>Pseudomonas aeruginosa</span>
following subcutaneous administration 
<span>W. Wicha* (Bruck An Der Leitha, Austria), S. Paukner</span>
</p>

<p class="sessionid">E0033</p><span class="title">Synergistic Potency Unveiled: -Lactam and - Lactamase Inhibitor Combination against  
<span>Mycobacterium abscessus</span>
with Dual Action of - Lactamase Inhibition and Multi-Target Receptor Inactivation 
<span>E. Shin* (Cleveland, United States), K.M. Dousa, C.R. Bethel, M. Nantongo, S.M. Holland, E.J. Rubin, J.B. Bulitta, K. Barry, R.A. Bonomo</span>
</p><p>

<p class="sessionid">E0034</p><span class="title"><span class="presenters"></span>
infection 
<span>W. Wang* (Foster City, United States), S. Liu, B. Rimal, Y. Xu, Q. Dai, G. Lamichhane</span>
</p>

<p class="sessionid">E0035</p></p>Pharmacokinetic/pharmacodynamic modelling of immune response and meropenem activity in immunocompetent and neutropenic mouse lung infection models 
<span>R. Saporta* (Uppsala, Sweden), N. Tassi, O. Ticha, V. Biordi, A. Ginosyan, I. Loryan, E.I. Nielsen, I. Bekeredjian-Ding, B. Kerscher, L.E. Friberg</span>
</p>

<p class="sessionid">E0036</p><span class="title">Implementation of a model-based nomogram for amoxicillin precision dosing in patients suspected of infective endocarditis: preliminary results of the NOMOBA-AMX multicentre study 
<span>P. Le Turnier* (Cayenne, French Guiana), S. Jamard, A. Lorleac'h, C. Deschanvres, F. Andry, A. Coste, P. Danneels, T. Guimard, P. Gicquel, H. Harrabi, N. Issa, J.B. Lainé, R. Lamberet, A. Le Bot, M. Maillet, P. Petitgas, V. Rabier,</span>
</p><p class="presenter">S. Sunder, J.M. Turmel, D. Boutoille, C. Delaunay, M. Grégoire, A.G. Leroy, M. Wargny, R. Bellouard</p>

<p class="sessionid">E0037</p><span class="title">No time to waste: hospital-wide assessment of IV- vial and line residuals and impact on target attainment. </span><span class="presenters">D. Vanneste* (Leuven, Belgium), M. Gijsen, W. Zhang, O. Elkayal, V. Caubergs, J. Wauters,
 S. Desmet, E. Dreesen, I. Spriet</span></p><p>

<p class="sessionid">E0038</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY034</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 10<span> </span>
</p><p>2-hour Symposium</p><p> 
<span>  Endoscopy:   infection   risks   and   mitigation</span>
</p><table>
<tr><td><p class="presenters">Elisabeth Presterl (Vienna, Austria)</p><p class="presenters">Gordon Ramage (Glasgow, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">S0097</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Should we be concerned about infection from contaminated endoscopes? <span> </span>Claire Aumeran (Clermont-Ferrand, France)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0098</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Prevention of multidrug-resistant infections from contaminated duodenoscopes </p><span class="presenter">Margreet C. Vos (Rotterdam, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0099</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Understanding the causes of medical device contamination: it is all biofilm! </p><span class="presenter">Roberto Rusconi (Milan, Italy)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0100</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Does the European medical Device Regulation bring us safer duodenoscopes? </p><span class="presenter">Markus Hell (Salzburg, Austria)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Biofilms (ESGB), ESCMID Study Group for Nosocomial Infections (ESGNI) <br/></p><p> 

</p><p>ESCMID Global 2025 - Programme</p><p> 



<p class="sessionid">OS002</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 11<span> </span>
</p><p>2-hour Oral Session</p><p> 
<span> Translating   metagenomics   into   clinical   practice</span>
</p><p class="presenters"></p>
<p>

<p class="sessionid">O0011</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0012</p><span class="title">Interpretative Criteria for Adjudicating Clinical Significance to Next-Generation Sequencing Results from Bronchial-alveolar Lavage and Bronchial Wash. 
<span>J. Alexander* (Orlando, United States), A. Charles</span>
</p><p>

<p class="sessionid">O0013</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0014</p><span class="title">Detection of pathogenic microorganisms using metagenomic next-generation sequencing in ICU patients with ongoing antibiotic therapy 
<span>T. Schroeder* (Nuertingen, Germany), M. Eliwi Alsaffan,
 A. Dervishi, P. Kawaletz, H. Stäudle</span></p><p>

<p class="sessionid">O0015</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0016</p></p>Same-day pan-microbial metagenomics for personalized therapy and pathogen surveillance on the intensive care unit: a single-centre prospective study 
<span>L.B. Snell* (London, United Kingdom), A. Alcolea-Medina, G. Humayun, N. Al-Yaakoubi, D. Ward, C. Alder, V. Patel, F. Vivian, C. Meadows, W. Duncan, R. Paul, N. Barrett, R. Batra, J. Edgeworth, J. Whitehorn, G. Nebbia</span>
</p>

<p class="sessionid">O0017</p><span class="title">Evaluation of the diagnostic efficacy of targeted next- generation sequencing in the detection of pathogens in bronchoalveolar lavage fluid from patients with lower respiratory tract infections in ICU 
<span>B. Ran* (Taiyuan, China), Y. Liu, X. Wu, X. Lin, X. Li, Q. Zhan, C. Wang, L. Huang, T. Zhai, Y. Cai, Y. Song, Q. Zhang, C. Zhang, J. Hao, L. Jin, Z. Huang</span>
</p>

<p class="sessionid">O0018</p><span class="title">Prognostic and diagnostic value of Next-generation sequencing in female reproductive tract infection and HPV persistence 
<span>C. Peng* (Shiyan, China), S. Qi, C. Jiachang, P. Chunyan, W. Taiquan, X. Xianru, Y. Jianying, Y. Qirong, Z. Pengyuan, L. Jun</span>
</p>

<p class="sessionid">O0019</p><span class="title">A promising approach to rapid, non-culture diagnosis of invasive fungal infections (IFIs) by targeted next- generation sequencing (tNGS) 
<span>M.H. Nguyen* (Pittsburgh, United States), H. Badrane, B.A. Stevens,
 S. Cheng, G. Guigon, E. Santiago, M. Rambaud, B. Hao, E. Driscoll, W. Maynard, C. Clancy</span></p><p>

<p class="sessionid">O0020</p><span class="title"><span class="presenters"></span>
</p><p>S. Mercier-Delarue, A. Senhaji, A.L. Munier, F. Caméléna, J. Le Goff, M. Salmona <br/></p><p> 

</p><p> 



<p class="sessionid">SY035</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 12<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Barriers to TB/HIV elimination in low- and high-incidence settings</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Daria Podlekareva (Copenhagen, Denmark)</p></td></tr>
<tr><td>

<p class="sessionid">S0101</p></p></td><td><p class="start">08:30</p></td><td><p class="title">HIV and TB epidemic: the storm hasn’t subsided yet <span> </span>Tetiana Koval (Poltava, Ukraine)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0102</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Approaches for latent and active TB screening in</p></td></tr></table><table>
<tr><td></td><td></td><td><p>people living with HIV <span> </span>Raimonda Matulionyte (Vilnius, Lithuania)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0103</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Integration of HIV and TB care to improve patient outcome in resource-limited settings </p><span class="presenter">Akaki Abutidze (Tbilisi, Georgia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0104</p></p></td><td><p class="start">10:00</p></td><td><p class="title">How researchers can influence policy and practice in HIV/TB care </p><span class="presenter">Jens D. Lundgren (Copenhagen, Denmark)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), Euroguidelines in Central and Eastern Europe Network Group <br/></p><p> 

</p><p> 



<p class="sessionid">EW041</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 13<span> </span>
</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">RSV infections: diagnosis, surveillance and treatment in the advent of vaccines</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Monika Redlberger-Fritz (Vienna, Austria)</p></td></tr>
<tr><td>

<p class="sessionid">W0126</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Costs of RSV infection, compared to other respiratory viruses <span> </span>Barbara Rath (Besançon, France)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0127</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Virology and host interactions of RSV</p></td></tr>
<tr><td>

<p class="sessionid">W0128</p></p></td><td><p class="start">09:10</p></td><td><p class="title">RSV surveillance in the EU/EEA in the vaccine era </p><span class="presenter">Eeva Broberg (Solna, Sweden)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0129</p></p></td><td><p class="start">09:30</p></td><td><p class="title">RSV fusion inhibitors and monoclonals: current status and future developments </p><span class="presenter">Peter Openshaw (London, United Kingdom)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), International Society for Influenza and other Respiratory Viruses (ISIRV) <br/></p><p> 

</p><p> 



<p class="sessionid">EW042</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 14<span> </span>
</p><p>Educational Session</p><p> 
<span> Traumatic wound infections: diagnosis and treatment options</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0130</p>   08:30   Multidrug-resistant infections after trauma in warzone 
<span>Shehan Hettiaratchy (Hampton, United Kingdom)</span>
</p><p>

<p class="sessionid">W0131</p><span class="start">08:50</span><span class="title">Fungal  infections during natural disasters 
<span>Anuradha Chowdhary (New Delhi, India)</span>
</p><p>

<p class="sessionid">W0132</p><span class="start">09:10</span><span class="title">Bacteriophage  therapy for multidrug-resistant wound infections in trauma 
<span>Tristan Ferry (Lyon, France)</span>
</p><p>

<p class="sessionid">W0133</p><span class="start">09:30</span><span class="title">Infection  of burn wounds 
<span>Nur Benzonana (Istanbul,</span>
</p><p>Türkiye)</p><p>Co-organised with: ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR), ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA), SEIMC (Sociedad Española Enfermedades Infecciosas Microbiología Clinica), International Society of Antimicrobial Chemotherapy (ISAC) <br/></p><p> 

</p><p> 



<p class="sessionid">SY037</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 16<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Unveiling the challenges: nosocomial infections in ECMO-supported patients</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0109</p><span class="start">08:30</span><span class="title">Source  of infection and pathogens 
<span>Christian Eckmann
 (Hannover, Germany)</span></p><p>

<p class="sessionid">S0110</p><span class="start">09:00</span><span class="title">Prophylaxis  and empiric treatment 
<span>Giacomo Grasselli
 (Besana In Brianza, Italy)</span></p><p>

<p class="sessionid">S0111</p><span class="start">09:30</span><span class="title">Diagnostic  criteria and definitions 
<span>Graeme Maclaren
 (Singapore, Singapore)</span></p><p>

<p class="sessionid">S0112</p><span class="start">10:00</span><span class="title">Microbial  films 
<span>Marta Hernández-Meneses (Barcelona, Spain)</span>
</p><p>Co-organised with: European Extracorporeal Life Support Organization (EuroELSO)</p><p>ESCMID Global 2025 - Programme <br/></p><p> 

</p><p> 



<p class="sessionid">EW039</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 2</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title"> 
<span> Are  urinary  tract  infections  still  the  same?</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Suzanne Geerlings (Amsterdam, Netherlands) Agnes Maria Sonnevend (Pécs, Hungary)</p></td></tr>
<tr><td>

<p class="sessionid">W0118</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Update on paediatric UTI  <span> </span>Michael Buettcher (Luzern, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0119</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Diagnosis and treatment of UTI in the era of antimicrobial resistance </p><span class="presenter">Jennifer Kranz (Aachen, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0120</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Can UTI be prevented? </p><span class="presenter">Chris Harding (Newcastle Upon Tyne, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0121</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Fungal and parasitic infections of the urinary tract </p><span class="presenter">Gladys Mbwanji (Mwanza, Tanzania, United republic of)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EW040</p></p></td><td><p>08:30  
<span>-</span>
10:30</p></td><td><p>Hall 3</p></td></tr>
<tr><td></td><td><p> 

</p><p>Educational Session</p></td><td></td></tr>
<tr><td><p> 
<span> OPAT:   from   aged   wine   to   new   vintage</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Birgit Koch (Rotterdam, Netherlands) Sonia Luque (Barcelona, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">W0122</p></p></td><td><p class="start">08:30</p></td><td><p class="title">OPAT: principles, practice and checklists <span> </span>Charlotte Quintens (Leuven, Belgium)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0123</p></p></td><td><p class="start">08:50</p></td><td><p class="title">COPAT: complex outpatient parenteral antimicrobial therapy  </p><span class="presenter">Ronald Andrew Seaton (Glasgow, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0124</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Antimicrobial stability and other challenges for OPAT practice?  </p><span class="presenter">Mark Gilchrist (London, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0125</p></p></td><td><p class="start">09:30</p></td><td><p class="title">New OPAT safety and efficacy data to guide practice </p><span class="presenter">Matthew Rawlins (Murdoch, Australia)</span>
</p></td></tr></table><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), Society of Infectious Diseases Pharmacists (SIDP) <br/></p><p> 

</p><p> 



<p class="sessionid">EW038</p></span>
<span class="start">08:30</span>-<span class="end">11:30</span><span class="location">Hall 4</span>

</p><p>Educational Session</p><p> 
<span>   EUCAST      Educational      Workshop</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Marlene Amara (Le Chesnay Cedex, France) Alasdair P. Macgowan (Bristol, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">W0113</p></p></td><td><p class="start">08:30</p></td><td><p class="title">EUCAST update <span> </span>Sören G. Gatermann (Bochum, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0114</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Setting clinical breakpoints, assessing evidence </p><span class="presenter">Anouk Edwina Muller (The Hague, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0115</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Benzylpenicillin susceptibility testing of  <span> </span>S. pneumoniae</span>
by disk diffusion <span> </span>Gunnar Kahlmeter (Tävelsås, Sweden)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0116</p></p></td><td><p class="start">09:30</p></td><td><p class="title">What to do when there are no breakpoints </p><span class="presenter">Barbara Juliane Holzknecht (Copenhagen, Denmark)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0117</p></p></td><td><p class="start">09:50</p></td><td><p class="title">Detection of resistance mechanisms </p><span class="presenter">Christian Giske (Stockholm, Sweden)</span>
</p></td></tr></table><p>Co-organised with: EUCAST Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">OS001</p></span>
<span class="start">08:30</span><span>-</span>
<span class="start">10:30</span><span class="location">Hall 5</span>

</p><p>2-hour Oral Session</p><p> 
<span>  One   Health   means   resistance   everywhere</span>
</p><p>Chairs       Alessandra Carattoli (Rome, Italy) Prasannakumar Palanikumar (Vellore, India)</p><p> 


<p class="sessionid">O0001</p></span>
Decoding the role of  
<span>bla</span>
 
<span>CPE-</span>
carrying plasmids on wings: A holistic view using the One Health approach 
<span>S.A. Martínez-Álvarez* (Logrono, Spain),</span>
</p><p class="presenter">P. Châtre, T. Cardona-Cabrera, P. François, U. Höfle, M. Zarazaga, J.Y. Madec, M. Haenni, C. Torres</p>

<p class="sessionid">O0002</p><span class="title">A novel isolation room model leveraging culture- independent Hi-C metagenomics for tracking antimicrobial resistance transmission between patients and hospital environmental reservoirs </span><span class="presenters">V. Koh* (Singapore, Singapore), R. Cabrera, J. Chua,</span>
</p><p class="presenter">J.S. Lee, N.S.B. Haidi Fitri, Z.X. Tan, X. Huan, N.M. Thevasagayam, T.K.B. Lee, K. Marimuthu, O.T. Ng</p>

<p class="sessionid">O0003</p><span class="title">Deciphering the pathogenic potentials and epidemiological identities of  </span><span class="presenters">Staphylococcus pseudintermedius</span>
colonizing companion dogs in Sao Paulo 
<span>I.B. Moses* (Sao Paulo, Brazil), L. Sartori,</span>
</p><p class="presenter">D.A. Henriques, M.M. Marini, F.M. Lima, R.X. Espinosa, I. Orlandino Da Silva, F.F. Santos, L. Gonzaga, A.T. Ribeiro De Vasconcelos, A.C. Gales</p>

<p class="sessionid">O0004</p><span class="title">Recent progress towards integrated surveillance of antimicrobial resistance in France </span><span class="presenters">L. Collineau* (Lyon, France), S. Bareille, G. Birgand, L. Lacmago,</span>
</p><p class="presenter">B. Lange, O. Lemenand, C. Chauvin</p>

<p class="sessionid">O0005</p><span class="title">Exploring the plasmidome of 3rd generation cephalosporin-resistant Enterobacterales in wild birds: Insights into horizontal gene transfer and AMR dissemination </span><span class="presenters">B. Timmer* (Debrecen, Hungary), L. Miló, B. Koleszár, C. Freytag, Á. Lovas- Kiss, L. Laczkó, G. Kardos</span>
</p>

<p class="sessionid">O0006</p><span class="title">Emergence of mobile colistin resistance in  
<span>Klebsiella</span>
at human-animal-environment interface in Bangladesh 
<span>S. Rahman* (Oxford, United Kingdom), A. Pondit, J. Parkhill, S. Saha, S.M.R. Islam, P.I. Disha, S.A. Nasreen, M.A.K. Azad, T. Walsh, R. Farzana</span>
</p>

<p class="sessionid">O0007</p><span class="title">Unveiling the invisible: antimicrobial resistance genes and pathogenic microbial diversity in sewage of North India's largest industrial hub, A metagenomic perspective 
<span>I. Singh* (Chandigarh, India), R. Sharma, A. Arora, B. Mohan, N. Taneja</span>
</p><p>

<p class="sessionid">O0008</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0009</p><span class="title">One Health intervention impacts on antibiotic resistance in Denmark, England and Senegal: A mathematical model comparison 
<span>G. Knight* (London, United Kingdom), R. Booton, J.V. Robotham, K. Aluzaite, D. Belay, J. Guitian, M. Dione, E. Emes</span>
</p>

<p class="sessionid">O0010</p><span class="title">Clinically important sequence types and resistance genes in  
<span>Enterobacteriaceae</span>
from coastal environments and gulls 
<span>V. Silva* (Lisbon, Portugal),</span>
</p><p>M. Quintelas, M. Caniça, R. Rivière, P. Poeta, G. Igrejas <br/></p><p> 

</p><p> 



<p class="sessionid">SY032</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 7</span>

</p><p>2-hour Symposium</p><p> 
<span>  New   insights   into</span>
 
<span>Candida</span>
 
<span>pathogenesis</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Aleksandra Barac (Belgrade, Serbia) Joshua Nosanchuk (Bronx, United States)</p></td></tr>
<tr><td>

<p class="sessionid">S0089</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Insights into the evolution of  <span> </span>Candida</span>
under antifungal pressure <span> </span>Attila Gacser (Szeged, Hungary)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0090</p></p></td><td><p class="start">09:00</p></td><td><p class="title">How do  <span> </span>Candida</span>
extracellular vesicles modify virulence during disease? <span> </span>Leonardo Nimrichter (Rio De Janeiro, Brazil)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0091</p></p></td><td><p class="start">09:30</p></td><td><p class="title">The commensal to pathogen transition: kind to killer </p><span class="presenter">Ilse D. Jacobsen (Jena, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0092</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Fungal-bacterial interactions: who wins? </p><span class="presenter">Rebecca Hall (Canterbury, United Kingdom)</span>
</p></td></tr></table><p> 

</p><p>ESCMID Global 2025 - Programme</p><p> 



<p class="sessionid">SY033</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 8</span>

</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Single-cell approaches to dissect cellular phenotypic heterogeneity of bacterial pathogen populations.</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Christian Stephan Lentz (Tromsø, Norway) Annelies Zinkernagel (Zurich, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">S0093</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Adaptive evolution and phenotypic heterogeneity of bacterial pathogens during infections <span> </span>Christoph Ernst (Cologne, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0094</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Single-cell imaging and heterogeneity in antimicrobial resistance </p><span class="presenter">Stefano Pagliara (Exeter, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0095</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Single-cell RNAseq and heterogeneity in bacterial transcription </p><span class="presenter">Anna Kuchina (Seattle, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0096</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Dissecting the function of individual bacteria in their spatial context </p><span class="presenter">Knut Drescher (Basel, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">SY043</p></p></td><td><p>09:30  
<span>-</span>
10:30</p></td><td><p>Hall 1</p></td></tr>
<tr><td></td><td><p> 

</p><p>1-hour Symposium</p></td><td></td></tr>
<tr><td><p> 
<span>   Year     in     infection     control</span>
</p></td></tr></table><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Nico Tom Mutters (Bonn, Germany) Ermira Tartari (Msida, Malta)</p></td></tr>
<tr><td>

<p class="sessionid">S0134</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Andrew James Stewardson (Melbourne, Victoria, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">S0135</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Kalisvar Marimuthu (Singapore, Singapore)</p></td></tr>
<tr><td>

<p class="sessionid">EF005</p></p></td><td><p>09:30  
<span>-</span>
10:30</p></td><td><p>Arena 2</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><p> 

</p><p> 
<span>  It's     all     in     the     blood
 Chair      Colin R. Mackenzie (Neuss, Germany) <br/></span></p><p>

<p class="sessionid">E0039</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0040</p><span class="title">Unnecessary clinical interventions due to blood culture contamination in a large Canadian hospital network 
<span>C. Hall* (Hamilton, Canada), C. Fuller, S. Ramondino, C. Main</span>
</p>

<p class="sessionid">E0041</p><span class="title">Utility of sigmoidal growth curve when no organisms are seen on Gram stain in positive blood cultures 
<span>D. Crilly* (London, United Kingdom), A. Bapat, J. Youngs, G. Maloney, E. Drakes</span>
</p>

<p class="sessionid">E0042</p><span class="title">Clinical microbiology laboratory consultancy to optimize blood culture workflow: Analysis of results 
<span>C. Magri* (Rome, Italy), C. Magrì, G. Menchinelli, D. Squitieri, B. Fiori, M. Cacaci, B. Posteraro, G. De Angelis, M. Sanguinetti</span>
</p><p>

<p class="sessionid">E0043</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0044</p><span class="title">Predicting blood culture positivity using machine learning with complete blood and differential counts in a tertiary care hospital of Turkiye 
<span>Ö. Türkmen Recen* (Izmir, Türkiye), M. Kıplapınar, H. Özdemir, S. Kurutepe, H. Gazi</span>
</p>

<p class="sessionid">E0045</p><span class="title">Performance of direct pathogen and -lactamase detection workflow using MALDI-TOF MS from positive blood culture specimens 
<span>K. Kosai* (Nagasaki, Japan), Y. Kawamoto, K. Yanagihara</span>
</p>

<p class="sessionid">E0046</p><span class="title">Waiting for follow-up blood cultures is not always necessary for diagnosis of central line-associated bloodstream infections 
<span>L. Van Balen* (Maastricht, Netherlands), R. Koeck</span>
</p>

<p class="sessionid">E0047</p><span class="title">Economic and health gains associated with the adoption of the 2-hour phenotypic antimicrobial susceptibility testing in patients with bloodstream infection in Europe 
<span>C. Pina-Vaz* (Oporto, Portugal), F. Aragão, C. Palos, C. Mimoso, I. Neves, M.J. Janeiro,</span>
</p><p>J.A. Paiva <br/></p><p> 

</p><p> 



<p class="sessionid">EF006</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Emerging  developments  in  antifungal  pharmacology</span>
</p><p class="presenter">Chair       Roger Brüggemann (Nijmegen, Netherlands) <br/></p>

<p class="sessionid">E0048</p><span class="title">NATURE-US: the natural history of antifungal failure in invasive candidiasis </span><span class="presenters">L. Ostrosky-Zeichner* (Houston, United States), P.G. Pappas, M.H. Miceli,
 A. Spec, C.Z. Grimes, F. Lewis, M. Mammadova, E. McKie, M. Middle, M. Kordalewska, D.S. Perlin, D.P. Kontoyiannis, O.A. Cornely, J. Vazquez, D. Angulo</span></p><p>

<p class="sessionid">E0049</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0050</p><span class="title">Enhancing Isavuconazole Pharmacokinetics: A Comprehensive Population (PPK) Model from Three Phase 3 Trials and Covariate Exploration 
<span>A. Desai* (Northbrook, United States), L. Kovanda</span>
</p>

<p class="sessionid">E0051</p><span class="title">Identification of efflux inhibitors for  
<span>Candida albicans</span>
through a drug repurposing strategy 
<span>D. Marques* (Lisbon, Portugal), S. Santos Costa, L. Rodrigues</span>
</p>

<p class="sessionid">E0052</p><span class="title">Clinical outcomes of micafungin 100 mg vs. 150 mg daily for the treatment of  
<span>Candida auris</span>
fungemia 
<span>J. Hou* (Chicago, Il, United States), Y. Wang, R. Burgos, L. Danziger, E. Drwiega</span>
</p>

<p class="sessionid">E0053</p><span class="title">Resolution of clinical signs in adults with invasive candidiasis and/or candidaemia treated with rezafungin or caspofungin: ReSTORE and STRIVE trial pooled analysis 
<span>G.R. Thompson* (Davis, California, United States), A. Soriano, M. Bassetti,</span>
</p><p class="presenter">P.M. Honore, J. Vazquez, S. Dickerson, O.A. Cornely</p>

<p class="sessionid">E0054</p><span class="title">Ibrexafungerp is effective in treatment of patients with candidiasis, including candidaemia, caused by  </span><span class="presenters">Candida auris</span>
: a multicentre, open-label study (CARES) 
<span>M.H. Miceli* (Ann Arbor, United States),</span>
</p><p class="presenter">T.F. Patterson, D. Juneja, G.R. Thompson Ill, P. Vergidis, A. Spec, T.J. Walsh, D. Angulo, J. Breedt,</p><p class="presenter">N. Yaddanapudi, R.S. Siebert, E. McKie, F. Lewis, M. Middle, M. Hoenigl</p>

<p class="sessionid">E0055</p><span class="title">High-dose isavuconazole therapy is well-tolerated and significantly improves survival in a fruit fly model of invasive mucormycosis </span><span class="presenters">S. Wurster* (Houston, United States), N.D. Albert, N.P. Wiederhold, R.E. Lewis, D.P. Kontoyiannis</span>
</p>

<p class="sessionid">E0056</p></p>Pharmacokinetics, pharmacodynamics, safety, and efficacy of innovative dosing schedules of liposomal amphotericin B for treatment of experimental invasive pulmonary aspergillosis in persistently neutropenic rabbits 
<span>R. Petraitiene* (New York, United States), E. Naing, A. Garcia, V. Zigmantaite,</span>
</p><p>R. Grigaleviciute, A. Pockevicius, M. Zimmerman,</p><p>A.H. Groll, T.J. Walsh, V. Petraitis <br/></p><p> 

</p><p> 



<p class="sessionid">FO050</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 1<span> </span>
</p><p>Open Forum</p><p> 
<span>  HIV:    a    global    ethical    Conundrum</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Seif Al-Abri (Muscat, Oman)</p></td></tr>
<tr><td>

<p class="sessionid">F0147</p></p></td><td><p class="start">11:00</p></td><td><p class="title">HIV, from key population to general population: a Pandora's Box <span> </span>Syed Faisal Mahmood (Karachi, Pakistan)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">F0148</p></p></td><td><p class="start">11:10</p></td><td><p class="title">Ethical considerations in preventing mother-to-child HIV transmission  </p><span class="presenter">Glory Alexander (Bangalore, India)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">F0149</p></p></td><td><p class="start">11:20</p></td><td><p class="title">HIV drug trials in Africa: ethical concerns </p><span class="presenter">Shah Reena</span>
</p></td></tr></table><table>
<tr><td></td><td><p>(Nairobi, Kenya)</p></td></tr>
<tr><td>

<p class="sessionid">F0150</p></p></td><td><p class="start">11:30</p></td><td><p class="title">HIV-related stigma and discrimination in the healthcare setting </p><span class="presenter">Teymur Noori (Stockholm, Sweden)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Ethics Advisory Committee (EEAC) <br/></p><p> 

</p><p> 



<p class="sessionid">EF014</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Infection  control  and  prevention  around  the  World</span>
</p><p>Chair      Divyashree Shanthamurthy (Mumbai, India) <br/></p>


<p class="sessionid">E0092</p><span class="title">WHO Global Survey on Infection Prevention and Control Minimum Requirements: Laying the Foundation for 2030 Global Targets 
<span>P. Bischoff* (Geneva, Switzerland), S. Tomczyk, G. Satta, E. Tartari, A. Meinen, P. Rogers, L. Cihambanya, C.R. Ana Paula, I. Hewedy, Z. Li, P. Ramon-Pardo, A. Singh,</span>
</p><p class="presenter">B. Allegranzi</p>

<p class="sessionid">E0093</p><span class="title">Healthcare-associated infections in african intensive care units: A muliticentre prospective cohort study </span><span class="presenters">B. Gaye* (Dakar, Senegal), N. Madani, J. Ben Khlil, A. Ben Souissi, B. Seydina Alouine, G.F. Otiobanda, R.M. Hamidi, M.S. Chaibou, P.A. Leye, L. Oualili, T. Dendane, K. Abidi, M. Bouaziz, R. Ammar, M. Elombila, W. Naija, M. Kahloul, R. Herch, R. Toumi, E. Ennouri, M. Boussarsar, N. Ben Mrad, A. Soumare,</span>
</p><p class="presenter">T.M. Diop, N. Brahmi, A. Ben Jazia, H. Ben Ghezala,</p><p>A.A. Messadi, H. Fredj, A. Mokline, S. Abdellatif, T. Badis, L. Messaoud, A. Bouzid, S. Feki, H. Cheikhrouhou, A. Hachimi, B. Khemlich, F.Y. Bah, A.B. Faye, L. Ouanes Besbes, Z. Hammouda, M.S. Mebazaa, S. Elatrous, S. Ayed, W. Sellami, A. Ben Amri, M. Ferjani, O. Bouhamed, N. Hajjem, H. Daddy,</p><p>M. Gagara Mayaou, B. Marou Soumana, B. Diallo, B. Gafsi, F. Ben Salem, E. Milli, B. Idali, T. Merhabene, N. Ben Slimane, F. Kaaniche Medhioub, R. Allala, C. Kaddour, N. Baffoun, R. Hammami, H. Allouche, H. Ghadhoune, S. Soui, H. Hmouda, R. Ben Dabebiss, A. Sidibe, N. Diani, N. Benmouhoub, M.S. Ado Zakari, O. Mamane Nassirou, O. Bachar Loukoumi, A. Ben Fraj,</p><p>H. Jaoua, K. Ben Fadhl, T. Abdoulaye, T. Bagouma, H. Arfaoui, O. Kaabachi, O. Nasri, C. Ben Massoud, M. Niandou, M. Nanzir Sanoussi, H. Bassama, A. Jebri, H. Ben Fradj, A. Hafyene, N. Soraa, O. Kechini, A. Felhi,</p><p class="presenter">R. Abouqal, Y. Coulibaly</p>

<p class="sessionid">E0094</p><span class="title">Epidemiology of community-acquired versus</p><p>hospital-acquired sepsis in acute hospitals in Ireland - 2016-2022. </span><span class="presenters">E. Liddy* (Dublin, Ireland), A. Vellinga, D. Amin</span>
</p>

<p class="sessionid">E0095</p><span class="title">Epidemiology of Central Line-Associated Bloodstream Infections (CLABSIs) in a Network of Ten Hospitals across Greece: A 30-Month Surveillance Study – GRIPP-SNF Network 
<span>I. Kopsidas* (Neo Psychiko, Greece), E. Kourkouni, G.C. Tsopela,</span>
</p><p class="presenter">D. Kousi, A. Moutou, P. Varda, P. Pantelidou, A. Karaiiskou, D. Kaitelidou, T. Zaoutis, A. Koutsoukou</p>

<p class="sessionid">E0096</p><span class="title">Characterisation of plasmids disseminating antibiotic resistance in  </span><span class="presenters">Klebsiella pneumoniae</span>
isolates from Pretoria, South Africa 
<span>T. Govender* (Pretoria, South Africa), A. Moultrie, M. Moodley, J. Featherston, M. Mohlamonyane, J. Pitout, T. Hamiwe, T. Lentswe, S. Liknaitzky, K. Salvador-Oke, A. Smith, I. Arshad, M. Said, M. Ehlers, M. Kock</span>
</p>

<p class="sessionid">E0097</p><span class="title">Transmission dynamics of carbapenemase- producing bacteria between hospital and household settings in Benin 
<span>K. Sintondji* (Abomey-Calavi, Benin),</span>
</p><p class="presenter">V. Dougnon, B. Legba, B.G. Hougbenou, K. Fabiyi, H. Koudokpon, A. Dalsgaard, Y.M.G. Hounmanou</p>

<p class="sessionid">E0098</p><span class="title">Evaluating the impact of a rapid screening test for carbapenem-resistant organisms in Brazilian intensive care units. </span><span class="presenters">M. Salomão* (Sao Paulo Sp, Brazil), B. De Almeida Lessa Castro, C. Loredana P. A.</span>
</p><p class="presenter">M. Bezerra, E. Lino Dos Santos Junior, C. Lee Luna Fernandes, A. Pereira Funari, S. Bollinger, F. C. Lessa,</p><p class="presenter">G. Mahon, M. Westercamp, M. Chiarastelli Salomao</p>

<p class="sessionid">E0099</p><span class="title">Genomic Insights into the Rapid Rise of  </span><span class="presenters">Pseudomonas aeruginosa</span>


<p class="sessionid">ST463</p>: A High-Risk Clone's Adaptive Strategy in China 
<span>X. Dong*</span>
</p>

<p class="sessionid">E0100</p><span class="title">Nanopore long-read only genome assembly for public health surveillance of Enterobacterales bloodstream infections and plasmid epidemiology in England: A pilot study 
<span>D. Nagy* (Oxford, United Kingdom), N. Stoesser, S. Lipworth, V. Pennetta, G. Rodger, K. Hopkins, C. Jones, T. Neksus Study Group, S. Hopkins, D. Crook, A.S. Walker, J. Robotham, K.L. Hopkins, A. Ledda, D. Williams, R. Hope, C.S. Brown</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF015</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Advances in the diagnosis and treatment of skin, bone, and joint infections</span>
</p><p class="presenter">Chair       Norma Jung (Köln, Germany) <br/></p>

<p class="sessionid">E0101</p><span class="title">Potential benefits of PET-CT in the management of bone and joint infections in infective endocarditis: a retrospective analysis from the Mayo Clinic </span><span class="presenters">F. Petri* (Milan, Italy), F. Borgonovo, O.K. Mahmoud, R. Igwilo-Alaneme, T. Matsuo, S. El Zein, D. De Simone,</span>
</p><p class="presenter">A. Gori, E. Berbari</p>

<p class="sessionid">E0102</p><span class="title">Synovial fluid microRNA biomarkers enable accurate diagnosis of periprosthetic joint infection </span><span class="presenters">B.J.H. Frank* (Vienna, Austria), T. Krammer, J. Pfeiffer-Vogel, T. Nguyen, A. Diendorfer, M. Hackl, J. Hofstaetter</span>
</p><p>

<p class="sessionid">E0103</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0104</p><span class="title">Comparison of microbiology, management and outcome between patients with native and with post-surgical vertebral osteomyelitis: a 7-year retrospective study 
<span>G. Franceschi* (Modena, Italy),</span>
</p><p class="presenter">M. Pellegrino, M. Del Monte, A. Bedini, L. Benassi,</p><p>A. Soffritti, A. Tili, E. Dema, M. Palmisani, A. Veroni,</p><p class="presenter">G. Pavesi, M. Cristina</p>

<p class="sessionid">E0105</p><span class="title">Cefiderocol real-life use in bone and joint infection: a retrospective French multicenter study </span><span class="presenters">A. Diarra* (Tourcoing, France), V. Delastours, A. Bleibtreu, H. Wille, N. Sayre, N. Rouzic, K. Jaffal, I. Strachinaru, B. Valentin, M. Bermejo, P. Gazeau, A. Baldolli, B. Lefevre, A. Asquier, J. Courjon, R. Larcher, L. Escaut, L. Deconinck, N. Taar, V. Dacquet, T. Ferry,</span>
</p><p class="presenter">I. Eberl, M. Degrendel, P. Patoz, P.Y. Tortai, O. Robineau, E. Senneville</p>

<p class="sessionid">E0106</p><span class="title">Real-Life Experience with Dalbavancin as Suppressive Antibiotic Treatment in orthopaedic implant-related infections. </span><span class="presenters">R. Escudero-Sánchez* (Madrid, Spain), S. De La Villa Martínez, A. Rico Nieto, M. Sanchez-Somolinos, M. Tasias Pitarch, M. Salaver Lletí, M. Correa Ballester, R. Blanez Hernández, E. Calabuig Muñoz, M. Montero Alonso,</span>
</p><p class="presenter">L. Guio Carrion, J. Gomez Junyent, M.L. Sorli, F. Braojos Sanchez, A. Muñoz Gomez, M.J. Nuñez Oranto, E. Baos Muñoz, R. Manzano Lorenzo, J. Perez-Somarribas Moreno, J.M. Barbero Allende,</p><p class="presenter">M.J. Garcia Pais, F.J. Martínez Marco, A. Galeote Rivas, B. De La Torre Escuredo, J. Cobo</p>

<p class="sessionid">E0107</p><span class="title">Short or Long Antibiotic Regimes in Orthopaedics: the SOLARIO multicentre randomised controlled trial </span><span class="presenters">M. Dudareva* (Oxford, United Kingdom), M. Scarborough, M. Mcnally, M. Kumin, C. Scarborough, W. Vach, J. Ferguson</span>
</p>

<p class="sessionid">E0108</p><span class="title">Clinical and Antibacterial Diversity of  
<span>Staphylococcal</span>
Phenotypes in Skin and Soft Tissue Infections: A Resource-Limited Country Perspective. 
<span>F. Zeeshan* (Karachi, Pakistan), A. Naeem, F. Uddin</span>
</p>

<p class="sessionid">E0109</p><span class="title">Discrepancy between clinical-radiological diagnosis and surgical confirmation in 62 patients undergoing fasciotomy for suspected necrotizing fasciitis: a 11- year retrospective study. 
<span>F. Romani* (Modena, Italy), A. Bedini, A. Spadoni, G. Manzini, G. Franceschi, B. Fontana, M. Sarti, C. Mussini</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF016</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Rising  threats:  antimicrobial  resistance  in  STIs</span>
</p><p class="presenter">Chair       Marcos Rust (Feldkirch, Austria) <br/></p>

<p class="sessionid">E0110</p><span class="title">Important rise of antibiotic resistance of  </span><span class="presenters">Mycoplasma genitalium</span>
, a sexually transmitted pathogen, in a French University hospital 
<span>F. Doucet Populaire* (Clamart, France), W. Ben Nejma, C. Benet, M. Grimaldi, I. Kansau, S. Pozzi-Gaudin, C. Guillet-Caruba, N. Bourgeois-Nicolaos</span>
</p>

<p class="sessionid">E0111</p><span class="title">Molecular characterization of antimicrobial resistance and genotyping of  
<span>Mycoplasma genitalium</span>
positive samples of the Lisbon area, Portugal 
<span>M. Barros* (Lisbon, Portugal), F. Pereira, L. Rodrigues</span>
</p>

<p class="sessionid">E0112</p><span class="title">Antimicrobial Resistance in Mycoplasma genitalium: Surveillance and Management in São Paulo, Brazil 
<span>V. Passarelli* (São Paulo, Brazil), F. Goldemberg, A. Freitas, C. Picone, C. Lazari, G. Carnevale, M. Thomazella, S. Chamarelli, D. Gennari, C. Pedrozo, G. Hughes, S. Costa</span>
</p>

<p class="sessionid">E0113</p><span class="title">Impact of genotypic substitutions on treatment failure for  
<span>Mycoplasma genitalium</span>
infection 
<span>N.B. Bana* (Milan, Italy), A. Nava, D. Fanti, C. Vismara, G. Cavazza, E. Di Gennaro, F. Peracchi, L. Rezzonico, A. Mulè, L. Denti, M. Puoti, R. Rossotti</span>
</p>

<p class="sessionid">E0114</p></p>Macrolide-resistant  
<span>Mycoplasma genitalium</span>
: an emerging threat to public health? 
<span>J. Ciscar Soriano* (València, Spain), J. Ciscar-Soriano, M.D. Gómez- Ruiz, A. Valentín-Martín, A. Hernández-Cabezas,</span>
</p><p class="presenter">J.L. Lopez-Hontangas</p>

<p class="sessionid">E0115</p><span class="title">Comparison of carbapenem MIC in wild-type, MDR and XDR  </span><span class="presenters">Neisseria gonorrhoeae</span>
isolates 
<span>J. Brousseau* (Paris, France), A. Braille, M. Mainardis,</span>
</p><p class="presenter">F. Meunier, M. Mérimèche, F. Caméléna, B. Berçot</p>

<p class="sessionid">E0116</p><span class="title">Unsettling surge in antimicrobial resistance patterns of  </span><span class="presenters">Neisseria gonorrhoeae</span>
- A study from national reference centre in India. 
<span>D. Sharma* (Delhi, India), S. Muralidhar, N. Joshi</span>
</p>

<p class="sessionid">E0117</p><span class="title">Surveillance of  
<span>Neisseria gonorrhoeae</span>
antimicrobial resistance rate and treatment regimes in Singapore from 2014 to 2024 
<span>M. Giovanni* (Singapore, Singapore), A.L. Tan, B.K.W. Yeo, M.T.W. Chio, S.S. Goh, S.T. Koh, Y.E. Tan</span>
</p>

<p class="sessionid">E0118</p><span class="title">Molecular surveillance results of  
<span>N. gonorrhoeae</span>
in Korea 
<span>K.H. Roh* (Goyang, Korea, Republic of), C. Liu, Y.H. Suh, H. Lee, K. Lee</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">KN044</p></span>
<span class="start">11:00</span><span>-</span>
12:00 </span><span class="location">Hall 1</span>

</p><p>Keynote Lecture</p><p> 
<span>  Asia:    an    AMR    Hot    Zone</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0136</p>  11:00    
<span>David L. Paterson (Singapore, Singapore)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS010</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 10<span> </span>
</p><p>1-hour Case Session</p><p> 
<span>  Antimicrobial     drugs     in     action</span>
</p><p class="presenters"></p>

<p class="sessionid">O0072</p></p>
<span>In vivo</span>
cefiderocol resistance due to  
<span>cirA</span>
modification during treatment 
<span>E. Carretto* (Reggio Emilia, Italy), P. Pini, R. Farzana, C. Bedogni, R. Marrollo, P. Nardini,</span>
</p><p class="presenter">M. Bardaro, N.C. Facciolongo, S. Mezzadri, T. Walsh</p>

<p class="sessionid">O0073</p><span class="title">Long-term outcomes in dalbavancin-treated patients with vascular graft infection. </span><span class="presenters">A. Specklin* (Reims,</span>
</p>

<p class="sessionid">O0074</p></p>Aztreonam, ceftazidime/avibactam, and tigecycline combination for the management of multi-drug resistant  
<span>E.coli</span>
on peritonitis in a pediatric liver transplant recipient 
<span>R. Morales Junior* (Cincinnati, United States), V. Juodinis, C. Donini, J. Sampaio</span>
</p><p>

<p class="sessionid">O0075</p><span class="title"><span class="presenters"></span>
– a case series 
<span>M. Karolyi* (Vienna, Austria), D. Stahl, E. Pawelka, S. Omid, A. Kuran, M. Naegeli, A. Zoufaly, C. Well, S. Fischoeder,</span>
</p><p class="presenter">M. Ortler, C. Wenisch</p>

<p class="sessionid">O0076</p><span class="title">Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant  </span><span class="presenters">K. pneumoniae</span>
shunt-related ventriculitis: two case reports. 
<span>G. Giuliano* (Siena, Italy), M. Sambo, P. Castellani, S. Benedetti, F. Tarantino, M. Tumbarello</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY047</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 11<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> How long should contact isolation precautions be continued?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0141</p><span class="start">11:00</span><span class="title">Contact  isolation in patients with MDR organisms:</p><p>Why, when, where? 
<span>Gabriel Birgand (Nantes, France)</span>
</p><p>

<p class="sessionid">S0142</p><span class="start">11:30</span><span class="title">Is  discontinuation of contact precautions associated with an increase in infections? 
<span>Daniel Diekema (Harpswell, United States)</span>
</p><p>Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering Committee, Multidisciplinary Joint Committee Infection Control UEMS <br/></p><p> 

</p><p> 



<p class="sessionid">ME048</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 12<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> Cut  a  long  story  short:  choosing  NGS  platforms</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0143</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Etienne Ruppe (Paris, France)</p></td></tr>
<tr><td>

<p class="sessionid">M0144</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Stefan Green (Chicago, United States)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS011</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 13<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Around the lab in 80 ways: a journey through innovative therapeutics</span>
</p><p class="presenters"></p>


<p class="sessionid">O0077</p><span class="title">In vivo expression of an mRNA encoded multi- mechanistic mAb combination against Staphylococcus aureus and protection in a disease model 
<span>C. Tkaczyk* (Gaithersburg, United States), N. Michael, P. Mun Mun, T. George, S. Martin, G. Adam,</span>
</p><p class="presenter">M. Andal, D. Julie, S. Oleg, B. Elin, Y. Haitao, E. Mark,</p><p class="presenter">L. Ashley, D. Antonio, S. Bret</p>

<p class="sessionid">O0078</p><span class="title">Hijacking intrinsic resistance in Mycobacterium abscessus </span><span class="presenters">G. Phelps* (Memphis, United States), S. Kurt, A. Jenner, S. Anderson, T. Jayasinghe, E. Griffith, C. Thompson, L. Yang, B. Wicki, F. Bright, L. Boeck, V. Loudon, R. Lee, A. Wright, W. Wright, O. Grant-Chapman, J. Ochoado, D. Conner, B. Troyer, A. Iverson, J.W. Rosch, B. Schulthess, P. Geeleher, S. Hobbie, B. Meibohm, A. Obregon-Henao, P. Sander,
 R. Lee</span></p><p>

<p class="sessionid">O0079</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0080</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0081</p><span class="title">Identification of compounds capable of removing established bacterial biofilms 
<span>T. Inzana* (Brookville, United States), A. Gates, W. Weng, J. Cusumano, Y.J. Lee, N. Vogelaar</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">ME049</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 14<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> How  to  perform  clinical  trials  in  mycoses?</span>
 <br/></p><p>

<p class="sessionid">M0145</p>  11:00    
<span>Monica Slavin (Melbourne, Australia)</span>


<p class="sessionid">M0146</p>  11:12    
<span>Nkechi Azie (Barrington, United States)</span>
Co-organised with: ESCMID Fungal Infection Study Group (EFISG) <br/></p><p> 

</p><p> 



<p class="sessionid">OS012</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 15<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Climate Impact and One Health Approaches Against Infectious Diseases
 Chair      Chadia Wannous (Paris, France) <br/></span></p><p>

<p class="sessionid">O0082</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0083</p><span class="title">Effects of climate change on Aedes aegypti abundance and dengue transmission 
<span>L. Geng* (Singapore, Singapore)</span>
</p>

<p class="sessionid">O0084</p><span class="title">Impact of climate variables on Crimean-Congo hemorrhagic fever in Iran, Iraq, Kazakhstan, and Russia 
<span>M. Fereidouni* (Jahrom, Iran, Islamic Republic of), D. Bisanzio, I. Lizinfeld, N. Pshenichnaya, G. Abuova, M.R. Shirzadi, H. Abdulghafoor Khaleel, R. Alhilfi, M. Keshtkar-Jahromi</span>
</p>

<p class="sessionid">O0085</p><span class="title">Successful public health and one health response to a high pathogenicity avian influenza outbreak in poultry farms in Victoria, Australia: implications for future planning 
<span>E. Athan* (Geelong, Australia), A. Hussain, K. Blaney, L. Cardamone, N. Clarke, M. Hayes, M. Muleme, B. Mcnamara, E. Jalil, S. Holwill, C.K. Lim, H. O'brien, E. Layton, A. Fidao, S. Salmon, R. Kinnear</span>
</p>

<p class="sessionid">O0086</p><span class="title">Turning disease surveillance into reality: Using metagenomic sequencing with piggery wastewater 
<span>M. Muralidhar* (St Lucia, Australia), L. Omaleki, M.N. Naseem, J.R.B. Mesa, C. Turni</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS013</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 16<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>  Viral   challenges   in   organ   transplantation</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0087</p><span class="title"><span class="presenters">
 L.M. Allende, E. Paz-Artal, A. Andrés, F. López- Medrano, J.M. Aguado, I. Rodríguez-Góncer</span></p><p>

<p class="sessionid">O0088</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0089</p></p>Real-world administration of maribavir beyond the eight weeks established in the clinical trial 
<span>D.</span>
</p><p class="presenter">Martínez-Simón* (Barcelona, Spain), C. Ribera-Puig,</p><p class="presenter">M. Bodro, D. Campany, J. Esperalba, I. Los Arcos, P. Clèries-Rovira, A. Padullés, N. Sabé Fernández, M. Tuset, O. Len</p>

<p class="sessionid">O0090</p><span class="title">Prediction of BK Polyomavirus nephropathy in kidney transplantation by measuring neutralizing responses in a large cohort of donor and recipients </span><span class="presenters">M. Solis* (Strasbourg, France), W. Fardi, I. Benotmane, F. Gallais, S. Caillard, S. Fafi-Kremer</span>
</p><p>

<p class="sessionid">O0091</p><span class="title"><span class="presenters"></span>
</p><p>G. Werber <br/></p><p> 

</p><p> 



<p class="sessionid">SY045</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 2</span>

</p><p>1-hour Symposium</p><p> 
<span>  What   happens   following   TB   infection?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0137</p>   11:00   Post-TB disease: burden and treatment strategies 
<span>Deborah Chong (London, United Kingdom)</span>
</p><p>

<p class="sessionid">S0138</p><span class="start">11:30</span><span class="title">TB  sequelae and fungal infection 
<span>Helmut Salzer (Linz,</span>
</p><p>Austria)</p><p>Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), CPAnet <br/></p><p> 

</p><p> 

<span>YIA</span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 3</span>

</p><p>Awards</p><p> 
<span>  Young    Investigator    Award    Session</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">A001</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Deciphering the pathogenic traits and epidemiological identities of  <span> </span>Staphylococcus</span>
</p><p>pseudintermedius 
<span>: an emerging and underestimated</span>
</p></td></tr>
<tr><td></td><td></td><td><p>zoonotic pathogen <span> </span>Ikechukwu Benjamin Moses (Abakaliki, Nigeria)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">A002</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Drugs for Vector-borne Infections: Facts and Fibrillations </p><span class="presenter">Xin Hui Chan (Oxford, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">A003</p></p></td><td><p class="start">11:24</p></td><td><p class="title">Duke criteria for the diagnosis of infective endocarditis in clinical practice: are we there yet?  </p><span class="presenter">Matthaios Papadimitriou Olivgeris (Sion, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">A004</p></p></td><td><p class="start">11:36</p></td><td><p class="title">Finding a place for observational studies in infectious diseases research </p><span class="presenter">Anthony Bai (Kingston, Canada)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">A005</p></p></td><td><p class="start">11:48</p></td><td><p class="title">Clearing fungal fog in viral storms: deciphering influenza- and COVID-19-associated pulmonary aspergillosis </p><span class="presenter">Simon Feys (Leuven, Belgium)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY046</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 5</span>

</p><p>1-hour Symposium</p><p> 
<span>  New   frontiers   in   bacterial   pathogenesis</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Silvio Daniel Brugger (Zurich, Switzerland) Abdou Hachani (Melbourne, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">S0139</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Bacterial infections and cellular immunity <span> </span>Charlotte Odendall (London, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0140</p></p></td><td><p class="start">11:20</p></td><td><p class="title">Immuno-metabolism in bacterial diseases </p><span class="presenter">Tania Wong (New York, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">OS007</p></p></td><td><p>11:00  
<span>-</span>
12:00</p></td><td><p>Hall 6</p></td></tr>
<tr><td></td><td><p>1-hour Oral Session</p></td><td></td></tr></table><p> 

</p><p> 
<span> New developements in prophylaxis and treatment of COVID-19</span>
</p><p class="presenter">Chairs       Gülsen Özkaya Sahin (Lund, Sweden) Snjezana Zidovec Lepej (Zagreb, Croatia)</p>

<p class="sessionid">O0057</p><span class="title">Ensitrelvir for the prevention of COVID-19 among household contacts: key subgroup analyses of a randomized, double-blinded, placebo controlled post-exposure prophylaxis study, SCORPIO-PEP </span><span class="presenters">F. Hayden* (Virginia, United States), N. Ohmagari,</span>
</p><p class="presenter">T.W. Clark, M. Shinkai, A.F. Luetkemeyer, P. Sax,</p><p>W.P. Hanage, K.A. Gebo, H. Ikematsu, K. Izumikawa,</p><p class="presenter">C.C. Butler, A. Fukushi, S. Kezbor, H. Sakaguchi, S. Lacey, G. Ichihashi, T. Uehara</p>

<p class="sessionid">O0058</p><span class="title">Efficacy of nirmatrelvir/ritonavir on overall COVID- 19 related symptoms in immunocompromised adult participants from the EPIC-IC trial </span><span class="presenters">R. Mokgokong* (Tadworth, United Kingdom), P. Cislo, E. Tudone, E. Weinstein, J.C. Cappelleri</span>
</p><p>

<p class="sessionid">O0059</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0060</p></p>
<span>Efficacy and safety of sotrovimab vs oral antivirals in omicron waves: a retrospective analysisC. Cacace* (Napoli, Italy), A. Russo, M. Pisaturo, P. Grimaldi, F. Ambrisi, G. Granata, F.G. Numis, N. Coppola</span>
</p>

<p class="sessionid">O0061</p><span class="title">Pharmacokinetics and immunogenicity of <p class="sessionid" style="background-color: red;">AZD7442</p> (Tixagevimab/Cilgavimab) in hospitalised COVID-19 patients: results from the DisCoVeRy trial 
<span>C. Massonnaud* (Paris, France), M. Hites, N. Peiffer- Smadja, T.H.L. Han, G. Carcelain, F. Mentré, F. Ader</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS008</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 7</span>

</p><p>1-hour Oral Session</p><p> 
<span> Advancing Malaria Research: From Molecular Insights to Clinical Challenges</span>
</p><p class="presenter">Chairs      Kamruddin Ahmed (Kota Kinabalu, Malaysia) Giri Shan Rajahram (Kota Kinabalu, Malaysia) <br/></p>

<p class="sessionid">O0062</p><span class="title">Influence of second blood meals on  </span><span class="presenters">Plasmodium vivax</span>
development and infectivity in mosquitoes 
<span>S. Bantuchai* (Bangkok, Thailand), W. Nguitragool, J. Sattabongkot, C. Kumpitak</span>
</p>

<p class="sessionid">O0064</p><span class="title">Severe imported  
<span>Plasmodium falciparum</span>
malaria with hyperparasitaemia: evaluation of predictors for critical disease 
<span>T. Lingscheid* (Berlin, Germany), J. Jochum, P. Tober-Lau, J. Schöllgen, T. Zoller, L.E. Sander, M. Ramharter, F. Kurth</span>
</p>

<p class="sessionid">O0065</p><span class="title">The current status of  
<span>Plasmodium falciparum</span>
chloroquine resistance transporter gene (

<p class="sessionid">K76</p>T) and  
<span>Plasmodium falciparum</span>
multi-drug resistance gene 1 (

<p class="sessionid">N86</p>Y) in Cameroon 
<span>M. Fru* (Buea, Cameroon)</span>
</p>

<p class="sessionid">O0066</p><span class="title">SOFA score vs WHO severity criteria to guide antimalarial treatment - 10 years of imported malaria cases in a UK tertiary centre reviewed. 
<span>E. Savory* (Cambridge, United Kingdom), M. Routledge, B. Warne, E. Moore, D. Sparkes</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS009</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 8</span>

</p><p>1-hour Case Session</p><p> 
<span>   Osteoarticular      uninvited      guests</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0067</p><span class="title"><span class="presenters"></span>
in Croatia 
<span>N. Krajcar* (Zagreb, Croatia), L. Stemberger Marić, M. Vrdoljak Pažur, S. Roglić, R. Beck, G. Tešović</span>
</p><p>

<p class="sessionid">O0068</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">S. Chamorro Tojeiro, D. Gayoso Cantero, F. Norman,</p><p>B. Monge Maillo, C. Crespillo-Andújar, M.D.</p><p class="presenter">Corbacho-Loarte, S. De La Fuente-Herranz, J. Cobo Soriano, J. Urbano, M. Martín Martín, J.A. Pérez- Molina</p>

<p class="sessionid">O0069</p><span class="title">Two cases of septic osteoarthritis of  </span><span class="presenters">Cutibacterium acnes</span>
detected by 16S rRNA gene sequencing in immunocompetent adolescents 
<span>H. Okuno* (Osaka, Japan), K. Shiota, K. Amo</span>
</p>

<p class="sessionid">O0070</p><span class="title">A UK case of Melioidosis with osteomyelitis two years after geographical exposure 
<span>C. Darlow* (Liverpool, United Kingdom), L. Swithenbank, R. Taggart, V. Owen, N. Wong, S. Woolley, W.D. Harrison, L. Ratcliffe, J. Lewis</span>
</p><p>

<p class="sessionid">O0071</p><span class="title"><span class="presenters"></span>
complex infection with Mixed Osteoblastic and Osteolytic Lesions and Lymphadenopathy in Anti-IFN- Immunodeficiency Syndrome 
<span>N. Hiranburana* (Bangkok, Thailand), S. Khahakaew, K. Meesilpavikkai, M. Satja, G. Suwanpimolkul</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">LB001</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 9</span>
</p><p>1-hour Oral Session</p><p> 
<span> Advances in vaccine effectiveness for viral respiratory infections</span>
</p><p>Chair      Jean Paul Stahl (Corenc, France) <br/></p>


<p class="sessionid">L0001</p><span class="title">Immunogenicity of JN.1- and KP.2-encoding mRNA COVID-19 vaccines against JN.1 SARS-CoV-2 sublineages in adult participants 
<span>A. Figueroa* (Cambridge, United States), D. Edwards, K. Johnson,</span>
</p><p class="presenter">D. Motefiori, B. Girard, S. Hack, X. Cao, E. De Windt</p>

<p class="sessionid">L0002</p><span class="title">JN.1-adapted vaccine effectiveness against COVID-19 hospitalisation in Europe: a test-negative case-control study using id.DRIVE </span><span class="presenters">H.R. Volkman* (New York, United States), L. De Munter, J.L. Nguyen, T.M.P. Tran, C. Marques, E. Mesfun-Kap, L. Choi, L. Drikite,</span>
</p><p class="presenter">S. Valluri, J.V. Hernandez-Villena, J. Yang, I. Casas, E. Martro, B. Gruner, G. Icardi, A. Mira-Iglesias, C.M. Oñoro López, O. Pares-Badell, A. Orrico-Sanchez, S. Otero-Romero, A. Riva, A. Torres, F. Martinon Torres,</p><p class="presenter">L. Jodar, J.M. Mclaughlin, K. Bollaerts</p>

<p class="sessionid">L0003</p><span class="title">Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among adults ≥65 years of age in the United States </span><span class="presenters">A. Miles* (New York, United States),</span>
</p><p class="presenter">J.T. Vietri, S. Rosenstock, H. Li, J. Vojicic, L.R. Grant,</p><p class="presenter">A. Randall, B.D. Gessner, P. Balmer, A. Cane, P. Peyrani</p>

<p class="sessionid">L0004</p><span class="title">Safety and immunogenicity of the MERS vaccine, <p class="sessionid" style="background-color: red;">ChAdOx1</p> MERS, in older adults with and without prior <p class="sessionid" style="background-color: red;">ChAdOx1</p> exposure </span><span class="presenters">D. Jenkin* (Oxford, United Kingdom), E. Sheehan, R. Huq, T. Lambe, S. Gilbert,</span>
</p><p class="presenter">A.M. Collins, M.N. Ramasamy, A. Mujati, R. Kenneil,</p><p>N. Marchevsky, I. Haeusler, E. Vannaxay, N. Ebrahimi,</p><p class="presenter">S. Batawi, F. Cappuccini, R. White, L.S. Ortega, O. Mazur, H.T. Belhadef, B. Stoilova, D. Pulido-Gomez, H. Zhang, K. Conlin, M. Voysey, A. Hyder-Wright, L. Mclellan, O. Hamilton, V. Simpson, J. Court, N. Murphy, M. Farrar, P. Saunderson</p>

<p class="sessionid">L0005</p><span class="title">Vaccination in pregnancy with RSVpreF elicits IgG, IgA and total secretory antibody responses in milk of lactating individuals </span><span class="presenters">J. Atwell* (New York, United States), R. Powell, X. Yang, C. Decarlo, A. Fox, R. Fan,</span>
</p><p>S. Uppal, J. Deese, M. Vichnin, E. Gonzalez, B. Gessner <br/></p><p> 

</p><p> 



<p class="sessionid">SY051</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 1</span>

</p><p>1-hour Symposium</p><p> 
<span>   Year     in     infectious     diseases</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Nur Benzonana (Istanbul, Türkiye) Evelina Tacconelli (Verona, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">S0151</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Yoav Keynan (Winnipeg, Canada)</p></td></tr>
<tr><td>

<p class="sessionid">S0152</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Elisa Cordero Matia (Seville, Spain)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY053</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 16<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Developing guidelines with AI tools: are they ready for prime time?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0155</p><span class="start">13:30</span><span class="title">The  PROs and CONs of using AI tools for developing guidelines 
<span>Holger Schuenemann (Milano, Italy)</span>
</p><p>

<p class="sessionid">S0156</p><span class="start">14:00</span><span class="title">AI  in action: validated tools for speeding up your systematic reviews and how to use them 
<span>Sara Fernandez (Oslo, Norway)</span>
</p><p>Co-organised with: ESCMID Guidelines Subcommittee <br/></p><p> 

</p><p> 



<p class="sessionid">SY052</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 2</span>

</p><p>1-hour Symposium</p><p> 
<span> Exploring   children's   role   in   infection   spread</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0153</p><span class="start">13:30</span><span class="title">Are  children really super-spreaders of respiratory</p><p>viruses? 
<span>Emmanuel André (Leuven, Belgium)</span>
</p><p>

<p class="sessionid">S0154</p><span class="start">14:00</span><span class="title">Should  schools be closed at the start of the next</p><p>pandemic? 
<span>Vittoria Colizza (Paris, France)</span>
</p><p>Co-organised with: European Society of Paedriatic Infectious Diseases (ESPID) <br/></p><p> 

</p><p> 



<p class="sessionid">EF021</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Infections in hemato-oncological hosts: from bacterial to viral</span>
</p><p class="presenter">Chair       Genovefa Papanicolaou (New York, United States) <br/></p>

<p class="sessionid">E0139</p><span class="title">Vancomycin-resistant  </span><span class="presenters">Enterococcus faecium</span>
bloodstream infection in patients with hematological malignancy and stem cell transplant: a case-control study 
<span>J. Fung* (Vancouver, Canada),</span>
</p><p class="presenter">K. Aldhaheri, C. Nishi, J. Lau, A. Mah, A. Wright, R. Stubbins, M. Charles, S. Belga</p>

<p class="sessionid">E0140</p><span class="title">Bacteremia secondary to urinary tract infection in oncology patients: risk factors and impact of multidrug-resistant Gram-negative bacilli. </span><span class="presenters">I. Grafia* (Barcelona, Spain), A. Moll, S.J. Santillá, C. Rodrigo,</span>
</p><p class="presenter">E. Lillo, M. Garcia De Herreros, N. López, A. Soriano,</p><p class="presenter">M. Espasa, D. Marco, S. Fernández, J. Marco- Hernández, C. Zamora, J. Padrosa, L. Llavata, M. Viladot, A. Tuca, P. Puerta-Alcalde</p>

<p class="sessionid">E0141</p><span class="title">Rectal carriage of multidrug-resistant organisms and subsequent bloodstream infections in hematologic patients undergoing hematopoietic stem cell transplantation or chimeric antigen receptor T-cell therapy </span><span class="presenters">C. Charalampidis* (Athens, Greece), I. Konstantellos, P. Kazakou, K. Gkirkas, I. Lazana, C. Chatzidimitriou, A. Zormpa, E. Mastrostamati, I. Grigoropoulos, D. Kavatha, S. Tsiodras, P. Tsirigotis, K. Thomas</span>
</p>

<p class="sessionid">E0143</p><span class="title">The RUSTIC Study: Respiratory Virus Infection in a Contemporary Longitudinal Cohort of Patients with Haematological Malignancy 
<span>B. Teh* (Melbourne, Australia), V.G. Hall, A. Liu, K.Y. Yong, Z. Andrews,</span>
</p><p class="presenter">P. Kinsella, N. Laundy, J. Wolfe, L. Cooley, M.K. Yong, M.A. Slavin</p>

<p class="sessionid">E0144</p><span class="title">Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity </span><span class="presenters">P. Bono* (Milan, Italy), A. Parisi, E. Tagliaferri, R. Ungaro, G. Saporiti,</span>
</p><p class="presenter">F. Cavallaro, G. Bozzi, M.C. Goldaniga, G. Galli, N. Hejazifar, C. Biassoni, G. Giacomel, A. Valzano, M.R. Sciumè, N. Fracchiolla, A. Bandera, F. Passamonti,</p><p class="presenter">A. Callegaro, C. Alteri</p>

<p class="sessionid">E0145</p><span class="title">Safety and tolerability of SYN-004 in allogeneic hematopoietic cell transplant (HCT) recipients receiving meropenem (MER) or piperacillin/tazobactam (P/T) </span><span class="presenters">E. Dubberke* (Saint Louis, United States), M. Schroeder, H. Sappington,</span>
</p><p class="presenter">G. Lampen, K. Reske, T. Hink, V. Joachimstaler, E. Jeremy, M. Keller, A. Bristol, C. Le, S. Connelly, M. Moenk, V. Wacher, M. Kaleko, J. Kuti, M. Olsen</p>

<p class="sessionid">E0146</p><span class="title">Standardized gastrointestinal cytomegalovirus (CMV) tissue quantitative-nucleic-acid testing (QNAT) compared to immunohistochemistry in allogeneic hematopoietic cell transplant (HCT) recipients </span><span class="presenters">S. De Aragón De La Cruz* (Basel, Switzerland), C.S. Walti, N. Khanna, K. Leuzinger,</span>
</p><p class="presenter">J.P. Halter, H.H. Hirsch, K. Nägele, J. Passweg, J. Vosbeck</p>

<p class="sessionid">E0147</p><span class="title">Real-life experience with maribavir for the treatment of cytomegalovirus infection in hematological patients. </span><span class="presenters">J. Boan Perez* (Madrid, Spain), J.M. Sánchez-Pina, C. Aizpurúa, I. Rodríguez-Goncer, F. López-Medrano, R. San-Juan,</span>
</p><p>M. Fernández-Ruiz, E. Aparicio, M. Lizasoaín, J.M. Caro-Teller, J. Martínez, M. Calbacho, J.M. Aguado <br/></p><p> 

</p><p> 



<p class="sessionid">EF022</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Syndromic  testing  is  still  coming  of  age</span>
</p><p class="presenter">Chair      Tommaso Giani (Florence, Italy) <br/></p>

<p class="sessionid">E0148</p><span class="title">Bacterial infections of the central nervous system: addressing the diagnostic gap in non- community- acquired meningitis </span><span class="presenters">G. Menchinelli* (Rome, Italy), M. Cacaci, D. Squitieri, B. Fiori, T. D'inzeo, G. De Angelis,</span>
</p><p class="presenter">B. Posteraro, M. Sanguinetti</p>

<p class="sessionid">E0149</p><span class="title">Epidemiological surveillance of central nervous system infections through a rapid syndromic testing platform </span><span class="presenters">M. Rey* (Barcelona, Spain), L. Pau, C. Miravet, A. Molins, G. Hansen, M. Juanola-Falgarona</span>
</p>

<p class="sessionid">E0150</p><span class="title">Impact of Syndromic Panel Implementation on Meningitis/Encephalitis Diagnosis, Antimicrobial Use, Costs, and Hospital Stay in a Regional Australian Hospital 
<span>S. Subedi* (Brisbane, Australia), P. Harris, D. Paterson</span>
</p>

<p class="sessionid">E0151</p><span class="title">Performance evaluation of the NxTAG® GPP Panel for the detection of gastrointestinal pathogens by comparison with current routine methods in Nantes University Hospital. 
<span>S. Gibaud* (Nantes, France), L. Castain, S. Hartuis, C. Hervochon, B.M. Imbert, P. Lepape, S. Corvec</span>
</p>

<p class="sessionid">E0152</p><span class="title">Correct discrimination of Monkeypox virus clades by fast syndromic testing 
<span>S. Reister* (Hilden, Germany),</span>
</p><p class="presenter">L. Peñarrubia, M. Juanola-Falgarona, G. Pueyo, S. Jiménez-Guzmán, R. Diaz-Hernández, E. Padilla- Cámara, J. Michel, A. Puyskens, F. Van Deursen, D. Lueerssen</p>

<p class="sessionid">E0153</p><span class="title">Managing a  </span><span class="presenters">Mycoplasma pneumoniae</span>
Outbreak: Impact of Syndromic Panels on Antimicrobial Prescriptions in Pediatric Emergencies 
<span>L. Brusca* (Barcelona, Spain), L. Brusca-Vidao, M. Pallarés- Borrás, G. Santillana-Cernuda, M. Ballestero-Tellez,</span>
</p><p class="presenter">A. Boronat, J. Perez</p>

<p class="sessionid">E0154</p><span class="title">Performance of BIOFIRE® FILMARRAY® Pneumonia plus in general population, solid organ transplant recipients and patients with hematologic malignancies – Interim analysis </span><span class="presenters">R. Riccardi* (Bologna, Italy), M. Rinaldi, G. Ceccarelli, C. Campoli, C. Tondi,</span>
</p><p class="presenter">M. Casarini, B. Miani, G. Nigrisoli, S. Ambretti, P. Viale, M. Giannella</p>

<p class="sessionid">E0155</p><span class="title">Impact of the molecular rapid diagnostic panel testing in adjustment of antimicrobial therapy in febrile neutropenic patients with bacteremia </span><span class="presenters">S. Chantharasut* (Bangkok, Thailand), M. Chayakulkeeree, W. Kamolvit, A. Jitmuang, I. Thaipisuttikul</span>
</p>

<p class="sessionid">E0156</p></p>BacteREVEAL: Analytical performance and contribution of BioFire® <p class="sessionid" style="background-color: red;">BCID2</p> and Vitek®</p><p>REVEAL 
<span>TM</span>
 in intensive care patients with Gram- negative bloodstream infections 
<span>C. Roger* (Nimes, France), L. Oudiane, M. Benyahia, F. Salipante, A.</span>
</p><p>Dubois, L. Muller, J.P. Lavigne, A. Pantel <br/></p><p> 

</p><p> 



<p class="sessionid">EF023</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Effective  microbiology  for  the  management  of  sepsis
 Chair       Maurizio Sanguinetti (Rome, Italy) <br/></span></p><p>

<p class="sessionid">E0157</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">T. Neksus Study Group, S. Hopkins, D. Crook, A.S. Walker, J. Robotham, K.L. Hopkins, A. Ledda, D. Williams, R. Hope, C.S. Brown</p>

<p class="sessionid">E0158</p><span class="title">Investigating seasonality of antibiotic resistance associated with  </span><span class="presenters">E. coli</span>
and  
<span>Klebsiella pneumoniae</span>
bloodstream infections 
<span>S. Lipworth* (Oxford, United Kingdom), L. Gorman, A. Dowsey, K. Pouwels, K. Sanderson, C. Beck, R. Hope, C. Brown, K. Turner</span>
</p>

<p class="sessionid">E0159</p><span class="title">Sensitivity of a host-protein test for microbiologically confirmed bacterial infections 
<span>R. Navon* (Tirat Carmel, Israel), E. Reiner, O. Shaham, A. Neuberger,
 S. Shiber, S. Halabi, A. Epstein, T. Zalut, S. Motov, T.P. Aufderheide</span></p><p>

<p class="sessionid">E0160</p><span class="title"><span class="presenters"></span>
from gut colonisation and bloodstream infections reveal novel genetic associations 
<span>M. Hetland* (Stavanger, Norway), K.L. Wyres, H.B. Cooper, A. Correia, M.A. Winkler, A. Fostervold, N. Raffelsberger,</span>
</p><p class="presenter">A. Sundsfjord, Ø. Samuelsen, K.E. Holt, I.H. Löhr</p>

<p class="sessionid">E0161</p><span class="title">Conventional microbiology vs. conventional microbiology + nucleic acid-based multiplex real-time polymerase chain reaction (MPCR) test kit in septic shock: results of a matched cohort study </span><span class="presenters">G. Sanlidag Isbilen* (Izmir, Türkiye), G. Şanlıdağ İşbi̇len, B. Akkul,</span>
</p><p class="presenter">C. Tol, D. Akyol Seyhan, H. Sipahi, Ş. Aydemir, F. Çilli,</p><p class="presenter">B. Arda, O.R. Sipahi</p>

<p class="sessionid">E0162</p><span class="title">Contribution of  </span><span class="presenters">Escherichia coli</span>
microbiological factors to the presentation as sepsis/septic shock in patients with bacteraemia: a matched case-control study 
<span>N. Maldonado* (Seville, Spain), I. López- Hernández, L.E. López-Cortes, P.M. Martínez Pérez- Crespo, A. García-Montaner, M. Alcade-Rico, A. Sousa-Dominguez, A. Jover-Sáenz, J. Goikoetxea, Á. Pulido-Navazo, C. Labayru Echeverría, A.I. Aller- García, L. Boix-Palop, A. Del Arco-Jiménez, A. Smithson-Amat, J.M. Sánchez-Calvo, C. Natera- Kindelán, J.M. Reguera Iglesias, C. Armiñanzas- Castillo, F. Galán-Sánchez, A. Bahamonde, I. Gea- Lázaro, J. Fernández-Suárez, I. Pérez-Camacho, T. Marrodán-Ciordia, B. Becerril-Carral, Á. Pascual- Hernández, J. Rodríguez-Baño</span>
</p><p>

<p class="sessionid">E0163</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0164</p></p>Community-onset bloodstream infection among people with opioid use disorders: A twenty-year population-based cohort study in Queensland, Australia. 
<span>K. Laupland* (Herston, Australia), A. Stewart, F. Edwards, P. Harris, S. Coulter</span>
</p><p>

<p class="sessionid">E0165</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF024</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> A  never-ending  evolution  of  antimicrobial  resistance</span>
</p><p class="presenter">Chair      Antonio Oliver (Palma De Mallorca, Spain)</p>

<p class="sessionid">E0166</p><span class="title">Gfa, a novel integron-born fosfomycin resistance mechanism </span><span class="presenters">N. Kieffer* (Madrid, Spain), L. Ortiz- Miravalles, A. Hipolito, J.A. Escudero</span>
</p>

<p class="sessionid">E0167</p><span class="title">Regulons of RamA, RarA and SoxS mediated tigecycline resistance and oxidative stress among  
<span>in vitro</span>
tigecycline resistant evolution trajectory of  
<span>Klebsiella pneumoniae</span>
. 
<span>X. Wang* (Beijing, China), J. Kuai, Y. Zhao</span>
</p>

<p class="sessionid">E0168</p><span class="title">Assessing the impact of altered penicillin binding proteins on susceptibility to novel antimicrobials among clinical isolates of carbapenemase-producing Escherichia col 
<span>C. Tellapragada* (Stockholm, Sweden), P. Jonsson, C. Giske</span>
</p>

<p class="sessionid">E0170</p></p>
<span>Enterococcus faecalis</span>
penicillin-binding protein-4 sequence differences based on penicillin minimum inhibitory concentration 
<span>O. Funk* (Brooklyn, United States), A. Kozlenkov, C. Toro Chacon, J. Azzouzi, S. Brown, J. Cusumano</span>
</p>

<p class="sessionid">E0171</p><span class="title">Uncommon genomic rearrangements drive vancomycin resistance in  
<span>vanB</span>
-positive  
<span>Enterococcus faeciumK. Xanthopoulou* (Cologne, Germany), J. Mellüh, R. Arazo Del Pino, L. Casselmann, V. Persy, T. Burgwinkel, E. Gieraths, L. Maus, A. Klimka, P.G. Higgins</span>
</p>

<p class="sessionid">E0172</p><span class="title">Heteroresistance in  
<span>Enterococcus faecalis</span>
: prevalence and mechanistic insights across clinically relevant antibiotics 
<span>S. Heidarian* (Uppsala, Sweden),
 S. Lohsen, A. Guliaev, K. Hjort, S. Satola, D. I. Andersson</span></p><p>

<p class="sessionid">E0173</p><span class="title"><span class="presenters"></span>
mutations in  
<span>Staphylococcus aureusM. Roch* (Geneva, Switzerland), R. Sierra, C. Colomer Winter, F. Bezrukov, O. Panasenko, A. Guisolon, U. Von Ah, M. Villanueva, P. Redder, K. Kline, J. Prados, W.L. Kelley</span>
</p>

<p class="sessionid">E0174</p><span class="title">Novel continuous experimental evolution methodology revealing rapid resistance development and cross-resistance 
<span>T. Echelmeyer* (Greifswald, Germany), M. Ellmann, S.E. Heiden, M. Schwabe, H. Fickenscher, G. Maschkowitz, D. Nurjadi, R. Podschun, K. Schaufler, E. Eger</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS018</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 11<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Battling the Spore:</span>
 
<span>C. difficile</span>
 
<span>epidemiology and management</span>
</p><p class="presenter">Chairs      Nicolas Benech (Lyon, France) Fidelma Fitzpatrick (Dublin, Ireland) <br/></p>

<p class="sessionid">O0124</p><span class="title">Molecular epidemiology and antimicrobial resistome of Clostridioides difficile from private and public healthcare settings in three provinces in South Africa </span><span class="presenters">H. Shirinda* (Pretoria, South Africa), A.M. Smith, B. Prinsloo, M. Kock, M. Moodley, M. Said, M. Ehlers</span>
</p>

<p class="sessionid">O0125</p><span class="title">Screening for  
<span>Clostridioides difficile</span>
colonization at admission and during hospitalization 
<span>N. Khanafer* (Lyon, France), S. Bennia, G. Martin-Gaujard, L. Juillard, T. Rimmelé, L. Argaud, P. Cassier, O. Martin,</span>
</p><p class="presenter">P. Vanhems</p>

<p class="sessionid">O0126</p><span class="title">Revolutionizing CDI treatment: Are shorter antibiotic regimens the future </span><span class="presenters">M. Duricek* (Prague, Czech Republic), J. Benes, K. Halmova</span>
</p>

<p class="sessionid">O0127</p></p>Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of  
<span>Clostridioides difficile</span>
infection 
<span>E. Rubio-Martín* (Seville, Spain), R. Escudero-Sánchez, Á. Gutiérrez Liarte, A. Ibañez Zurriaga, C. Saez Bejar, B. Díaz Pollán, C. Marcelo Calvo, G. Ruiz Carrasco, G. Pérez Caballero, A.M. Rodríguez Benavente, S. De La Villa,</span>
</p><p class="presenter">J.D. Ruiz-Mesa, L.F. Caballero Martínez, I. Márquez Gómez, E. Calabuig, M. Tasias, R. Blanes, M.Á. López Zúñiga, J. Rodríguez Granger, P. Merino Amador, A. Salinas, D. Rodríguez-Pardo, M. Villamarín Merlo, G. Maestro De La Calle, J. Mateo Flores, J.B. Pérez Gilaberte, R.M. Martínez Álvarez, F. Martínez García,</p><p>N. Cobos-Trigueros, J. Llenas-García, M. Solivella- Rodríguez, L. Ramos Merino, B. Castelo López, M.M.</p><p>Montero, D. Echeverría-Esnal, J. López-Contreras, P. Duch Llorach, M.R. Oltra-Sempere, C. Pinto-Pla, Í. Pineda, J.L. Del Pozo, J. Rodríguez-Baño, A. Halperin,</p><p class="presenter">A. Muriel García, S. Moreno Guillén, J. Cobo</p>

<p class="sessionid">O0128</p><span class="title">Gut phageome profiling in  </span><span class="presenters">Clostridioides difficile</span>
infection and faecal microbiota transplantation 
<span>C. Chen* (Lausanne, Switzerland), T. Pillonel, J. Schaer,</span>
</p><p>G. Greub, G. Resch, B. Guery, C. Bertelli, T. Galpérine <br/></p><p> 

</p><p> 



<p class="sessionid">OS019</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 12<span> </span>
</p><p>1-hour Oral Session <br/></p><div><p>Microbiome Dynamics and Health: From Pathogenesis to Therapeutic Potential</p></div><p><p class="presenters"></p>


<p class="sessionid">O0129</p></p>Multi-omics integrated analysis revealed the key role of Fusobacterium periodonticum in colorectal tumorigenesis by decanoic acid promoting neutrophil chemotaxis. 
<span>X. Chu* (Beijing, China), Q. Yang</span>
</p>

<p class="sessionid">O0130</p><span class="title">Exploring the respiratory microbiome in COPD patients: The role of  
<span>Haemophilus</span>
spp. in disease pathogenesis 
<span>P. Camps-Massa* (Barcelona, Spain), L. Saiz-Escobedo, J. Guerrero, E. Cuevas, D. Guevara- Nuñez, F. Tubau, J. Burgos, M. Lopez, A. González- Díaz, C. Ardanuy, M. Dominguez, S. Santos, S. Martí</span>
</p>

<p class="sessionid">O0131</p><span class="title">Using the in vitro MiGut system to simulate the ulcerative colitis microbiome and post-antibiotic recovery supported by a pre-defined consortium of microbes 
<span>I. Moura* (Leeds, United Kingdom), W. Davis Birch, N. Beauchemin, M. Vulic, K. Bentley, P. Culmer, M. Mayol, C. Ford, M. Henn, E. Halvorsen, M. Wilcox, N. Kapur, A. Buckley</span>
</p><p>

<p class="sessionid">O0132</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0133</p><span class="title">Colonization resistance of the intestinal microbiota to multidrug-resistant bacteria? 
<span>K. Villageois-Tran* (Bobigny, France), C. Emavivie, H. Skerdi, E.N. Saad,</span>
</p><p>M. Julie, E. Ruppé <br/></p><p> 

</p><p> 



<p class="sessionid">ME055</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 14<span> </span>
</p><p>Meet-the-Expert <br/></p><div><p>Long acting injectables to treat and prevent infections: an example from HIV field</p></div><p><table>
<tr><td>

<p class="sessionid">M0159</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Monica Gandhi (Salt Lake City, United States)</p></td></tr>
<tr><td>

<p class="sessionid">M0160</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Pedro Cahn (Buenos Aires, Argentina)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS020</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 15<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>  How    to    evaluate    AMS    programs</span>
</p><p class="presenters"></p>


<p class="sessionid">O0134</p></p>Preference-based instrumental variables for estimating the causal effects of antibiotic prescribing decisions in common infections: Assessing potential validity using CPRD data 
<span>N. Nguyen* (Oxford, United Kingdom), K. Pouwels, J.V. Robotham, S. Yu, S. Wordsworth</span>
</p>

<p class="sessionid">O0135</p><span class="title">Novel antibiotic spectrum metrics to quantify the impact of antimicrobial stewardship: a multicentre study 
<span>B. Moshy* (London, United Kingdom), R. Llewellyn, R. Lester, G. Pollara, T. Samuels, J. Sarah,</span>
</p><p class="presenter">B. Gemma, I. Balakrishnan</p>

<p class="sessionid">O0136</p><span class="title">Utilizing a weighted-incidence syndromic antibiogram to evaluate antimicrobial therapies and resistance trends in community-acquired infections in a community teaching hospital </span><span class="presenters">V. Huang* (Glendale, United States), T. Pham, A. Vogler, H. Chhen, C. Vandenberg</span>
</p>

<p class="sessionid">O0137</p><span class="title">Capturing days of therapy per days of service as a stewardship tool to identify outliers in prescribing broad-spectrum antimicrobials in the hospital setting 
<span>A. Hopkins* (Livingston, United States), A. Farkas, S. Tamirisa, G. Severance, A. Yassin, E. Jaime</span>
</p><p>

<p class="sessionid">O0138</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">ME054</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 3</span>

</p><p>Meet-the-Expert <br/></p><div><p>How antimicrobial tolerance impacts polymicrobial biofilm-associated infections</p></div><p><table>
<tr><td>

<p class="sessionid">M0157</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Hans Steenackers (Leuven, Belgium)</p></td></tr>
<tr><td>

<p class="sessionid">M0158</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Brian Conlon (Chapel Hill, United States)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS017</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 5</span>

</p><p>1-hour Case Session</p><p> 
<span>       Bad              bacteria</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0119</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0120</p></p>Whipple's disease: one of medicine's great imitators 
<span>S. Kesavan* (Nottingham, United Kingdom),
 F. Heard, S. Kesevan, E. Hart, V. Fleming, C. Santos,</p><p>R. Thomson</span></p><p>

<p class="sessionid">O0121</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0122</p><span class="title">A clinical case of  
<span>Legionella longbeachae</span>
pneumonia featuring unique epidemiological features in a major italian hospital 
<span>S. Guerriero* (Rome, Italy), M. La Sorda, F. De Maio, S. Cardinali, M. Di Donato, P. Del Vecchio, C. Tarli, M. Fantoni, R. Murri, M. Sanguinetti,</span>
</p><p>C. Torti</p>

<p class="sessionid">O0123</p></p>
<span>Francisella tularensis</span>
– First autochthonous case in the UK 
<span>G. Vanstone* (Truro, United Kingdom), A. Belfield, L. Vincent, V. Perks, D. Wadham, B. Marques Silva, A. Evans, O. Lloyd, N.C. Gordon, C. Arumugam,</span>
</p><p>A. Ainarozidou <br/></p><p> 

</p><p> 



<p class="sessionid">ME061</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 3</span>

</p><p>Meet-the-Expert <br/></p><div><p>How to use large language models and machine learning for improving One Health</p></div><p><table>
<tr><td>

<p class="sessionid">M0170</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Javier Fernández (Oviedo, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">M0171</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Nicolas Radomski (Teramo, Italy)</p></td></tr></table><p>Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Epidemiological Markers (ESGEM), Portuguese Society of Microbiology (SPM) <br/></p><p> 

</p><p> 



<p class="sessionid">FO063</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 1<span> </span>
</p><p>Open Forum <br/></p><table>
<tr><td><p>Science communication in a noisy world: podcasting and social media in ID/CM</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Emily G. Mcdonald (Montreal, Canada)</p></td></tr>
<tr><td>

<p class="sessionid">F0174</p></p></td><td><p class="start">14:45</p></td><td><p class="title">The ID:IOTS guide to creating a successful CM/ID podcast&quot; <span> </span>Callum Mutch (Edinburgh, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">F0175</p></p></td><td><p class="start">14:55</p></td><td><p class="title">Using social media for CM/ID education </p><span class="presenter">Scott Jake (Oakland, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">F0176</p></p></td><td><p class="start">15:05</p></td><td><p class="title">Podcasting and social media for antimicrobial stewardship and pharmacy </p><span class="presenter">Erin Mccreary (Pittsburgh, United States)</span>
</p></td></tr></table><p>Co-organised with: CMI Communications Board of Editors <br/></p><p> 

</p><p> 



<p class="sessionid">EF029</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Vaccination   uptake-challenges   and   opportunities</span>
</p><p class="presenter">Chair      Joanne M. Langley (Halifax, Canada) <br/></p>

<p class="sessionid">E0195</p><span class="title">Electronic nudges to increase influenza vaccination uptake among patients with heart failure: insights from 3 nationwide randomized trials enrolling &gt;2 million patients </span><span class="presenters">N.D. Johansen* (Hellerup, Denmark),</span>
</p><p class="presenter">M. Vaduganathan, A.S. Bhatt, D. Modin, B.L. Claggett,</p><p class="presenter">K.H. Janstrup, C.S. Larsen, L. Larsen, L. Wiese, M. Dalager-Pedersen, E.L. Dueger, S. Samson, M.M. Loiacono, R.C. Harris, L. Køber, S.D. Solomon, P. Sivapalan, J.U.S. Jensen, T. Biering-Sørensen</p>

<p class="sessionid">E0196</p><span class="title">Psychological Predictors of  </span><span class="presenters">Influenza</span>
Vaccination Intent Among Healthcare Workers in Bulgaria 
<span>P. Velikov* (Sofia, Bulgaria), V. Rangelova, Y. Axentieva,</span>
</p><p class="presenter">Y. Tcholakov, V. Borisova-Nenov, D. Ivanov, A. Zasheva, A. Hori</p>

<p class="sessionid">E0197</p><span class="title">Determinants of COVID-19 vaccine uptake in patients with hematologic malignancies: a nationwide cohort study </span><span class="presenters">Q. Hofsink* (Amsterdam, Netherlands), T. Osmenaj, B.I. Lissenberg-Witte, S. Hahné, J. Heijmans, I.S. Nijhof, A. Goorhuis, M.D. Hazenberg,
 C.E. Rutten, S. Haggenburg, P. Den Tex, A. Dinmohamed, J. Kemmeren, H. De Melker, S. Van Den Hof</span></p><p>

<p class="sessionid">E0199</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0200</p><span class="title">Prevalence and associated factors of parental refusal rates for routine immunisation: A cross-sectional study in Peshawar, Khyber Pakhtunkhwa, Pakistan- 2024 
<span>M. Hakim* (Hayat Abad Peshawar Kp Pakistan, Pakistan)</span>
</p>

<p class="sessionid">E0201</p><span class="title">Shingles Prevalence, Vaccine Awareness, and Acceptance in People Living with HIV 
<span>D. Yaman* (Izmir, Türkiye), D. Akdağ, M. Taşbakan, H. Pullukçu,</span>
</p><p class="presenter">D. Gökengin</p>

<p class="sessionid">E0202</p><span class="title">Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden, 2018−2022 </span><span class="presenters">A. Palmborg* (Stockholm, Sweden), F. Angulo, P. Zhang, A. Pilz, J. Stark, M. Jennifer, L. Jodar</span>
</p>

<p class="sessionid">E0203</p><span class="title">Monkeypox (mpox) vaccination willingness and determinants among people living with HIV (PLWH) in turkey 
<span>C. Boşnak* (Altındağ, Türkiye), T.K. Şahin, E. Erul, M.Ç. Sönmezer, A.Ç. Inkaya, S. Ünal</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF030</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Viruses   crossing   the   blood-brain   barrier</span>
</p>

<p class="sessionid">E0204</p><span class="title">Clinical characteristics and outcome of Herpes simplex virus type 1 and varicella zoster virus encephalitis: A prospective population-based cohort study 
<span>L. Duerlund* (Aarhus, Denmark), L. Larsen, M. Storgaard, H. Mens, L. Weise, M.P.G. Jepsen, B.R. Hansen, H.R. Von Lüttichau, C.Ø. Andersen, H. Nielsen, J. Bodilsen</span>
</p>

<p class="sessionid">E0205</p><span class="title">Arbovirus associated neurological disease in adults and children in Brazil: a multicentre case-control study 
<span>S. Lant* (Liverpool, United Kingdom), R. Mehta, M.L. Brito Ferreira, C. Soares, R. Medialdea Carrera, M. Tulius, P. Brasil, C. Miguelote, A. Henriques Souza, M. Ellul, M. Griffiths, M.M. Jardim Rodrigues, R. Braga, L. Pamplona, C. Spitz, F. Militao, A. Rosala Hallas, G. Burnside, R. Vivancos,</span>
</p><p class="presenter">S. Leonhard, L. Rodrigues De Mendonça-Vieira, B. Jacobs, C. Brito, P. Sequiera, D. Brown, L. Turtle, R. Franca, A. Bispo, T. Solomon</p>

<p class="sessionid">E0206</p><span class="title">Challenges in managing Central nervous system infections: Battling the Unknown Enemy, West Nile virus vs unknown etiology </span><span class="presenters">C. Marin* (Bucharest, Romania), A. Paun, E. Nedu, S. Tetradov, S. Lazar,</span>
</p><p class="presenter">M. Nica, G. Tardei, I.A. Condurache, S.A. Florescu,</p><p class="presenter">S.M. Ruta, C.P. Popescu</p>

<p class="sessionid">E0207</p><span class="title">Spatial and temporal profiling of the immune responses induced by Japanese encephalitis virus in a mouse model </span><span class="presenters">Z. Ou* (Shenzhen, China), Z. Wang, Q. Chen, X. He, P. Ren, J. Li, G. Cheng</span>
</p><p>

<p class="sessionid">E0208</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0209</p><span class="title">B and T cell responses to Tick-borne Encephalitis Virus 
<span>N. Mayola Danes* (Stockholm, Sweden), R. Varnaitė, N. Mayola Danés, K. Blom, H.G. Ljunggren,</span>
</p><p class="presenter">S. Gredmark-Russ</p>

<p class="sessionid">E0210</p><span class="title">Enterovirus infections in pediatric central nervous system (CNS) diseases: molecular epidemiology and neuroimaging insights </span><span class="presenters">D. Sharma* (Chandigarh, India), R. Pathania, P. Bhattacharya, M. Gautam, A. Bansal, S. Vyas, A. Ghosh, K. Goyal, M. P Singh</span>
</p>

<p class="sessionid">E0211</p><span class="title">Neuroimaging findings and their correlation with autopsy findings: Prospective study on Rabies encephalitis 
<span>M. Mohata* (New Delhi, India), V. Suri,</span>
</p><p>P. Singh, G.K. Mohi, A. Bhalla, R. Mohindra, R.K. Soni, K. Gupta</p>

<p class="sessionid">E0212</p></p>
<span>Toxoplasma gondii</span>
IgG Screening and Central Nervous System Complications among People with HIV in the Combination Antiretroviral Therapy Era 
<span>T. Ou* (New Taipei City, Taiwan, China), T.Y. Tsai, S.H. Huang, T.Y. Wu, W.D. Liu, H.Y. Sun, K.Y. Lin, C.C.</span>
</p><p>Hung <br/></p><p> 

</p><p> 



<p class="sessionid">EF031</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> AMS  around  the  world:  know  your  data!</span>
</p><p class="presenter">Chair      Eoghan De Barra (Dublin, Ireland) <br/></p>

<p class="sessionid">E0213</p><span class="title">Duration of antibiotic treatment for respiratory tract infections in primary care. </span><span class="presenters">C. Llor* (Barcelona, Spain),</span>
</p><p class="presenter">M.P. Hansen, J. Lykkegaard, J.K. Olsen, B.H. Lindberg, I.K. Rebnord, R. Radzeviciene, L. Jaruseviciene, P.T. Lundgren, P. Bruno, A. Kowalczyk,</p><p class="presenter">C. Lionis</p>

<p class="sessionid">E0214</p><span class="title">Antibiotic prescribing for common acute infections in Pakistan - an analysis using IQVIA prescriber healthcare surveys </span><span class="presenters">N. Nguyen* (Oxford, United Kingdom), K. Pouwels, M. Sharland, S. Mangla, A. Cook, M. Thorn, P. Stephens</span>
</p>

<p class="sessionid">E0215</p><span class="title">Antibiotic prescribing for common acute infections in Egypt - an analysis using IQVIA prescriber healthcare surveys 
<span>N. Nguyen* (Oxford, United Kingdom), S. Mangla, A. Cook, M. Thorn, P. Stephens, K. Pouwels,</span>
</p><p class="presenter">M. Sharland</p>

<p class="sessionid">E0216</p><span class="title">Population based analysis of the impact of Japan's AMR national action plan and the COVID-19 pandemic on antimicrobial prescription </span><span class="presenters">R. Koizumi*</span>
</p><p class="presenter">(Tokyo, Japan), S. Tsuzuki, Y. Asai, K. Aoyagi, N. Ohmagari</p>

<p class="sessionid">E0217</p><span class="title">Quality of antibiotic prescribing in Portuguese hospitals: a snapshot of the first National Antimicrobial Prescribing Survey. </span><span class="presenters">C. Palos* (Lisbon, Portugal), C. Ierano, R. James, J.A. Paiva, K. Thursky,</span>
</p><p class="presenter">P. Sousa</p>

<p class="sessionid">E0218</p><span class="title">Evaluating the impact on 28-day mortality of different empiric AWaRe antibiotic treatment strategies for hospital-acquired infections across different hospital settings. </span><span class="presenters">C. Lim* (Oxford, United Kingdom), K.B. Pouwels, D. Limmathurotsakul, Q. Gu, D.E. Eyre, A.S. Walker, M. Sharland, B.S. Cooper</span>
</p>

<p class="sessionid">E0219</p><span class="title">Update on WHO's Global antibiotic use surveillance system (GLASS-AMU) 
<span>B. Huttner* (Geneva, Switzerland), A. Muller, M. Escher, V. Ivanoska, D. Tong</span>
</p>

<p class="sessionid">E0220</p><span class="title">Harmonisation trajectory of Global-Point Prevalence Survey (Global-PPS) and WHO-PPS 
<span>A. Versporten* (Antwerp, Belgium), A. Muller, M. Escher, I. Pauwels,</span>
</p><p class="presenter">D. Tong, A. Boven, V. Ivanovska, B. Huttner, E. Vlieghe</p>

<p class="sessionid">E0221</p><span class="title">Implementation of prospective audit and feedback strategy in intensive care units: Analysis of antimicrobial prescription patterns in a Guatemalan tertiary care hospital </span><span class="presenters">N. Sandoval* (Guatemala, Guatemala), G. Ozaeta, G. Reyes, K. Carrascosa</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">KN056</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture <br/></p><table>
<tr><td><p>Defending against dengue: global epidemiology and strategies for prevention and control</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Anu Kantele (Helsinki, Finland) Carlos Seas (Lima, Peru)</p></td></tr>
<tr><td>

<p class="sessionid">K0161</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Fernanda Boulos (São Paulo, Brazil)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS026</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 11<span> </span>
</p><ol id="l1"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Carbapenem resistance Gram-negatives, what's new in treatment?</span>
</p><p class="presenter">Chair       Maria Milagro Montero (Barcelona, Spain) <br/></p>

<p class="sessionid">O0180</p><span class="title">Ceftriaxone sulbactam disodium EDTA combination(CSE) as a treatment option for carbapenem resistant gram negative bacilli - to be or not to be? </span><span class="presenters">Y. Verma* (Hisar, India), K. Narang, D. Bandlish, C. Sharma</span>
</p>

<p class="sessionid">O0181</p></p>Sulbactam-durlobactam as an effective alternative option against NDM-producing  
<span>Escherichia coli</span>
including cefiderocol and aztreonam-avibactam- resistant isolates in Swizterland 
<span>C. Le Terrier* (Fribourg, Switzerland), P. Nordmann, A. Delaval, L. Poirel</span>
</p>

<p class="sessionid">O0182</p><span class="title">Optimising Difficult-to-treat Gram-negative Bacterial Infection Outcomes with Personalised Fosfomycin-Based Combination Therapy Guided by  
<span>in vitro</span>
Antibiotic Combination Testing 
<span>T. Lim* (Singapore, Singapore), J.Q. Teo, J.J.Y. Ho, T.G. Lee, L.J. Sin, K.K.K. Goh, N. Mohamed Yusoff, W. Lee, N.G.S. Chua, J.S. Chung, A.L.H. Kwa</span>
</p>

<p class="sessionid">O0183</p><span class="title">Management of infections caused by <p class="sessionid" style="background-color: red;">ST308</p> New Dehli metallo- 
<span>ß</span>
-lactamase-producing  
<span>Pseudomonas aeruginosa</span>
with  
<span>in vitro</span>
-guided combination antibiotic therapy 
<span>J. Teo* (Singapore, Singapore), J.H. Toh, H.Y. Chang, S.H. Tan, W. Lee,</span>
</p><p>T.P. Lim, Y.E. Tan, S.J. Chung, A.L.H. Kwa</p>

<p class="sessionid">O0184</p></p>
<span>In vitro</span>
activity of cefepime/enmetazobactam against clinical isolates of  
<span>Enterobacterales</span>
in Portugal: A multicentre retrospective study 
<span>H. Cruz* (Porto, Portugal), C. Chaves, L. Carneiro</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS027</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 12<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Staphylococcus aureus</span>
 
<span>: colonisation, virulence, and persistence
 Chair      Stefano Giulieri (Melbourne, Australia) <br/></span></p><p>

<p class="sessionid">O0185</p><span class="title"><span class="presenters"></span>
nasal colonisation status 
<span>D. Aggarwal* (London, United Kingdom), K.L. Bellis, B. Blane, M.C. De Goffau, J. Wagner, D.Y.K. Ng, K.E. Raven, P. Naydenova, S. Kaptoge, R. Henry, C. Perry,</span>
</p><p class="presenter">M.R. Walker, C. Churcher, S. Girgis, C.R. De Sousa, L. Sarkane, J. Brennan, S. Duthie, E. Johnson, M. Juhasz, S. Irvine, A. Mcmahon, A. Van Tonder, E. Di Angelantonio, A. Butterworth, J.A. Geoghegan, J. Danesh, J. Parkhill, S.J. Peacock, E. Harrison</p>

<p class="sessionid">O0186</p><span class="title">Development of a  </span><span class="presenters">Staphylococcus aureus</span>
human nasal colonisation model 
<span>A. Hachani* (Melbourne, Australia), B. Tran, E. Cho, R. Guérillot, B. Howden, T. Stinear, E. Vincan</span>
</p>

<p class="sessionid">O0187</p></p>Selection-free, virulence gene promoter-controlled CRISPR interference system for  
<span>in vivo</span>
pathogenesis study of  
<span>Staphylococcus aureus</span>
- A proof of concept 
<span>R. Miah* (Tromsø, Norway), M. Johannessen,
 M. Kjos, C. Lentz</span></p><p>

<p class="sessionid">O0188</p><span class="title"><span class="presenters"></span>
to reduce transmission of LA-MRSA from pigs to humans 
<span>B. Duim* (Utrecht, Netherlands), A. Vlasblom, A. Rittscher-Fogg, R. Rattigan, L. Wajda, D. Crespo-Piazuelo, M. Broekhuizen-Stins, L. Portengen, G. Van Eijden, C. Elend, S. Patel, L. Smit, M. Claesson, P. Lawlor, A. Zomer, J. Wagenaar</span>
</p>

<p class="sessionid">O0189</p></p>Rifampicin-induced  
<span>Staphylococcus aureus</span>
persister formation is driven by CodY and oxidative stress level 
<span>N. Pordone* (Lyon, France), J. Guillemot, K. Rodriguez, N. Personnic, E. Botelho-Nevers, P.O. Verhoeven</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY059</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 13<span> </span>
</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Value-based syndromic diagnostics in medical microbiology: Pro / Con debate</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Hege Vangstein Aamot (Lørenskog, Norway) Eric Claas (Leiden, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0166</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Pro: clinical benefit and potential for improved patient outcomes <span> </span>Kirstine K. Søgaard (Aalborg, Denmark)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0167</p></p></td><td><p class="start">15:15</p></td><td><p class="title">Con: limitations, costs, and possible overuse of syndromic panels </p><span class="presenter">Gilbert Greub (Lausanne, Switzerland)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), Société de Pathologie Infectieuse de Langue Française <br/></p><p> 

</p><p> 



<p class="sessionid">SY060</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium</p><p> 
<span>  We   need   to   talk   about   toilets…</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0168</p><span class="start">14:45</span><span class="title">Infection  risks from sanitation engineering 
<span>Davey
 Jones (Bangor, United Kingdom)</span></p><p>

<p class="sessionid">S0169</p><span class="start">15:15</span><span class="title">Ventilation  in toilets: how can we improve it? 
<span>Michael</span>
</p><p>Gormley (Edinburgh, United Kingdom)</p><p>Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Legionella Infections (ESGLI) <br/></p><p> 

</p><p> 



<p class="sessionid">OS028</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 15<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Unlocking the potential of the human microbiome for clinical diagnostics</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0190</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0191</p><span class="title">Comparison of Second-Generation and Third- Generation Sequencing technologies for 16S rRNA amplicon-based gut microbiome analysis 
<span>E. Rubio García* (Barcelona, Spain), E. Rubio-García, A. Pulgarin, R. López-Aladid, L. Martínez-Priego, N. Palau, A. Mendoza, R. Isanta, A. Montalban, J.L. Villanueva-Cañas, M.M. Montero, M. Sanduzzi, M. Reig, C. Casals-Pascual</span>
</p>

<p class="sessionid">O0192</p><span class="title">Donor for fecal microbiota transplantation: a challenging research. 
<span>B.S. Orena* (Milan, Italy), M.F. Liporace, A. Maraschini, D. Girelli, D. Pizzotti, E. Petrillo, C. Alteri, C. Amoroso, F. Caprioli, A. Callegaro, L. Cariani</span>
</p>

<p class="sessionid">O0193</p><span class="title">Antibiotic resistance genes diversity and antimicrobial effects in the vaginal microbiome during pregnancy 
<span>N. Boutouchent* (Rouen, France), S. Kennedy</span>
</p>

<p class="sessionid">O0194</p><span class="title">Distinct gut microbiota and metabolic profiles in brain tumor patients: Bridging microbial insights to CNS oncology 
<span>A. Gundogdu* (Kayseri, Türkiye), O.U. Nalbantoglu, M. Ulgen, M.A. Sav, G. Ekinci, H.F. Kelestimur, U. Ture</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">ME062</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 16<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> Untangling the web: antimicrobial dose adjustments in renal impairment</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0172</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Claire Roger (Nimes, France)</p></td></tr>
<tr><td>

<p class="sessionid">M0173</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Isabel Spriet (Leuven, Belgium)</p></td></tr></table><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Critically Ill Patients (ESGCIP) <br/></p><p> 

</p><p> 



<p class="sessionid">SY057</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 2</span>

</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Macrolides in community-acquired pneumonia: therapeutic necessity or path to overuse?</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Marc J.M. Bonten (Utrecht, Netherlands) Karin Thursky (Carlton, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">S0162</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Pro: maximising outcomes with evidence-based use <span> </span>Evangelos Giamarellos-Bourboulis (Athens, Greece)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0163</p></p></td><td><p class="start">15:15</p></td><td><p class="title">Con: the risks of routine (over)use </p><span class="presenter">Aurélien Dinh (Garches, France)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY058</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 4</span>

</p><ol id="l2"><li data-list-text="1-"><p>hour Symposium</p></li></ol><p> 
<span>  Top    papers    in    transplant    ID</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Nicolas Mueller (Zurich, Switzerland) Alessandra Mularoni (Palermo, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">S0164</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Top 10 papers in infections in SOT <span> </span>Patricia Munoz (Madrid, Spain)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0165</p></p></td><td><p class="start">15:15</p></td><td><p class="title">Top 10 paper in infections in HCT and cellular therapy </p><span class="presenter">Joshua Hill (Seattle, United States)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS025</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 5</span>

</p><ol id="l3"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Bacterial battles: a paediatric perspective on infections and interventions</span>
</p><p class="presenter">Chairs      Angelika Berger</p><p class="presenter">Julie Toubiana (Paris, France) <br/></p>

<p class="sessionid">O0175</p><span class="title">Strong Alignment Between National Standard Treatment Guidelines and WHO AWaRe Book Recommendations for Primary Care Pediatric Infections </span><span class="presenters">D. Dona* (Padova, Italy), D. Donà, G. Brigadoi, A. Cantarutti, M. Masetti, G. Autore, S. Mathur, M. Sharland, S.M.R. Esposito</span>
</p><p>

<p class="sessionid">O0176</p><span class="title"><span class="presenters"></span>
in a paediatric haematology department 
<span>S. Frigui Ep Oueslati* (Tunis, Tunisia), N. Fitouri, S. Frigui, Y. Chebbi, I. Fezaa, M. Ouederni, C. Drira, W. Achour</span>
</p>

<p class="sessionid">O0177</p></p>Interleukin-6 as a diagnostic biomarker for sepsis in neonates, children and pregnant women – a real- world cohort study 
<span>Sean Olann Whelan (Dublin, Ireland)</span>
</p>

<p class="sessionid">O0178</p><span class="title">Impact of rapid diagnostic stewardship interventions to reduce blood culture utilization in a pediatric medical center 
<span>E. Vaugon* (Los Angeles, United States), C. Costales, T. Barter, L. Posch, E. Orgel, J. Dien Bard</span>
</p><p>

<p class="sessionid">O0179</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EW071</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 15<span> </span>
</p><p>Educational Session</p><p> 
<span> The rare art of writing scientific articles: from conception to submission</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0205</p><span class="start">16:15</span><span class="title">Expressing  yourself correctly: writing tips 
<span>Angela
 Huttner (Geneva, Switzerland)</span></p><p>

<p class="sessionid">W0206</p><span class="start">16:35</span><span class="title">Constructing  your manuscript for an original article 
<span>Jesús Rodríguez-Baño (Seville, Spain)</span>
</p><p>

<p class="sessionid">W0207</p><span class="start">16:55</span><span class="title">The  use of artificial intelligence tools for writing</p><p>articles: what to do and not to do 
<span>Erlangga Yusuf (Rotterdam, Netherlands)</span>
</p><p>

<p class="sessionid">W0208</p><span class="start">17:15</span><span class="title">Selecting  the best journal for my manuscript 
<span>Andre Kalil (Omaha, United States)</span>
</p><p>Co-organised with: CMI Board of Editors <br/></p><p> 

</p><p> 



<p class="sessionid">SY069</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 16<span> </span>
</p></li><li data-list-text="2-"><p>hour Symposium</p></li></ol><p> 
<span>  Controlled    human    infection    models</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0197</p><span class="start">16:15</span><span class="title">Updates  on the dengue human infection model 
<span>Kirsten Lyke (Baltimore, United States)</span>
</p><p>

<p class="sessionid">S0198</p><span class="start">16:45</span><span class="title">CHIM  in endemic countries 
<span>Melissa Kapulu (Kilifi,
 Kenya)</span></p><p>

<p class="sessionid">S0199</p><span class="start">17:15</span><span class="title">Controlled  human infection models of parasitic infections 
<span>Meta Roestenberg (Leiden, Netherlands)</span>
</p><p>

<p class="sessionid">S0200</p><span class="start">17:45</span><span class="title">Controlled  human infection models of non-typhoidal</p><p>SalmonellaMalick Gibani (London, United Kingdom)</p><p>Co-organised with: British Infection Association (BIA) <br/></p><p> 

</p><p> 



<p class="sessionid">EF033</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Current  treatment  options  for  invasive  fungal  infections</span>
</p><p class="presenter">Chair       Andreas H. Groll (Münster, Germany) <br/></p>

<p class="sessionid">E0232</p><span class="title">The paediatric European Confederation of Clinical Mycology (ECMM) Quality (paed-EQUAL) Score for the management of candidaemia in children and neonates </span><span class="presenters">Z.D. Pana* (Nicosia, Cyprus), A.H. Groll, A. Bal, R. Sprute, F. Carlesse, S. Mellinghoff, S. Butzer,</span>
</p><p class="presenter">D. Ludwig-Bettin, K. Mehler, J. Stemler, D. Seidel, A. Marek, U. Ristau-Schäfer, O. Cornely</p>

<p class="sessionid">E0233</p><span class="title">Prevalence rate, species distribution and antifungal susceptibility of bloodstream infections caused by rare yeasts of the Saccharomycetales order documented in 28 Brazilian medical centers </span><span class="presenters">C. Palamin Buonafine* (São Paulo, Brazil), C.P. Buonafine, A.E. Dos Santos, L.M. Favarello, R.C. Cognialli, V.R. Aquino, C.B. Agnelli, A.V. Mendes, T. Guimaraes, T.C. Sukiennik, F. Carlesse, P.T. Castro,</span>
</p><p class="presenter">C.C. Baqueiro, E.C. Francisco, A.L. Colombo</p>

<p class="sessionid">E0234</p><span class="title">Rezafungin showed high  </span><span class="presenters">in vitro</span>
activity and very low resistance rate against a collection of yeasts causing fungaemia in patients admitted to a tertiary hospital in Madrid from 2014 to 2024 
<span>J. Guinea* (Madrid, Spain), P. Escribano, A. Gomez, A. Burillo,</span>
</p><p class="presenter">P. Muñoz</p>

<p class="sessionid">E0235</p><span class="title">Posaconazole Drug-Drug Interaction Potential is Similar Across Bodyweight </span><span class="presenters">R.E. Wrishko* (Rahway, United States), P. Kothare, T.J. Bateman, M.G. Johnson, A. Stoch</span>
</p>

<p class="sessionid">E0236</p><span class="title">Phase 2, open-label, non-comparative clinical trial evaluating the safety and efficacy of posaconazole in paediatric patients 2 to &lt;18 years old with invasive aspergillosis 
<span>H. Kang* (Seoul, Korea, Republic of), A.C. Arrieta, C. Dhooge, A. Kelemen,</span>
</p><p class="presenter">M. Macías-Parra, L. Aranda, Y.V. Dinikina, I. Kassis,</p><p class="presenter">S. Cesaro, T. Mackey, A. Shepherd, A.K. Shah, H. Waskin, M.G. Johnson</p>

<p class="sessionid">E0237</p><span class="title">Activity of manogepix against a worldwide collection of mould isolates from 2023 </span><span class="presenters">M. Winkler* (North Liberty, United States), S. Edeker, A. Klauer,</span>
</p><p>P. Rhomberg, M. Castanheira</p>

<p class="sessionid">E0239</p></p>
<span>Candida auris</span>
displays an inoculum effect with multiple antifungal drug classes 
<span>R. Ben-Ami* (Tel Aviv, Israel), R. Shadhan, A. Novikov, N. Mizrahi</span>
</p>

<p class="sessionid">E0240</p></p>
<span>In vitro</span>
olorofim activity against  
<span>Aspergillus</span>
spp clinical isolates collected as part as two national surveys on azole resistance conducted in Spain ( 
<span>ASPE</span>
IN II and III) 
<span>J. Guinea* (Madrid, Spain), P. Escribano, J. Moraga, A. Gomez, P. Muñoz</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF034</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Surgical site infections: epidemiology, risk factors, and prevention strategies</span>
</p><p class="presenter">Chair       Trisha Peel (Melbourne, Australia) <br/></p>

<p class="sessionid">E0241</p><span class="title">Incidence of Surgical Site Infections (SSIs) from the automated patient-based surveillance system, SPICMI, France </span><span class="presenters">P. Astagneau* (Paris, France), B. Nkoumazok, N. Benhajkassen, I. Arnaud, D. Verjat- Trannoy, J. Auraix, K. Lebascle</span>
</p>

<p class="sessionid">E0242</p></p>Beta-lactam versus non-beta-lactam antimicrobial prophylaxis and its association with the surgical site infection rate, a nationwide cohort study with 348 793 patients 
<span>S. Largiadèr* (Lucerne, Switzerland), D. Berthod, A. Widmer, N. Troillet, C. Perdrieu, S. Harbarth, R. Sommerstein</span>
</p>

<p class="sessionid">E0245</p></p>
<span>Cutibacterium</span>
species in Neurosurgical Infections: Not Such a &quot;Cute&quot; Pathogen After All 
<span>J. Donnelly* (Dublin, Ireland), B. Dinesh, S. O'donnell</span>
</p>

<p class="sessionid">E0246</p><span class="title">The polymicrobial nature of wound infections in an emergency orthopaedic ward in Northern Nigeria - implications for treatment and patient outcome 
<span>K.</span>
</p><p class="presenter">Cook* (Oxford, United Kingdom), F.S. Mohd, M.Y. Ahmad, A. Aliyu, K. Iregbu, C. Achi, T. Walsh, K. Sands</p>

<p class="sessionid">E0247</p><span class="title">Efficacy of Octenidine Dihydrochloride Versus Chlorhexidine Gluconate Solutions in Reducing Surgical-Site Infections in Total Hip and Knee Arthroplasty: A Comparative Analysis </span><span class="presenters">A. Abialevich* (Beer Sheva, Israel), V. Benkovich, G. Benkovich</span>
</p>

<p class="sessionid">E0249</p><span class="title">Impact on rates of surgical site infection of requiring pre-authorization of surgical antibiotic prophylaxis choice and post-operative antibiotic doses 
<span>C.M. Villavicencio* (Taguig, Philippines), M.C. Hufano, R.R. Gabunada, Z. Alano</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY067</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 11<span> </span>
</p><p>2-hour Symposium</p><p> 
<span>   STIs:     an     ongoing     crisis</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0189</p><span class="start">16:15</span><span class="title">STI  treatment options are running out due to AMR 
<span>Magnus Unemo (Örebro, Sweden)</span>
</p><p>

<p class="sessionid">S0190</p><span class="start">16:45</span><span class="title">Genomic  surveillance of  
<span>Neisseria gonorrhoeae</span>
</p><p>strains 
<span>Petra Wolffs (Maastricht, Netherlands)</span>
</p><p>

<p class="sessionid">S0191</p><span class="start">17:15</span><span class="title">Evolutionary  insights into syphilis and  
<span>Treponema
 pallidumMathew Beale (Hinxton, United Kingdom)</span></p><p>

<p class="sessionid">S0192</p><span class="start">17:45</span><span class="title">Challenges  in chlamydial STI infections 
<span>Cecile Bebear</span>
</p><p>(Bordeaux, France)</p><p>Co-organised with: Deutsche Gesellschaft für Hygiene und Mikrobiologie <br/></p><p> 

</p><p> 



<p class="sessionid">SY068</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 12<span> </span>
</p></li><li data-list-text="2-"><p>hour Symposium</p></li></ol><p> 
<span> Tick-borne encephalitis: contemporary diagnosis and management</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Joanna Maria Zajkowska (Białystok, Poland) Dace Zavadska (Riga, Latvia)</p></td></tr>
<tr><td>

<p class="sessionid">S0193</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Tick-borne encephalitis: immune response and clinical experience <span> </span>Sara Gredmark Russ (Stockholm, Sweden)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0194</p></p></td><td><p class="start">16:45</p></td><td><p class="title">TBE immune responses and vaccine effectiveness </p><span class="presenter">Karin Stiasny (Vienna, Austria)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0195</p></p></td><td><p class="start">17:15</p></td><td><p class="title"><p class="sessionid" style="background-color: red;">NS1</p> antibodies: diagnostics and screening of seroprevalence of TBE virus infection </p><span class="presenter">Gerhard Dobler (Munich, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0196</p></p></td><td><p class="start">17:45</p></td><td><p class="title">Treatment for TBE: where do we stand? </p><span class="presenter">Daniel Ruzek (Brno, Czech Republic)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">LB006</p></p></td><td><p>16:15  
<span>-</span>
18:15</p></td><td><p>Hall 13</p></td></tr>
<tr><td></td><td><p>2-hour Oral Session</p></td><td></td></tr>
<tr><td><p> 
<span> The Trial Run: recent trials on S. aureus bacteraemia management</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Julia Anna Bielicki (London, United Kingdom) Vance Fowler (Durham, United States)</p></td></tr>
<tr><td>

<p class="sessionid">L0031</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Introduction <span> </span>, Julia Anna Bielicki (London, United Kingdom), Vance Fowler (Durham, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0032</p></p></td><td><p class="start">16:20</p></td><td><p class="title">Description of SNAP trial</p></td></tr>
<tr><td>

<p class="sessionid">L0033</p></p></td><td><p class="start">16:30</p></td><td><p class="title">Benzylpenicillin versus (flu)cloxacillin for the treatment of penicillin-susceptible  <span> </span>Staphylococcus aureus</span>
bacteraemia: a randomised controlled trial of the  <span> </span>S. aureus</span>
network adaptive platform (SNAP) <span> </span>S. Tong* (Melbourne, Australia), S. Aureus Network Adaptive Platform Trial Group</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0034</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Cefazolin versus (flu)cloxacillin for the treatment of penicillin-resistant, methicillin-susceptible Staphylococcus aureus bacteraemia: a randomised controlled trial within the S. aureus network adaptive platform (SNAP) </p><span class="presenter">J. Davis* (Newcastle, Australia), S. Aureus Network Adaptive Platform Trial Group</span>
</p></td></tr></table><table>
<tr><td>

<p class="sessionid">L0035</p></p></td><td><p class="start">17:00</p></td><td><p class="title">Cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a</p><p>randomised, controlled, non-inferiority trial </p><span class="presenter">X.</span>
</p></td></tr>
<tr><td></td><td></td><td><p>Lescure* (Paris, France), F. Vandenesch, X. Duval, S. Tubiana, C. Burdet, N. Saïdani, A. Lemaignien, E. Canoui, L. Surgers, M. Esposito Farese, V. Le Moing,</p><p>P. Tattevin</p></td></tr>
<tr><td>

<p class="sessionid">L0036</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Trial Discussion </p><span class="presenter">Julia Anna Bielicki (London, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0037</p></p></td><td><p class="start">17:30</p></td><td><p class="title">Trial Discussion </p><span class="presenter">Vance Fowler (Durham, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0038</p></p></td><td><p class="start">17:45</p></td><td><p class="title">Open Discussion and Q&amp;A</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS032</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 14<span> </span>
</p><p>2-hour Oral Session</p><p> 
<span>  Unraveling    respiratory    viruses,    2025</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0222</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0223</p><span class="title">Unveiling animal susceptibility to influenza viruses (<p class="sessionid" style="background-color: red;">H1</p><p class="sessionid" style="background-color: red;">N1</p>(<p class="sessionid" style="background-color: red;">pdm09</p>) and <p class="sessionid" style="background-color: red;">H5</p><p class="sessionid" style="background-color: red;">N1</p> HPAIV) using animal- derived respiratory organoids 
<span>F. Tarrés-Freixas* (Bellaterra, Spain), G. Ceada, N. Navarro, M. Pérez- Simó, N. Carmona-Vicente, L. Bonillo-Lopez, A. Moreno, C. López, J. Segalés, N. Majó, K. Kochanowski, J. Vergara-Alert</span>
</p>

<p class="sessionid">O0224</p><span class="title">Exploring the impact of acute lung hypoxia on <p class="sessionid" style="background-color: red;">CD8</p> T cell phenotypes following severe influenza infection. 
<span>B. Huckestein* (Memphis, United States),</span>
</p><p class="presenter">P. Thomas</p>

<p class="sessionid">O0225</p><span class="title">Virological characterisation of RSV after Nirsevimab Breakthrough Infections in a Multicentre Observational Real-world Study in France </span><span class="presenters">S. Fourati* (Créteil, France), A. Reslan, J. Bourret, Y. Rahou, L. Chollet, S. Pillet, P. Tremeaux, N. Candace Dossou, E. Gault, M. Salmona, B.M. Imbert, A. Mirand, S. Larrat, A. Moisan, S. Marot, A. Schnuriger, N. Veyrenche, I. Engelmann, L. Handala,</span>
</p><p class="presenter">A. Henry, V. Stephan, S. Brichler, V. Avettand- Fenoel, N. Zemali, C. Lefeuvre, C. Pronier, L. Deroche, M.C. Jaffar, L. Mouna, C. François, A. Regueme, C. Hartard, S. Roger, F. Gallais, A. Ly, C. Rodriguez, G. Dos Santos, J. Buchrieser, O. Schwartz, J.M. Pawlotsky, F. Lemoine, E. Audureau,</p><p class="presenter">M.A. Rameix-Welti</p>

<p class="sessionid">O0226</p><span class="title">Baseline immunity to highly pathogenic avian influenza viruses in a healthcare worker cohort </span><span class="presenters">C. Geurts Van Kessel* (Rotterdam, Netherlands), M. Power, W. Rijnink, L. Gommers, T. Bestebroer, W. Soochit, W. Tan, B. Verstrepen, S. Bogers, G. Van Nierop, R. Sikkema, A. Grifoni, A. Sette, M. Koopmans, R. Fouchier, M. Richard, R. De Vries, C. Geurtsvankessel</span>
</p>

<p class="sessionid">O0227</p><span class="title">Impact of reinfection on post-acute sequelae of COVID-19 over multi-organ systems 
<span>J. Tan* (Singapore, Singapore), J.T. Lim, L.E. Wee, C. Chiew, B. Ong, D. Lye</span>
</p>

<p class="sessionid">O0228</p><span class="title">Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections – a Danish nationwide cohort study 
<span>Stanislava Bratkovic (Copenhagen, Denmark)</span>
</p>

<p class="sessionid">O0229</p><span class="title">The burden of respiratory syncytial virus in children</p><p>&lt;3 years old presenting to primary, secondary and tertiary care in England: report from the STOP RSV prospective surveillance study 
<span>E. Carter* (Liverpool, United Kingdom), H. Hill, D. Ferreira, A. Collins, C. Solórzano, L. Mclellan, L. Kerruish, F. Fyles, S. Drysdale, P. Gonzalez-Dias, G. Duncan, K. Davies, P. Crozier, P. Saunderson, R. Kramer, M. Bangert, N. Vassilouthis, S. Messahel, B. Caroline, S. Brearey, J.</span>
</p><p class="presenter">Bernatoniene, S. Bhowmik, J. Perry, P. Mottram, P. Mcnamara, D. Lewis, N. Van Kinnekan, A. Finn</p>

<p class="sessionid">O0230</p><span class="title">Targeted metagenomic sequencing of influenza, RSV, and symptomatic respiratory infections from UK healthcare workers </span><span class="presenters">M. Knoll* (Hinxton, United Kingdom), L. Findlater, B. Katie, J. Wagner, T. Diego,</span>
</p><p>D. Rajan, S. Frances Field, S. Thurston, A. Wong, B. Hyatt, N. Thesin, J. Robinson, R. Yeadon, A. Galvin,</p><p>B. Blane, Y.L. Huang, K. Howe, M. Forbes, K. Figueroa, F. Schwach, S. Stott, A. Marhino, A. Frick- Kretschmer, B. Dave, T. Maddison, S. Hopkins, S. Foulkes, J. Islam, A. Atti, V. Hall, E. Harrison <br/></p><p> 

</p><p> 



<p class="sessionid">SY064</p></span>
<span class="start">16:15</span><span>-</span>
18:15 </span><span class="location">Hall 2</span>

</p><p>2-hour Symposium</p><p> 
<span> PK/PD   to   avoid   emergence   of   resistance?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0177</p>  16:15   PK/PD and antibacterial therapy 
<span>Dolors Soy-Muner
 (Barcelona, Spain)</span></p><p>

<p class="sessionid">S0178</p>  16:45   PK/PD and antifungal therapy 
<span>Roger Brüggemann (Nijmegen, Netherlands)</span>
</p><p>

<p class="sessionid">S0179</p>  17:15   PK/PD and antiviral therapy 
<span>Joe Standing (London,
 United Kingdom)</span></p><p>

<p class="sessionid">S0180</p>   17:45   PK/PD considerations in anthelminthic treatment 
<span>Jennifer Keiser (Allschwil, Switzerland)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EW070</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 3</span>

</p><p>Malaria: when the drugs don’t work Management of treatment failure in non- endemic countries</p><p><p>Educational Session <br/></p><p class="presenters"></p><p>

<p class="sessionid">W0201</p><span class="start">16:15</span><span class="title">Malaria  in the non-endemic setting: who to treat as an outpatient and how to detect treatment failure 
<span>Emmanuel Bottieau (Antwerp, Belgium)</span>
</p><p>

<p class="sessionid">W0202</p><span class="start">16:35</span><span class="title">Malaria  resistance mutations in the non-endemic</p><p>setting: role of genomic surveillance 
<span>Anna Rosanas Urgell (Antwerp, Belgium)</span>
</p><p>

<p class="sessionid">W0203</p><span class="start">16:55</span><span class="title">How  to manage  
<span>Plasmodium Knowlesi</span>
infection 
<span>Giri
 Shan Rajahram (Kota Kinabalu, Malaysia)</span></p><p>

<p class="sessionid">W0204</p><span class="start">17:15</span><span class="title">Epidemiology  and control of  
<span>Plasmodium</span>
</p><p>KnowlesiKimberly Fornace (Singapore, Singapore)</p><p>Co-organised with: British Infection Association (BIA) <br/></p><p> 

</p><p> 



<p class="sessionid">SY065</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 4</span>

</p><p>2-hour Symposium
</p><p> 
<span>  Gram-positives,   are   they   still   going?</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Diederik Bathoorn (Groningen, Netherlands) Stefania Stefani (Catania, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">S0181</p></p></td><td><p class="start">16:15</p></td><td><p class="title">The vanco chronicles: enterococci's global journey <span> </span>Guido Werner (Wernigerode, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0182</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Pitfall in susceptibility testing of Gram- positives </p><span class="presenter">Helena Zemlickova (Prague, Czech Republic)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0183</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Drivers for daptomycin and linezolid resistance in Gram-positives </p><span class="presenter">Glen Carter (Melbourne, Australia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0184</p></p></td><td><p class="start">17:45</p></td><td><p class="title">What is new in treatment against MDR Gram- positives? </p><span class="presenter">Alex Soriano (Barcelona, Spain)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">SY066</p></p></td><td><p>16:15  
<span>-</span>
18:15</p></td><td><p>Hall 5</p></td></tr>
<tr><td></td><td><p>2-hour Symposium</p></td><td></td></tr></table><table>
<tr><td><p> 

</p><p>Biomarker testing to manage respiratory infections in primary care in low resource settings</p></td></tr>
<tr><td><p class="presenters">Sonia Lewycka (Hanoi, Vietnam)</p><p class="presenters">Heiman Wertheim (Nijmegen, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0185</p></p></td><td><p class="start">16:15</p></td><td><p class="title">The Vietnamese experience with CRP testing in the community setting <span> </span>Thi Thuy Nga Do (Ha Noi, Vietnam)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0186</p></p></td><td><p class="start">16:45</p></td><td><p class="title">The Nigerian experience with CRP testing in the community setting </p><span class="presenter">Augustine Onwunduba (Awka, Nigeria)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0187</p></p></td><td><p class="start">17:15</p></td><td><p class="title">CRP testing in diagnosing tuberculosis in Zambia and South Africa </p><span class="presenter">Helen Ayles (Lusaka, Zambia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0188</p></p></td><td><p class="start">17:45</p></td><td><p class="title">The health economics of CRP testing in LMICs </p><span class="presenter">Yoel Lubell (Bangkok, Thailand)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EF035</p></p></td><td><p>17:15  
<span>-</span>
18:15</p></td><td><p>Arena 1</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><p> 

</p><p> 
<span>  Genomics    in    pathogen    surveillance</span>
</p><p class="presenter">Chair       Vítor Borges (Lisbon, Portugal) <br/></p>

<p class="sessionid">E0250</p><span class="title">Genomic Surveillance of Invasive Group A Streptococcus in Argentina's 2023 Epidemic: Unveiling Hypervirulent <p class="sessionid" style="background-color: red;">emm1</p> Lineages and Pediatric <p class="sessionid" style="background-color: red;">emm12</p> Burden </span><span class="presenters">L. Cipolla* (Buenos Aires, Argentina),
 A. Gianecini, T. Poklepovich, C. Giovacchini, M. Prieto</span></p><p>

<p class="sessionid">E0251</p><span class="title"><span class="presenters"></span>
using core-genome multilocus sequence typing 
<span>I. Yassine* (Oxford, United Kingdom), K.A. Jolley, J.E. Bray, M.J. Jansen Van Rensburg, F. Patel,
 A. Sheppard, H.J. Zar, V. Allen, L. Ah Tow, M.C.J. Maiden, M.P. Nicol, A.B. Brueggemann</span></p><p>

<p class="sessionid">E0252</p><span class="title"><span class="presenters"></span>
clones causing adult invasive infections 
<span>M. Ramirez* (Lisbon, Portugal), A. Friães, J. Vermeiren, R. Mamede, C.R. Bettencourt,</span>
</p><p class="presenter">M.P. Bajanca-Lavado, J. Melo-Cristino, P. Group For The Study Of Streptococcal Infections</p>

<p class="sessionid">E0253</p><span class="title">Unveiling the Hidden Complexity of  </span><span class="presenters">Providencia</span>
: Genomic Insights into Species Reclassification and Antibiotic Resistance 
<span>X. Dong* (Hangzhou, China)</span>
</p>

<p class="sessionid">E0254</p><span class="title">Genomic description of outbreak of VIM-1 carrying  
<span>Enterobacter</span>
in Switzerland suggests plasmid transmission between sequence types 
<span>H. Seth-Smith* (Zurich, Switzerland), M. Greutmann, C. Beckmann, E. Gruner, R. Capaul, G. Greub, P.M. Keller, S. Tschudin- Sutter, L. Berlinger, S.D. Brugger, T. Roloff, O. Nolte,</span>
</p><p class="presenter">L. Poirel, P. Nordmann, A. Egli</p>

<p class="sessionid">E0255</p><span class="title">Genomic epidemiology of  </span><span class="presenters">Klebsiella pneumoniae</span>
bloodstream infections in a german tertiary centre: increased virulence in carbapenem-resistant strains 
<span>L. Knegendorf* (Hannover, Germany), M. Lindenberg,</span>
</p><p class="presenter">C. Baier, J. Erdmann, S. Häußler, D. Schlüter</p>

<p class="sessionid">E0256</p><span class="title">Phylogenetic mixing and undetected circulation of multiple  </span><span class="presenters">Candida auris</span>
lineages following recognition of imported cases in Italy 
<span>V. Di Pilato* (Genoa, Italy),</span>
</p><p class="presenter">E. Willison, L. Calabrese, L. Magnasco, C. Elisa, G. Daniele Roberto, M. Mikulska, B. Matteo, M. Anna</p>

<p class="sessionid">E0257</p><span class="title">Using Long-Read Sequencing for Core Plasmid Multilocus Sequence Typing to Investigate Plasmid Relationships Among Bacterial Species in German Hospital Wastewater </span><span class="presenters">A.K. Bari* (Groningen, Netherlands), B. Sinha, J.W.A. Rossen, B.B. Xavier,</span>
</p><p class="presenter">T.T. Severs, M.J. Cardoso, M. Savin</p>

<p class="sessionid">E0258</p><span class="title">Screening for rectal colonization with multidrug- resistant pathogens: usage of rapid metagenomic long-read technology </span><span class="presenters">S. Purushothaman* (Zurich, Switzerland), A.M. Rooney, S. Moser, A. Egli</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF036</p><span> </span><span class="start">17:15</span>-<span class="end">18:15<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>   Heads     up!     CNS     infections</span>
</p><p class="presenter">Chair       Jacob Bodilsen (Aalborg, Denmark)</p>

<p class="sessionid">E0259</p><span class="title">Central Nervous System Involvement by  </span><span class="presenters">Mycobacterium avium Complex</span>
in Advanced HIV: A Rare and Underdiagnosed Challenge 
<span>E. Sienra Iracheta* (Tlalpan, Mexico), M. Aranda Aurelio, A. Camiro Zuñiga, D.H. Martínez Oliva, A. Llamas Lopez,</span>
</p><p class="presenter">A.P. Rodriguez Zulueta</p>

<p class="sessionid">E0260</p><span class="title">Acute disseminated encephalomyelitis following bacterial meningoencephalitis – Two Case reports &amp; Review of Literature </span><span class="presenters">M. Priyadarshi* (Delhi, India), M. Salunkhe, A. Mohan, P. Gupta, A. Agarwal, V. Goel, R. Bhatia</span>
</p>

<p class="sessionid">E0261</p></p>
<span>Streptococcus equi</span>
Subspecies  
<span>zooepidemicus</span>
Endocarditis and Meningitis in a 62-Year-Old Patient: A Case Report and Literature review 
<span>D. Chemello* (Modena, Italy), G. Franceschi, S. Alessandra, B. Andrea, S. Mario, M. Marianna, M. Cristina</span>
</p>

<p class="sessionid">E0262</p><span class="title">Breaking barriers: meropenem-vaborbactam as a game-changer for KPC central nervous system infections 
<span>F. Prataviera* (Udine, Italy), S. Giuliano, S. Flammini, J. Angelini, P.G. Cojutti, C. Tascini</span>
</p><p>

<p class="sessionid">E0263</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0264</p><span class="title">Triple Threat: Sequential Meningitis Infections in an Immunosuppressed Patient with Morganella morganii, Acinetobacter baumannii, and Vancomycin-resistant Enterococcus faecium 
<span>Y. Çakir Kiymaz* (Sivas, Türkiye), Y. Çakır Kıymaz, E. Kıymaz,
 Z. Bulut, S.A. Büyüktuna, N. Elaldı</span></p><p>

<p class="sessionid">E0265</p><span class="title"><span class="presenters"></span>
infection with cerebral abscesses in an immunocompromised child 
<span>B. Winkel* (Utrecht, Netherlands), J. Jans, M. Luesink, R.J. Nievelstein, F. Hagen, J. Buil, T. Wolfs, T. Van Der Bruggen</span>
</p>

<p class="sessionid">E0266</p><span class="title">Treatment of herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient 
<span>A. Birkmann* (Wuppertal, Germany), C. Lueck, C. Rautenberg, S. Bonsmann, A. Marini, M. Sumner, T. Schroeder, S. Voigt</span>
</p><p>

<p class="sessionid">E0267</p><span class="title"><span class="presenters"></span>
</p><p>Sunday, 13 April 2025</p><p> 

</p><p> 



<p class="sessionid">SY075</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 15<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Diphtheria:  from  re-emergence  to  vaccine  strategies</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0221</p>   08:30   Diphtheria: from clinical picture to medical management 
<span>Regina Oladokun (Oyo, Nigeria)</span>
</p><p>

<p class="sessionid">S0222</p><span class="start">09:00</span><span class="title">The  epidemiology of diphtheria worldwide over the last half-century: more than one comeback 
<span>Andreas Hoefer (Solna, Sweden)</span>
</p><p>

<p class="sessionid">S0223</p>   09:30   There’s more than one toxigenic Corynebacterium:</p><p>the current genomics landscape of diphtheria- associated strains 
<span>Sylvain Brisse (Paris, France)</span>
</p><p>

<p class="sessionid">S0224</p><span class="start">10:00</span><span class="title">Diphtheria  vaccination: a reappraisal  
<span>Gayatri</span>
</p><p>Amirthalingam (London, United Kingdom)</p><p>Co-organised with: ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">EF039</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Novel   approaches   to   antiviral   therapy</span>
</p><p class="presenter">Chair       Pinyo Rattanaumpawan (Bangkok, Thailand) <br/></p>

<p class="sessionid">E0288</p><span class="title">Obeldesivir exhibits broad anti-RSV activity and a high barrier to resistance in vitro and is efficacious in a non-human primate challenge model of RSV infection </span><span class="presenters">J. Pitts* (Foster City, United States), J.L.R. Zamora, S. Manhas, T. Aeschbacher, J. Chan, V. Cutillas, V. Nair, N. Riola, A. Vijjapurapu, M. Vermillion, S. Eng, C. Richards, D. Han, J. Perry, S. Chaudhuri, I. Liu, C. Martinez, N. Peinovich, K.H. Sun, A. Cai, R. Martin, J. Moshiri, C. Hedskog, V. Avadhanula, P. Piedra, K. Stobbelaar, P. Delputte, T. Cihlar, S. Fletcher, J. Bilello</span>
</p>

<p class="sessionid">E0289</p></p>EDP-323, a first-in-class, oral, RSV L-protein inhibitor reduces disease severity (respiratory mucus production) and accelerates viral clearance in a human viral challenge study 
<span>J. Devincenzo* (Watertown, United States), A. Ahmad, S. Chen, B. Löndt, A. Mann, J. Mori, A. Catchpole, S. Rottinghaus</span>
</p>

<p class="sessionid">E0290</p><span class="title">A Combined  
<span>In Silico</span>
and  
<span>In Vitro</span>
Pipeline for Optimizing Nanobodies Targeting Surface Proteins of Pathogens: Applications to SARS-CoV-2, WNV, and Influenza A Virus 
<span>C.L. Pierri* (Bari, Italy), G.C.M. Perrone, A.L. Francavilla, S. Todisco, M.N. Sgobba,</span>
</p><p class="presenter">V. Scaglione, D.I. De Luca, F. Mastropirro, S. Spadone, L. Guerra, M. Volpicella, A. De Grassi</p>

<p class="sessionid">E0291</p><span class="title">Bemnifosbuvir and Remdesivir exhibit potent antiviral activity against tick-borne encephalitis virus  </span><span class="presenters">in vitroD. Grandgirard* (Bern, Switzerland), S. Leoni, R. Dijkman, L. Eyer, D. Ruzek, S.L. Leib</span>
</p>

<p class="sessionid">E0292</p><span class="title">Combinations of antiviral drugs demonstrating synergistic inhibition of multiple respiratory RNA viruses 
<span>S. Ellis* (London, United Kingdom), A.I. Jacobs, M. Woodall, S. Zhang, J.F. Standing, J. Breuer</span>
</p>

<p class="sessionid">E0293</p><span class="title">The safety and pharmacokinetics of ABI-5366, a novel, oral, long-acting HSV helicase-primase inhibitor: Interim results from a Phase 1a/1b study in healthy participants 
<span>A. Gaggar* (South San Francisco, United States), E. Gane, C. Schwabe, G. Wang, J. Liu, S. Knox, K. Kitrinos, K. Zomorodi</span>
</p>

<p class="sessionid">E0294</p><span class="title">Efficacy of ganciclovir against CMV infection is dependent on treatment initiation time 
<span>L. Sudarsono* (Leiden, Netherlands), X. Liu, J.G.C. Van Hasselt, A.G. Märtson</span>
</p>

<p class="sessionid">E0295</p><span class="title">Efficacy of molnupiravir and baloxavir against influenza A <p class="sessionid" style="background-color: red;">H1</p><p class="sessionid" style="background-color: red;">N1</p> infection  
<span>in vitro</span>
and  
<span>in vivoD. Liu* (Hong Kong, Hong-Kong SAR, China), K.Y. Leung, R. Zhang, Y. Fan, K.H. Chan, F.N.I. Hung</span>
</p>

<p class="sessionid">E0296</p><span class="title">Human defensin derived peptide showing broad antiviral activity against human adenoviruses 
<span>X. Wang* (Hongkong, China), H. Zhao</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF040</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> New frontiers in parasitic disease and migrant health research</span>
 <br/></p>

<p class="sessionid">E0298</p><span class="title">Targeting metabolic bioenergetics: the ‘Achilles' heel' of  
<span>LeishmaniaD. Sarkar* (Kolkata, India)</span>
</p>

<p class="sessionid">E0299</p><span class="title">Leishmaniasis in Southern Alicante (Spain): what is the new patient profile? 
<span>M.D. Hernández Rabadán* (Orihuela, Spain), C. Bernal Alcaraz, M.B. Martínez López, D. López Parra, J. Llenas García</span>
</p>

<p class="sessionid">E0300</p></p>
<span>Schistosoma haematobium</span>
infection is associated with oncogenic gene expression in cervical mucosa, with enhanced effects following treatment 
<span>Anna Mertelsmann (Zürich, Switzerland)</span>
</p>

<p class="sessionid">E0301</p><span class="title">Associations between water and sanitation service, risk of intestinal schistosomiasis, infection intensity, and liver fibrosis in selected households living near Lake Albert: a descriptive cross-sectional study? 
<span>G. Lam* (London, United Kingdom), D. Dee, A. Edielu, E. Ohuma, V. Anguajibi, E. Webb, A. Wamboko, P.</span>
</p><p class="presenter">Mawa, J. Friedman, A. Bustinduy</p>

<p class="sessionid">E0302</p><span class="title">Schistosomiasis detected by Screening of sub- Saharan African Unaccompanied Minor Refugees in Berlin between 2023 and 2024 </span><span class="presenters">G. Equihua Martinez* (Berlin, Germany), A.K. Lindner, M.C. Moreno-Del Castillo, J. Hammer, M. Nürnberg, P. Pitzinger, T. Geppert, F. Mockenhaupt, B. Kampmann, F. Olgemöller</span>
</p>

<p class="sessionid">E0303</p><span class="title">NADPH oxidase of the mosquitoes and the antioxidant genes repertoire of the bacteria coordinate mosquito-bacteria interaction in midgut 
<span>B. Song* (Kowloon, Hong-Kong SAR, China), J. Zeb, N. Buchon, O. Sparagano, P. Butaye</span>
</p>

<p class="sessionid">E0304</p><span class="title">Molecular detection and sequencing of the genes encoding the predicted enzymes; Amidase, NADH ubiquinone oxidoreductase, and sodium neurotransmitter symporter in  
<span>Onchocerca volvulusA. Acheampong* (Sunyani, Ghana), J. Larbi,</span>
</p><p class="presenter">P.C. Kudzordzi, P. Nyarko, K.B. Otabil</p>

<p class="sessionid">E0305</p><span class="title">Tuberculosis outcomes among international migrants living in Europe compared to the non-migrant population: a systematic review and meta-analysis </span><span class="presenters">G. Guido* (Bari, Italy), S. Cotugno, L. Frallonardo, R. Papagni, V. Giliberti, F.V. Segala, C. Polizzotto, G. Di Franco, M. Affronti, E. Piccione, G. Gualano, F. Palmieri, M. Barbagallo, N. Veronese, A. Saracino, F. Di Gennaro</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EW079</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 11<span> </span>
</p><p>Educational Session</p><p> 
<span> New  guidelines  for  management  of  brain  infections</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Jacob Bodilsen (Aalborg, Denmark) Kartika Maharani (Jakarta, Indonesia)</p></td></tr>
<tr><td>

<p class="sessionid">W0237</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Tuberculous meningitis: what can we learn from the first global guidelines? <span> </span>Joseph Donovan (Ho Chi Minh City, Vietnam)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0238</p></p></td><td><p class="start">08:50</p></td><td><p class="title">WHO guidelines on bacterial meningitis: change of clinical practice? </p><span class="presenter">Matthijs Brouwer (Amsterdam, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0239</p></p></td><td><p class="start">09:10</p></td><td><p class="title">ESCMID encephalitis guidelines 2024: what’s new? </p><span class="presenter">Tom Solomon (Liverpool, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0240</p></p></td><td><p class="start">09:30</p></td><td><p class="title">WHO guidelines for cryptococcal meningitis: success stories and barriers to implementation </p><span class="presenter">Nelesh Govender (Johannesburg, South Africa)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain (ESGIB) <br/></p><p> 

</p><p> 



<p class="sessionid">SY073</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 12<span> </span>
</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Proxy indicators: bridging the gap between surveillance and antimicrobial stewardship</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Bhanu Sinha (Groningen, Netherlands) Annelies Verbon (Bosch En Duin, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0213</p></p></td><td><p class="start">08:30</p></td><td><p class="title">A broad spectrum of possibilities: spectrum scores as a unifying metric <span> </span>Céline Pulcini (Nancy, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0214</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Proxy indicators to estimate appropriateness of antibiotic prescriptions </p><span class="presenter">Diane Ashiru-Oredope (London, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0215</p></p></td><td><p class="start">09:30</p></td><td><p class="title">How to bridge the gap between surveillance and antimicrobial stewardship </p><span class="presenter">Mark G. J. De Boer (Leiden, Netherlands)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0216</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Health economics, surveillance and antimicrobial stewardship </p><span class="presenter">Zhu Nina Jiayue (London, United Kingdom)</span>
</p></td></tr></table><p>Co-organised with: Dutch Committee on Antimicrobial Policy, ESCMID Education Subcommittee, International Society for Infectious Diseases (ISID) <br/></p><p> 

</p><p> 



<p class="sessionid">SY074</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 13<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Difficile</span>
 
<span>to treat: advanced management strategies in difficult to treat CDI</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0217</p><span class="start">08:30</span><span class="title">Severe  CDI: when standard protocols fail 
<span>Hynek
 Bartos (Prague, Czech Republic)</span></p><p>

<p class="sessionid">S0218</p><span class="start">09:00</span><span class="title">Therapies  for complicated CDI 
<span>Emma Bishop (Clayton
 Vic, Australia)</span></p><p>

<p class="sessionid">S0219</p><span class="start">09:30</span><span class="title">Recurrent  CDI: Breaking the cycle 
<span>Andrea Marino
 (Catania, Italy)</span></p><p>

<p class="sessionid">S0220</p><span class="start">10:00</span><span class="title">Live  biotherapeutic products for  
<span>Clostridioides</span>
</p><p>difficile  infection<span> </span>Simon Goldenberg (London, United Kingdom)</p><p>Co-organised with: ESCMID Study Group for Clostridioides difficile (ESGCD) <br/></p><p> 

</p><p> 



<p class="sessionid">OS038</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 14<span> </span>
</p><p>2-hour Oral Session</p><p> 
<span> Making  fast  for  making  better:  AMR  rapid  diagnostics</span>
</p><p class="presenter">Chairs      Giulia De Angelis (Rome, Italy) Onur Karatuna (Växjö, Sweden) <br/></p>

<p class="sessionid">O0278</p><span class="title">Point of care rapid lateral flow antibiotic resistance test to detect carbapenem resistance in lower respiratory tract infections </span><span class="presenters">J. Rogers* (Bedford, United Kingdom), A. Gregg, Q. Liu, S. Owen, C. Chen,
 M. Edward, S. Jiang, W. Lu, L. Mynheer, W. Finch</span></p><p>

<p class="sessionid">O0279</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0280</p><span class="title">The NitroSpeed Taniborbactam NP test; easy detection of -lactamase sensitivity to taniborbactam 
<span>O. Raro* (Fribourg, Switzerland), S. Herrera-Espejo, M. Bouvier, A. Kerbol, L. Poirel, P. Nordmann</span>
</p>

<p class="sessionid">O0281</p><span class="title">Rapid detection of -lactamase-mediated resistance to aminopenicillins from urines. 
<span>P. Nordmann* (Fribourg, Switzerland), N. Helsens, C. Duployez, L. Poirel, R. Dessein</span>
</p>

<p class="sessionid">O0282</p><span class="title">Rapid detection of antibiotic resistance in direct urine samples 
<span>M. Bot* (Arnhem, Netherlands), J. Flipse, S. Bongers, J. Hoogerwerf, J. Ten Oever, H. Wertheim,
 M. Van Meer</span></p><p>

<p class="sessionid">O0283</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0284</p><span class="title"><span class="presenters"></span>
with the Urogenital and Resistance kit (AusDiagnostic) 
<span>A. Braille* (Paris, France), M. Mainardis, F. Meunier, M. Mathar, M. Mérimèche, B. Condamine, F. Caméléna, B. Berçot</span>
</p>

<p class="sessionid">O0285</p><span class="title">Comparative evaluation of rapid antimicrobial susceptibility testing assays for Gram-negative bacteria from positive blood cultures 
<span>D. Squitieri* (Rome, Italy), G. Menchinelli, C. Magrì, T. D'inzeo, M. Cacaci, B. Posteraro, G. De Angelis, M. Sanguinetti</span>
</p>

<p class="sessionid">O0286</p><span class="title">Rapid detection of Carbapenemases directly from positive blood culture bottle: A tool for early shifting from empirical to targeted therapy 
<span>K. Chaudhary* (New Delhi, India), H. Gautam, P. Batra, S. Mohapatra,</span>
</p><p>S. Sood, B. Dhawan, B. Das Kumar <br/></p><p> 

</p><p> 



<p class="sessionid">SY076</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 16<span> </span>
</p><p>2-hour Symposium <br/></p><div><p>AMR Surveillance in low resource countries: insights into clinical and policy translation</p></div><p><p>Chairs      Kwame Ohene Buabeng (Ho, Ghana)</p><p>H. Rogier Van Doorn (Hanoi, Vietnam)</p><table>
<tr><td>

<p class="sessionid">S0225</p></p></td><td><p class="start">08:30</p></td><td><p class="title">New indicators in national monitoring and evaluation of AMR supported by improved data utilisation </p><span class="presenter">Direk</span>
</p></td></tr>
<tr><td></td><td></td><td><p>Limmathurotsakul (Bangkok, Thailand)</p></td></tr>
<tr><td>

<p class="sessionid">S0226</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Interdisciplinary investigation of the drivers and burden of AMR in urinary tract infections </p><span class="presenter">Stephen Mshana (Mwanza, Tanzania, United republic of)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0227</p></p></td><td><p class="start">09:30</p></td><td><p class="title">A clinically-oriented AMR surveillance network: case- based surveillance and implementation </p><span class="presenter">Paul Turner (Siem Reap, Cambodia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0228</p></p></td><td><p class="start">10:00</p></td><td><p class="title">National prescribing guidelines based on AMR surveillance data </p><span class="presenter">Vilada Chansamouth (Vientiane, Lao People's democratic republic)</span>
</p></td></tr></table><p>Co-organised with: CAESAR network, ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) <br/></p><p> 

</p><p> 



<p class="sessionid">EW077</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 2</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">New tools in acute bacterial infections and sepsis: from machine learning to precision medicine</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Benjamin Mcfadden (Perth, Australia) Rita Murri (Rome, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">W0229</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Differentiating acute infection, sepsis and sepsis mimics in the ED? <span> </span>Lisa Mellhammar (Lund, Sweden)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0230</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Machine learning for early recognition of sepsis </p><span class="presenter">Karsten Borgwardt (Martinsried, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0231</p></p></td><td><p class="start">09:10</p></td><td><p class="title">How to avoid common mistakes in randomised clinical study design </p><span class="presenter">Yin Mo (Singapore, Singapore)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0232</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Improved clinical trials in community-acquired pneumonia using precision medicine </p><span class="presenter">Lennie Derde (Utrecht, Netherlands)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Scientific Affairs Subcommittee, European Clinical Research Alliance on Infectious Diseases (ECRAID), ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), European Sepsis Alliance (ESA), ESCMID Study Group for Antimicro <br/></p><p> 

</p><p> 



<p class="sessionid">SY072</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 3</span>

</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Tackling the emergence of dengue and other  <span> </span>Aedes</span>
-borne diseases in Europe</p></td></tr>
<tr><td><p class="presenters">Fernanda Boulos (São Paulo, Brazil)</p><p class="presenters">Martin P. Grobusch (Amsterdam, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0209</p></p></td><td><p class="start">08:30</p></td><td><p class="title">How dengue, chikungunya and zika virus disease became emerging threats to Europe <span> </span>Celine Gossner (Solna, Sweden)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0210</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Surveillance of dengue in urbanised tropical regions </p><span class="presenter">Vincent Junxiong Pang (Singapore, Singapore)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0211</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Mosquito surveillance and control: opportunities and challenges </p><span class="presenter">Tba</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0212</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Tracking autochthonous arboviral infection </p><span class="presenter">Luisa Barzon (Padua, Italy)</span>
</p></td></tr></table><p>Co-organised with: European Centre for Disease Prevention and Control (ECDC) <br/></p><p> 

</p><p> 



<p class="sessionid">EW078</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 4</span>

</p><p>Educational Session</p><p> 
<span> Implementing metagenomics in my lab and mistakes to avoid</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0233</p><span class="start">08:30</span><span class="title">Is  metagenomics right for my lab? 
<span>Paula Mölling</span>
</p><p>(Örebro, Sweden)</p><table>
<tr><td>

<p class="sessionid">W0234</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Understanding the experimental and certification aspects of metagenomics </p><span class="presenter">Mads Albertsen (Aalborg, Denmark)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0235</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Navigating tools, techniques, and procurement </p><span class="presenter">Basil Britto Xavier (Groningen, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0236</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Setting realistic goals and outcomes for metagenomics integration </p><span class="presenter">Claire Bertelli (Lausanne, Switzerland)</span>
</p></td></tr></table><p>Co-organised with: Danish Society for Clinical Microbiology, ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), Trainee Association of ESCMID (TAE) Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">OS037</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 5</span>

</p><p>2-hour Oral Session <br/></p><div><p>Whole genome sequencing: tracking transmission and reservoirs in outbreaks</p></div><p><p class="presenters"></p><p>

<p class="sessionid">O0268</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0269</p><span class="title">Why do routine genome-oriented surveillance for Pseudomonas aeruginosa? 
<span>A. Rath* (Regensburg, Germany), L. Grancicova, B. Kieninger, A. Caplunik- Pratsch, J. Fritsch, A. Eichner, W. Schneider-Brachert</span>
</p>

<p class="sessionid">O0270</p><span class="title">TreeTime estimation depicts transmission dynamics of clinical and environmental  
<span>Pseudomonas aeruginosa</span>
from common reservoirs in healthcare environment through whole genome sequencing (WGS) 
<span>Ö. Yetis* (London, United Kingdom), Ö. Yetiş,</span>
</p><p class="presenter">F. Dyrkell, S. Ali, P. Wilson</p>

<p class="sessionid">O0271</p><span class="title">Understanding  </span><span class="presenters">Serratia</span>
transmission during a neonatal ICU outbreak: A combined genotyping and risk factor analysis 
<span>K. Jaakkola* (Lyon, France), C. Dananché, A. Fischer, J.C. Picaud, P. Cassier, M. Colomb-Cotinat, S. Haÿs, J.P. Rasigade</span>
</p>

<p class="sessionid">O0272</p><span class="title">Genomic Insights into the Regional Transmission of KPC-Producing Bacteria: Clonal and Non-Clonal Plasmid Sharing 
<span>C. Shankar* (Ann Arbor, United States), A.M. Pirani, D.B. Narayanan, B. Brennan, S. Mcnamara, A. Miles-Jay, A. Bahr, E.S. Snitkin</span>
</p>

<p class="sessionid">O0273</p></p>Genome-oriented analysis of the first outbreaks involving the novel Serratia sarumanii at a neonatal unit 
<span>A. Rath* (Regensburg, Germany), B. Kieninger,</span>
</p><p class="presenter">L.J. Klages, A. Eichner, A. Keller-Wackerbauer, S.M. Wellmann, A. Ambrosch, J. Fritsch, A. Caplunik- Pratsch, M. Kabesch, J. Kalinowski, W. Schneider- Brachert</p>

<p class="sessionid">O0274</p><span class="title">Evaluating the Utility of Whole-Genome Sequencing to Optimise Infection Prevention and Control in a Hospital Setting: Findings from the GENOTIPE Study </span><span class="presenters">J. Price* (Brighton, United Kingdom), I. Sey, A. Yeoh, D. Wlazly, A. Davies, O. Makanjuola, J. Leach, S. Mookerjee, M. Krutikov</span>
</p><p>

<p class="sessionid">O0275</p><span class="title"><span class="presenters"></span>
in a Neonatal Intensive Care Unit: Genomic Characterization and Surveillance. 
<span>D. Pereira* (Porto Alegre, Brazil), P. Barth, L. Konkewicz, W. Latosinski,</span>
</p><p class="presenter">G. De Oliveira, L. Lutz, M. Mott, C. Constante, C. Wilhelm, L. Antochevis, R. Paiva, K. Tragnago, A. Barth, A. Martins</p>

<p class="sessionid">O0276</p><span class="title">Unveiling the Clonal Dynamics and transmission mechanism of Carbapenem-Resistant  </span><span class="presenters">Klebsiella pneumoniae</span>
in the ICU environment 
<span>X. Han* (Hangzhou, China), J. Zhou, Y. Jiang, Y. Yu</span>
</p>

<p class="sessionid">O0277</p><span class="title">Survey of Infection Prevention staff perception of WGS integration into routine IPC practice 
<span>D. Ling* (Melbourne, Australia), B. Baral, V. Madigan</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF041</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Contemporary  diagnostic  approaches  for  fungal  infections</span>
</p><p class="presenter">Chair       Ilse D. Jacobsen (Jena, Germany) <br/></p>

<p class="sessionid">E0306</p><span class="title">Evaluation of persistence of C. auris colonization in a cohort of patients discharged from a C. auris endemic area </span><span class="presenters">M. Bavastro* (Genoa, Italy), L. Mezzogori, M. Bonaffini, L. Magnasco, F. Centorrino, V. Di Pilato, E. Willison, F. Portunato,</span>
</p><p class="presenter">D.R. Giacobbe, A. Vena, A. Marchese, M. Mikulska,</p><p class="presenter">M. Bassetti</p>

<p class="sessionid">E0307</p><span class="title">A pilot study of digital retinal photography (DRP) and tele-ophthalmology of patients with candidemia. </span><span class="presenters">C. Clancy* (Pittsburgh, United States),</span>
</p><p class="presenter">C. Hadi, E. Waxman, J.A. Viehman, A. Eller, M. O'donnell, F. Silveira, P. Samantha, B. Smith, S. Padival, V. Nauriyal, M.H.T. Nguyen</p>

<p class="sessionid">E0308</p><span class="title">Epidemiology and diagnosis of Pneumocystis pneumonia : a 11 years-surveillance in France </span><span class="presenters">A. Alanio* (Paris, France), K. Boukris-Sitbon, M. Desnos-Ollivier, D. Garcia-Hermoso, F. Lanternier,
 O. Lortholoary</span></p><p>

<p class="sessionid">E0309</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">N.V. Rhijn, D. Denning</p>

<p class="sessionid">E0310</p><span class="title">Implementation and performance of a universal Mucorales PCR assay for diagnosis of mucormycosis </span><span class="presenters">A. Haas* (Salt Lake City, United States), K. Hanson</span>
</p>

<p class="sessionid">E0311</p><span class="title">Blood cultures (BCs) contain populations of genetically diverse Candida strains that may differ in antifungal resistance and tolerance 
<span>C. Clancy* (Pittsburgh, United States), S. Cheng, H. Badrane,</span>
</p><p class="presenter">B. Hao, G. Fleres, E. Driscoll, D. Chris, E. Josh, M.H. Nguyen</p>

<p class="sessionid">E0312</p><span class="title">Clinical validation of a urinary antigen test as an aid to diagnose invasive aspergillosis in hematology patients </span><span class="presenters">Y. Vanbiervliet* (Leuven, Belgium), R. Aerts,
 T. Mercier, E. Boon, G. Gysembert, E. Houben, K. Lagrou, J. Maertens</span></p><p>

<p class="sessionid">E0313</p><span class="title"><span class="presenters"></span>
clinical isolates 
<span>M. Siopi* (Athens, Greece), B. Spruijtenburg, I. Anagnostakis, C. Anthoulaki, A. Argyropoulou, S. Varveraki, C. Vossou, A. Votsi, P. Giannopoulou, K. Gartzonika, M. Damala, I. Daskalakis, I. Dendrinos, V. Dimitriou, E. Dimitroulia,</span>
</p><p>L.P. Drosopoulou, O. Zarkotou, L. Zachariadou, V. Ippa, A. Kampas, P. Karagiannidou, S. Karabela, A. Katsaka, A. Katsiaflaka, E. Kafkoula, M. Kimouli, I. Lamprou, O. Legga, V. Mamali, M. Martsoukou, G. Mouratis, C. Mparka, T. Biniari, A. Xanthaki, E. Oikonomopoulou, M. Orfanidou, F. Paliogianni, E. Palla, A. Pantazatou, K. Panteli, E. Papadogeorgaki,</p><p>M. Papadogianni, K. Papaefstathiou, P. Papanikolaou, J. Papaparaskevas, G. Parvouleskou,</p><p>E. Perivolioti, S. Pournaras, C. Silleli, T. Skalidis, E. Souki, A. Spiliopoulou, C. Stergiou, S. Tsiplakou, P. Tsolakidou, N. Charalampaki, E. Chinou, G.S. Christodoulatos, G. Chronopoulou, E. Chrysou, E. Meijer, A. Tsakris, J. Meletiadis, G. Vrioni <br/></p><p> 

</p><p> 



<p class="sessionid">EF042</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Prosthetic    and    device-associated    infections
 Chair      Marjan Wouthuyzen-Bakker (Groningen, Netherlands) <br/></span></p><p>

<p class="sessionid">E0315</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0316</p><span class="title">MIGRATING mesh - an unusual cause of pyogenic liver abscess 
<span>M. Caris* (Leiden, Netherlands), J. Rutgers, A. Inderson, S.M. Arend, L.M.F. Kuijpers</span>
</p>

<p class="sessionid">E0317</p><span class="title">Ceftaroline salvage monotherapy: successful treatment of a cerebrospinal fluid drain infection caused by a multidrug-resistant  
<span>Staphylococcus epidermidis</span>
strain 
<span>M.D. Di Trapani* (Bozen, Italy), T. Kamal Eldin, G. Spoladore, D. Drusiani, B. Ladinser, R. Aschbacher</span>
</p>

<p class="sessionid">E0318</p><span class="title">Timeline of early infections post porcine xenothymokidney transplant 
<span>H. Neumann* (New York, United States), M. Ringer, R. Alpizar-Rivas, J. Stern, F. Zervou, V. Halpern-Cohen, J. Hogan, A. Griesemer, R. Montgomery, S. Williams, S. Mehta</span>
</p>

<p class="sessionid">E0319</p><span class="title">Invasive Non-tuberculous mycobacteria Infection in children undergoing Cardiac Surgery at the specialized Cardiology Hospital of Peshawar 
<span>M. Khan* (Peshawar, Pakistan)</span>
</p>

<p class="sessionid">E0320</p><span class="title">Use of multiplex PCR assay analysis in patients with suspected implant-based breast reconstruction infection: a single center experience 
<span>A. Pagotto* (Udine, Italy), G.G. Caputo, A. Scarabosio, A. Sartor,</span>
</p><p class="presenter">A. Colombo, P.C. Parodi, C. Tascini</p>

<p class="sessionid">E0321</p><span class="title">PET CT controls and Dalbavancin therapeutic drug monitoring can help guiding Dalbavancin treatment duration of complicated cardiovascular infections </span><span class="presenters">C. Kujat* (Kiel, Germany), M. Jüptner, D. Pape, J. Frank,</span>
</p><p class="presenter">A.T.D. Thiem, B. Panholzer, B. Steinborn, S. Ewering,</p><p class="presenter">A. Friedrichs</p>

<p class="sessionid">E0322</p><span class="title">A complex case of pelvic bone infection caused by carbapenem-resistant  </span><span class="presenters">Acinetobacter baumanii</span>
successfully treated with eravacycline 
<span>M. Zagarrigo* (Bologna, Italy), S. Tedeschi, M. De Paolis, G. Fornaro,</span>
</p><p class="presenter">A. Pozzi, E. Zamparini, P. Viale</p>

<p class="sessionid">E0323</p><span class="title">Oritavancin in a patient with recurrent endocarditis by Enterococcus faecalis: a new therapeutic option? </span><span class="presenters">M. Bongiovanni* (Lugano, Switzerland), B. Barda, E. Bernasconi</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">KN080</p></span>
<span class="start">09:30</span>-<span class="end">10:30</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture</p><p> 
<span> Infections after solid organ transplantation: past, present and future</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0241</p>  09:30   
<span>Jay Fishman (Boston, United States)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY082</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 6</span>

</p><p>1-hour Symposium</p><p> 
<span> How  to  address  anti-science  in  our  community?</span>
</p><table>
<tr><td><p class="presenters">Tuba Dal (Ankara, Türkiye)</p><p class="presenters">Tyra Grove Krause (Copenhagen, Denmark)</p></td></tr>
<tr><td>

<p class="sessionid">S0243</p></p></td><td><p class="start">11:00</p></td><td><p class="title">The rise of anti-science: lessons for the future scientist <span> </span>Marion Koopmans (Rotterdam, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0244</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Open science for public trust </p><span class="presenter">Lisa Hansen (Ottawa, Canada)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">FO090</p></p></td><td><p>11:00  
<span>-</span>
12:00</p></td><td><p>Arena 1</p></td></tr>
<tr><td></td><td><p> 

</p><p>Open Forum</p></td><td></td></tr>
<tr><td><p> 
<span>  European   CM/ID   exam:   going   forward</span>
</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Siri Goepel (Tuebingen, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">F0259</p></p></td><td><p class="start">11:00</p></td><td><p class="title">View from medical microbiology <span> </span>Maeve Doyle (Waterford, Ireland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">F0260</p></p></td><td><p class="start">11:10</p></td><td><p class="title">view from infectious diseases </p><span class="presenter">Eoghan De Barra (Dublin, Ireland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">F0261</p></p></td><td><p class="start">11:20</p></td><td><p class="title">view from trainees (TAE) </p><span class="presenter">Christian Kraef (Copenhagen, Denmark)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">F0262</p></p></td><td><p class="start">11:30</p></td><td><p class="title">European exam - how to prepare? </p><span class="presenter">Annelies Verbon (Bosch En Duin, Netherlands)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Education Subcommittee, ESCMID Professional Affairs Subcommittee, UEMS Section of Medical Microbiology, UEMS Section of Infectious Diseases <br/></p><p> 

</p><p> 



<p class="sessionid">EF049</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Sometimes   it's   hard   to   be   a   woman</span>
</p><p class="presenter">Chair       Debora Konopnicki (Brussels, Belgium) <br/></p>

<p class="sessionid">E0354</p><span class="title">Interleukins 17 and 18: Key players in Cervical Cancer Progression in Indian Population </span><span class="presenters">P. Gupta* (Bhopal, India), A. Vyas, A. Halder, S. Purwar</span>
</p><p>

<p class="sessionid">E0355</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0357</p><span class="title">Rubella screening in pregnancy – Slovakian one- center retrospective analysis around COVID-19 pandemic 
<span>Z. Paraličová* (Kosice, Slovakia), D. Javorská</span>
</p>

<p class="sessionid">E0358</p><span class="title">The impact of maternal influenza infection and vaccination during pregnancy on birth outcomes 
<span>B. Goundappa* (Pittsburgh, United States), X. Zhang,</span>
</p><p class="presenter">B. Gk, H.E.A. D'agostino, H. Liu, A.M. Rick</p>

<p class="sessionid">E0359</p><span class="title">Use of valaciclovir therapy during pregnancy for the prevention of congenital cytomegalovirus infection: a monocentric experience </span><span class="presenters">G. Lorenzetti* (Rome, Italy), S. Garattini, L. Romani, M. Di Giuseppe, M. De Luca, L. Cursi, S. Bernardi, S. Chiurchiù, S. Mercadante, C. Tripiciano, A. Krzysztofiak, C. Vassallo, I. Fabietti, L. Caforio, L. Lancella, F.I. Calò Carducci</span>
</p>

<p class="sessionid">E0360</p></p>Multi-systemic long-term sequelae following SARS- CoV-2 Omicron infection in pregnancy: a population-based cohort study 
<span>Y.Y. Tan* (Singapore, Singapore), E.X.H. Loy, A.T. Tay, J.T. Lim, C.J. Chiew, D.C.B. Lye, L.E. Wee</span>
</p>

<p class="sessionid">E0361</p><span class="title">The Impact of <p class="sessionid" style="background-color: red;">OAS1</p> <p class="sessionid" style="background-color: red;">rs4766664</p> and <p class="sessionid" style="background-color: red;">OAS3</p> <p class="sessionid" style="background-color: red;">rs10735079</p> Polymorphisms on the Clinical Course of COVID-19 in Pregnant Women 
<span>S. Kirik Yilmaz* (Konya, Türkiye), S. Kırık Yılmaz, S. Sumer, N. Demir Aktug, O. Ural, E. Ozdemir Marzioglu, O. Secilmis, T. Cora</span>
</p>

<p class="sessionid">E0362</p></p>Sex-stratified analysis of T cell activation, exhaustion, proliferation and HIV reservoir among PLWH 
<span>L. Santinelli* (Rome, Italy), M. Andreotti, L. Maddaloni, Z. Michelini, G. Bugani, F. Romano, E. Gentili Cacciola, G. Antonelli, C.M. Mastroianni, C. Scagnolari, G. D'ettorre</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF050</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>   Expanding      MALDI-TOF      applications</span>
</p><p class="presenter">Chair      Belen Rodriguez-Sanchez (Madrid, Spain) <br/></p>

<p class="sessionid">E0363</p><span class="title">Application of MALDI-TOF Mass Spectrometry and Machine Learning for the Detection of Vancomycin- Resistant  </span><span class="presenters">Enterococcus faeciumM. Sánchez Cueto* (Madrid, Spain), M. Sánchez-Cueto, M. Blázquez- Sánchez, M. Marín, E. Cercenado, P. Muñoz, B. Rodríguez-Sánchez, D. Rodríguez-Temporal</span>
</p>

<p class="sessionid">E0364</p><span class="title">Early detection of ampicillin susceptibility in  
<span>Enterococcus faecium</span>
with MALDI-TOF MS and machine learning 
<span>T. Pichl* (Munich, Germany), L. Miranda, N. Wantia, K. Borgwardt, J. Sattler</span>
</p>

<p class="sessionid">E0365</p><span class="title">Rapid antifungal resistance prediction based on MALDI TOF mass spectrometry 
<span>D. Duroux* (Zurich, Switzerland), Y. Yang, J. Sattler, A. Egli</span>
</p>

<p class="sessionid">E0366</p><span class="title">Rapid prediction of fluconazole resistance by machine-learning analysis of  
<span>Candida parapsilosis</span>
MALDI-TOF mass profiles 
<span>C. Magri* (Rome, Italy), C. Magrì, V. Ivagnes, M. Sanguinetti, E. De Carolis</span>
</p>

<p class="sessionid">E0367</p><span class="title">Optimizing pretreatment for MALDI-TOF MS: Evaluating the dispersion method for filamentous fungal identification 
<span>R. Huang* (Shenzhen, China), Y. Li, Y. He, T. Ma, F. Lu</span>
</p>

<p class="sessionid">E0368</p><span class="title">Rapid detection of colistin resistance in Acinetobacter baumannii by a MALDI-TOF MS-based assay 
<span>E. Kırbaş* (Van, Türkiye), I.D. Nix, K. Sparbier,</span>
</p><p class="presenter">O. Drews, B. Oberheitmann, M. Kostrzewa, G. Hasçelik, B. Sancak</p>

<p class="sessionid">E0369</p><span class="title">Discrimination of clinical  </span><span class="presenters">Pseudomonas</span>
strains at the species level using a large-scale genomically predicted protein mass database with MALDI-MS 
<span>K. Teramoto* (Kyoto, Japan), Y. Sekiguchi, L. Sellami,</span>
</p><p class="presenter">M. Tohya, T. Kirikae</p>

<p class="sessionid">E0370</p><span class="title">Automatic differentiation of  </span><span class="presenters">Clostridioides difficile</span>
ribotypes using MALDI-TOF MS and web-based classification models 
<span>M. Blazquez Sanchez* (Madrid, Spain), M.C. Blazquez-Sanchez, J.M. Moreno, A. Guerrero-López, G.P. Mark, V. Gómez-Verdejo, P. Muñoz, M. Marín, L. Alcalá, D. Rodriguez-Temporal,</span>
</p><p class="presenter">B. Rodriguez-Sanchez</p>

<p class="sessionid">E0371</p><span class="title">Identification of sepsis-causing bacteria using shotgun proteomics </span><span class="presenters">L. Meekes* (Rotterdam, Netherlands), D. Rustad, C. Güzel, T.K. Jenssen, H. Hauge, C. Klaassen, M. Bexkens, N. Strepis, T. Luider,</span>
</p><p>W. Goessens <br/></p><p> 

</p><p> 



<p class="sessionid">EF051</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 4<span> </span>
</p><p class="presenter">ePoster Flash Session <br/></p><div><p>The enemy of my enemy: From jumbo phages to cocktails for difficult to treat infections</p></div><p><p>Chair      Paul G. Higgins (Cologne, Germany) <br/></p>

<p class="sessionid">E0372</p><span class="title">Anti-<p class="sessionid" style="background-color: red;">K2</p> recombinant phage depolymerases as anti- virulence agents against hypervirulent  </span><span class="presenters">Klebsiella pneumoniaeM. Roch* (Geneva, Switzerland), R. Sierra, D. Andrey</span>
</p>

<p class="sessionid">E0373</p><span class="title">Jumbo  
<span>Klebsiella</span>
bacteriophage demonstrates efficient multidrug-resistant  
<span>Klebsiella pneumoniae</span>
killing and significant clinical potential 
<span>Y. Liu* (Singapore, Singapore), Y. Zhong, S. Thong, L.H.A. Kwa</span>
</p>

<p class="sessionid">E0374</p><span class="title">A new phage cocktail targeting at  
<span>Klebsiella pneumoniaeX. Yin* (Chengdu, China), Y. Feng, H. Luo, Z. Zong</span>
</p><p>

<p class="sessionid">E0375</p><span class="title"><span class="presenters"></span>
in murine models 
<span>A.M. Örmälä- Tiznado* (Stockholm, Sweden), S. Patpatia, J. Bengoechea, C. Frantzen, A. Garcia Navarro, C. Giske</span>
</p>

<p class="sessionid">E0376</p><span class="title">A novel broad-spectrum phage cocktail effictive for carbapenem resistant  
<span>Acinetobacter baumannii</span>
of capsular type 104/2/7 in vitro 
<span>L. Wei* (Chengdu, China), Y. Feng, Z. Zong</span>
</p>

<p class="sessionid">E0377</p><span class="title">Proteomic and Genomic Characterization of a Novel Bacteriophage of a New Genus Infecting  
<span>Pseudomonas aeruginosaS. Unlu* (Ankara, Türkiye),
 A. Uskudar Guclu</span></p><p>

<p class="sessionid">E0378</p><span class="title"><span class="presenters"></span>
and  
<span>P. aeruginos</span>
a in the context of Cystic Fibrosis 
<span>A. Glorieux* (Brussels, Belgium), S. De Soir, M. Merabishvili, J.P. Pirnay, D. De Vos, F. Van Bambeke</span>
</p><p>

<p class="sessionid">E0379</p><span class="title"><span class="presenters"></span>
strains isolated from orthopaedic infections 
<span>S. Patpatia* (Helsinki, Finland), A. Camporeale, S. Kiljunen, C. Giske, A.M. Örmälä-Tiznado</span>
</p><p>

<p class="sessionid">E0380</p><span class="title"><span class="presenters"></span>
phages: assessing the risk of bacterial resistance emergence through selective pressure 
<span>M. Degreze* (Lyon, France), M. Medina, F. Laumay, L. Blazère, E. Helluin, F. Laurent,</span>
</p><p>C. Kolenda <br/></p><p> 

</p><p> 



<p class="sessionid">KN081</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture</p><p> 
<span> The  new  frontiers  in  antimicrobial  stewardship</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0242</p>  11:00    
<span>Karin Thursky (Carlton, Australia)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY084</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 10<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Sleeping sickness and Chagas: a tale of the two trypanosomes</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0247</p><span class="start">11:00</span><span class="title">Human  African Trypanosomiasis: recent diagnostic and medical practices 
<span>Jean-Mathieu Bart (Conakry, Guinea)</span>
</p><p>

<p class="sessionid">S0248</p><span class="start">11:30</span><span class="title">American  Trypanosomiasis: Diagnosis, screening and management 
<span>Tba</span>
</p><p>Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) <br/></p><p> 

</p><p> 



<p class="sessionid">OS047</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 11<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>   Clinical     studies      in      UTI</span>
</p><p class="presenter">Chairs      Iva Butic (Zagreb, Croatia)</p><p class="presenter">Paul Christoffer Lindemann (Bergen, Norway) <br/></p>

<p class="sessionid">O0344</p><span class="title">Short versus long antibiotic treatment for pyelonephritis and complicated UTIs: an updated systematic review and meta-analysis of RCTs </span><span class="presenters">I. Zahavi* (Haifa, Israel), D. Kunwar, J. Olchowski, H. Dallasheh, M. Paul</span>
</p>

<p class="sessionid">O0345</p><span class="title">Antibiotic treatment duration of complicated urinary tract infection patients in Europe: results from the Ecraid POS-cUTI study 
<span>C. Kats* (Utrecht, Netherlands), J.M. Bravo-Ferrer, T.T. Doesschate,</span>
</p><p class="presenter">P.D. Van Der Linden, P. Martinez, O. Awwad, E. Rubio,</p><p class="presenter">P. Clevenbergh, A. Barac, A. Cano, E. Merino, P. Andrade, L. Jacquin, B. Koprivica, R. Espindola, P. Muñoz, T. Lafon, M. Mendris, J. Van Laethem, D. Viglino, A. Ternhag, J. Rupp, A. Hernandez-Torres, D. Chadwick, B. Carevic, M. Bonten, E. Tacconelli, J. Rodríguez-Baño</p>

<p class="sessionid">O0346</p><span class="title">Prevalence and impact of multidrug resistance in a cohort of patients admitted to emergency department for urinary tract infections: the UTILITY study, a prospective multicentre study </span><span class="presenters">L. Onorato* (Naples, Italy), E. Allegorico, M. Macera, C. Monari, B. Migliaccio, F.G. Numis, C. Nasta, M.T. Florio, R. Sciorio, G. Guiotto, M. Giordano, R. Raucci, F. Dello Vicario, R. Nasti, A. Voza, N. Coppola</span>
</p>

<p class="sessionid">O0347</p><span class="title">Weekly sequential antibioprophylaxis for UTI in neurogenic bladder 
<span>R. Calin* (Paris, France), C. Chesnel, C. Hentzen, M. Teng, F. Le Breton, V. Phe, F. Adda, C. Palacios, G. Amarenco, G. Pialoux</span>
</p>

<p class="sessionid">O0348</p><span class="title">Evidence for the duration of antibiotic therapy for chronic bacterial prostatitis: a systematic review 
<span>L. Cordes* (Geneva, Switzerland), A. Huttner, R. Calin,</span>
</p><p>K. Gupta, M. Lafaurie, M. Lambregts, V. Lavergne, B. Trautner <br/></p><p> 

</p><p> 



<p class="sessionid">OS048</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 12<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Complexities  of  infections  in  solid  organ  transplantation</span>
</p><p class="presenter">Chair       Silvia Corcione (Turin, Italy) <br/></p>

<p class="sessionid">O0349</p><span class="title">Solid Organ Transplants from donors with positive blood cultures: watch out for carbapenem-resistant Enterobacterales </span><span class="presenters">A. Cona* (Palermo, Italy), C.
 Curatolo, P. Giordani, F. D'andrea, M. Campanella, E. Conoscenti, S. Caruso, G. Mulè, D. Lo Porto, F. Monaco, F. Cardinale, G. Di Martino, D. Di Carlo, N. Coppola, A. Mularoni</span></p><p>

<p class="sessionid">O0350</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0351</p><span class="title">Serologic follow up of solid organ transplant recipients who receive organs from syphilis seropositive donors. 
<span>O. Fernandez Garcia* (Edmonton, Canada), D. You, J. Gratrix, A. Singh, K. Doucette</span>
</p>

<p class="sessionid">O0352</p><span class="title">Prophylaxis strategies and risk of cytomegalovirus in solid organ transplant recipients 
<span>A. Dahl* (KøbenhaVn V, Denmark), M. Koller, O.J. Manuel, K.S. Moestrup,
 J. Reekie, E. Tusch, C.G. Crone, M. Perch, F. Gustafsson, S.S. Sorensen, N. Schultz, K. Schønning,</p><p>J. Lundgren, N. Mueller, M. Helleberg</span></p><p>

<p class="sessionid">O0353</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY085</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 13<span> </span>
</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Diagnosing the undiagnosed fraction: the final step towards viral hepatitis elimination</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Mojca Maticic (Ljubljana, Slovenia) Snjezana Zidovec Lepej (Zagreb, Croatia)</p></td></tr>
<tr><td>

<p class="sessionid">S0249</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Role of reflex testing strategies in identifying patients with chronic viral hepatitis <span> </span>Oana Sandulescu (Bucharest, Romania)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0250</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Management and elimination of hepatitis in hard-to- reach persons </p><span class="presenter">Suda Tekin (Istanbul, Türkiye)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Viral Hepatitis (ESGVH), Romanian Society for Infectious Diseases and HIV/AIDS <br/></p><p> 

</p><p> 



<p class="sessionid">SY086</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Impact on including a measure of viability in molecular diagnostic tests</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0251</p>   11:00   Viability markers in support of development of Chlamydia  screening recommendations<span> </span>Petra Wolffs (Maastricht, Netherlands)</p><p><p class="sessionid" style="background-color: red;">S0252</p><span class="start">11:30</span><span class="title">Measuring  viability to improve the correlation of AMR markers and clinical outcomes in  
<span>Neisseria gonorrhoeaeTatum Mortimer (Athens, United States)</span>
</p><p>Co-organised with: ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) <br/></p><p> 

</p><p> 



<p class="sessionid">ME089</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 15<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span>  How    to    teach    Medical    Mycology</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0257</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Katrien Lagrou (Leuven, Belgium)</p></td></tr>
<tr><td>

<p class="sessionid">M0258</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Mihai Mares (Iasi, Romania)</p></td></tr></table><p>Co-organised with: European Confederation of Medical Mycology (ECMM) <br/></p><p> 

</p><p> 



<p class="sessionid">SY087</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 16<span> </span>
</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Innovating antimicrobial drug discovery and host-pathogen interaction studies using chemical biology</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Laurent Poirel (Fribourg, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">S0253</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Bacterial PROTACs: Do proteolysis-targeting degraders represent a viable strategy for new antimicrobials? <span> </span>Morreale Francesca Ester (London, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0254</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Activity-based protein profiling of bacterial pathogens: new enzymes and their functions at the host-microbe interface </p><span class="presenter">Christian Stephan Lentz (Tromsø, Norway)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">ME088</p></p></td><td><p>11:00  
<span>-</span>
12:00</p></td><td><p>Hall 2</p></td></tr>
<tr><td></td><td><p>Meet-the-Expert</p></td><td></td></tr></table><p> 

</p><p> 
<span> Global  AMR  Policy  after  UNGA:  what  do  we  do  now!</span>
 <br/></p><table>
<tr><td><p>

<p class="sessionid">M0255</p> <p class="sessionid" style="background-color: red;">M0256</p></p></td><td><p>11:00</p><p>11:12</p></td><td><p>Gisela Robles Aguilar (Oxford, United Kingdom) Mike Sharland (London, United Kingdom)</p></td><td></td></tr>
<tr><td>

<p class="sessionid">OS043</p></p></td><td></td><td><p>11:00  
<span>-</span>
12:00</p><p>1-hour Oral Session</p></td><td><p>Hall 3</p></td></tr></table><p> 

</p><p> 
<span> Navigating disinfection challenges: resistance, outbreaks, and efficacy</span>
</p><p class="presenter">Chairs      Hillary A. Craddock (Dublin, Ireland)</p><p class="presenter">Stephanie J. Dancer (Glasgow, United Kingdom) <br/></p>

<p class="sessionid">O0324</p><span class="title">Prolonged disinfectant exposure impacts the antimicrobial resistance of healthcare-associated microorganisms: a systematic review </span><span class="presenters">Â.R. Fernandes* (Porto, Portugal), A. Gonçalves Rodrigues, L. Cobrado</span>
</p>

<p class="sessionid">O0325</p></p>Sink-associated outbreak of verona integron- encoded metallo-??-lactamase-producing carbapenem-resistant  
<span>Pseudomonas aeruginosa</span>
in a Dutch intensive care unit 
<span>M. Van Den Bos Kromhout* (Zwolle, Netherlands), S. Debast, M. Van Den Bos- Kromhout, S. De Vries-Van Rossum, S. Abma-Blatter,
 B. Immeker, K. Zuur, M. Hijmering, J.W.A. Rossen</span></p><p>

<p class="sessionid">O0326</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">L.K. Vejrum, A.L. Laugesen, M. Kemp</p>

<p class="sessionid">O0327</p><span class="title">Tolerance of  </span><span class="presenters">Klebsiella pneumoniae</span>
biofilms to disinfection with peracetic acid 
<span>M. Arvand* (Berlin, Germany), A.M. Richter, D. Csertö, K. Konrat</span>
</p>

<p class="sessionid">O0328</p><span class="title">Bringing balance to the formulation: disinfection efficacy and material compatibility 
<span>J. Jennings* (Halifax, United Kingdom), T. Langford, H. Mansbridge, E. Fraser, I. Poles, J. Clarke</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">LB002</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 4</span>
</p><p>1-hour Oral Session</p><p> 
<span>  Investigation    of    intriguing    outbreaks</span>
 <br/></p>

<p class="sessionid">L0006</p><span class="title">Molecular surveillance of artemisinin and</p><p>sulfadoxine-pyrimethamine resistance in  
<span>Plasmodium falciparum</span>
isolates from Uganda: results of ERASE study 
<span>M. L'episcopia* (Rome, Italy), F.V. Segala, J. Ictho, R. Papagni, I. Obua, E. De Vita, N. Olang, R. Novara, V. Totaro, L. Olal, G. Patti, C. Bignom, C. Agaro, G. Dall'oglio, B. Ngole, S. Okori, P. Lochoro, G.</span>
</p><p class="presenter">Putoto, F. Di Gennaro, C. Severini, A. Saracino</p>

<p class="sessionid">L0007</p><span class="title">Investigation of an international pseudo-outbreak involving  </span><span class="presenters">Paraburkholderia fungorum</span>
blood culture contamination 
<span>J. Moran-Gilad* (Jerusalem, Israel),</span>
</p><p class="presenter">J.L. Dale, A. Michael-Gayego, A. Gross, V. Temper, S. Lim, C. Lees, K. Knowles, J. Strahilevitz, Y. Oster, D. Grupel, D. Reshef, B.A. Smith, B. Warren, E.L. Palavecino, P. Snippes Vagnone</p>

<p class="sessionid">L0008</p><span class="title">Evolving cluster of severe infective endocarditis with non-toxigenic C. diphtheriae amongst people experiencing homelessness and substance misuse in the UK </span><span class="presenters">R. Cordery* (London, United Kingdom), T. Patel, T. Anwar, N. Utjesanovic, A. Aryee, E. Mavrogiorgou, N. Karogiannis, D.J. Litt, J. D'aeth, C. Primus, S. Das, K. Paranthaman, G. Amirthalingham</span>
</p>

<p class="sessionid">L0009</p></p>AI-driven live cough rate tracking for public health surveillance 
<span>M. Kågebäck* (Göteborg, Sweden), E. Carlsson</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS044</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 5</span>

</p><p>1-hour Case Session</p><p> 
<span>  Unusual   presentations   of   unusual   parasites</span>
</p><p class="presenter">Chairs      Emmanuel Bottieau (Antwerp, Belgium)</p><p class="presenter">Marcelo Victor Radisic (Buenos Aires, Argentina) <br/></p>

<p class="sessionid">O0329</p><span class="title">Atypical neonatal cutaneous myiasis: a diagnostic challenge mimicking pustular rash in a resource- limited setting </span><span class="presenters">D. Ekwem Amarachi* (Gulu, Uganda),
 E. Namara, E. Ssenuni, A. Amuge, V. Omona, R. Okidi,</p><p>R. Olum</span></p><p>

<p class="sessionid">O0330</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">J.M. Bérenegr, S. Ranque</p>

<p class="sessionid">O0331</p><span class="title">Uterine Myiasis: A Rare Case of External Genitourinary Myiasis </span><span class="presenters">R.L. Johnson* (Birmingham, United States), J.C.F. Nakazaki, P. Legua</span>
</p><p>

<p class="sessionid">O0332</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0333</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY083</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 7</span>

</p><p>1-hour Symposium</p><p> 
<span> Lyme neuroborreliosis: challenges in diagnosis and treatment</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0245</p><span class="start">11:00</span><span class="title">Challenges  in diagnosis of Lyme neuroborreliosis 
<span>Rick Dersch (Freiburg, Germany)</span>
</p><p>

<p class="sessionid">S0246</p><span class="start">11:30</span><span class="title">Challenges  in treatment of Lyme neuroborreliosis 
<span>Anne Marit Solheim (Kristiansand, Norway)</span>
</p><p>Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), ESCMID Study Group for Lyme Borreliosis (ESGBOR) <br/></p><p> 

</p><p> 



<p class="sessionid">OS045</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 8</span>

</p><p>1-hour Oral Session</p><p> 
<span> Social  behavioural  dynamics  of  antibiotic  use  and  AMR</span>
</p><p class="presenter">Chairs      Sonia Lewycka (Hanoi, Vietnam) Filippo Medioli (Milan, Italy) <br/></p>

<p class="sessionid">O0334</p><span class="title">Investigating the Knowledge, Attitudes, and Practices around Antimicrobial Resistance and Stewardship Among Syrian Healthcare Professionals: A Cross- Sectional Survey </span><span class="presenters">A. Abbara* (London, United
 Kingdom), H. Alhosni, F. Alahdab</span></p><p>

<p class="sessionid">O0335</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">K. Gautam</p>

<p class="sessionid">O0336</p><span class="title">Healthcare providers' perspectives on antibiotic use and resistance in pregnancy, childbirth, and children under five years of age across four levels of hospitals in Lao PDR, 2024 </span><span class="presenters">S. Vantava* (Vientiane Capital, Lao People's democratic republic), K. Thilakoun, D. Sypaseuth, C. Khamla, I. Bounxou, P. Vanpheng, B. Phetsamone, S. Bangthong, K. Sengchanh, S. Latsamy, S. Vanphanom, L. Annick, S. Somphou</span>
</p>

<p class="sessionid">O0337</p><span class="title">High gender gap in female labour force participation and reduced gender inequality linked to high antibiotic consumption: Evidence from a global analysis 
<span>D. Samria* (Bangalore, India), D. Batheja, A. Nandi</span>
</p><p>

<p class="sessionid">O0338</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS046</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 9</span>

</p><p>1-hour Oral Session</p><p> 
<span> Vaccines and prophylaxis against respiratory viral infections</span>
</p><p class="presenters"></p>

<p class="sessionid">O0339</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">S. Samson, M.M. Loiacono, R. Harris, C. Schade Larsen, A.M. Reimer Jensen, N.E. Landler, S. Tellerup Nielsen, L. Russell, T. Skovsgaard Itenov, B.L. Claggett, S.D. Solomon, M.J. Landray, G.H. Gislason,</p><p class="presenter">L. Køber, P. Sivapalan, J.U. Stæhr Jensen, T. Biering- Sørensen</p>

<p class="sessionid">O0341</p><span class="title">Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses </span><span class="presenters">C. Grassi* (Cambridge, United States), S. Chalkias, P. Dennis, D. Petersen, K. Radhakrishnan, L. Vaughan, R. Handforth, N. Vicic, A. Rossi, R. Wahid, D. Edwards, J. Feng, W. Deng, H. Zhou, E. De Windt, V. Urdaneta, B. Girard, S. Faust, S. Walsh, C. Cosgrove, R. Das</span>
</p>

<p class="sessionid">O0342</p></p>
<span>Effectiveness of RSV vaccine in lung transplant recipients: neutralizing antibody response against reference and seasonal strainsN. Shirin* (Ramat Gan, Israel), L. Levy, D. Yahav, M. Benzimra, Y. Bezalel, T. Hoffman, T. Sinai, M. Jurkowicz, O. Deri, N. Matalon,
 M. Saute, Y. Lustig, E. Nachum, M. Peled, I. Nemet, M. Mandelboim</span></p><p>

<p class="sessionid">O0343</p><span class="title"><span class="presenters"></span>
</p><p> 

</p><p> 



<p class="sessionid">SY093</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 11<span> </span>
</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Immunosenescence and immune response to vaccination</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Petar Velikov (Sofia, Bulgaria) Dafna Yahav (Ramat-Gan, Israel)</p></td></tr>
<tr><td>

<p class="sessionid">S0267</p></p></td><td><p class="start">13:30</p></td><td><p class="title">How immunosenescence impacts vaccine response <span> </span>Andrea Cossarizza (Modena, Italy)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0268</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Strategies to tackle immunosenescence and improve immune response to vaccination in the elderly </p><span class="presenter">Inna Ovsyannikova (Rochester, United States)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infections in the Elderly (ESGIE), ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">EW096</p><span> </span><span class="start">13:30</span>-<span class="end">15:30<span class="location">Hall 15<span> </span>
</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Tools for successful development as a medical educator</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Giorgia Caruana (Sion, Switzerland) Yoav Keynan (Winnipeg, Canada)</p></td></tr>
<tr><td>

<p class="sessionid">W0273</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Developing your educator professional identity <span> </span>Todd Cassese (Bronx, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0274</p></p></td><td><p class="start">13:50</p></td><td><p class="title">What do IPC doctors need to learn to be prepared </p><span class="presenter">Simone Scheithauer (Göttingen, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0275</p></p></td><td><p class="start">14:10</p></td><td><p class="title">Communities of practice: successful experience of a transformative collaboration and roadmap </p><span class="presenter">Erin Bonura (Portland, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0276</p></p></td><td><p class="start">14:30</p></td><td><p class="title">The critical need for ongoing innovations in medical education </p><span class="presenter">Clémentine Schilte (Paris, France)</span>
</p></td></tr></table><p>Co-organised with: Infectious Diseases Society of America (IDSA), ESCMID Professional Affairs Subcommittee, Trainee Association of ESCMID (TAE) Steering Committee, British Infection Association (BIA), Young Leader Circle of the American Society of Microbiology <br/></p><p> 

</p><p> 



<p class="sessionid">FO097</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 1<span> </span>
</p><p>Open Forum <br/></p><table>
<tr><td><p>Essential diagnostics in Low-Resource Settings: why are we still talking?</p></td></tr>
<tr><td><p>Chair</p></td><td></td><td><p>Truls Michael Leegaard (Lørenskog, Norway)</p></td></tr>
<tr><td>

<p class="sessionid">F0277</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Training skilled personnel in LMIC and brain drain: is the solution the problem? <span> </span>Sipho Kenneth Dlamini (Observatory, South Africa)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">F0278</p></p></td><td><p class="start">13:40</p></td><td><p class="title">Leveraging surveillance networks to strengthen basic bacteriology </p><span class="presenter">Dissou Affolabi (Cotonou, Benin)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">F0279</p></p></td><td><p class="start">13:50</p></td><td><p class="title">Clinical bacteriology laboratories in low-resource settings: considerations for sustainability </p><span class="presenter">Makeda Semret (Montreal, Canada)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Professional Affairs Subcommittee, Dutch Society for Medical Microbiology (NVMM), ESCMID Parity Commission,Federation of European Microbiological Societies (FEMS), ESCMID Study Group for Antimicrobial stewardship (ESGAP), Société belge d'Infectiolo <br/></p><p> 

</p><p> 



<p class="sessionid">FO098</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 2<span> </span>
</p><p>Open Forum <br/></p><div><p>Best of ID Week</p></div><p><p>Chair      Tina Tan (Chicago, United States) <br/></p>

<p class="sessionid">F0280</p></p>
<span>, Seth Cohen (Seattle, United States), Erin Mccreary (Pittsburgh, United States), Ilan Youngster (Beer Yaakov, Israel)</span>
 <br/></p><p> 


</p><p>ePoster Flash Session</p><p> 
<span> Beware the sink! Pathogen reservoirs in drains and waste water</span>
</p><p class="presenter">Chair       Stephan Juergen Harbarth (Geneva, Switzerland) <br/></p>

<p class="sessionid">E0391</p><span class="title">Genomic Epidemiology to Investigate Healthcare Environment as Reservoir for Carbapenem- Resistant Organisms in an Academic Hospital in Miami, Florida. </span><span class="presenters">A. Jimenez* (Miami, United States),</span>
</p><p class="presenter">S. Hawken, S. Arenas, K. Mokoban, D. Pronty, O. Martinez, J. Colson, A. Richardson, T. Ferreira, B. Shukla</p>

<p class="sessionid">E0392</p><span class="title">Two clusters of carbapenemase-producing Enterobacterales linked to hospital wastewater drainage in utility rooms – an outbreak investigation </span><span class="presenters">I. Vock* (Basel, Switzerland), G. Capoferri, P. Urwyler, P. Domene, D. Roy, S. Kuster,</span>
</p><p class="presenter">N. Gürtler, B. Ivan, P.M. Keller, S. Tschudin-Sutter</p>

<p class="sessionid">E0393</p><span class="title">Assessing the burden of carbapenemase and colistin antimicrobial resistance genes in hospital wastewater </span><span class="presenters">E. Au* (Calgary, Canada), N. Acosta, B. Waddell, J. Lee, K. Du, R.B. Weyant, B. Dalton, M. Bautista, J. Mccalder, R. Clark, J. Pitout, J. Kim, B. Missaghi, O. Larios, J. Vayalumkal, J. Leal, E. Rennert-May, J. Kanji, P. Westlund, B. Lee, X.L. Pang, K. Frankowski, C. O'grady, J.M. Conly, C.R. Hubert, M. Parkins</span>
</p>

<p class="sessionid">E0394</p><span class="title">Hospital wastewater as a reservoir for carbapenemase-producing organisms 
<span>A. Anantharajah* (Brussels, Belgium), C. Altintas, T. Lavalleye, A. Delaunoy, I. Meyts, E. Dumitreasa, A. Bennert, C. Schirvel, A. Verroken, H. Rodriguez- Villalobos</span>
</p>

<p class="sessionid">E0396</p><span class="title">Reversing and controlling microbial proliferation in the water system of a high-risk hospital ward after extended closure and reconstruction 
<span>D. Chaput* (Glasgow, United Kingdom), K. Clarkson, L. Bagrade, A. Marek, D. Kelly, D. Watson, A. Leanord,</span>
</p><p class="presenter">T. Steele</p>

<p class="sessionid">E0397</p><span class="title">Whole-genome sequencing as part of the tracking and managing Carbapenemase producing Enterobacterales transmission in an acute hospital setting </span><span class="presenters">D. Coffey* (Cork, Ireland), R. Waldron, D. Neshev, M. Cormican, C. Clarke, L. Hayes</span>
</p>

<p class="sessionid">E0398</p><span class="title">Is there a solution for hospital acquired infections due to the aquatic reservoir in the near patient environment? 
<span>H. Zayyad* (Poriya, Israel), R. Khouri,</span>
</p><p class="presenter">N. Saleh, A. Peretz</p>

<p class="sessionid">E0399</p><span class="title">Reducing Antimicrobial Resistance (AMR) across the One Health Landscape: Diverse Perspectives on AMR risks and their mitigation in sinks, drains, and wastewater </span><span class="presenters">H.A. Craddock* (Dublin, Ireland), A. Kearney, F. Fitzpatrick, C. Finn, M.T. Pryce, D. Fitzgerald-Hughes</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF055</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  The    cutting    edge    in    tuberculosis</span>
</p><p class="presenter">Chair       Graeme Ayton Meintjes (Observatory, South Africa) <br/></p>

<p class="sessionid">E0400</p><span class="title">Personalised risk predictions for incident TB and preventive treatment uptake. </span><span class="presenters">R. Rose-Key* (London, United Kingdom), R. Gupta, M. Noursadeghi</span>
</p>

<p class="sessionid">E0401</p><span class="title">Programmatic migrant screening for tuberculosis identifies a spectrum of clinical phenotypes and outcomes: cohort data from a national migrant screening programme 
<span>M. Gohar* (Leicester, United Kingdom), C. Martin, A. Ayobami, H. Patel, M. Patel,</span>
</p><p class="presenter">L. Ahyow, B. Srini, G. Rishi, P. Mark, S. Nilesh, C. Trevithick, K. Pierun, M. Wiselka, L. Gray, I. Abubakar, R. Baggaley, A. Cooper, P. Haldar, M. Pareek</p>

<p class="sessionid">E0402</p><span class="title">An investigation into the relationship between human and animal  </span><span class="presenters">Mycobacterium bovis</span>
isolates</p><p>using whole genome analysis. 
<span>M. Mansfield* (Dublin, Ireland), E. Roycroft, S. Mok, P. Flanagan,</span>
</p><p class="presenter">M. Mc Elroy, B. Byrne, H. Cameron, D. Farrell, S.V. Gordon, J. Wagener, M.M. Fitzgibbon, T.R. Rogers</p>

<p class="sessionid">E0403</p><span class="title">Distinguishing relapse from reinfection in tuberculosis patients from Lithuania </span><span class="presenters">L. Vasiliauskaite* (Vilnius, Lithuania), L. Vasiliauskaitė,</span>
</p><p class="presenter">A. Zinola, F. Di Marco, V.E. Davidavičienė, B. Nakčerienė, A. Vaitulionytė, D.M. Cirillo, T. Kačergius</p>

<p class="sessionid">E0404</p><span class="title">Rapid Resistance Profiling of Mycobacterium tuberculosis from Clinical Specimens using Targeted Next-Generation Sequencing: A Pilot Validation Study </span><span class="presenters">P. Chheda* (Mumbai, India), S. Shivaprakash, T. Dama, G. Thandassery</span>
</p>

<p class="sessionid">E0405</p><span class="title">Inflammation precedes early respiratory worsening in HIV-negative tuberculosis patients during antituberculosis treatment 
<span>A. Van Laarhoven* (Nijmegen, Netherlands), L. Kurver, E. Klein Teeselink, A. Lemson, C. Bosteels, N. Carpaij, J. Van Ingen, E. Ardiansyah, C. Van Arkel, R. Vullinghs, C. Magis Escurra, W. Hoefsloot, R. Van Crevel</span>
</p>

<p class="sessionid">E0406</p><span class="title">Impact of fluoroquinolone resistance on the cost- effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis 
<span>C. Kim* (London, United Kingdom), S. Sweeney, H. Sohn, G.M. Knight,</span>
</p><p class="presenter">C.F. Mcquaid</p>

<p class="sessionid">E0407</p><span class="title">A longitudinal study on the evolution of drug resistance during tuberculosis treatment </span><span class="presenters">E. Danso* (Accra, Ghana), P. Asare, P. Tetteh, A. Tetteh, A.A. Boadu, S. Osei-Wusu, A. Asante-Poku, Y. Klinogo, A. Sylverken, J. Afriyie-Mensah, A. Adjei, D. Yeboah- Manu</span>
</p>

<p class="sessionid">E0408</p><span class="title">Phase 1, randomized, double-blind, parallel-group, dose-escalation safety and tolerability of PLGA encapsulated first line antitubercular drugs nanoparticles in healthy volunteers 
<span>A.K. Pandey* (Chandigarh, India), N. Shafiq, S. Malhotra, C. Mothsara, G. Khuller, J. Verma, L. Verma</span>
 <br/></p><p> 

</p><p> 

<span>SEL</span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 1</span>

</p><p class="header">Special Session</p><p><span class="title">      Selective             Pressure</span>
</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">JS1</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 12</span>
</p><p>Journal Session</p><p> 
<span> Late-breaker  research  from  CMI  and  CMI  Communications</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">J001</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched</p></td></tr>
<tr><td></td><td></td><td><p>cohort study (2020–2023) <span> </span>Gaetan Gavazzi (Grenoble, France)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">J002</p></p></td><td><p class="start">13:45</p></td><td><p class="title">Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial </p><span class="presenter">Thomas Holland (Durham, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">J003</p></p></td><td><p class="start">14:00</p></td><td><p class="title">The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round: A prospective cohort study </p><span class="presenter">Elise Mitri (Heidelberg, Australia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">J004</p></p></td><td><p class="start">14:15</p></td><td><p class="title">Efficacy and safety of mechanical thrombectomy in acute ischemic stroke secondary to infective endocarditis </p><span class="presenter">Tba</span>
</p></td></tr></table><p> 

</p><p>1-hour Oral Session</p><p> 
<span>  New   solutions   for   difficult-to-treat   infection</span>
 <br/></p><p>

<p class="sessionid">L0011</p><span class="title"><span class="presenters"></span>
(ExPEC) 

<p class="sessionid">ST131</p> 
<span>C. Morros-Bernaus* (Penryn, United Kingdom), J. Westley, E. R. Wyrsch, S. P. Djordjevic,</span>
</p><p class="presenter">A. F.C. Leonard, D. Sünderhauf, S. Van Houte</p>

<p class="sessionid">L0012</p><span class="title">Ultra-narrow spectrum antibiotic against multi-drug resistant gonococci with novel mode of action </span><span class="presenters">N. Nguyen* (Vienna, Austria), N. Nhung, A.K. Mix</span>
</p><p>

<p class="sessionid">L0013</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">L0014</p><span class="title">Epidermicin <p class="sessionid" style="background-color: red;">NI01</p>, a first-in-class peptide antibiotic candidate, has potent efficacy in a robust MRSA wound infection model and low allergic reaction liabilities 
<span>M. Upton* (Plymouth, United Kingdom), G. Barker, V. Bennett, I. Fotheringham, S. Baxter, H. Curry</span>
</p>

<p class="sessionid">L0015</p><span class="title">Minimum inhibitory concentrations of quabodepistat in Mycobacterium tuberculosis clinical isolates from patients with drug-susceptible pulmonary tuberculosis 
<span>I. Kontsevaya* (Munich, Germany), Y. Hayashi, D. Towle, N. Hariguchi, Y. Liu, S. Takuva</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY094</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Farm  to  fork:  food-borne  antimicrobial  resistance</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0269</p><span class="start">13:30</span><span class="title">Foodborne  risk in meat and fishery products and impact on AMR 
<span>Anders Dalsgaard (Frederiksberg C, Denmark)</span>
</p><p>

<p class="sessionid">S0270</p><span class="start">14:00</span><span class="title">Control  challenges associated with food-borne</p><p>multidrug resistance 
<span>Luisa Maria Vieira Peixe (Porto, Portugal)</span>
</p><p>Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG) <br/></p><p> 

</p><p> 



<p class="sessionid">ME095</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 16<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span>  Local   antimicrobials   for   deep   infections</span>
 <br/></p><p>

<p class="sessionid">M0271</p>  13:30    
<span>Karolina Akinosoglou (Patra, Greece)</span>
</p><p>

<p class="sessionid">M0272</p>  13:42    
<span>Pierre Tattevin (Rennes, France)</span>
</p><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Infectious Diseases of the Brain (ESGIB) <br/></p><p> 

</p><p> 



<p class="sessionid">OS052</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 2</span>

</p><p>1-hour Oral Session</p><p> 
<span> AI  in  infectious  diseases:  the  lab  and  beyond</span>
</p><p class="presenter">Chair      Miranda Langendam (Amsterdam, Netherlands) <br/></p>

<p class="sessionid">O0381</p><span class="title">Accurate strain typing of key bacterial pathogens through artificial intelligence analysis of MALDI-TOF mass spectra </span><span class="presenters">N. Macesic* (Melbourne, Australia),</span>
</p><p class="presenter">H.A. Nguyen, A. Peleg, J. Song, J.A. Wisniewski, D.L. Dowe</p>

<p class="sessionid">O0382</p><span class="title">CarbaDetector: An Artificial Intelligence-Driven Prediction Model for Detecting Carbapenemase- Producing Enterobacterales Using Disk-Diffusion </span><span class="presenters">L.K. Muhsal* (Oldenburg, Germany), C. Cimen, J. Sattler,</span>
</p><p class="presenter">O. Nolte, L. Dortet, R. Bonnin, A. Egli, A. Hamprecht</p>

<p class="sessionid">O0383</p><span class="title">AI-Driven Early Infectious Disease Detection in Dutch Primary Care: leveraging Bidirectional Encoder Representations from Transformers (BERT) and Early Recognition using Neural Information Encoding (ERNIE) </span><span class="presenters">G. Danoe* (Groningen, Netherlands), M. Homburg, M.Y. Berger, T. Olde Hartman, A. Voss, A. Hamprecht, M. Brilman, L.L. Peters, M.S. Berends</span>
</p>

<p class="sessionid">O0384</p><span class="title">Predicting potentially infection-related findings in structured radiology reports 
<span>J. Xu* (Oxford, United Kingdom), J.B. Delbrouck, J. Wei, A.S. Walker, C.P. Langlotz, D. Eyre</span>
</p>

<p class="sessionid">O0385</p><span class="title">Application of Artificial Intelligence in Assisting X-ray Diagnosis of Pediatric Pulmonary Infections 
<span>H. Zhang* (Shanghai, China), X. Xu, J. Ai</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS053</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 3</span>

</p><p>1-hour Oral Session</p><p> 
<span> Immune  evasion  and  intracellular  survival  strategies</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0386</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0387</p><span class="title">Intracellular lifestyle of  
<span>Acinetobacter baumannii</span>
: Role of phospholipase 

<p class="sessionid">A2</p> and transcriptional factor EB (TFEB) 
<span>Y. Smani* (Seville, Spain), C. Atalaya Rey, I. Molina Panadero, A. Lora González, A. Hmadcha</span>
</p><p>

<p class="sessionid">O0388</p><span class="title"><span class="presenters"></span>
on suppressing autophagy responses of macrophages 
<span>Z.E. Kuloğlu* (Istanbul, Türkiye), Ö. Albayrak, D. Güllü, G. Ekinci, F. Can</span>
</p>

<p class="sessionid">O0389</p></p>c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection 
<span>C. Dollé* (Zurich, Switzerland), E. Sarti, R. Wolfensberger, K. Kusjeko, S. Bredl, R.A. Speck, M. Greter, J.H. Rueschoff, D. Mai, A. Diercks, P. Sander,
 G.S. Olson, J. Nemeth</span></p><p>

<p class="sessionid">O0390</p><span class="title"><span class="presenters"></span>
</p><p>J.S. Friedland, D.L.W. Chong <br/></p><p> 

</p><p> 



<p class="sessionid">SY091</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 4</span>

</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Emerging infectious diseases: staying informed and prepared in a globalised world</p></td></tr>
<tr><td><p class="presenters">Nitin Gupta (Manipal, India)</p><p class="presenters">Pikka Jokelainen (Copenhagen, Denmark)</p></td></tr>
<tr><td>

<p class="sessionid">S0263</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Lessons learnt from previous outbreaks <span> </span>Tba</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0264</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Disease X: preparedness for the next pandemic </p><span class="presenter">Yee Sin Leo (Singapore, Singapore)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Emerging Infections Subcommittee, Deutsche Gesellschaft für Infektiologie, Deutsche Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e.V. <br/></p><p> 

</p><p> 



<p class="sessionid">SY092</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 5</span>

</p><p>1-hour Symposium <br/></p><div><p>Sex differences in management and outcome of patients with serious bacterial infections</p></div><p><p>Chairs      Michele Bartoletti (Milan, Italy)</p><p>Merel Lambregts (Leiden, Netherlands)</p><table>
<tr><td>

<p class="sessionid">S0265</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Sex impacts incidence, management, and outcome in bacteraemia </p><span class="presenter">Annette Westgeest (Leiden, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0266</p></p></td><td><p class="start">14:00</p></td><td><p class="title">The complex interplay between gender and sepsis </p><span class="presenter">Ines Lakbar (Montpellier, France)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) <br/></p><p> 

</p><p> 



<p class="sessionid">ME101</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 14<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> How to master conflict management and negotiation in healthcare</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0285</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Esther Calbo (Terrassa, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">M0286</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Jan A.J.W. Kluytmans (Utrecht, Netherlands)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">FO102</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 1<span> </span>
</p><p>Open Forum</p><p> 
<span> Navigating  the  future  of  pandemics  across  One  Health
 Chair      Xavier Lescure (Paris, France) <br/></span></p><p>

<p class="sessionid">F0287</p><span class="start">14:45</span><span class="title">Status  of the One Health Joint Plan of Action by the Quadripartite 
<span>Chadia Wannous (Paris, France)</span>
</p><p>

<p class="sessionid">F0288</p><span class="start">14:55</span><span class="title">National  surveillance responsibilities under the updated international health regulations 
<span>Tba</span>
</p><p>

<p class="sessionid">F0289</p>   15:05   Long-term consequences of emerging viral diseases 
<span>Alfonso J. Rodriguez-Morales (Pereira, Colombia)</span>
</p><p>Co-organised with: ESCMID Emerging Infections Subcommittee, ESCMID Study Group for Public Health Microbiology (ESGPHM), Trainee Association of ESCMID (TAE) Steering Committee, Brazilian Society of Infectious Diseases (SBI), Latin American Society for Travel Medicine <br/></p><p> 

</p><p> 



<p class="sessionid">EF059</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Bacterial  infections  in  the  post  pandemic  era</span>
</p><p>Chair      Özlem Kurt Azap (Ankara, Türkiye) <br/></p>
<p>

<p class="sessionid">E0424</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0425</p><span class="title">Targeted probe-capture culture-independent sequencing identifies emergence of Macrolide- Resistant  
<span>Bordetella pertussis</span>
in Australia 
<span>W. Fong* (Westmead, Australia), R. Rockett, K. Tam, T. Nguyen,</span>
</p><p class="presenter">E. Sim, C. Suster, J. Agius, S. Chandra, A. Watt, D. Speers, M. Graham, T. Tran, C. Lim, M. Wehrhahn, A. Ginn, D. Gray, J. Robson, L. Papanicolas, I. Gardner,</p><p>A. Howard-Jones, A. Outhred, K. Kennedy, L. Cooley,</p><p class="presenter">Q. Wang, N. Jeoffreys, S. Chen, K. Basile, T. Golubchik, J. Kok, V. Sintchenko</p>

<p class="sessionid">E0426</p><span class="title">Invasive pneumococcal disease in Spanish adults. Multicenter analysis of serotypes and lineages in the post-pandemic period. </span><span class="presenters">R. España Bonilla* (Barcelona, Spain), R. España-Bonilla, A. González-Díaz, J.M. Marímón, A. Manzanal, E. Cercenado, S. De La Villa,</span>
</p><p class="presenter">B. Viñado, M. Bernat-Sole, M. Campos-Ruiz, M.D. Quesada, A. Casabella, M.L. Machado, R. Tejero, M.Á. Galán, S. Calvo-Silveria, D. Berbel, J. Yuste, S. Martí,</p><p class="presenter">J. Càmara, C. Ardanuy</p>

<p class="sessionid">E0427</p><span class="title">Group A streptococcal infections in Germany from 2017 to 2024: a post-pandemic rebound above expected numbers? </span><span class="presenters">A. Von Laer* (Berlin, Germany), J. Mutevelli, A. Dörre, S. Haller, M. Feig, S. Buda, A. Hoffmann, I. Noll</span>
</p>

<p class="sessionid">E0428</p><span class="title">Invasive group A streptococcus infections is often preceeded by seasonal influenza. 
<span>J. Westin* (Gothenburg, Sweden), M. Nygren, U. Snygg-Martin,
 L. Gustavsson, N. Sundell</span></p><p>

<p class="sessionid">E0429</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">E. Girardi, C. Fontana</p>

<p class="sessionid">E0430</p><span class="title">Treatment outcomes of bedaquiline-based longer oral regimens in Indian children above 5-years of age </span><span class="presenters">D. Gandhi* (Mumbai, India), I. Shah, R. Ansari, H. Warse, S. Kalawadia, T. Yangchen, D. Shah, V. Puri, S. Mattoo, M. Bodhanwala</span>
</p><p>

<p class="sessionid">E0431</p><span class="title"><span class="presenters"></span>
Disease in the Northwestern United States (2002–2022): Insights from Electronic Health Records 
<span>M. Blum* (Leuven, Belgium), C. Onwuchekwa, M.A. Schmidt, J. Poolman, T. Verstraeten, J. Geurtsen</span>
</p>

<p class="sessionid">E0432</p><span class="title">A prospective controlled cross-sectional study demonstrates significantly higher IgG seroprevalence of leptospirosis among Munich's Eisbach river surfers 
<span>F. Voit* (München, Germany), D. Schult- Hannemann, M.H. Richter, L. Wagner, J. Ostermaier,</span>
</p><p>K. Stollberg, E. Luge, P. Bahn, M. Lee, J. Ten-Pas, J. Erber, M. Kosch, M. Mayr, C.D. Spinner, J. Schneider <br/></p><p> 

</p><p> 



<p class="sessionid">EF060</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>   AMR     in     the     community
 Chair      Camilla Wiuff Coia (Copenhagen, Denmark) <br/></span></p><p>

<p class="sessionid">E0433</p><span class="title"><span class="presenters"></span>
urinary tract infections at intermunicipal level in France 
<span>M. Prime* (Nantes, France), O. Lemenand, S. Thibaut, T. Coeffic, B. Perrot, J. Caillon, D. Boutoille, E. Batard, G. Birgand</span>
</p>

<p class="sessionid">E0434</p><span class="title">Prolonged community outbreak of OXA-48- producing  
<span>Escherichia coli</span>
linked to a food premises: Lower Hutt, New Zealand, 2018-2022 
<span>C. Thornley* (Lower Hutt, New Zealand), M. Kelly, M. Bloomfield,</span>
</p><p class="presenter">A. Nesdale, R. White</p>

<p class="sessionid">E0435</p><span class="title">Low rates of macrolide resistance found in  </span><span class="presenters">Mycoplasma pneumoniae</span>
cases in Australia 
<span>R. Rockett* (Westmead, Australia), J. Kok, K.G. Tam, T. Golubchik, C. Suster, W. Fong, V. Sivalingam, M.C. Wehrhahn, A. Ginn, J. Robson, I. Gardner, L. Papanicolas, K. Kennedy, M. Graham, T. Tran, D. Speers, L. Cooley, J. Harbidge, S. Campbell, K. Basile,</span>
</p><p class="presenter">V. Sintchenko, S.C.A. Chen</p>

<p class="sessionid">E0436</p><span class="title">Epidemiology of antibiotic resistance associated with</p><p>E. coli/Klebsiella pneumoniae bloodstream infections in England 2012-2023 </span><span class="presenters">S. Lipworth* (Oxford, United Kingdom), L. Gorman, A. Dowsey, K. Pouwels, K. Sanderson, C. Beck, R. Hope, C. Brown, T. Katy</span>
</p><p>

<p class="sessionid">E0437</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0438</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0439</p><span class="title">Risk factors for antimicrobial resistance in community commensal  
<span>Staphylococcus aureus</span>
isolates, a sub- analysis of the AMRIC project. 
<span>M. Joyce* (Manchester, United Kingdom), Z. Aiken, N. Zhu, A. Hawker, L. Eastwood, S. Leaver, K.L. Hopkins, R. Hope, S. Eccles, S. Neilson, M. Neilson, G. Edwards,</span>
</p><p class="presenter">S. Hopkins, C. Brown, D.M. Lecky</p>

<p class="sessionid">E0440</p><span class="title">Prevalence and risk factors for antimicrobial resistance in invasive pneumococcal disease in southern Ontario in the late post <p class="sessionid" style="background-color: red;">PCV13</p> era (2014- 2023) </span><span class="presenters">A. Mcgeer* (Toronto, Canada), A. Shigayeva, A. Golden, I. Martin, G. Zhanel, H. Adam, K. Barker, W.
 Gold, R. Lovinsky, M. Muller, K. Ostrowska, D. Ricciuto, D. Richardson, C. Vermeiren, K. Hassan, M. Lefebvre, A.X. Li, N. Malik, M. Pejkovska, A. Sultana,</p><p>T. Vikulova, C. Kandel, Z. Zhong</span></p><p>

<p class="sessionid">E0441</p><span class="title"><span class="presenters"></span>
in the Netherlands: an 11-year trend analysis of surveillance data 
<span>I. Nauta* (Bilthoven, Netherlands), W. Altorf-Van Der Kuil, D.W. Notermans, A.F. Schoffelen</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF061</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Infections in the immunocompromised: a multifaceted overview
 Chair      Effrossyni Gkrania-Klotsas (Cambridge, United Kingdom) <br/></span></p><p>

<p class="sessionid">E0442</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0443</p><span class="title">Analysis of viral load kinetics and risk factors for Epstein-Barr virus DNAemia and Post-transplant lymphoproliferative disorders in pediatric liver transplant recipients - a single centre experience 
<span>B. Kasztelewicz* (Warsaw, Poland), K. Skrok, I. Jankowska, P. Kaliciński, K. Dzierżanowksa-Fangrat</span>
</p>

<p class="sessionid">E0444</p><span class="title">Impact of pre-transplant infection on post-transplant morbidity and graft survival in liver transplant recipients: a prospective cohort study 
<span>L. Mani- Perren* (Bern, Switzerland), S.F. Perrodin, A. Berzigotti, V. Banz, C. Hirzel, L.N. Walti</span>
</p>

<p class="sessionid">E0445</p><span class="title">Risks of live-attenuated vaccines in children with primary immunodeficiency 
<span>S. Frigui Ep Oueslati* (Tunis, Tunisia), S. Ben Jaafar, S. Frigui, Y. Chebbi, M. Ouederni, W. Achour</span>
</p>

<p class="sessionid">E0446</p><span class="title">Chagas reactivation/ transmission in kidney transplantation. 
<span>M. Radisic* (Buenos Aires, Argentina), N. Pujato, M.C. Lopez-Albizu, R. Del Grosso</span>
</p><p>

<p class="sessionid">E0447</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0448</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">Molino-Bernal, J. Hand, A. Lowe, M. Bodro, E. Vanino,</p><p>A. Fernández-Cruz, A. Ramos-Martínez, M.J. Makek,</p><p>R. Bou Mjahed, O. Manuel, N. Kamar, A. Calvo-Cano,</p><p class="presenter">L. Rueda-Carrasco, P. Muñoz, A. Álvarez-Uría, S. Pérez-Recio, N. Sabé, R. Rodríguez-Álvarez, A. Mularoni, E. Vidal, J. Alonso-Titos, T. Del Rosal, A.Y. Classen, C. Mejía-Chew, F. López-Medrano</p>

<p class="sessionid">E0449</p><span class="title">Impact of bronchoalveolar lavage results on clinical decision-making among immunocompromised, critically ill patients. </span><span class="presenters">C. Fanelli* (Sassari, Italy), R. Mondaca, R. Colima, D. Prado, R.R. Abud, S. Morales,</span>
</p><p>M.M. Vera, E. Kattan</p>

<p class="sessionid">E0450</p></p>
<span>Campylobacter</span>
spp. bloodstream infections: preliminary results from a multicenter differential clinical analysis in immunocompromised and immunocompetent patients. 
<span>M. Paniagua-García* (Seville, Spain), J.M. Bernal-Aznar, S. Herrera- 

<p class="sessionid">Espejo1</p>, S. Salto-Alejandre, A. Valiente, M.C. Domínguez, M.Á. López-Zúñiga, F. Cobo, L. Alsina- Manrique De Lara, C. Marti-Castellote, M. Monsonis-</span>
</p><p>Cabed, V. García-López, A. Polo, J. Laporte-Amargos,</p><p>G. López De Egea, M.Á. Galán-Ladero, E. Ruiz De Gopegui-Bordes, G. Sena-Corrales, J.A. Girón, F. Galán, M. Chávez-Caballero, M.O. Mohamed- Balghata, S. Winderickx, J.M. García De Lomas, F.J. Martinez-Marcos, M. Giannella, M. Garzaro, M. Fernández, M. Freire, M.L. Pedro-Botet Montoya, S. López Cardenas, E. Cendejas, A.V. Halperin Benito, A. Romero Palacios, M. Navarro, C.A. Alonso, A. Gimeno-Gascón, S. Jiménez Jorge, J. Pachón, M.E. Pachón-Ibáñez, E. Cordero-Matía <br/></p><p> 

</p><p> 



<p class="sessionid">SY100</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 12<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> The  challenge  of  a  healthy  microbiota  in  neonates</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0283</p><span class="start">14:45</span><span class="title">Infant  gut microbiome development 
<span>Debby Bogaert (Edinburgh, United Kingdom)</span>
</p><p>

<p class="sessionid">S0284</p><span class="start">15:15</span><span class="title">Metagenomic  signatures and antibiotic disruption of the gut microbiome in neonates 
<span>Gautam Dantas (Saint Louis, United States)</span>
</p><p>Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), European Society of Paedriatic Infectious Diseases (ESPID) <br/></p><p> 

</p><p> 



<p class="sessionid">OS058</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 16<span> </span>
</p><p>1-hour Case Session</p><p> 
<span>  In    the    field    with    fungi</span>
</p><p class="presenter">Chairs      Beatriz L. Gomez (Bogota, Colombia) Leonardo Nimrichter (Rio De Janeiro, Brazil) <br/></p>

<p class="sessionid">O0419</p><span class="title">Fosmanogepix expanded access in patients with  </span><span class="presenters">Fusarium</span>
infections 
<span>S. Dadwal* (Duarte, United States), A. Baluch, J. Dickter, J.R. Newman, M.H. Nguyen, R. Weihe, H. Schlamm, L. Ostrosky-Zeichner</span>
</p>

<p class="sessionid">O0420</p></p>Voriconazole's hidden toll: unveiling periostitis in a heart transplant recipient and a hematologic patient. 
<span>G. Motoa* (Boston, United States), A. Woolley, N. Issa</span>
</p><p>

<p class="sessionid">O0421</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0422</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0423</p><span class="title"><span class="presenters"></span>
and  
<span>Aspergillus</span>
infections: insights from compassionate use and clinical trials 
<span>S. Sedik* (Graz, Austria), R. Krause, C. Zurl, I. Zollner-Schwetz, M. Linhofer, C. Hoegenauer, G. Gorkiewicz, M. Hoenigl,</span>
</p><p>J. Prattes <br/></p><p> 

</p><p> 



<p class="sessionid">OS056</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 2</span>

</p><p>1-hour Oral Session</p><p> 
<span> Emerging  trends  in  viral  hepatitis  across  Europe</span>
</p><p class="presenters"></p><p> 


<p class="sessionid">O0409</p></span>
One of the largest outbreak of hepatitis A in the 21 
<span>st</span>
 century in Europe 
<span>I. Hockickova* (Košice, Slovakia), I. Hockicková, J. Hockicko, D. Javorská, Š. Zamba, A. Vasiľová, M. Ševčík, A. Cehelská, D. Hudáčková, P. Kristian</span>
</p>

<p class="sessionid">O0410</p><span class="title">Higher prevalence of Cytomegalovirus and Epstein–</p><p>Barr virus in acute-on-chronic liver failure – cause or consequence? 
<span>J. Sonnenberg* (Muenster, Germany),</span>
</p><p class="presenter">K. Thiyagarajah, E. Görgülü, P. Lembeck, M. Glitscher,</p><p>F. Uschner, M. Brol, W. Gu, R. Schierwagen, S. Klein,</p><p>M. Schulz, T. Wiedemann, J. Reißing, J. Söhne, N. Kraus, M. Praktinjo, J. Fischer, H.P. Erasmus, J. Vasseur, S. Zeuzem, H. Storf, C. Welsch, J. Trebicka,</p><p class="presenter">S. Ciesek, J. Chang, T. Bruns, E. Hildt, K.H. Peiffer</p>

<p class="sessionid">O0411</p><span class="title">Delta in Denmark: current prevalence of hepatitis delta virus infection </span><span class="presenters">H. Watson* (Lyon, France), P. Jepsen, H. Vilstrup, H. Krarup</span>
</p>

<p class="sessionid">O0412</p><span class="title">RatHEV as an aetiological agent of acute hepatitis in Europe: results from the ESGHV-RHEV Study 
<span>A. Rivero-Juarez* (Córdoba, Spain), M. Casares, B. Becerril, Á. Dencs, G. Gherlan, J. Caballero, L. Rios- Muñoz, A.B. Pérez, A. Fuentes, C. Freyre, F. Franco- Álvarez De Luna, I. Viciana, M.D.C. Domínguez, M. Altindis, G. Özkaya, A. Rivero, A. Rivero-Juárez</span>
</p>

<p class="sessionid">O0413</p><span class="title">Understanding the incidence and risk factors of low- level viremia in chronic hepatitis B: A propensity- matched comparison of tenofovir and entecavir 
<span>I. Hasanoglu* (Ankara, Türkiye), R. Guner, E. Zerdali, A. Batirel, Y. Onlen, E. Parlak, B. Kurtaran, S. Tosun, I. Yilmaz Nakir, O. Gunal, N. Eser, H. Yaqoobi, O. Tabki,</span>
</p><p>T. Turunc, U. Balci, S. Komur, E.E. Tutuncu, L.N. Altunal, N.D. Sari, D.S. Yildiz, H.D. Ozkaya, I.E. Yildiz,</p><p>S. Kaya, O. Karabay, S. Alkan, F. Tabak <br/></p><p> 

</p><p> 



<p class="sessionid">OS057</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 3</span>

</p><p>1-hour Oral Session</p><p> 
<span> Precision  Medecine:  from  models  to  patient  care</span>
</p><p class="presenter">Chairs      Anouk Edwina Muller (The Hague, Netherlands) Sebastian Wicha (Hamburg, Germany) <br/></p>

<p class="sessionid">O0414</p><span class="title">Pharmacokinetics and pharmacodynamics of BPaLM, BPaLC and BPaL regimens for treatment of RR-TB </span><span class="presenters">F. Kloprogge* (London, United Kingdom), B.T. Nyang'wa, I. Motta, R. Moodliar, V. Solodovnikova, S. Rajaram, M. Rasool, Z. Huang, C. Berry, G. Davies, D. Moore</span>
</p>

<p class="sessionid">O0415</p><span class="title">Physiologically Based Pharmacokinetic Modeling for Nemonoxacin in Predicting the Respiratory System Pharmacokinetic Profile: Based on Comprehensive Preclinical and Clinical Data 
<span>Y. Chen* (Shanghai, China), J. Zhao, J. Zhang</span>
</p>

<p class="sessionid">O0416</p></p>Context-specific genome-scale metabolic modelling reveals metabolic alterations in multidrug-resistant  
<span>Klebsiella pneumoniae</span>
in response to polymyxin B/zidovudine combination 
<span>J. Zhao* (Melbourne, Australia), Y.W. Lin, J. Tao, Y. Zhu, T. Velkov, J. Li</span>
</p>

<p class="sessionid">O0417</p></p>Agent-based model predictions of polymyxin B activity on Acinetobacter baumannii 
<span>H. Soeorg* (London, United Kingdom), Y. Yuan, J. Readman, J.F. Standing</span>
</p>

<p class="sessionid">O0418</p><span class="title">Monthly dalbavancin dosing for suppressive therapy: a case series and pharmacokinetic estimation analysis 
<span>C. Volk* (Madison, United States), W. Kufel,</span>
</p><p>P. Hutson, R. Mahapatra, W. Rose <br/></p><p> 

</p><p> 



<p class="sessionid">SY099</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 4</span>

</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>How innovations of AMR and HAI surveillance systems help the clinical practice</p></td></tr>
<tr><td><p class="presenters">Pascal Astagneau (Paris, France)</p><p class="presenters">Mandy Wootton (Cardiff, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">S0281</p></p></td><td><p class="start">14:45</p></td><td><p class="title">The EUCAST system in surveillance of AMR <span> </span>Sören G. Gatermann (Bochum, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0282</p></p></td><td><p class="start">15:15</p></td><td><p class="title">Insights into developments in the surveillance of HAIs </p><span class="presenter">Diamantis Plachouras (Solna, Sweden)</span>
</p></td></tr></table><p>Co-organised with: EUCAST Steering Committee, EUCIC Steering Committee, European Centre for Disease Prevention and Control (ECDC)</p><p> 

</p><p> Movie Session<span> </span><span class="start">15:00</span>-<span class="end">18:30<span class="location">Hall 5<span> </span></p><p class="header">Special Session</p><p><span class="title">  Behind     the     scenes:     Contagion</span>
</p><p class="presenters"></p><p> 

</p><p> 



<p class="sessionid">SY107</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 15<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Communicating (your) ID science for policy and societal impact</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0297</p><span class="start">16:15</span><span class="title">Communicating  to policy makers and for societal impact 
<span>Balázs Babarczy (Budapest, Hungary)</span>
</p><p>

<p class="sessionid">S0298</p><span class="start">16:45</span><span class="title">Influencing  behaviour through the media and a multichannel communications strategy 
<span>Charlotte Hutchinson (London, United Kingdom)</span>
</p><p>Co-organised with: CMI Board of Editors <br/></p><p> 

</p><p> 



<p class="sessionid">EW109</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 2</span>

</p><p>Educational Session</p><p> 
<span> Infections  in  cancer  patients:  tips  for  daily  practice</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0301</p><span class="start">16:15</span><span class="title">Tailoring  pharmacologic prophylaxis in patients with</p><p>non-haematologic cancer: from viruses to fungi 
<span>Janne Vehreschild (Frankfurt, Germany)</span>
</p><p>

<p class="sessionid">W0302</p><span class="start">16:35</span><span class="title">Pneumonitis  or pneumonia? A practical approach to lung infiltrates in patients with solid tumours 
<span>Tba</span>
</p><p>

<p class="sessionid">W0303</p><span class="start">16:55</span><span class="title">The  diagnostic dilemmas and treatment challenges of mycobacteria in cancer patients 
<span>Şiran Keske (Istanbul, Türkiye)</span>
</p><p>

<p class="sessionid">W0304</p>  17:15   HTLV-1 and T-cell lymphoma - predict &amp; prevent 
<span>Lucy</span>
</p><p>Cook (London, United Kingdom)</p><p>Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), International Immunocompromised Host Society (ICHS) <br/></p><p> 

</p><p> 



<p class="sessionid">EF065</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> The  Antibiotic  bakery:  Novel  compounds  in  the  pipeline</span>
</p><p>Chair      Susanne Haeussler (Braunschweig, Germany) <br/></p>

<p class="sessionid">E0471</p></p>
<span>In vitro</span>
activity and  
<span>in vivo</span>
proof-of-efficacy of epimutilin derivatives AR-7732, AR-7731, AR-9842 and AR-10058 against AMR bacterial pathogens 
<span>S. Paukner* (Vienna, Austria), W.W. Wicha</span>
</p>

<p class="sessionid">E0472</p></p><p class="sessionid" style="background-color: red;">SC5005</p> and DHA: A Novel, Rapid-Acting Combination Therapy for Biofilm Eradication in Catheter-Associated Infections 
<span>Y. Hui Hui* (Taipei, Taiwan, China), H.H. Yeo, H.N. Huang, Y.T. Huang,</span>
</p><p>Y.S. Lu, H.C. Chiu</p>

<p class="sessionid">E0473</p></p>
<span>In vitro</span>
potency of ceftibuten with xeruborbactam against -lactamase-producing isolates of Enterobacterales (ENT) from the SENTRY global surveillance programme 
<span>O. Lomovskaya* (San Diego, California, United States), M. Castanheira, J. Lindley</span>
</p>

<p class="sessionid">E0474</p><span class="title">Effect of novel antimicrobial peptides SET-<p class="sessionid" style="background-color: red;">M33</p>L and SET-<p class="sessionid" style="background-color: red;">M33</p>L-PEG on  
<span>Pseudomonas aeruginosa</span>
biofilm formation. 
<span>A. Fontanot* (Rotterdam, Netherlands), W. Unger, J. Hays, P. Croughs, A. De Bruijn, C. Falciani,</span>
</p><p class="presenter">A. Pini, R. Ecker, I. Ellinger</p>

<p class="sessionid">E0475</p><span class="title">Broad spectrum coverage of serine -lactamase and high  </span><span class="presenters">in vitro</span>
potency against KPC- and OXA-48-like- producing Enterobacterales of meropenem in combination with the novel diazabyciccloctane - lactamase inhibitor 

<p class="sessionid">ANT3310</p> 
<span>L. Sánchez-Peña* (A Coruña, Spain), S. Rodríguez-Pallares, T. Blanco- Martín, L. González-Pinto, M. Outeda-García, P. Aja- Macaya, I. López-Hernández, J.C. Vázquez-Ucha, G. Bou, A. Beceiro, J. Arca-Suárez</span>
</p>

<p class="sessionid">E0476</p><span class="title">Antibacterial potential of D-limonene and diallyl disulfide and their interaction with gentamicin against multidrug-resistant  
<span>Pseudomonas aeruginosa</span>
in rat pneumonia model 
<span>Y. Almuhanna* (Shaqra, Saudi Arabia), M. Asad</span>
</p>

<p class="sessionid">E0477</p></p>
<span>In vivo</span>
pharmacokinetic/pharmacodynamic targets of a novel macrolide antibiotic nafithromycin, determined in neutropenic murine lung infection model of  
<span>Streptococcus pneumoniaeA. Muller* (The Hague, Netherlands), R. Chavan, S. Takalkar, V. Zope,</span>
</p><p class="presenter">K. Umarkar, P. Tayde, M. Tellis, S. Bhagwat, M. Patel,</p><p class="presenter">B. Veeraraghavan</p>

<p class="sessionid">E0478</p><span class="title">NiPharmins: novel low resistance-inducing antimicrobials with antibiofilm activity against  </span><span class="presenters">Staphylococcus aureusA. Nunes* (Lisbon, Portugal),</span>
</p><p>B. Alves, J.P. Carrilho, N.R. Candeias <br/></p><p> 

</p><p> 



<p class="sessionid">EF066</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Modelling infectious disease burden and impact of vaccination</span>
</p><p class="presenter">Chair      David Fisman (Toronto, Canada) <br/></p>

<p class="sessionid">E0480</p><span class="title">Evaluating the Impact of Re-vaccination on Pneumococcal Disease in Individuals Previously Vaccinated with <p class="sessionid" style="background-color: red;">PPSV23</p> in Germany: Comparative Approach </span><span class="presenters">O. Sharomi* (Mt Carmel, United States), S. Oluwaseun, M. De Lepper, S. Mihm, T.C. Reuter, C. Solleder, G. Meleleo, T. Malik, K. Bakker, R. Oidtman</span>
</p>

<p class="sessionid">E0481</p><span class="title">Modeling the public health impact of a 21-valent PCV in the Canadian adult population 
<span>O. Sharomi* (Rahway, United States), R. Oidtman, M.C. Meilleur,
 S. Weinrich, K. Bakker</span></p><p>

<p class="sessionid">E0482</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0483</p><span class="title">Shifting from risk-based to age-based approach for pneumococcal vaccination in adults in France: a comprehensive evaluation 
<span>O. Sharomi* (Mt Carmel, United States), S. Oluwaseun, M. Breau-Brunel, F. Gaëlle, B. Lionel, C. Jérémy, M. Giulio, N. Robert, O. Rachel, M. Tufail, B. Kevin</span>
</p><p>

<p class="sessionid">E0484</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0485</p><span class="title">Improving Danish all-cause mortality monitoring by nowcasting weekly deaths 
<span>A. Kalnæs* (Copenhagen, Denmark), J. Nielsen, L. Vestergaard, S. Nørgaard</span>
</p>

<p class="sessionid">E0486</p><span class="title">Modelling to identify an optimal ring vaccination strategy to mitigate a smallpox outbreak 
<span>V. Costantino* (Sydney, Australia), M. Kunasekaran, T. Leroyd, K. Yeo, R.C. Macintyre</span>
</p>

<p class="sessionid">E0487</p><span class="title">The impact of introducing meningococcal C/ACWY booster vaccination among adolescents in Germany: a dynamic transmission modelling study 
<span>F. Günther* (Berlin, Germany), U. Reinacher, S. Chisholm, M. Griskaitis, M. Höhle, S. Scholz, V. Schönfeld, O. Wichmann, T. Harder, F.G. Sandmann</span>
</p>

<p class="sessionid">E0488</p><span class="title">Potential public health impacts of gonorrhoea vaccination programmes under declining incidences: a modelling analysis 
<span>L. Geng* (Singapore, Singapore)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF067</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Blood    parasitology    at    its    best</span>
</p><p class="presenter">Chair      Miriam José Álvarez-Martínez (Barcelona, Spain) <br/></p>

<p class="sessionid">E0489</p><span class="title">Unexepected P.malariae diagnosis in Italian woman with no history of travel to endemic areas </span><span class="presenters">A. Busni* (Milan, Italy), L. Tartaglione, S. Torri, A. Longhi, E.M. Zavaroni, F. Crippa, C.S. Vismara</span>
</p><p>

<p class="sessionid">E0490</p><span class="title"><span class="presenters"></span>
and  
<span>Plasmodium falciparumU.A. Zainulabid* (Pahang, Malaysia), X.K. Cheong, P. Periyasamy, A.F. Mohd Salleh, N. Ghazali, N.W. Hassan, K. Sangaran, A. Mohd Yasin, Z.M. Idris</span>
</p>

<p class="sessionid">E0491</p><span class="title">Trick or Treat? An unrelenting malaria case 
<span>C. Uhomoibhi* (Dublin, Ireland), E. De Barra, C. Leddy,</span>
</p><p class="presenter">A. Brown</p>

<p class="sessionid">E0492</p><span class="title">&quot;64% Parasitaemia in Falciparum Malaria: Challenges in Managing Severe Infection and Delayed Haemolysis&quot; </span><span class="presenters">F. Murphy* (Dublin, Ireland), A. Albadi, P. Coakley, C. Mcnally</span>
</p>

<p class="sessionid">E0493</p><span class="title">Benznidazole treatment in Chagas Disease: a case series in Luigi Sacco Hospital, Milan (Italy) 
<span>F. Sabaini* (Milan, Italy), A. Giacomelli, M. Beltrami, L.R. Galimberti, S. Antinori</span>
</p>

<p class="sessionid">E0494</p><span class="title">The Challenge of Managing Visceral Leishmaniasis in Immunocompromised Patients 
<span>S. Vita* (Rome, Italy),</span>
</p><p class="presenter">A. D'abramo, A. Corpolongo, M.V. Tomassi, F. Faraglia, T. Ascoli Bartoli, A. Mariano, A. Vulcano, G. Maffongelli, E. Nicastri</p>

<p class="sessionid">E0495</p><span class="title">Diagnosis and management of visceral leishmaniasis in children in France : a national retrospective study </span><span class="presenters">J. De Larminat* (Paris, France), N. Dahane, N. Argy, M. Rifai, O. Haas Ferrua, C. Pomares, N. Rasandisona Ravonjena, D. Dupont, J.P. Lemoine, T. Cesar, O. Pineau, P. Picherit Steinbrucker, S. Azohana, S. Guilmon-Crepon, I. Allouche, C. Ravel, A. Faye</span>
</p>

<p class="sessionid">E0496</p><span class="title">Chronic cutaneous leishmaniasis following visceral leishmaniasis in a pediatric patient: a rare report of extensive facial involvement 
<span>A. Mohta* (Bikaner, India)</span>
</p>

<p class="sessionid">E0497</p><span class="title">Therapeutic challenges in the management of Disseminated leishmaniasis in a patient with HIV co- infection 
<span>N. T R* (Jodhpur, India), T. Kanagiri, S. Angirekula, N. Kaur, Y. Khatod, D. Kumar, A. Purohit,</span>
</p><p>G.K. Bohra <br/></p><p> 

</p><p> 



<p class="sessionid">EF068</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> A global perspective on antimicrobial resistance surveillance</span>
</p><p class="presenter">Chair       Mirfin Mpundu (Lusaka, Zambia) <br/></p>

<p class="sessionid">E0498</p><span class="title">Global, regional and country-level prevalence of antimicrobial resistance in human bacterial infections under surveillance in WHO's Global Antimicrobial Resistance and Use Surveillance System (GLASS) </span><span class="presenters">E. Van Kleef* (Geneva, Switzerland), O. Tosas Auguet,
 S. Tolba, S. Eremin, D. Marcano, K.B. Pouwels, B.S. Cooper, A.S. Dean, S. Bertagnolio</span></p><p>

<p class="sessionid">E0499</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0500</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0501</p><span class="title">Bridging gaps in antimicrobial resistance surveillance: the CAESAR network's first decade 
<span>R. Janssen* (Bilthoven, Netherlands), S. Woudt, D. Boudville, C. Ruesen, W. Van Den Reek, J. Monen, O. Karatuna, A. Tambić-Andrašević, D. Lo Fo Wong, M.</span>
</p><p class="presenter">Gelormini</p>

<p class="sessionid">E0502</p><span class="title">Global, regional, and national temporal trends in mortality for carbapenem-resistant bacteria from 1990 to 2021: An age-period-cohort analysis </span><span class="presenters">C. Zhihui* (Shanghai, China), Z. Mingchen, W. Jing, Y. Xiangru, J. Jialin, Z. Wenhong</span>
</p>

<p class="sessionid">E0503</p><span class="title">Global Trends and Impact of Antimicrobial Resistance in Paediatric Populations: An Analysis Using WHO AWaRe Classification and Priority Pathogens 
<span>Joseph Harwell (North Melbourne, Australia)</span>
</p>

<p class="sessionid">E0504</p><span class="title">Antibiotic resistance profile and comparative evaluation of WHO AWaRe Guidelines at the Emergency's Children's Surgical Hospital in Uganda 
<span>L. Barcellini* (Milan, Italy), F. Riccaboni, V. Fabiano, F. Forlanini, A. Banfi, E. Crivellaro, A. La Mendola, A. Mohammed Zain, G.V. Zuccotti, L. Folgori, L. Napolitano</span>
</p>

<p class="sessionid">E0505</p><span class="title">Initiatives in antimicrobial resistance surveillance: Using automated bacteraemia surveillance for hospital-wide multidrug resistance monitoring 
<span>F.D. Ruether* (Berlin, Germany), L.A. Peña Diaz, M. Behnke, C. Geffers, S.J.S. Aghdassi</span>
</p>

<p class="sessionid">E0506</p><span class="title">Global and regional prevalence of antimicrobial resistance in GLASS target bacterial pathogens for bloodstream, urinary tract and gastrointestinal infections: a systematic review of the global literature (2019-2024) 
<span>B. Caddey* (Calgary, Canada), G. Lazarus, S. Bertagnolio, D.B. Nobrega, R.L. Hamers,</span>
</p><p>A. Dean, V.K. Wangsaputra, F. Febrina, J.M. Conly,</p><p>H.W. Barkema, E. Van Kleef, O. Tosas-Auguet <br/></p><p> 

</p><p> 



<p class="sessionid">KN103</p></span>
<span class="start">16:15</span>-<span class="end">17:15</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture</p><p> 
<span> Tuberculosis: where are we now and where should we be</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0290</p>  16:15    
<span>Guy Thwaites (Ho Chi Minh City, Vietnam)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS063</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 11<span> </span>
</p><ol id="l4"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Improving  blood  culture  diagnostics:  rethinking  the  basics</span>
</p><p class="presenter">Chairs      Direk Limmathurotsakul (Bangkok, Thailand) Pilar Retamar Gentil (Seville, Spain) <br/></p>

<p class="sessionid">O0461</p><span class="title">Blood culture volume, guideline adherence and pathogen yield of 35,433 paediatric blood cultures in Germany </span><span class="presenters">J. Forster* (Würzburg, Germany), A.L. Sieg,</span>
</p><p class="presenter">V. Rücker, H. Haefner, T. Bähr, S. Rössler, J. Held, V. Le Saout – Chapot, M. Hogardt, B. Spielberger, E.A. Idelevich, M. Christner, S. Zimmermann, S. Schneitler, M. Mauritz, C.S. Stingu, M. Gerlach, U. Von Both, S. Schoeler, L. Marr, J. Zens, E. Komini, M. Krone</p>

<p class="sessionid">O0462</p><span class="title">Changing the paradigm: are two sets of blood cultures always needed? </span><span class="presenters">R. Rosa* (Miami, United States), J. Somani, K. Manzanillo, H. Dinh, G. Rosello,</span>
</p><p class="presenter">L. Abbo</p>

<p class="sessionid">O0463</p><span class="title">Evaluating clinical and economic empact of reducing blood culture incubation timings: Time to shift the paradigm? </span><span class="presenters">R. Gupta (bagga)* (London, Canada), R. Gupta, J. Delport, T. Mazzulli</span>
</p>

<p class="sessionid">O0464</p><span class="title">Revolutionizing hospital workflows with blood culture-free ultra-rapid antimicrobial susceptibility testing: A clinical pilot study 
<span>S. Kwon* (Seoul, Korea, Republic of), K. Sunghoon, K. Dong Young, J. Jisung,
 K. Tae Hyun, K. Junwon, J. Hyelyn, L. Gi Yoon, P. Wan Beom</span></p><p>

<p class="sessionid">O0465</p><span class="title"><span class="presenters"></span>
footprints from blood plasma for improved diagnostics in sepsis 
<span>M. Sonntag* (Stuttgart, Germany), J. Mueller, A. Von Haeseler, Y. Vainshtein, S.O. Decker, T. Brenner, K. Sohn</span>
</p><p> 

</p><p> 



<p class="sessionid">ME108</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 12<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> Navigating travel medicine: expert tips for safe international travel</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0299</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Sophie Schneitler (Homburg, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">M0300</p></p></td><td><p class="start">16:27</p></td><td><p class="title">Andreas Neumayr (Basel, Switzerland)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS062</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 13<span> </span>
</p></li><li data-list-text="2-"><p>hour Oral Session</p></li></ol><p> 
<span>  Heterogeneity   and   complexity   of   sepsis</span>
</p><p class="presenter">Chairs       Despoina Koulenti (London, United Kingdom) Sylvain Meylan (Lausanne, Switzerland) <br/></p>

<p class="sessionid">O0451</p><span class="title">A consensus immune dysregulation framework for sepsis: results of the SUBSPACE consortium </span><span class="presenters">A. Moore* (Emerald Hills, United States), T. Sweeney,</span>
</p><p class="presenter">A. Rogers, P. Khatri, H. Zheng, A. Ganesan, Y. Hasin- Brumshtein, M. Maddali, J. Levitt, T. Van Der Poll, B. Scicluna, E.J. Giamarellos-Bourboulis, A. Kotsaki, I. Martin-Loeches, A. Garduno, J. Sevransky, D. Wright, R. Rothman, M. Atreya, L. Moldawer, P. Efron, M. Kralovcova, T. Karvunidis, H. Giannini, N. Meyer</p>

<p class="sessionid">O0452</p><span class="title">BLOODICU: Bloodstream infections and their outcomes in ICU patients - Insights from the PROSAFE Study </span><span class="presenters">C. Genovese* (Milan, Italy), M. Offer, G. Tricella, G. Scaglione, E. Palomba, G. Montrucchio, F. Agostini, F. Dore, G. Monti, B. Viaggi, A. Gori, S. Finazzi, M. Colaneri</span>
</p>

<p class="sessionid">O0453</p><span class="title">Deciphering the Dynamics of  
<span>Klebsiella pneumoniae</span>
Colonization and Infection: Genomic Insights and Microbiome Interactions in ICU Patients 
<span>W. Yu* (Beijing, China)</span>
</p>

<p class="sessionid">O0454</p><span class="title">Antibiotics with anti-anaerobe activity promote enteric pathobionts in ICU patients 
<span>S. Taylor* (Adelaide, Australia), S. Miller, E. Vasil, B. Reddi,</span>
</p><p class="presenter">L.A. Chapple, S. Bihari, M. Chapman, G. Rogers, L. Papanicolas</p>

<p class="sessionid">O0455</p><span class="title">Association between blood culture time to positivity and 30-day bacteremia mortality differs for bacterial groups </span><span class="presenters">M.H. Øvre* (Herlev And Gentofte, Denmark), J.B. Boel, J.G. Holler, S. Skovgaard, D.S. Hansen, T.S. Itenov, B.J. Holzknecht</span>
</p>

<p class="sessionid">O0456</p><span class="title">Treatment patterns of patients with sepsis/SIRS/septic shock treated with ceftolozane/tazobactam – results from SPECTRA 
<span>E. Yucel* (Rahway, United States), A. Soriano, F. Thalhammer, S. Kluge, P. Viale, M. Allen, B. Akrich,</span>
</p><p class="presenter">J. Levy, H. Yang, S. Kaul</p>

<p class="sessionid">O0457</p><span class="title">Risk of myocardial infarction and stroke following bloodstream infection: a population-based self- controlled case series </span><span class="presenters">J. Underwood* (Cardiff, United Kingdom), N. Reeve, V. Best, A. Akbari, H. Ahmed</span>
</p>

<p class="sessionid">O0458</p><span class="title">Is transthoracic echocardiography required in all patients with  
<span>Staphylococcus aureus</span>
bacteremia? Validating the VIRSTA and VIRSTA+ scores to define the population at low risk of endocarditis 
<span>M. Verdejo Gómez* (Barcelona, Spain), D. Malano- Barletta, M.Á. Verdejo, G. Cuervo, C. Pitart, M. Hernández-Meneses, M. Bodro, S. Herrera, C. Garcia-Vidal, P. Puerta, A. Del Rio, M. Espasa, J.A. Martínez, L. Morata, A. Soriano</span>
</p><p>

<p class="sessionid">O0459</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0460</p><span class="title">Host response plasma biomarkers and transcriptomic alterations in critically ill patients with suspected aspiration pneumonia 
<span>S. Doeleman* (Amsterdam, Netherlands), D. Susanne, E. Michels,</span>
</p><p>J. Butler, F. Uhel, O. Cremer, T. Van Der Poll</p><p> 

</p><p> 



<p class="sessionid">SY106</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Strain dynamics in determining gut microbial colonisation resistance</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Silvio Daniel Brugger (Zurich, Switzerland) Li Yang Hsu (Singapore, Singapore)</p></td></tr>
<tr><td>

<p class="sessionid">S0295</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Strain dynamics in serious bacterial infections in infants <span> </span>Drew Schwartz (Saint Louis, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0296</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Long-term colonisation dynamics of carbapenemase- producing Enterobacterales </p><span class="presenter">Niranjan Nagarajan (Singapore, Singapore)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">OS064</p></p></td><td><p>16:15  
<span>-</span>
17:15</p></td><td><p>Hall 16</p></td></tr>
<tr><td></td><td><p>1-hour Oral Session</p></td><td></td></tr></table><div><p>Viral immune response - nature or nurture? Exploring the limits of immune response</p></div><p><p> 

</p><p class="presenter">Chairs       Malin Flodström-Tullberg (Stockholm, Sweden) Florian Krammer (New York, United States) <br/></p>

<p class="sessionid">O0466</p><span class="title">Orthopoxvirus-specific antibody dynamics up to two years after monkeypoxvirus infection or vaccination </span><span class="presenters">C. Van Dijck* (Antwerp, Belgium), N. Berens-Riha, L. Zaeck, I. Brosius, R. De Vries, J. Marien, L. Liesenborghs</span>
</p>

<p class="sessionid">O0467</p></p>DENG-VAC study: preliminary data on immunogenity and reactogenity of Qdenga vaccine versus natural infection 
<span>A. D'abramo* (Rome, Italy),</span>
</p><p class="presenter">S. Vita, F. Colavita, E. Cimini, P. De Marco, E. Lalle,</p><p class="presenter">G. Maffongelli, L. Rosa, S. Cammisa, G. Delia, M. Fabrizio, N. Emanuele</p>

<p class="sessionid">O0468</p><span class="title">Long-Lasting Immunity Followed by Natural CCHFV Infection </span><span class="presenters">H. Karakoc* (Trabzon, Türkiye), H.N. Karakoç Parlayan, A. Aslanabadi, D. Yapar, Q. Murphy, G. Kaplan, O. Akdoğan, A. Çelikbaş, A. Koroglu, F. Aksoy, E. Karaaslan, A. Abbasi, M. Karimi, M. Hojabri, G. Yilmaz, S.M. Ciupe, S.D. Pegan, É. Bergeron, G. Lewis, N. Baykam, M.M. Sajadi</span>
</p>

<p class="sessionid">O0469</p><span class="title">Why does rabies virus not induce an anti-viral immune response : insights from experimental models and a human cohort 
<span>C. Geurts Van Kessel* (Rotterdam, Netherlands), C. Embregts, A. Gohar,</span>
</p><p class="presenter">B. Verstrepen, J. Aijaz, N. Salahuddin, C. Geurtsvankessel</p>

<p class="sessionid">O0470</p><span class="title">Establishing a human challenge model for human metapneumovirus: disease characteristics and immune responses </span><span class="presenters">N. Noulin* (London, United Kingdom), A. Mann, N. Veselinski, J. Mori, B. Löndt,</span>
</p><p>K. Bradley, M. Kalinova, S. Ascough, G. Boivin, C. Chiu, A. Catchpole <br/></p><p> 

</p><p> 



<p class="sessionid">SY104</p></span>
<span class="start">16:15</span>-<span class="end">17:15</span><span class="location">Hall 3</span>

</p><ol id="l5"><li data-list-text="1-"><p>hour Symposium</p></li></ol><table>
<tr><td><p>Targeted vs. standard perioperative prophylaxis in Solid Organ Transplant with MDR Gram-negative colonisation</p></td></tr>
<tr><td><p class="presenters">Elda Righi (London, United Kingdom)</p><p class="presenters">David Van Duin (Chapel Hill, Nc, United States)</p></td></tr>
<tr><td>

<p class="sessionid">S0291</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Standard prophylaxis <span> </span>Maddalena Giannella (Bologna, Italy)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0292</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Targeted approaches </p><span class="presenter">Maristela P. Freire (Sao Paulo, Brazil)</span>
</p></td></tr></table><p>Co-organised with: European Association for the study of the liver (EASL) <br/></p><p> 

</p><p> 



<p class="sessionid">SY105</p></span>
<span class="start">16:15</span>-<span class="end">17:15</span><span class="location">Hall 4</span>
</p><ol id="l6"><li data-list-text="1-"><p>hour Symposium</p><table>
<tr><td><p>Novel beta-lactams and beta-lactamase inhibitors: a diagnostic and therapeutic approach</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Robert A. Bonomo (Cleveland, United States) Arjana Tambic Andrasevic (Zagreb, Croatia)</p></td></tr>
<tr><td>

<p class="sessionid">S0293</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Novel beta-lactams and beta-lactamase inhibitors: challenges for laboratory diagnostics <span> </span>Anna Sramkova (Pilsen, Czech Republic)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0294</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Clinical perspectives of novel beta-lactams and beta- lactamase inhibitors </p><span class="presenter">Parikshit Prayag (Pune, India)</span>
</p></td></tr></table><p>Co-organised with: EUCAST Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">LB004</p></span>
<span class="start">16:15</span><span>-</span>
18:15 </span><span class="location">Hall 9</span>
</p></li><li data-list-text="2-"><p>hour Oral Session</p></li></ol><p> 
<span>   Trials     in     severe     infections</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Steven Tong (Melbourne, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">L0016</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): a randomised, pragmatic trial <span> </span>F. Cogliati Dezza* (Seville, Spain), L. Barrera Pulido, I. Borreguero Borreguero, F. Docobo Peréz, V. Palomo Jiménez, S. De La Rosa Riestra, J. Bravo-Ferrer Acosta, M.A. Lopez Zuñiga, F. Cobo, J. Gómez-Junyent, J.P. Horcajada, E. Merino, M. Parra, J. Lopéz-Contreras,</span>
</p><p>A. Rivera, D. Sousa Regueiro, M. Pampin Garcia, S. Lopez Cardenas, M.C. Goméz Sanchez, I. Peréz Camacho, S.M. Martin Ramos, E. Leon Jimenez, A.I. Aller García, M.T. Peréz-Rodríguez, A. Sousa, M.C. Fariñas, A.D.L.R.A. Fracisco, L. Gisbert Pérez, J. Goikoetxea Agirre, A. Cano, F.J. Martínez-Marcos,</p><p>M.J. García País, R. Escudero Sanchez, S. De La Villa,</p><p>J.R. Yuste Ara, M.A. Esteban-Moreno, A. Ruiz- Sancho, M. Pedrosa Aragón, J. Alba Fernandez, A. Barrios Blandino, H.H. Vilchez Rueda, R. Álvarez- Marín, A. Romero Palacios, A.E. Roura Piloto, E. Nuño Álvarez, Z.R. Palacios Baena, L. López Cerero, J. Rodríguez-Baño</p></td></tr>
<tr><td>

<p class="sessionid">L0017</p></p></td><td><p>16:27</p></td><td><p>HRS-8427 versus imipenem-cilastatin for complicated urinary tract infections: a randomised, double-blind phase 2 study <span> </span>M. Ju* (Shanghai, China),</span>
</p><p>M. Wang, J. Yuan, H. Huang, G. Bi, J. Lyv, X. Lyv, L.</p><p>Xue, H. Yang, D. Fan, H. Wu, X. Wang, J. Xu, X. Li, Q. Zhang</p></td></tr>
<tr><td>

<p class="sessionid">L0018</p></p></td><td><p class="start">16:39</p></td><td><p class="title">Efficacy and safety in a Phase 2 study of intravenous <p class="sessionid" style="background-color: red;">BV100</p> combined with polymyxin B versus best available therapy in adult subjects with ventilator- associated bacterial pneumonia suspected or confirmed to be due to carbapenem resistant  <span> </span>Acinetobacter baumanniiG. Dale* (Basel, Switzerland), F. Fratzeskaki, I. Tsagkaris, A. Armaganidis, M. Katsiashvili, D. Kazaishvili, T. Gaphrindashvili, K. Japaridze, E. Mouloudi, M. Kapanadze, T. Kachibaia, A. Sarkany, E. Zakynthinos,</span>
</p><p>P. Delique, M. Davila, L. Husband, P. Timofeev, F. Jung, C. Kemmer</p></td></tr>
<tr><td>

<p class="sessionid">L0019</p></p></td><td><p class="start">16:51</p></td><td><p class="title">Neutralising plasma versus placebo for hospitalised patients with West Nile fever: a double-blind randomised controlled trial </p><span class="presenter">M. Canetti* (Tel Aviv, Israel), G. Regev-Yochay, N. Barda, Y. Shusterman, E. Magiel, N. Baharav, A. Belkin, I. Margalit, V. Indenbaum, E. Tomer, Y. Lustig, Y. Ottolenghi, G. Joseph, H. Yonath, E. Leshem, I. Levy, Y. Peretz, S. Amit, L. Miller, M. Misgav, N. Landa, M. Brod, A. Wieder-Finesod, N. Maggio, D. Yahav</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0020</p></p></td><td><p class="start">17:03</p></td><td><p class="title">Randomised placebo controlled trial of faecal microbiota transplantation to tackle antimicrobial resistance: inducing bacteriophage network remodelling and enteric pathogen reduction </p><span class="presenter">L.A. Edwards* (London, United Kingdom), B. Auch, T. Portlock, B.H. Mullish, B. Merrick, C. Woodhouse, T. Tranah, J.M. Blanco, L. Meoli, A. Clavé <p class="sessionid" style="background-color: red;">Llavall1</p>, V.T. Kronsten, A. Zamalloa, V.C. Patel, J.R. Marchesi, I. Liachko, S. Goldenberg, D.L. Shawcross</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0021</p></p></td><td><p>17:15</p></td><td><p>Double-dose dolutegravir and lamivudine versus efavirenz-based antiretroviral therapy for patients</p></td></tr></table><table>
<tr><td></td><td><p>coinfected with HIV and tuberculosis: a multicentre, open-label, randomised trial <span> </span>Y. Shen* (Shanghai, China), X. Le</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0022</p></p></td><td><p class="start">17:27</p></td><td><p class="title">Initial vancomycin taper for the prevention of recurrent Clostridioides difficile infection: the TAPER- V randomised controlled trial <span> </span>E.G. Mcdonald* (Montreal, Canada), Y. Chen, B. Coburn, N. Daneman,</span>
</p><p>S. Hota, C. Frenette, C.E. Kandel, L. Kong, Y. Longtin,</p><p>V.G. Loo, D. Macfadden, M. Muller, T.S. Steiner, L. Valiquette, T.C. Lee</p></td></tr>
<tr><td>

<p class="sessionid">L0023</p></p></td><td><p class="start">17:39</p></td><td><p class="title">Beneficial effects of a clinical metagenomics intervention on clinical outcomes, healthcare economics, and quality of life in patients with sepsis/septic shock: results of the DigiSep-trial <span> </span>T. Brenner* (Essen, Germany), A. Skarabis, S.J. Schaller, T. Von Groote, C. Putensen, U. Günther, M. Sauer, S.O. Decker, F. Dusse, M. Weiss, K. Suchodolski, T.P. Simon, P. Rosenberger, O. Moerer,</span>
</p><p>M. Unterberg, J.C. Schewe, H. Bracht, S. Hutzl, M. Feißt, U. Marschall, P. Brandenburg, J. Englisch, P. Stevens, J. Schmidt, M.W. Pletz, J. Brands, A. Antinoro, L.O. Warner, M.A. Weigand, D.M. Hart, G. Marx, J. Mossanen, T. Breuer, H. Häberle, K. Nitzsche, P. Thalmann, J. Brezinski, J. Saam, T. Schwerhoff, S. Grumaz, M. Steinmann, M. Gaasch, B. Pasieka, U. Jaekel, T. Brandenburger, F. Bach, H. Mutlak, S. Utzolino, M.M. Berger</p></td></tr>
<tr><td>

<p class="sessionid">L0024</p></p></td><td><p class="start">17:51</p></td><td><p class="title">Shortened antibiotic treatment for 5 days in patients hospitalised with community-acquired pneumonia (<p class="sessionid" style="background-color: red;">CAP5</p>): a multicentre randomised controlled noninferiority trial </p><span class="presenter">S. Bastrup Israelsen* (Hvidovre, Denmark), L. Hagens Mygind, F. Al-Zergani, B. Lindegaard, A. Knudsen, S. Tingsgård, L. Thorlacius- Ussing, I. S Johansen, H. Nielsen, P. Ravn, T. Benfield</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L0025</p></p></td><td><p class="start">18:03</p></td><td><p class="title">High-dose rifampicin in the treatment of tuberculous meningitis: results of the HARVEST phase III multi- country randomised clinical trial </p><span class="presenter">R. Van Crevel* (Nijmegen, Netherlands), D. Meya, R. Rovina, D. Boulware, B. Dai, N. Engen, F. Cresswell, K. Naidoo, A. Rizal, D. Imran, R. Lessels, L. Tugume, R. Hamers, M. Kabahubya, S. Marais, Y. Moosa, N. Bahr, E. Svensson, L. Te Brake, R. Aarnoutse</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EF074</p></p></td><td><p>17:30  
<span>-</span>
18:30</p></td><td><p>Arena 1</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><p><br/>
</p><p> 
<span> New  methods  for  rapid  pathogen  detection  and  typing</span>
</p><p class="presenter">Chair      Sylvain Brisse (Paris, France) <br/></p>

<p class="sessionid">E0532</p><span class="title">Rapid detection of Shiga toxin-producing  </span><span class="presenters">Escherichia coli</span>
( 
<span>

<p class="sessionid">stx2</p>a</span>
and  
<span>

<p class="sessionid">stx2</p>d</span>
) in korean diarrheal stool samples: a performance evaluation 
<span>L. Hyeonji* (Seoul, Korea, Republic of), H.J. Lee, H.J. Kim, S.S. Choi, H.J. Choo, H.J. Huh, E.J. Won</span>
</p><p>

<p class="sessionid">E0533</p><span class="title"><span class="presenters"></span>
isolated from older adult patients with bacteraemia (2011–2021) 
<span>J. Geurtsen* (Leiden, Netherlands), M. De Been, O. Go, M. Aitabi, C. Willame, E. Weerdenburg</span>
</p>

<p class="sessionid">E0534</p><span class="title">Strategy for the rapid typing of  
<span>Salmonella</span>
spp using infrared spectroscopy: a one health perspective 
<span>J. Jiménez* (Santiago, Chile), D. Fredes, A. Piña, I. Mercado, J. Miranda, S. Henríquez, T. González, A. Adell, A. Moreno-Switt, A. Wozniak, P. García</span>
</p>

<p class="sessionid">E0535</p></p>WGS-based surveillance as a paradigm shift in outbreak detection, AMR monitoring and source attribution in  
<span>CampylobacterA. Nunes* (Lisbon, Portugal), M.L. Lemos, S. Ortiz, I. Santos, S. Ramos,</span>
</p><p class="presenter">M. Oleastro</p>

<p class="sessionid">E0536</p><span class="title">Prevalence of  </span><span class="presenters">Staphylococcus aureus</span>
clonal complex 97 amongst BORSA isolates in a large UK hospital 
<span>H. Gareth* (Birmingham, United Kingdom)</span>
</p>

<p class="sessionid">E0537</p><span class="title">The effectiveness of clinical laboratory tools in the surveillance of nontuberculous mycobacterium isolations within different counties in Taiwan 
<span>H.W. Chu* (Taipei, Taiwan, China), T.F. Lee, C.C. Shu, Y.T. Huang</span>
</p>

<p class="sessionid">E0538</p><span class="title">Rapid detection of oxazolidinone-resistance-related</p><p>mutations in  
<span>Enterococcus</span>
spp. by using High Resolution Melting-qPCR-typing analysis 
<span>R. Musumeci* (Monza, Italy), E. Giordano, M. Martinelli,</span>
</p><p class="presenter">M. Oggioni, D. Oggioni, V. Marano, E. Arighi, C. Villa,</p><p class="presenter">C. Giubbi, G. Mannarà, F. Perdoni, S. Frugoni, P. Congedo, C.E. Cocuzza</p>

<p class="sessionid">E0539</p><span class="title">An automated pipeline to genotype bacteriophages using third generation sequencing </span><span class="presenters">Z. Halász* (Debrecen, Hungary), E. Szoták, L. Dr. Laczkó, G. Dr. Kardos</span>
</p>

<p class="sessionid">E0540</p><span class="title">Novel approach for fast, automated strain typing and source tracking by Fourier-transform infrared spectroscopy 
<span>N. Mauder* (Bremen, Germany), M. Cordovana, M. Kostrzewa</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF075</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Healthcare    (workers')    safety    revisited</span>
</p><p class="presenter">Chair       Daniel Diekema (Harpswell, United States) <br/></p>

<p class="sessionid">E0541</p><span class="title">Preparedness and cooperation throughout the chain of care during regional-level outbreaks with multidrug resistant organisms: a network analysis and interview study </span><span class="presenters">B. Beishuizen* (Bilthoven, Netherlands), M. Stein, A. Tostmann, C. Rovers, A. Timen</span>
</p><p>

<p class="sessionid">E0542</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0543</p><span class="title">Analysis of the current situation of hospital inspection practices by German health authorities 
<span>A. Schwabe* (Bonn, Germany), J. Dannenberg, A.D. Wollkopf, F. Droop, S. Engelhart, N.T. Mutters</span>
</p>

<p class="sessionid">E0544</p><span class="title">A nationwide survey on the status and implementation of infection prevention and control practice on behalf of INSIEME Project (Italian National project for contrast antibiotic resistance a cooperation between Simit (Italian society of infectious diseases) E (&amp;) Ministry of hEalth) 
<span>M. Meschiari* (Modena, Italy), F.V. Segala, E. Ricchizzi,</span>
</p><p class="presenter">A. Gallerani, V. Scaglione, R. Castoldi, F. Almerigogna, I. Spalliera, A. Parente, S. Coladonato,</p><p>P. Grimaldi, C. Camaioni, M. Abbott, A. Carretta, S. Audagnotto, A. Pan, C. Fanelli, S. Cicalini, P. Tanzili,</p><p class="presenter">E. Ponatali, I. Gentile, R.F. Del Vecchio, A. Oliva, A. Mularoni, M. Lichtner, F. Di Gennaro, A. Marino, R. Murri, C. Mussini</p>

<p class="sessionid">E0545</p><span class="title">High level of measles immunity among Dutch healthcare workers with self-reported “unknown” measles immunity status. </span><span class="presenters">C. Meijer* (Nijmegen, Netherlands), J. Leijser, M. Mccall, C. Rovers, E. Bowles, N. Van Der Geest, A. Tostmann</span>
</p>

<p class="sessionid">E0546</p><span class="title">Factors associated with positive latent TB screening results in healthcare workers at two tertiary referral hospitals in Ireland 
<span>C. Anderson* (Dublin, Ireland),</span>
</p><p class="presenter">D. Mcgee, M. Coleman, A. Hehir, L. Dolan, N. Noonan, V. Tormey, C. Bergin, C. Fleming, L. Townsend</p>

<p class="sessionid">E0547</p><span class="title">Systematic review of determinants of vaccine hesitancy among healthcare workers </span><span class="presenters">V. Gabellone* (Lecce, Italy), F. Nuccetelli, R. Prato, E. Gabrielli, P.L. Lopalco</span>
</p>

<p class="sessionid">E0548</p></p>Post-pandemic questions on vaccine usage: Two qualitative analyses of open-ended responses comparing hypothetical and novel vaccines 
<span>P. Shamsrizi* (Hamburg, Germany), S. Eitze, D. Heinemeier, A. Tänzer, M.A. Jenny</span>
</p>

<p class="sessionid">E0549</p><span class="title">Do healthcare professionals working in acute healthcare settings identify infection prevention and control related knowledge deficits? 
<span>A. Kearney* (Dublin, Ireland), H. Humphreys, D. Fitzgerald Hughes</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF076</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Knowing  me,  knowing  you:  behaviour  influencing  AMS
 Chair       Elena Carrara (Verona, Italy) <br/></span></p><p>

<p class="sessionid">E0550</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0551</p><span class="title">Behaviour change vs policy change: Key drivers of inappropriate antibiotic use among health care professionals in LMICs – insights from Indian community setting 
<span>N. P Mathew* (Manipal, India), U. B, M. Varma, V. K E, R. Ruiter, G. Thunga, C. Mukhopadhyay</span>
</p><p>

<p class="sessionid">E0552</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">V.C. Nguyen, R.L. Hamers, E.J. Nelwan, S. Sakinah, A. Karkey, M.K. Upadhyaya, E. Dodds Ashley, D. Anderson, H.R. Van Doorn, H. Vu</p>

<p class="sessionid">E0553</p><span class="title">SpeakAB, a pilot study to encourage nurses to speak up about antibiotic care </span><span class="presenters">M. Bos* (Nijmegen, Netherlands), J. Schouten, H. Vermeulen, M. Hulscher, C. De Bot</span>
</p>

<p class="sessionid">E0554</p><span class="title">Understanding what matters to patients in antimicrobial stewardship in hospitals. PERSPEcT study update 
<span>B. Jacob* (Dublin, Ireland), E. De Barra</span>
</p>

<p class="sessionid">E0555</p><span class="title">Determinants of antibiotic prescribing in hospitals from low, middle and high-income countries in Asia 
<span>S. Chhabra* (Singapore, Singapore), S. Nair, A. Bramley, J.Y. Chee, K. Vignesvaran, R.E.D. See, L.J. Sun, A.H. Ching, B.S. Cooper, E. Charani, Y. Mo</span>
</p><p>

<p class="sessionid">E0556</p><span class="title"><span class="presenters"></span>
&quot;: The behavioural and phenomenological science of antimicrobial use in haemato-oncology. 
<span>C. Eades* (London, United Kingdom), L. Byrne-Davis, R. Rautemaa-Richardson, T. Felton</span>
</p>

<p class="sessionid">E0557</p><span class="title">Addressing Antimicrobial Resistance: Expert Insights and Policy Recommendations for Effective Interventions 
<span>B. Madran* (Istanbul, Türkiye), F. Almeida, E. Carrara, D. Kofteridis, N. Rocha-Pereira,</span>
</p><p class="presenter">G. Pieve, N. Tziolos, İ. Kayı, Ş. Keske, E. Önder, S. Sakarya</p>

<p class="sessionid">E0558</p><span class="title">Implementation of hospital antimicrobial stewardship in Europe using a data-driven behaviour change approach: insights from the drive-AMS EU project </span><span class="presenters">I. Pauwels* (Antwerp, Belgium), R. Janssen, E. Iosifidis,</span>
</p><p>N. Milevska-Kostova, M. Lupşe, J.A. Paiva, E. Roilides,</p><p>T. Schoffelen, R. Valinteliene, A. Versporten, E. Vlieghe, J. Schouten <br/></p><p> 

</p><p> 



<p class="sessionid">EF077</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>      Viral             aphrodites</span>
</p><p class="presenter">Chair       Rémi Charrel (Marseille, France) <br/></p>

<p class="sessionid">E0559</p><span class="title">Potential for international spread of Oropouche virus via commercial air travel </span><span class="presenters">M. Torres Portillo* (Toronto, Canada), A. Marwah, M. Kraemer, A. Thomas, K. Khan, I. Bogoch</span>
</p>

<p class="sessionid">E0560</p><span class="title">Estimating mpox Clade Ib outbreak size in the Democratic Republic of the Congo to attenuate surveillance gaps during the early stages of the 2024 outbreak 
<span>M. Torres Portillo* (English, Canada),</span>
</p><p class="presenter">A. Marwah, A. Thomas-Bachli, I. Bogoch, K. Khan</p>

<p class="sessionid">E0561</p><span class="title">Disparate epitope recognition between MPXV- infected and Smallpox-vaccinated individuals </span><span class="presenters">A. Otter* (Salisbury, United Kingdom), S. Jones, B. Hicks, B. Hallis, C. Rowe</span>
</p>

<p class="sessionid">E0562</p><span class="title">Diverse residual and late-onset symptoms of severe fever with thrombocytopenia syndrome: insights from a multicenter questionnaire study in Western Japan 
<span>R.M. Sada* (Osaka, Japan), S. Yamamoto, T. Toyokawa, T. Takahashi, A. Yamanaka, M. Kawamura, K. Yokota, Y. Fukumori, T. Taniguchi, R. Tanizaki, K. Iwata, S. Kutsuna</span>
</p>

<p class="sessionid">E0563</p></p>Post-Acute Sequelae and Excess Healthcare Utilization Following Dengue Infection: A Population-Based Cohort Study 
<span>J.T. Lim* (Singapore, Singapore), I. Wee, W.Z. Tan</span>
</p>

<p class="sessionid">E0564</p><span class="title">Challenges of dengue in haematological malignancy patients: Analysis from the DANGO registry during the 2023-2024 outbreak in Argentina 
<span>G.A. Méndez* (Posadas, Argentina), J. Salmanton-García, C. Niveyro, P.A. Villalba Apestegui, V.I. Martín, L.M. Compañy Kec, M.C. Tomasino, M.D.C. Marull, H.I. Bernard, C.P.L. Fernández, M.F. Tosin, M.F. Hobecker, K.B. Duranona, A.D. Jara, O.A. Cornely</span>
</p>

<p class="sessionid">E0565</p><span class="title">Key predictors of critical illness and mortality in Crimean-Congo haemorrhagic fever 
<span>D. Yigci* (Istanbul, Türkiye), D. Güllü, N. Baykam, A. Kocagül Çelikbaş, D. Yapar, Ö. Akdoğan, K. Özden, R. İnan Sarıkaya, İ. Hasanoğlu, H.R. Güner, E. Doğan, F. Karakeçili, H. Alay, Z. Türe Yüce, E. Eryılmaz Eren, A. Erbay, Ş.E. Gök, Ç. Kader, G. Ünüvar Kalın, A. Yetişgen, M. Özgüler, A. Şenol, Ö. Gündağ, M. Çağlar Özer, F. Soyak, B. Tanır, I.D. Alıravcı, G. Çınar, B. Öztürk, E. Gürbüz, F. Pınarlık, M. Kuşkucu, Ö. Ergönül</span>
</p>

<p class="sessionid">E0566</p><span class="title">Kyasanur Forest Disease in 2024: A Retrospective Cohort Study from a tertiary care centre in South India 
<span>P. Venkata Swathi Kiran* (Udupi, India), P.K. Tirlangi, N. Gupta, R. Bhat, P. Ravindra, S.K. Pothumarthy</span>
</p>

<p class="sessionid">E0567</p><span class="title">Unravelling the aetiology of summer flu-like illness in Czechia 
<span>M.F. Kříha* (Ceske Budejovice, Czech Republic), V. Hönig, J. Kamiš, M. Dvořáková, L. Tardy, D. Teislerová, A. Chrdle, M. Palus, D. Růžek</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY112</p></span>
<span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 1</span>

</p><p>1-hour Symposium</p><p> 
<span>   Year      in      public      health</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Ziad A. Memish (Riyadh, Saudi Arabia) Catherine Moore (Cardiff, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">S0309</p></p></td><td><p class="start">17:30</p></td><td><p class="title">Li Yang Hsu (Singapore, Singapore)</p></td></tr>
<tr><td>

<p class="sessionid">S0310</p></p></td><td><p class="start">18:00</p></td><td><p class="title">Rita Oladele (Lagos, Nigeria)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY111</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 11<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> PK/PD  in  drug  development:  what’s  in  it  for  me?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0307</p>   17:30   PK/PD from the EUCAST/regulatory perspective:</p><p>what tools do we need? 
<span>Joseph Meletiadis (Athens, Greece)</span>
</p><p>

<p class="sessionid">S0308</p>  18:00   PK/PD for new anti-TB drugs  
<span>Elin Svensson (Uppsala,</span>
</p><p>Sweden)</p><p>Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG) <br/></p><p> 

</p><p> 



<p class="sessionid">OS070</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 12<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> What’s  new  in  antifungal  guidelines  and  management</span>
</p><p class="presenters"></p>


<p class="sessionid">O0512</p><span class="title">Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM 
<span>R. Sprute* (Cologne, Germany), O.A. Cornely, M. Bassetti, C. Sharon, A. Groll, O. Kurzai, C. Lass-Flörl, L. Ostrosky- Zeichner, R. Rautemaa-Richardson, G. Revathi, M.E. Santolaya, L. White, L.P. Zhu</span>
</p>

<p class="sessionid">O0513</p><span class="title">Impact of achieving early mycological eradication with rezafungin on all-cause mortality and ICU length of stay 
<span>M. Bassetti* (Genoa, Italy), G.R. Thompson, A. Soriano, S. Dickerson, I. Bielicka, O.A. Cornely</span>
</p>

<p class="sessionid">O0514</p><span class="title">An open-label study of ibrexafungerp in patients with refractory fungal infections (FURI) 
<span>O.A. Cornely* (Cologne, Germany), B.D. Alexander, P.G. Pappas,</span>
</p><p class="presenter">T.F. Patterson, M. Hoenigl, M.H. Miceli, P. Vergidis, A. Spec, G.R. Thompson, L. Ostrosky-Zeichner, R.S. Siebert, M. Middle, E. McKie, F. Lewis, D. Angulo</p>

<p class="sessionid">O0515</p><span class="title">Novel immunotherapy approach using pan- </span><span class="presenters">Candida</span>
monoclonal antibodies to treat life-threatening invasive candidiasis and tackle global AMR 
<span>Y. Zhao* (Aberdeen, United Kingdom), C.A. Munro, S. Palliyil</span>
</p>

<p class="sessionid">O0516</p><span class="title">Relative contribution of pharmacokinetics and immune signatures to clinical outcomes in patients with HIV-associated cryptococcal meningitis. 
<span>K. Stott* (Liverpool, United Kingdom), D. Tembo, C. Kajanga,</span>
</p><p>A. Ahmadu, K.D. Ruwanthi, M. Moyo, D. Lawrence, T. Harrison, J. Jarvis, D. Namakhwa, D. Lalloo, W. Hope,</p><p>H. Mwandumba <br/></p><p> 

</p><p> 



<p class="sessionid">OS071</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 14<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Intestinal parasitic uncovered: epidemiology and treatment success</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0517</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0518</p></p>Giardiasis: Who gets it? Experience from a Central London Teaching Hospital. 
<span>A. Boté Casamitjana* (London, United Kingdom), A. Boté-Casamitjana, S. Eisen, L. Nabarro, N. Longley, G. Godbole</span>
</p>

<p class="sessionid">O0519</p><span class="title">Assessing the Effect of Antimicrobial Treatment on the Accuracy of Serial Serum and Urine Testing for Detecting E. histolytica cfDNA 
<span>P. Datta* (Chandigarh, India), D. Rattan, A. Duseja, N. Sharma, N. Kalra, S. Khurana</span>
</p>

<p class="sessionid">O0520</p><span class="title">Longitudinal observation of  
<span>Blastocystis</span>
sp. and  
<span>Dientamoeba fragilis</span>
in children: a very rare occurrence in chronic diseases with gut dysbiosis 
<span>J. Hurych* (Prague, Czech Republic), J. Havlova, V. Neuman, K. Litosova, K. Hubackova, L. Hlinakova, M. Kubat, O. Hradsky, J. Bronsky, K.L. Kolho, P. Saavalainen, H. Malcova, D. Cebecauerova, P. Dřevínek, Z. Sumnik, O. Cinek</span>
</p>

<p class="sessionid">O0521</p><span class="title">High prevalence of the zoonotic Angiostrongylus cantonensis in rats in Spain 
<span>J. Caballero Gómez* (Córdoba, Spain), T. Fajardo-Alonso, I. García- Bocanegra, M. Gonzálvez, A. Beato-Benítez, R. Cuadrado-Matías, M.Á. Quevedo, R. Guerra, R. Martínez, A. Rivero-Juárez, J. Martínez, E. Martínez- Nevado, P. Soriano, D. Crailsheim, J. Lazpita, A. González, P. Foronda, J. Caballero-Gómez</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS072</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 15<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Training  models  -  a  new  model  for  training</span>
</p><p class="presenter">Chairs      Erin Bonura (Portland, United States) Casandra Bulescu (Bucharest, Romania) <br/></p>

<p class="sessionid">O0522</p><span class="title">Can <p class="sessionid" style="background-color: red;">ChatGPT4</p>o help build Objective Structured Clinical Examination (OSCE) stations in infectious diseases ? </span><span class="presenters">S. Villard* (Paris, France), Y. Guedj, L.</span>
</p><p class="presenter">Khider, L. Maisonobe, J. Mesnier, Y. Nguyen, B. Oules, M. Sanchez, S. Voicu, N. Burnichon, A. Faye, A. Mageau, T. Mirault, A. Pellat, C.A. Hobson, D. Bouzid,</p><p class="presenter">M. Thy, N. Peiffer-Smadja</p>

<p class="sessionid">O0523</p><span class="title">Large language model in real-world clinical infectious diseases: are we there yet? </span><span class="presenters">G. Carra* (Switzerland, Switzerland), M. Van Singer, A. Cancela Costa, P.A. Crisinel, L. Cobuccio, F. Desgranges, A. Filali, Y. Fougère, T. Galpérine, E. Gauthiez, B. Guery, M. Jaboyedoff, S. Meylan, A. Munting, E. Kampouri, M. Papadimitriou-Olivgeris, M. Plebani, V. Suttels, P. Valladares, M.A. Hartley, J.L. Raisaro, D. Kaufmann,</span>
</p><p class="presenter">N. Boillat-Blanco</p>

<p class="sessionid">O0524</p><span class="title">Artificial Intelligence-Powered Transformation: Enhancing Public Health Education at Tampere University Towards Sustainable Development Goal 3 </span><span class="presenters">S. Ahmad* (Tampere, Finland)</span>
</p>

<p class="sessionid">O0525</p><span class="title">A Survey on Perceived Priorities for the Implementation of Artificial Intelligence in Developing ESCMID Guidelines 
<span>J. Molina Gil-Bermejo* (Seville, Spain), J. Molina, J.R. Paño-Pardo, B. Nagavci, M. Paul, T. Kostyanev, M.W. Langendam, J.P. Stahl, E. Tacconelli, S. Tschudin-Sutter, M. Zervos, L. Scudeller</span>
</p><p>

<p class="sessionid">O0526</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS073</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 16<span> </span>
</p><p>1-hour Case Session</p><p> 
<span>    Still        going        viral</span>
</p><p class="presenter">Chairs      Ursula Hofer (London, United Kingdom) Yee Sin Leo (Singapore, Singapore) <br/></p>

<p class="sessionid">O0527</p><span class="title">Clinical outcomes of adoptive cell therapy for EBV reactivation and EBV-PTLD in primary immunodeficiencies: prophylactic and therapeutic applications of post-allo-HSCT memory T cell infusions. </span><span class="presenters">A. Tessitore* (Trieste, Italy), N. Maximova,</span>
</p><p class="presenter">S. Braidotti, M. Granzotto, R. Simeone</p>

<p class="sessionid">O0528</p><span class="title">Histopathological proof of herpes simplex pneumonitis in a patient with severe COVID-19 pneumonia </span><span class="presenters">J. Heylen* (Leuven, Belgium), B. Lopuhaa,</span>
</p><p class="presenter">L. Maessen, S. Feys, L. Vanderbeke, G. De Vlieger, K. Lagrou, G. Hermans, M. Peetermans, E. Van Wijngaerden, P. Meersseman, A. Wilmer, G. De Hertogh, G. Verjans, J. Von Der Thüsen, J. Van Kampen, J. Wauters</p>

<p class="sessionid">O0529</p><span class="title">Transmission of dengue virus from donors to recipient after solid organ transplantation. Case series in Argentina. </span><span class="presenters">L. Barcan* (Buenos Aires, Argentina), S. Villamandos, R. Gago, M. Aguirre, A. Martinoia, A. Patterer, M. Uranga, C. Sarkis, E. Temporiti, N. Pujato, S. Claudia, D. Calfunao, C. Nyveyro, M. Martinez, A. Smud, P. Giorgio, L. Barcán</span>
</p>

<p class="sessionid">O0530</p><span class="title">Rash without borders: waning immunity in a travelling physician 
<span>R. Ville Benavides* (Mexico City, Mexico),</span>
</p><p class="presenter">R. Ville-Benavides, I. Avendaño-Gutiérrez</p>

<p class="sessionid">O0531</p><span class="title">A handful of Orf: a case of successful management with cidofovir in a renal transplant recipient </span><span class="presenters">A. Kaya* (Izmir, Türkiye), G.S. İzgi, B. Yaman, Y. Tiftikçioğlu, I. Karaaslan, M. Taşbakan</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY110</p></span>
<span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 3</span>

</p><ol id="l7"><li data-list-text="1-"><p>hour Symposium</p></li></ol><p> 
<span> Immune reconstitution syndrome in infectious diseases: Who. Are. You?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0305</p>   17:30   IRIS in HIV immunocompromised hosts: a failure of</p><p><p class="sessionid" style="background-color: red;">S0306</p><span class="start">18:00</span><span class="title">Dysregulated  host responses to infection 
<span>Michal</span>
</p><p>Holub (Praha, Czech Republic) <br/></p><p> 

</p><p> 



<p class="sessionid">OS069</p></span>
<span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 4</span>

</p><ol id="l8"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Determining  new  and  revising  old  breakpoints</span>
</p><p class="presenter">Chairs      Jaroslav Hrabak (Plzen, Czech Republic) Erika Matuschek (Växjö, Sweden) <br/></p>

<p class="sessionid">O0507</p><span class="title">EUCAST disk diffusion testing of ten additional species of anaerobic bacteria </span><span class="presenters">J. Ahman* (Växjö, Sweden), J. Åhman, E. Matuschek, B.J. Holzknecht,
 P.C. Lindemann, H. Marchandin, S. Copsey-Mawer, T. Morris, G. Kahlmeter</span></p><p>

<p class="sessionid">O0508</p><span class="title"><span class="presenters"></span>
validated across ten European reference laboratories. 
<span>M. Sewell* (Cardiff, United Kingdom), C. Farley, A.V. Krøvel, M. Golob, D. Kese, U. Roisin, D. Lindsay, S. Nadarajah, B. Afshar, V. Gaia, S. Paukner, C. Michel, E. Fedoua, J.M. González-Rubio, F. González-Camacho, M. Petzold,</span>
</p><p class="presenter">M. Scaturro, C. Ginevra, G. Descours, S. Jarraud, L. Jones, O.B. Spiller</p>

<p class="sessionid">O0509</p><span class="title">Antimicrobial susceptibility testing of the combination of aztreonam and avibactam in carbapenem-resistant Enterobacterales: a practical evaluation using the CLSI and EUCAST methods </span><span class="presenters">L. Chan* (Kennedy Town, Hong-Kong SAR, China),</span>
</p><p class="presenter">D.Y.L. Lok, R.C.W. Wong, A.L.H. Lee, I.Y.Y. Cheung,</p><p class="presenter">V.C.Y. Chow</p>

<p class="sessionid">O0510</p><span class="title">Determination of optimal disk diffusion mass for zosurabalpin </span><span class="presenters">M. Castanheira* (North Liberty, United States), J. Maher, Y. Edah, A. Trauner</span>
</p>

<p class="sessionid">O0511</p><span class="title">The clinical significance of aminoglycoside susceptibility breakpoints modification 
<span>O. Henig* (Tel Aviv, Israel), M. Elbaz, N. Bishouty, Y. Yaakobi, R. Ben- Ami</span>
</p><p>Monday, 14 April 2025</p><p> 

</p><p> 



<p class="sessionid">SY116</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 15<span> </span>
</p></li><li data-list-text="2-"><p>hour Symposium</p></li></ol><table>
<tr><td><p>Climate Change: changing risks and adaptation strategies for a world on the move</p></td></tr>
<tr><td><p class="presenters">Rachel Lowe (Barcelona, Spain)</p><p class="presenters">Giacomo Stroffolini (Lausanne, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">S0323</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Vector-borne diseases in Europe and clinical consequences <span> </span>Tuba Dal (Ankara, Türkiye)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0324</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Rising temperatures and risks of fungal disease </p><span class="presenter">Anuradha Chowdhary (New Delhi, India)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0325</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Strategies for climate prevention and adaptation in a moving world </p><span class="presenter">Kristie Ebi (Seattle, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0326</p></p></td><td><p class="start">10:00</p></td><td><p class="title">AMR in climate change-affected countries </p><span class="presenter">Esmita Charani (London, South Africa)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) <br/></p><p> 

</p><p> 



<p class="sessionid">EF079</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> AMS around the world: what we can learn from each other</span>
</p><p class="presenter">Chair      Benedikt Huttner (Geneva, Switzerland) <br/></p>

<p class="sessionid">E0578</p><span class="title">Battlefield Stewardship: Implementing Antimicrobial Management in the Ukrainian Trauma Pathway </span><span class="presenters">H.
 Uren* (Lviv, Ukraine), N. Aliieva, O. Voitovych</span></p><p>

<p class="sessionid">E0579</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0580</p><span class="title">Antimicrobial stewardship program for antibiotic use in the community: impact of multidisciplinary local guidelines during the 2023-2024 influenza a <p class="sessionid" style="background-color: red;">H1</p><p class="sessionid" style="background-color: red;">N1</p> season in northern Italy 
<span>R. Corsini* (Reggio Emilia, Italy), P. Pavone, L. Donghi, S. Filippini, A. Valcavi, S. Filippi, F. Marchi, F. Violi, A. Gandolfi, E. Casini, M. Bardaro, G. Russello, P. Nardini, G. Formoso, G. Dolci,</span>
</p><p class="presenter">S. Mezzadri</p>

<p class="sessionid">E0581</p><span class="title">Effectiveness of Clinical Algorithms combined with Point-of-Care testing to improve Antibiotic Prescribing practices of physicians in outpatient setting of low middle-income country </span><span class="presenters">S. Qureshi* (Karachi, Pakistan), S. Ahmed, N. Nasir, F.N. Qamar</span>
</p>

<p class="sessionid">E0582</p><span class="title">Antibiotic prescribing behaviour in a public Bangladeshi hospital: a snapshot from BALANCE study 
<span>M.S. Kabir* (Dhaka, Bangladesh), R. Farzana,</span>
</p><p class="presenter">S.M.R. Islam, A. Monir, A. Sharmin, J.B. Joyee, F. Humayra, M. Sultana, M.N. Haque, T.R. Walsh</p>

<p class="sessionid">E0583</p><span class="title">Tailored response to antimicrobial resistance emergence: remote-created stewardship program in a low/middle-income country pediatric hospital </span><span class="presenters">P. Favier* (Valencia, Spain), M.A. Aguilera, G. Rapetti Salik, M. Quipildor, M.M. Maresca, I.A. Falco</span>
</p>

<p class="sessionid">E0584</p><span class="title">Weekly interdisciplinary antimicrobial stewardship rounds at two surgical wards show notable potential in optimising antimicrobial treatment 
<span>M. Krauss* (Vienna, Austria), C. Labut, G. Brunhofer-Bolzer, G. Laml-Wallner, B. Unterkoefler, M. Andtisch, E. Presterl, H. Burgmann, B. Willinger, I. Minichmayr, P. Starzengruber, F. Loetsch, H. Lagler</span>
</p><p>

<p class="sessionid">E0585</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">A. Colombo, D. Destefani, M. Bissig, E. Bernasconi</p>

<p class="sessionid">E0586</p><span class="title">“Prescribing antibiotics is a gamble…”: A mixed- methods approach to current practices and implementation challenges of antimicrobial stewardship in a Ugandan tertiary care hospital </span><span class="presenters">L. Jung* (Leipzig, Germany), L. Atikoro, D. Owachi, A. Schneider, S. Schönherr, A. Von Braun, C. Kabugo</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF080</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Acinetobacter baumannii</span>
 
<span>, still a strong knight to be knocked</span>
</p><p class="presenter">Chair       Parikshit Prayag (Pune, India) <br/></p>

<p class="sessionid">E0587</p><span class="title">Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii </span><span class="presenters">H. Haddad* (Sousse, Tunisia)</span>
</p>

<p class="sessionid">E0588</p><span class="title">Clonal dissemination of highly resistant  
<span>Acinetobacter baumannii</span>


<p class="sessionid">ST2</p>: Insights from the BALANCE study 
<span>C. Abdellaoui* (Oxford, United Kingdom), R. Farzana, M.N. Haque, M. Sultana, A. Sharmin, R.I. Rony, T. Ahmed Rifat, Z.T. Chaity, S. Afroj, S. Parvin, M. Ea De Kraker, S. Harbarth, N. Hassoun-Kheir, M. Hamza, G. Jana, S. Jamshaid, R. Yaseen, G. Fatima, M. Nawaz, S.N.Z. Rizvi, U. Ibrahim, K. Shafique, A. Naqvi, R. Zahra, B. Hassan,</span>
</p><p class="presenter">E. Carretto, K. Sands, K.J. Hoog, T.R. Walsh</p>

<p class="sessionid">E0589</p><span class="title">Prevalence and genomic characterization of Sulbactam-Durlobactam-resistant and Carbapenem-resistant Acinetobacter baumannii in ICU Patients in a tertiary hospital in Hanoi, Northern Vietnam </span><span class="presenters">D. Nurjadi* (Luebeck, Germany), S. Boutin,</span>
</p><p class="presenter">Q.T. Nguyen, A.M.P. Thi, N.M. Truong, T.K.P. Nguyen, T.S. Bui, V.T. Nguyen, L. Göpel, L. Huber, K. Kocer, T.K.L. Le, T.T. Tran, T.T. Nguyen, H.S. Le, T.P.</p>

<p class="sessionid">E0590</p><span class="title">In vitro activity of nitroxoline among  </span><span class="presenters">Acinetobacter baumannii</span>
and  
<span>Stenotrophomonas maltophilia</span>
clinical isolates 
<span>E. Wohlfarth* (Cologne, Germany),</span>
</p><p class="presenter">P.G. Higgins, M. Kresken</p>

<p class="sessionid">E0591</p><span class="title">Assessing biocide resistance genes and susceptibility to biocides in carbapenem-resistant  </span><span class="presenters">Acinetobacter baumannii</span>
isolates from Thai hospitals 
<span>M.R.D. Wiradiputra* (Bangkok, Thailand),</span>
</p><p class="presenter">K. Thirapanmethee, P. Khuntayaporn, M.T. Chomnawang</p>

<p class="sessionid">E0592</p><span class="title">Epidemiological and Genomic Characteristics of  </span><span class="presenters">Acinetobacter baumannii</span>
in a Hospital in Zhejiang, China: A Study from 2015 to 2020 
<span>Y. Zhang* (Hangzhou, China), X. Hua</span>
</p>

<p class="sessionid">E0593</p><span class="title">Evaluation of the susceptibility of Carbapenem- resistant  
<span>Acinetobacter baumannii</span>
to sulbactam- durlobactam 
<span>J. Caierão* (Porto Alegre, Brazil), L. Silva Dornelles, G. Da Silva Collar, M. Preussler Mott, A. Luís Barth</span>
</p>

<p class="sessionid">E0594</p><span class="title">Clonal dissemination of  
<span>Acinetobacter baumannii</span>
International Clone 2 Carrying ArmA and emergence of OXA-23-

<p class="sessionid">NDM1</p> co-producers in India 
<span>G. Nagaraj* (Bangalore, India), N. Geetha, S. Varun, K. Ravikumar</span>
</p><p>

<p class="sessionid">E0595</p><span class="title"><span class="presenters"></span>
's phenotypic and genotypic traits in oncological patients 
<span>F. Sivori* (Rome, Italy), I. Cavallo, M. Truglio, G. Fabrizio, M. Francalancia, F. Fraticelli, E. Abril, E.G. Di Domenico,</span>
</p><p>F. Pimpinelli <br/></p><p> 

</p><p> 



<p class="sessionid">EW119</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 11<span> </span>
</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title"> 
<span> This bacterium might harbour AmpC, what should I do?!</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Sören G. Gatermann (Bochum, Germany) Pranita Tamma (Ellicott City, United States)</p></td></tr>
<tr><td>

<p class="sessionid">W0335</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Laboratory identification of AmpC and its impact on</p><p>/i&gt;in vitro resistance <span> </span>Ana Gales (Sao Paulo, Brazil)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0336</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Divergent levels of AmpC expression in Gram- negative pathogens </p><span class="presenter">Antonio Oliver (Palma De Mallorca, Spain)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0337</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Rational choice of antimicrobial therapy against AmpC-producing pathogens </p><span class="presenter">Patrick Harris (Herston, Australia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0338</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Novel antimicrobials active against AmpC: what RCTs tell us in support of their use? </p><span class="presenter">Amy Mathers (Charlottesville, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">SY114</p></p></td><td><p>08:30  
<span>-</span>
10:30</p></td><td><p>Hall 13</p></td></tr>
<tr><td></td><td><p> 

</p><p>2-hour Symposium</p></td><td></td></tr>
<tr><td><p> 
<span>    Sepsis        Global        2025</span>
</p></td></tr>
<tr><td><p class="presenters">Brigitte Lamy (Bobigny, France)</p><p class="presenters">Willem Joost Wiersinga (Amsterdam, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0315</p></p></td><td><p class="start">08:30</p></td><td><p class="title">The ESCMID-ISF Sepsis Award Lecture <span> </span>Andrew Moore (Emerald Hills, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0316</p></p></td><td><p class="start">08:45</p></td><td><p class="title">The WHO Global Maternal Sepsis Study </p><span class="presenter">Carolina Carvalho Ribeiro Do Valle (Sao Paulo, Brazil)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0317</p></p></td><td><p class="start">09:15</p></td><td><p class="title">Sepsis: year in review </p><span class="presenter">Sylvain Meylan (Lausanne, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0318</p></p></td><td><p class="start">09:45</p></td><td><p class="title">How to design and implement a Sepsis National Action Plan (SNAP) </p><span class="presenter">Erika Vlieghe (Edegem, Belgium)</span>
</p></td></tr>
<tr><td><p>Co-organised with: ESCMID Study Group for Bloodstream Infections,</p></td></tr></table><p>Endocarditis and Sepsis (ESGBIES), International Sepsis Forum (ISF) <br/></p><p> 

</p><p> 



<p class="sessionid">SY115</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 14<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Challenges in infection management, prevention and antimicrobial</span>
</p><table>
<tr><td><p>stewardship in long-term care facilities</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Gaetan Gavazzi (Grenoble, France) Giusy Tiseo (Pisa, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">S0319</p></p></td><td><p class="start">08:30</p></td><td><p class="title">The burden of nosocomial infections in long-term facilities  <span> </span>Virginie Prendki (Genève-Thônex, Switzerland)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0320</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Pneumonia in the elderly: management and prevention </p><span class="presenter">Marcos Restrepo (San Antonio, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0321</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Challenges in the clinical diagnosis of infection in the elderly </p><span class="presenter">Maheen Abidi (Denver, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0322</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Challenges in implementing antimicrobial stewardship in long-term care facilities </p><span class="presenter">Elena Carrara (Verona, Italy)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infections in the Elderly (ESGIE), ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">SY117</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 16<span> </span>
</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Survival of the parasites: is treatment failure due to antimicrobial resistance?</p></td></tr>
<tr><td><p class="presenters">Hanne Brekke (Oslo, Norway)</p><p class="presenters">Jaco J. Verweij (Tilburg, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0327</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Nitroimidazole refractory  <span> </span>Giardia intestinalis</span>
</p><p>infection <span> </span>Pavla Tůmová (Praha, Czech Republic)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0328</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Treatment failure in scabies </p><span class="presenter">Francisco Bravo (Lima, Peru)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0329</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Recurrent  <span> </span>Enterobius</span>
infections <span> </span>Sarah Eisen (London, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0330</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Recent advances in the treatment of Visceral Leishmaniasis and PKDL </p><span class="presenter">Shyam Sundar (Varanasi, India)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) <br/></p><p> 

</p><p> 



<p class="sessionid">EW118</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 2</span>

</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">How can we infer and track plasmid outbreaks?</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Alessandra Carattoli (Rome, Italy) Jacob Moran-Gilad (Beer Sheva, Israel)</p></td></tr>
<tr><td>

<p class="sessionid">W0331</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Evolutionary modelling of plasmids <span> </span>Manuel Ares Arroyo (Paris, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0332</p></p></td><td><p class="start">08:50</p></td><td><p class="title">How plasmids shape the emergence of nosocomial pathogens </p><span class="presenter">Jukka Corander (Oslo, Norway)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0333</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Understanding the complexity of plasmid outbreaks using bioinformatics </p><span class="presenter">Torsten Seemann (Melbourne (VIC), Australia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0334</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Plasmid transmission at the One Health interface </p><span class="presenter">Nicole Stoesser (Oxford, United Kingdom)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Study Group for Veterinary Microbiology (ESGVM) <br/></p><p> 

</p><p> 



<p class="sessionid">SY113</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 3</span>

</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Haemorrhagic viral infections</p></td></tr>
<tr><td><p class="presenters">Önder Ergönül (Istanbul, Türkiye)</p><p class="presenters">Catherine Houlihan (Porton Down, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">S0311</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Filovirus disease: evolving therapeutic strategies <span> </span>Ian Crozier (Frederick, United States)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0312</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Jack in the box: Re-emergence of Kyasanur Forest Disease in India </p><span class="presenter">Kavitha Saravu (Manipal, India)</span>
</p></td></tr></table><table>
<tr><td>

<p class="sessionid">S0313</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Crimean Congo Haemorrhagic Fever: Newer insights into pathogenesis leading to new vaccines and therapeutics </p><span class="presenter">Ali Mirazimi (Stockholm, Sweden)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0314</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Venezuelan Equine Encephalitis: Impact of newer strategies for vector control </p><span class="presenter">Carlos Seas (Lima, Peru)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">OS078</p></p></td><td><p>08:30  
<span>-</span>
10:30</p></td><td><p>Hall 5</p></td></tr>
<tr><td></td><td><p>2-hour Oral Session</p></td><td></td></tr></table><p><br/>
</p><p> 
<span>  Trending     topics     in     tuberculosis</span>
</p><p class="presenter">Chairs       Delia Goletti (Rome, Italy)</p><p class="presenter">Sean Wasserman (London, United Kingdom) <br/></p>

<p class="sessionid">O0568</p><span class="title">Lineage-specific immune responses to  </span><span class="presenters">Mycobacterium tuberculosis</span>
: insights into 

<p class="sessionid">L4</p> and <p class="sessionid" style="background-color: red;">L6</p> pathogenesis 
<span>M. Silva* (Porto, Portugal), J. Couto, M. Cardoso, B. Cá, M. Saraiva</span>
</p>

<p class="sessionid">O0569</p><span class="title">Deciphering the functional role of distinctive  
<span>Mycobacterium tuberculosis</span>
peptidoglycan modifications in modulating antibiotic resistance and the immune response 
<span>C. Silveiro* (Lisbon, Portugal), F. Olivença, M. Mandal, D. Pires, E. Anes,</span>
</p><p class="presenter">M.J. Catalão</p>

<p class="sessionid">O0570</p><span class="title">Increased innate immune and neutrophil blood transcriptomic signatures associate with poor outcome in HIV-1 tuberculous meningitis </span><span class="presenters">J. Barnacle* (London, United Kingdom), A. Davis, R.J. Wilkinson, K. Wilkinson, C. Stek, M. Maxebengula,</span>
</p><p class="presenter">N. Bangani, G. Kelly, M. Rodriguez-Lopez, R. Lai, S. Wasserman, G. Meintjes, A. O' Garra</p>

<p class="sessionid">O0571</p><span class="title">Subpopulations in clinical samples of  </span><span class="presenters">Mycobacterium tuberculosis</span>
can give rise to rifampicin resistance and shed light on how resistance is acquired 
<span>V. Brunner* (Oxford, United Kingdom), P. Fowler</span>
</p><p>

<p class="sessionid">O0572</p><span class="title"><span class="presenters"></span>
complex whole genome sequencing analysis pipelines 
<span>R. Spies* (Ho Chi Minh City, Vietnam), D. Crook, T. Peto, P. Fowler, R. Turner, H. Thai, J. Watson, T. Walker</span>
</p>

<p class="sessionid">O0573</p><span class="title">Lung ultrasound for the detection of pulmonary tuberculosis using expert and AI-guided interpretation 
<span>Veronique Suttels (Lausanne, Switzerland)</span>
</p>

<p class="sessionid">O0574</p><span class="title">Nanomotion Technology for Rapid Antimicrobial Susceptibility Testing of  
<span>Mycobacterium tuberculosis</span>
: Evaluating Novel Benzothiazinone Derivatives. 
<span>A. Vocat* (Lausanne, Switzerland), A. Luraschi-Eggemann, C. Antoni, G. Cathomen, D. Cichocka, G. Greub, O. Riabova, V. Makarov, O. Opota, A. Mendoza, S. Cole, A. Sturm</span>
</p>

<p class="sessionid">O0575</p><span class="title">Rapid drug susceptibility testing of  
<span>Mycobacterium tuberculosis</span>
directly from clinical samples using targeted next-generation sequencing 
<span>E. Rosendal* (Lisbon, Portugal), J. Isidro, S. Carneiro, R. Macedo</span>
</p>

<p class="sessionid">O0576</p><span class="title">Enhancing cerebral tuberculosis therapy with an innovative particulate nose-to-Brain drug delivery system: Insights from pharmacokinetic and pharmacodynamic studies 
<span>K. Jadhav* (Sas Nagar, India), K. Sudhakar Jadhav, A.K. Singh, R.K. Verma</span>
</p>

<p class="sessionid">O0577</p></p>Multi-drug resistant tuberculosis among migrants in Europe 
<span>S. Hayward* (London, United Kingdom),</span>
</p><p>K. Rustage, L.B. Nellums, J.S. Friedland, S. Hargreaves <br/></p><p> 

</p><p> 



<p class="sessionid">SY120</p></span>
<span class="start">09:30</span>-<span class="end">10:30</span><span class="location">Hall 1</span>

</p><p>1-hour Symposium</p><p> 
<span>   Year     in     clinical     microbiology</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Fidelma Fitzpatrick (Dublin, Ireland) Maurizio Sanguinetti (Rome, Italy)</p></td></tr>
<tr><td>

<p class="sessionid">S0339</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Mario Ramirez (Lisbon, Portugal)</p></td></tr>
<tr><td>

<p class="sessionid">S0340</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Anna Papa-Konidari (Thessaloniki, Greece)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">EF081</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Clinical features and outcome of invasive fungal infections</span>
</p><p class="presenter">Chair      Marcus De Melo Teixeira (Brasília, Brazil) <br/></p>

<p class="sessionid">E0596</p><span class="title">Management, outcomes and predictors of mortality of  </span><span class="presenters">Cryptococcus</span>
infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand 
<span>J. Coussement* (Melbourne, Australia),</span>
</p><p class="presenter">C.H. Heath, M.B. Roberts, R.J. Lane, T. Spelman, O.C. Smibert, A. Longhitano, C.O. Morrissey, B. Nield, M. Tripathy, J.S. Davis, K.J. Kennedy, S.A. Lynar, L.C. Crawford, S.J. Crawford, B.J. Smith, A.P. Gador- Whyte, R. Haywood, A.A. Mahony, J.C. Howard, G.B. Walls, G.M. O’kane, M.T. Broom, C.L. Keighley, O. Bupha-Intr, L. Cooley, J.A. O’hern, J.D. Jackson, A.J. Morris, C. Bartolo, A.R. Tramontana, K.C. Grimwade,</p><p class="presenter">V. Au Yeung, R. Chean, E. Woolnough, B.W. Teh, M.A. Slavin, S.C.A. Chen</p>

<p class="sessionid">E0597</p><span class="title">Incidence of invasive fungal infections in hospitalised paediatric patients in England </span><span class="presenters">A. Warris* (Exeter, United Kingdom), L. Ferreras-Antolin, G. Kiely, Z. Riaz,
 M. Czachorowski, M. Gerino, K.K. Rai, Z. Akhter, J. Owczarek, C. Castillo, I. Jimenez</span></p><p>

<p class="sessionid">E0598</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">M. Peetermans, G. Hermans, Y. Debaveye, E. Van Wijngaerden, S. Van Der Merwe, G. De Hertogh</p>

<p class="sessionid">E0599</p><span class="title">Non- </span><span class="presenters">Aspergillus</span>
mould infections in Australia and New Zealand: a multi-centre study on epidemiology and clinical outcomes 
<span>C.F. Neoh* (Melbourne, Australia), S.C.A. Chen, A.J. Morris, C.H. Heath, S.J. Tan, R. Lane, S.Y. Tio, M.B. Roberts, S.Y. Tay, K. Kennedy, S. Van Hal, H. Murray, R. Pickles, A. Douglas, K. Urbancic, M. Menon, A. Stewart, P. Simos, N.M. Vaselli, J. Howard, C. Keighley, S. Miyakis, R. Beresford, L. Cooley, O. Smibert, M. Sehu,
 K.Y. Yong, A. Crowe, M. England, O. Robinson, S. Lynar, K. Daveson, C. Halliday, S. Kidd, D.C.M. Kong,</p><p>T. Spelman, L. Worth, M. Slavin</span></p><p>

<p class="sessionid">E0600</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0601</p><span class="title">How often does Mucormycosis (MCM) contribute to mortality in Hematologic Malignancy (HM) patients? Analysis of 103 patients over 20 years 
<span>S. Wurster* (Houston, United States), T.M. John, J. Ying, D.P. Kontoyiannis</span>
</p>

<p class="sessionid">E0602</p><span class="title">Emergence of  
<span>Wickerhamomyces anomalus</span>
invasive infections in injecting drug users 
<span>M. Lefranc* (Bordeaux, France), M. Desnos-Ollivier, P. Baudino, K. Boukris-Sitbon, C. Plaisant, F. Dalle, F. Lanternier, S. Imbert</span>
</p><p>

<p class="sessionid">E0603</p><span class="title"><span class="presenters">
 G. Eustache, T. Belleville, A. Marc, J. Malherbe, P. Bouju, P. Jaubert, O. Lesieur, M. Leclerc, P. Fillâtre, A. Frérou, R. Prével, A. Cady, F. Morio, M. Pihet, G. Nevez, L. Delhaes, S. Imbert, H. Guegan, J. Bonhomme, E. Perraud, C. Dupin, D. Du Cheyron, Y. Launey, C. Aubron</span></p><p>

<p class="sessionid">E0604</p><span class="title"><span class="presenters"></span>
and  
<span>Candida</span>
-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance 
<span>A. Stewart* (Boston, United States), K. Laupland, F. Edwards, S. Koo, S. Hammond, P. Harris, D. Paterson,</span>
</p><p>M. Slavin, S. Chen <br/></p><p> 

</p><p> 



<p class="sessionid">FO129</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 1<span> </span>
</p><p>Open Forum</p><p> 
<span> Predatory  journals  in  CM/ID:  from  symptoms  to  cure
 Chair      Emily G. Mcdonald (Montreal, Canada) <br/></span></p><p>

<p class="sessionid">F0356</p><span class="start">11:00</span><span class="title">The  genesis of predatory journals: symptoms and root problems 
<span>Leonard Leibovici (Petah-Tiqva, Israel)</span>
</p><p>

<p class="sessionid">F0357</p><span class="start">11:10</span><span class="title">The  role of editors and publishers of ‘reputable</p><p>journals’: what can they do to stop predatory journals? 
<span>Till Bärnighausen (Heidelberg, Germany)</span>
</p><p>

<p class="sessionid">F0358</p><span class="start">11:20</span><span class="title">The  roles of authors and academic institutions:</p><p>towards governance and regulation  
<span>Luigia Scudeller (Pavia, Italy)</span>
</p><p>

<p class="sessionid">F0359</p><span class="start">11:30</span><span class="title">Bibliometric  literacy in scientific publication 
<span>Lauren</span>
</p><p>Maggio (Chicago, United States)</p><p>Co-organised with: CMI Communications Board of Editors <br/></p><p> 

</p><p> 



<p class="sessionid">EF089</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Emerging  Infectious  Diseases,  Zoonoses  and  Outbreaks</span>
 <br/></p><p>

<p class="sessionid">E0640</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0641</p><span class="title">Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us? 
<span>I. Sanz-Muñoz* (Valladolid, Spain), J. Sánchez-Martínez, C. Rodriguez-Crespo, I. Arroyo- Hernántes, C.S. Concha-Santos, M.L. De Dlego, S. Rojo-Rello, M. Domíguez-Gil, M. Hernández-Pérez, A. Martín-Toribio, A. Mostafa, L. Martínez-Sobrido, J.M. Eiros, A. Nogales</span>
</p>

<p class="sessionid">E0642</p><span class="title">The UK Imported Fever Service (IFS): National VHF testing 2023-2024 
<span>A. Belfield* (Salisbury, United Kingdom), A. Thompson, H. Umpleby, B. Hack, S. Poole, J. Furneaux, J. Owen, J. Osborne, C. Petridou,</span>
</p><p class="presenter">T. Brooks, N.C. Gordon, T. Rampling, C. Houlihan, C.E. Warrel</p>

<p class="sessionid">E0643</p><span class="title">Reemergence of Poliovirus in Pakistan: Challenges and Implications for Global Health Security </span><span class="presenters">S. Ahmad* (Tampere, Finland)</span>
</p>

<p class="sessionid">E0644</p><span class="title">Preparing an emerging infectious diseases unit for high-consequence infectious diseases 
<span>A. Silva-Pinto* (Porto, Portugal), C. Silva, A.S. Santos, M. Teixeira, L. Santos</span>
</p><p>

<p class="sessionid">E0645</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0646</p></p>
<span>Salmonella</span>
serovars in wild European hedgehogs ( 
<span>Erinaceus europaeus</span>
): an over 12-year monitoring in the Ferrara Province, Italy 
<span>E. Massella* (Piacenza, Italy), M. Munari, S. Russo, L. Cirasella, C. Torreggiani, R. Taddei, A. Luppi, S. Rubini</span>
</p>

<p class="sessionid">E0647</p></p>Clinico-epidemiological and Microbiological Investigation of Diphtheria Outbreak in Odisha, India, 2024 
<span>I. Praharaj* (Bhubaneswar, India), S. Panda, S. Subhadra, J. Sabat, S. Mallik, S. Xalxo, N. Manisha, S. Priyadarshini, S. Nayak, N. Ray, S. Mallick, S. Pati</span>
</p><p>

<p class="sessionid">E0648</p><span class="title"><span class="presenters"></span>
</p><p>S. D. Blacksell, S. S. Y. Kang, N. P. J. Day, R. J. Maude,</p><p>S. J. Lee, Y. Lubell, T. J. Peto <br/></p><p> 

</p><p> 



<p class="sessionid">EF090</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Addressing the need for speed: advances in point-of-care testing</span>
</p><p class="presenter">Chair      Jennifer Dien Bard (Los Angeles, United States) <br/></p>

<p class="sessionid">E0649</p><span class="title">Rapid respiratory microbiological POCTs and antibiotic use in primary care: the RAPID-TEST RCT </span><span class="presenters">E. Brown* (Bristol, United Kingdom), A.D. Hay, S. Abbs,</span>
</p><p class="presenter">M. Ridd, S. Granier, A. Lane, P. Muir, J. Taylor, G. Young, K. Eastwood, H. Dash, L. Bradshaw, R. Clarke,</p><p class="presenter">M. Lui, E. Bridgeman, R. Brierley, H. Thornton, P. Mitchell, L. Zhu, L. Yardley, C. Metcalfe</p>

<p class="sessionid">E0650</p><span class="title">Evaluation of the prototype BIOFIRE® nasal HR panel (nHRP) in children with acute respiratory illness, a nasal swab-based rapid hoSt gene expression test </span><span class="presenters">G. Storch* (Saint Louis, Missouri, United States), M. Wallendorf, C. Rindlisbacher, J. Jackson, M. Hockin</span>
</p>

<p class="sessionid">E0651</p><span class="title">Evaluation of the analytical performance of the Biosynex AMPLIQUICK Fecal Bacteriology kit in the diagnossis of bacterial intestinal infections 
<span>P. Lehours* (Bordeaux, France), Q. Beaufils, L. Benejat,</span>
</p><p class="presenter">A. Ducournau, J. Aptel, A. Chevalier, M. Jauvain</p>

<p class="sessionid">E0652</p><span class="title">Development and Validation of a Novel Rapid Antigen Test for Norovirus Detection: A Comparative Performance Analysis </span><span class="presenters">N. Younes* (Doha, Qatar), G. Nasrallah</span>
</p>

<p class="sessionid">E0653</p><span class="title">A Rapid Molecular POCT System for Detection of Carbapenem-Resistant Enterobacterales (CRE) 
<span>S.Y. Choi* (Daejeon, Korea, Republic of), C. Lee, H.O. Park</span>
</p><p>

<p class="sessionid">E0654</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0655</p><span class="title">Development of a frugal multiplexed paper sensor for rapid detection of sepsis-causing pathogens 
<span>C. Singhal* (Faridabad, India), S. Chatterjee, S. Gupta,</span>
</p><p class="presenter">M. Yadav, C. Sharma, S. Pandey, D. Kumar, P. Joshi,</p><p>J. Jaya, R. Dwivedi, S. Tanwar, S. Sharma, S. Shamsi,</p><p class="presenter">A. Tyagi, N. Kumar, S. Chaudhuri</p>

<p class="sessionid">E0656</p><span class="title">Multianalyte POCT device for a sample-to-result detection of nucleic acid and protein </span><span class="presenters">L. Pommiès* (Gif Sur Yvette, France), H. Boutal, D. Fras, H. Volland</span>
</p>

<p class="sessionid">E0657</p><span class="title">A smartphone app for point-of-care quantification of lateral flow assays 
<span>R. Armiger* (London, United Kingdom), R. Reid, P. Georgiou, A. Holmes, J. Herberg</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">KN121</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture</p><p> 
<span>  HIV:   from   needle   parks   to   injectables</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0341</p>  11:00    
<span>Huldrych Günthard (Zürich, Switzerland)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS085</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 10<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Planes, Pains, and Pathogens: The Perils of Travel Medicine</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0620</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">A. Mancon, D. Mileto, S. Antinori</p>

<p class="sessionid">O0621</p><span class="title">Tracing the itch: A spatiotemporal analysis of scabies rates and its risk factors using the Global Burden of Disease data </span><span class="presenters">S. Gupta* (Auckland, New Zealand), S. Thornley, G. Sundborn, C. Grant</span>
</p>

<p class="sessionid">O0622</p><span class="title">Molecular epidemiological characterization of enterotoxigenic and enteroaggregative  
<span>Escherichia coli</span>
causing traveller's diarrhoea and their relationship with clinical features 
<span>P. Oliveras Julia* (Barcelona, Spain), P. Oliveras, E. Riera, L. Horvath,
 R.M. Albarracín, M.E. Valls, M.J. Álvarez-Martínez, M. Alguacil, E. Guiral, M. Espasa, D. Camprubi-Ferrer, J. Vila</span></p><p>

<p class="sessionid">O0623</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">O0624</p><span class="title"><span class="presenters"></span>
</p><p>V. Jegorova, P. Hubacek, A. Briksi, J. Havlova, K. Dundrova, L. Kolarik, I. Zicklerova, L. Richterova, O. Beranek, T. Ernestova, L. Kohout, G. Meseznikov, A. Nycova, B. Pisova, R. Šindlerová, M. Tulach, Z. Uhříková, M. Vidlička, M. Štefan, F. Stejskal <br/></p><p> 

</p><p> 



<p class="sessionid">OS086</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 11<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Marker  based  diagnostics:  forget  the  pathogen</span>
</p><p class="presenters"></p>


<p class="sessionid">O0625</p><span class="title">A 29-mRNA molecular host response test demonstrates enhanced accuracy compared to a protein-based host response test for the diagnosis of bacterial and viral infections 
<span>N. Whitfield* (Sunnyvale, United States), C. Lu, O. Liesenfeld</span>
</p>

<p class="sessionid">O0626</p><span class="title">Diagnostic accuracy of a bacterial versus viral host- protein test for pediatric inpatients with acute infection 
<span>T. Gottlieb* (Tirat Carmel, Israel), L. Bont, A. Klein, M. Stein, M. Mor, I. Srugo, R. Navon, E. Eden,</span>
</p><p class="presenter">B.P. Muller</p>

<p class="sessionid">O0627</p><span class="title">Diagnostic accuracy of combined urine lipocalin 2 and copper test in acute pyelonephritis or cystitis </span><span class="presenters">V. Havlicek* (Prague, Czech Republic), J. Hrbacek, T. Pluhacek, J. Houst, A. Palyzova, D. Luptakova, D.A. Stevens, J. Novak, R. Dobias, R. Zachoval</span>
</p>

<p class="sessionid">O0628</p><span class="title">Diagnostic Performance of Whole-Blood RNA Signatures for Tuberculosis Diagnosis in a Cohort of Patients with Non-Tuberculous Mycobacterial Lung Disease 
<span>P. Escalante* (Rochester, Mn, United States),
 B. Piatkowski, B. Pathakumari, V. Van Keulen, N. Fadra, P. Arias-Sanchez, L. Gutierrez, S. Karnakoti, T. Peikert</span></p><p>

<p class="sessionid">O0629</p><span class="title"><span class="presenters"></span>
</p><p>V. Jegorova, T. Ernestova, L. Kohout, G. Meseznikov,</p><p>A. Nycova, R. Šindlerová, M. Tulach, M. Vidlička, V. Grebenyuk <br/></p><p> 

</p><p> 



<p class="sessionid">PM2</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 12</span>
</p><p>Panel Discussion</p><p> 
<span>    AMR        and        vaccines</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Charlotte Vernhes (Brussels, Belgium) Ghada Zoubiane (London, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">L005</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Overview of the current evidence of the impact of vaccines on AMR <span> </span>Adam Cunningham (Birmingham, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">L006</p></p></td><td><p class="start">11:20</p></td><td><p class="title">Panel discussion: gaps, needs, and opportunities to leverage vaccines against AMR </p><span class="presenter">, Adam Cunningham (Birmingham, United Kingdom), Sipho Kenneth Dlamini (Observatory, South Africa), Erin Duffy (Boston, United States), Mateusz Hasso-Agopsowicz (Geneva, Switzerland)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY126</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 13<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Why is the concept of complicated UTI so complicated?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0350</p><span class="start">11:00</span><span class="title">The  concept of complicated UTI: underlying conditions matter 
<span>Suzanne Geerlings (Amsterdam, Netherlands)</span>
</p><p>

<p class="sessionid">S0351</p><span class="start">11:30</span><span class="title">The  concept of complicated UTI: the site of infection matters most 
<span>Jesús Rodríguez-Baño (Seville, Spain)</span>
</p><p>Co-organised with: ESCMID Education Subcommittee <br/></p><p> 

</p><p> 



<p class="sessionid">ME128</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 14<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> How to apply organoid models to study infectious disease</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0354</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Jennifer Rohn (London, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">M0355</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Nathalie Sauvonnet (Paris, France)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS087</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 15<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>  Antimicrobial    resistance    around    birth</span>
</p><p class="presenters"></p>


<p class="sessionid">O0630</p><span class="title">Prevalence and risk factors of antibiotic resistance genes in breastmilk and neonatal oral cavity of preterm mother-infant pairs 
<span>A. Sharma* (Chandigarh, India), S. Dutta, M. Biswal, A. Chakraborty, V. Suri, P. Ray</span>
</p>

<p class="sessionid">O0631</p><span class="title">Effect of maternal peripartum antibiotic exposure on the microbial diversity, relative abundance of taxa, and resistome in breastmilk 
<span>A. Chakraborty* (Chandigarh, India), S. Dutta, P. Sikka, D. Puri, A. Kumar, P. Kumar, A. Pal, A. Arora</span>
</p>

<p class="sessionid">O0632</p><span class="title">Dynamics of gastrointestinal colonisation by antibiotic-resistant bacteria in high-risk infants in Swiss and Greek neonatal intensive care units 
<span>A. Braspenning* (Antwerp, Belgium), L. Timbermont, L. Van Heirstraeten, M. Berkell, A. Cook, E. Sieswerda,</span>
</p><p class="presenter">C.H. Van Werkhoven, J. Bielicki, S. Malhotra-Kumar</p>

<p class="sessionid">O0633</p><span class="title">Harnessing functional omics to decipher how probiotics reduce antibiotic resistance gene carriage in infants' gut </span><span class="presenters">V. Pettersen* (Tromsø, Norway), A. Bargheet, G.H. Bø, C. Klingenberg</span>
</p>

<p class="sessionid">O0634</p><span class="title">Dynamics of gut resistome and mobilome in early life: A meta-analysis 
<span>V. Pettersen* (Tromsø, Norway), A. Bargheet, H.T. Noordzij, A.J. Ponsero, C. Jian, K. Korpela, M. Valles-Colomer, J. Debelius, A. Kurilshikov</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS088</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 16<span> </span>
</p><p class="presenter">1-hour Oral Session <br/></p><div><p>Advancing diagnostics and preventive measures in hemato-oncological patients</p></div><p><p class="presenters"></p>

<p class="sessionid">O0635</p><span class="title">Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy </span><span class="presenters">M. Freire* (Sao Paulo, Brazil), A. Villani. Jr, M. P. Freire, F. Lazzar Neto, L.A. De Padua Covas Lages, M. Salaroli De Oliveira, E. Abdala, F. L.S. Nunes, A.S. S. Levin</span>
</p>

<p class="sessionid">O0636</p><span class="title">Viral metagenomics in patients with persistent unexplained neutropenic fever- some clues to the cause of fever? 
<span>A. Douglas* (Melbourne, Australia),</span>
</p><p class="presenter">L. Caly, M.A. Slavin, I. Savic, J. Moselen, A. Aziz, G. Papadakis, G. Ng, J. Druce, K. Thursky</p>

<p class="sessionid">O0637</p><span class="title">Results of Optifil study: 18F-FDG-PET/CT guided antifungal stewardship in invasive pulmonary aspergillosis </span><span class="presenters">F. Lanternier* (Paris, France), C. Maunoury, F. Montravers, F. Marquant, S. Poiree, C. Elie, C. Robin, A. Thiebaut, F. Ader, F. Suarez, E. Blanchard, O. Lortholary</span>
</p>

<p class="sessionid">O0638</p></p>Long-term immunogenicity and boostability of the 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation: a prospective cohort study 
<span>S. Haggenburg* (Amsterdam, Netherlands), J. Schnyder, H. Garcia Garrido, M. Schoordijk, A. Reiners, B. Meek, M. Hazenberg, A. Goorhuis</span>
</p>

<p class="sessionid">O0639</p><span class="title">Humoral and cellular immune response to adjuvanted respiratory syncytial virus vaccine <p class="sessionid" style="background-color: red;">RSVPreF3</p> in adults after allogeneic hematopoietic cell transplantation 
<span>J. Lötscher* (Basel, Switzerland), C.S. Walti, J. Halter, N. Khanna, S. Heller, S. Schmid, K. Leuzinger</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS082</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 2</span>

</p><p>1-hour Oral Session</p><p> 
<span> New  insights  in  bloodstream  infections  and  endocarditis</span>
</p><p class="presenter">Chairs      Barbara Hasse (Zurich, Switzerland) José M. Miro (Barcelona, Spain) <br/></p>

<p class="sessionid">O0605</p><span class="title">Different from the start – Sex differences in Staphylococcus aureus bacteremia mortality </span><span class="presenters">A. Westgeest* (Leiden, Netherlands), M. Lambregts, F. Ruffin, V.G. Fowler, J.T. Thaden</span>
</p><p>

<p class="sessionid">O0606</p><span class="title"><span class="presenters"></span>
infections: the BARISTA study 
<span>S. Giulieri* (Melbourne, Australia), D. Daniel, M. Duarte Aguilera, D. Velasquez-Reyes, R. Guérillot, A. Gador-Whyte, F. James, E. Goodall, P. Fuge-Larsen,</span>
</p><p class="presenter">M. Henri, J. Trubiano, M. Leroi, K. Bond, T. Stinear, S. Tong, J. Kwong, B. Howden</p>

<p class="sessionid">O0607</p><span class="title">Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection – an exploratory post-hoc analysis of the BALANCE randomized clinical trial </span><span class="presenters">S. Ong* (Melbourne, Australia), R. Pinto, A. Rishu, S. Tong, R. Commons,</span>
</p><p class="presenter">J.M. Conly, G. Evans, M. Fralick, C. Kandel, P. Lagacé- Wiens, T. Lee, S. Lother, D. Macfadden, J. Marshall, V. Martel-Laferrière, M. Mayette, E. Mcdonald, J. Neary,</p><p>J. Prazak, E. Raby, A. Regli, B.A. Rogers, S. Smith, L. Taggart, H.T. Wang, T. Wuerz, D. Yahav, P. Young,</p><p class="presenter">R.A. Fowler, N. Daneman</p>

<p class="sessionid">O0608</p><span class="title">Bloodstream infection pathogen diversity and clinical impact revealed through unbiased whole genome sequencing: a prospective genomic epidemiology study </span><span class="presenters">N. Macesic* (Melbourne, Australia), J. Hawkey,</span>
</p><p class="presenter">J.A. Wisniewski, A. Peleg</p>

<p class="sessionid">O0609</p><span class="title">Risk of infection of intracardiac devices in patients with valvular infective endocarditis who carry cardiovascular implanted electronic devices. Analysis on a national cohort </span><span class="presenters">A. Blanco Arévalo* (Barcelona, Spain), A. Blanco-Arevalo, E. Calbo, P. Muñoz, D. Monzón, M. Valerio, M. Hernandez Meneses, J.M. Miró, M. Cobo Belastegui, A. De Alarcón, R. Rodríguez, I. Villanueva Benito, J.C. Lopez-Azor, L. Garcia-Alvarez, L. Boix</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY122</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 3</span>

</p><p>1-hour Symposium <br/></p><div><p>Chronic infections in the era of CFTR modulators: what is going on in cystic fibrosis lungs these days?</p></div><p><p>Chairs      Pavel Drevinek (Prague, Czech Republic)</p><p>Helle Krogh Johansen (Copenhagen, Denmark)</p><table>
<tr><td>

<p class="sessionid">S0342</p></p></td><td><p class="start">11:00</p></td><td><p class="title">The lung microbiome of people with cystic fibrosis receiving modulator therapy </p><span class="presenter">Sebastien Boutin</span>
</p></td></tr>
<tr><td></td><td></td><td><p>(Lübeck, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">S0343</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Tackling chronic infections in people with cystic fibrosis receiving modulator therapy: is it still necessary? </p><span class="presenter">Alessandra Bragonzi (Milano, Italy)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Biofilms (ESGB), Czech Society for Medical Microbiology <br/></p><p> 

</p><p> 



<p class="sessionid">SY123</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 4</span>

</p><p>1-hour Symposium</p><p> 
<span> Infection prevention and control and intensive care: challenges and solutions</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0344</p><span class="start">11:00</span><span class="title">Intensive  care unit (ICU) and infection: two sides of a coin 
<span>Reto Schuepbach (Zurich, Switzerland)</span>
</p><p>

<p class="sessionid">S0345</p>  11:20   Ventilator- associated pneumonia (VAP) and ICU</p><p>enviroment: how can we improve practices? 
<span>Despoina Koulenti (London, United Kingdom)</span>
</p><p>Co-organised with: ESCMID Study Group for Critically Ill Patients (ESGCIP), EUCIC Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">OS083</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 5</span>

</p><p>1-hour Oral Session</p><p> 
<span>    Don't        'rash'        it</span>
</p><p class="presenter">Chairs       Heli Harvala (Turku, Finland)</p><p class="presenter">Catherine Moore (Cardiff, United Kingdom) <br/></p>

<p class="sessionid">O0610</p><span class="title">Current Prevalence of Parvovirus B 19 Infections: Ankara Bilkent City Hospital Experience 2019- 2024 </span><span class="presenters">B. Dinc* (Ankara, Türkiye), F.G. Aslan, F. Kırca,</span>
</p><p class="presenter">A. Toyran, S. Aydoğan, B. Dinç</p>

<p class="sessionid">O0611</p><span class="title">Managing an outbreak of parvovirus <p class="sessionid" style="background-color: red;">B19</p> infection in pregnancy: clinical outcomes from a single-centre study </span><span class="presenters">M. Melchio* (Genoa, Italy), E. Ricci, E. Cristina,</span>
</p><p class="presenter">E. Di Marco, P. Caligiuri, F. Prefumo, S. Mangini, A. Mesini, M. Mariani, C. Russo Artimagnella, C. Saffioti</p>

<p class="sessionid">O0612</p><span class="title">The dark side of the „fifth disease” endemic: human parvovirus <p class="sessionid" style="background-color: red;">B19</p> infections transmitted through blood transfusions in adults with malignant hematological diseases </span><span class="presenters">B.G. Szabo* (Budapest, Hungary), D. Korozs, P. Remenyi, J. Sinko</span>
</p>

<p class="sessionid">O0613</p><span class="title">Key learnings from a measles outbreak with multiple hospital exposures in Ireland, May-July 2024 
<span>A.M. Murray* (Dublin, Ireland), G. Larkin, D. Hickey</span>
</p>

<p class="sessionid">O0614</p><span class="title">Measles virus in the context of subacute sclerosing panencephalitis (SSPE) 
<span>J. Dina* (Caen, France), S. Medragh, J. Adnet, T. Belveyre, C. Vauloup-Fellous</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY124</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 6</span>

</p><p>1-hour Symposium</p><p> 
<span>  Antimicrobial   prescribing:   myths   or   pearls?</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0346</p><span class="start">11:00</span><span class="title">Why  treat IV when PO is possible? 
<span>Bradley Spellberg (Los Angeles, United States)</span>
</p><p>

<p class="sessionid">S0347</p>   11:30   De-escalation of antibiotic therapy to narrow-</p><p>spectrum IV drugs 
<span>Flaminia Olearo (Hamburg, Germany)</span>
</p><p>Co-organised with: CMI Communications Board of Editors, ESCMID AMR Action Subcommittee, ESCMID Study Group for Antimicrobial stewardship (ESGAP), Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Scientific Affairs Subcommittee</p><p> 

</p><p> 



<p class="sessionid">SY125</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 7</span>

</p><p>1-hour Symposium</p><p> 
<span>  Cutting   edge    methods    in   mycology</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0348</p><span class="start">11:00</span><span class="title">Imaging  for diagnosing mycoses: focus on 18F-FDG</p><p>PET/CT 
<span>Ana Fernández-Cruz (Majadahonda (Madrid), Spain)</span>
</p><p>

<p class="sessionid">S0349</p><span class="start">11:30</span><span class="title">Exploring  the intersection of fungal metagenomics and medical mycology 
<span>Marcus De Melo Teixeira (Brasília, Brazil)</span>
</p><p>Co-organised with: ESCMID Fungal Infection Study Group (EFISG), ESCMID Education Subcommittee, Medical Mycology Study Group (GEMICOMED) within the SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiology), ESCMID Study Group for Critically Ill Patients (ESGCIP), Società Italiana per la Terapia Antinfett <br/></p><p> 

</p><p> 



<p class="sessionid">OS084</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 8</span>

</p><p>1-hour Case Session</p><p> 
<span>  Weird     and     unusual     infections</span>
</p><p class="presenters"></p>


<p class="sessionid">O0615</p><span class="title">Vertical Transmission of Clade Ib monkeypoxvirus during Pregnancy: Clinical and Histopathological description of 3 cases 
<span>E. Hasivirwe Vakaniaki* (Kinshasa, Congo, the Democratic Republic of the),
 N.R. Swar Kuispond, H. Yuichiro, S. Tadaki, R. Bulakali Chirimwami, L. Liesenborghs, P. Mbala-Kingebeni, E. Bangwen, I. Brosius, T. Wawina-Bokalanga, S. Sabiti Nundu</span></p><p>

<p class="sessionid">O0616</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">B. O´donell Cortés</p>

<p class="sessionid">O0617</p><span class="title">Wild hippopotamus bite and  </span><span class="presenters">Aeromonas</span>
spp. infection: a treatment challenge. First case report. 
<span>J. Alza Arcila* (Medellín, Colombia), N.M. Daza Alarcon,</span>
</p><p class="presenter">M.V. Montoya Garcia, A. Múnera-Echeverri, F.F. Jiménez Quiroz, J. Alza-Arcila</p>

<p class="sessionid">O0618</p><span class="title">From the sea to the land: an emerging species </span><span class="presenters">K. Rodríguez Martínez* (Santo Domingo, Dominican Republic), K. Rodríguez, A. Fernández, K. Espaillat, J. Cruz, X. Rodríguez, T. Flores</span>
</p>

<p class="sessionid">O0619</p><span class="title">The first findings of Wohlfahrtiimonas chitiniclastica and Ignatzschineria species bacteremia in two cases with maggot infested wounds in Scandinavia 
<span>A.L. Engsbro* (Slagelse, Denmark), C. Mortensen, R. Jul,</span>
</p><p>W. Cebula, A.L. Laugesen, J.T. Møller, M. Kemp <br/></p><p> 

</p><p> 



<p class="sessionid">ME127</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 9</span>

</p><p>Meet-the-Expert</p><p> 
<span> EUCAST:  What's  new  in  susceptibility  testing</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0352</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Erika Matuschek (Växjö, Sweden)</p></td></tr>
<tr><td>

<p class="sessionid">M0353</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Rafael Canton (Madrid, Spain)</p></td></tr></table><p>Co-organised with: EUCAST Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">ME134</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 16<span> </span>
</p><p>Meet-the-Expert <br/></p><div><p>The older solid organ transplant recipient: between frailty, immunosenescence and infection</p></div><p><table>
<tr><td>

<p class="sessionid">M0367</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Maheen Abidi (Denver, United States)</p></td></tr>
<tr><td>

<p class="sessionid">M0368</p></p></td><td><p class="start">13:42</p></td><td><p class="title">Alaa Atamna (Petah-Tikva, Israel)</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infections in Compromised Hosts (ESGICH), ESCMID Study Group for Infections in the Elderly (ESGIE) <br/></p><p> 

</p><p> 



<p class="sessionid">SY131</p></span>
<span class="start">13:30</span><span>-</span>
<span class="start">14:30</span><span class="location">Hall 2</span>

</p><p>1-hour Symposium</p><p> 
<span>  Vaccines    and    antimicrobial    resistance</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0361</p><span class="start">13:30</span><span class="title">The  impact of current and future vaccines on AMR:</p><p>from pneumococcal to COVID-19 
<span>Mateusz Hasso- Agopsowicz (Geneva, Switzerland)</span>
</p><p>

<p class="sessionid">S0362</p><span class="start">14:00</span><span class="title">Can  vaccines against AMR be translated into</p><p>policy? 
<span>William Hausdorff (Washington DC, United States)</span>
</p><p>Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">EW135</p></span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 3</span>

</p><p>Educational Session</p><p> 
<span> Transforming your research idea into an appropriate study design</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Casandra Bulescu (Bucharest, Romania) Mary Horgan (Dublin, Ireland)</p></td></tr>
<tr><td>

<p class="sessionid">W0369</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Designing high-quality research studies: methodological skills and knowledge <span> </span>Mical Paul (Haifa, Israel)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0370</p></p></td><td><p class="start">13:50</p></td><td><p class="title">How to design and run scientific studies using AI agents as research assistants </p><span class="presenter">Alyssa Bilinski (Cambridge, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0371</p></p></td><td><p class="start">14:10</p></td><td><p class="title">Designing your first study: how to construct a workable project when your work environment may not help </p><span class="presenter">Thomas Tängdén (Uppsala, Sweden)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0372</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Bridging early-career professionals with partners and seniors </p><span class="presenter">Giorgia Caruana (Sion, Switzerland)</span>
</p></td></tr></table><p>Co-organised with: CMI Board of Editors, CMI Communications Board of Editors, Trainee Association of ESCMID (TAE) Steering Committee <br/></p><p> 

</p><p> 



<p class="sessionid">FO136</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 1<span> </span>
</p><p>Open Forum</p><p> 
<span> Diversity in CM and ID: gender gaps and policy traps
 Chair      Andre Fuchs (Augsburg, Germany) <br/></span></p><p>

<p class="sessionid">F0373</p><span class="start">13:30</span><span class="title">How  to avoid parity traps in ID/CM research? 
<span>Muge
 Cevik (St Andrews, United Kingdom)</span></p><p>

<p class="sessionid">F0374</p><span class="start">13:40</span><span class="title">Gender  gaps in visibility at scientific conferences 
<span>Sarah Delliere (Paris, France)</span>
</p><p>

<p class="sessionid">F0375</p><span class="start">13:50</span><span class="title">Psychological  determinants of empowerment at individual and societal level 
<span>Tba</span>
</p><p>Co-organised with: ESCMID Education Subcommittee, ESCMID Parity Commission <br/></p><p> 

</p><p> 



<p class="sessionid">EF093</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Real world experience with modern HIV treatment: the art of ART</span>
 <br/></p>

<p class="sessionid">E0668</p><span class="title">Use of long-acting cabotegravir/rilpivirine in HIV- viraemic individuals: a metanalysis 
<span>M. Bongiovanni* (Lugano, Switzerland), B. Barda, G. Barilaro, E.</span>
</p><p class="presenter">Bernasconi</p>

<p class="sessionid">E0669</p><span class="title">Assessment of HIV-DNA, immune activation and senescence biomarkers during injectable cabotegravir/rilpivirine treatment </span><span class="presenters">M. Mazzitelli* (Padua, Italy), M.R. Petrara, C. Cozzolino, L. Sasset,</span>
</p><p class="presenter">D. Leoni, S. Gardin, E. Ruffoni, A. De Rossi, A. Cattelan</p>

<p class="sessionid">E0670</p><span class="title">Impact of Cabotegravir plus Rilpivirine Long-Acting on Body Composition: Results from a Prospective Study </span><span class="presenters">A. De Vito* (Sassari, Italy), A. Marongiu, A. Cano, M. Puci, A. Colpani, A. Mura, M.G. Catte, M.A. Deledda, S. Uzzau, S. Babudieri, G. Sotgiu, F. Deriu, A. Spanu, G. Madeddu</span>
</p>

<p class="sessionid">E0671</p></p>Real-World Efficacy and Tolerability of Long-Acting Cabotegravir/Rilpivirine in Older Woman with Polypharmacy and Comorbidities 
<span>M. Rosas Cancio- Suárez* (Madrid, Spain), A. Moreno, S. Del Campo Terrón, M.J. Vivancos, A. G. García De Morales, J. Martínez-Sanz, M.D. Corbacho, M. Suárez, C. Cano,</span>
</p><p class="presenter">R. Ron, M.J. Cárdenas-Isasi, M. Vélez-Díaz-Pallarés,</p><p class="presenter">S. Moreno, M.J. Pérez-Elías</p>

<p class="sessionid">E0672</p><span class="title">Two-year comparative analysis of lipid profile changes between INSTI-based single tablet regimens in treatment-naïve people living with HIV: real-world evidence from South Korea </span><span class="presenters">S.Y. Lim* (Seoul, Korea, Republic of), B. Chin, M.K. Kim, Y. Kim, G. Kim, J. Bang</span>
</p>

<p class="sessionid">E0673</p></p>Long-acting antiretroviral therapy in PLWH with prior HBV exposure 
<span>J. Mateo Gonzalez* (Valencia, Spain),</span>
</p><p class="presenter">J.I. Mateo-Gonzalez, M. Plaza-De-La-Torre, D. Martinez-Perez, J. Martinez-Andres, V. Abril-Lopez- De-Medrano, E. Ballester-Belda, M. Garcia- Rodriguez, C. Ricart-Olmos, M. Garcia-Deltoro</p>

<p class="sessionid">E0674</p><span class="title">Protease inhibitors in today's antiretroviral landscape: are we tracking resistance? </span><span class="presenters">J. Ciscar Soriano* (València, Spain), J. Ciscar-Soriano, M.D. Gómez-Ruiz, A. Hernández-Cabezas, A. Valentín- Martín, M. Montero-Alonso, J.L. López-Hontangas</span>
</p>

<p class="sessionid">E0675</p><span class="title">Effect after Switching from Efavirenz to Rilpivirine on Liver Steatosis Among People Living with HIV with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial 
<span>L. Srikham* (Sakon Nakhon, Thailand), S. Sriphoosanaphan, O. Putcharoen</span>
</p>

<p class="sessionid">E0676</p><span class="title">Impact of maternal dolutegravir on growth outcomes of HIV-exposed uninfected children: A prospective study 
<span>E. Yoram* (Morongoro, Tanzania, United republic of), E. Luoga, S. Glanzman, F. Vanobberghen,</span>
</p><p>M. Weisser, E. Dotto, G.J. Mollel, G. Sigalla, E. Nyenza, L. Moshi, L. Wilson, J. Okuma, D. Paris <br/></p><p> 

</p><p> 



<p class="sessionid">EF094</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Speed, convenience and performance of virus diagnostic methods</span>
</p><p class="presenter">Chair       Hans H. Hirsch (Basel, Switzerland) <br/></p>

<p class="sessionid">E0677</p><span class="title">Prospective evaluation of a rapid diagnostic test in a tertiary hospital and prospects for reinforced dengue surveillance in Catalonia (Northeastern Spain) </span><span class="presenters">L. Horvath* (Barcelona, Spain), L. Horvath Ruiz, J. Navero, M. Navarro, M. Pujada, A. Navarro,</span>
</p><p class="presenter">M. Garrido, B. Herrerías, P. Rodríguez, N. Zancada,</p><p class="presenter">B. Escudero-Perez, M.J. Martinez</p>

<p class="sessionid">E0678</p><span class="title">Sequence-Independent Single-Primer Amplification (SISPA) followed by Next-Generation Sequencing for Diagnosing Viral Respiratory Tract Infections </span><span class="presenters">P. Trindade* (Santa Maria, Brazil), B.C. Casarin, T.R. Y Castro, B.C. Piccoli, V.T. Santos, L.F. Tessele, A.V. Schwarzbold</span>
</p>

<p class="sessionid">E0679</p><span class="title">Seasonal trends and co-infection dynamics of respiratory pathogens: insights from a yearlong study 
<span>Z. Tsinaris* (Thessaloniki, Greece), A. Tychala,
 G. Meletis, A. Greco, T. Chatziantoniou, R. Dimitriadou, C. Chantzi, E. Georgiadou, G. Kagkalou,</p><p>O. Vasilaki, P. Mantzana, L. Skoura, E. Protonotariou</span></p><p>

<p class="sessionid">E0680</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0681</p><span class="title">Pathobiome characterization and role in disease severity in children under 5-years with respiratory infection symptoms 
<span>L. Terranova* (Milan, Italy), L. Corneo, G. Di Pietro, R. Pinzani, M. Bolis, L. Alagna,</span>
</p><p class="presenter">M. Caruso, F. Giorgetti, N. Hejazifar, E. Furchì, M. Carnevale Schianca, P. Bono, C. Tagliabue, F.B.A. Blasi, A. Callegaro, A. Bandera, S. Bosis, C. Alteri</p>

<p class="sessionid">E0682</p><span class="title">Viral viability markers of SARS-CoV-2: A Comparison of cell culture genomic RNA RT-PCR and subgenomic RNA RT-PCR </span><span class="presenters">C. Cuesta Chasco* (Barcelona, Spain), S. Alex, M. Mª Ángeles, C.C. Genoveva, A. Francesco, R. Cristina, V. Anna, H. Juan Carlos, F.A. Francesc, R.L. Luis Gerardo, N. Mireia, G. Ignacio, B. Marta, G.V. Carolina</span>
</p>

<p class="sessionid">E0683</p><span class="title">Diagnostic performance of Hepatitis B virus surface antigens in the Netherlands using type-specific external quality assessment 
<span>E. Vanhulle* (Bilthoven, Netherlands), M. Simões, H. Ten Bruin, G. Boland, A. Brandenburg, K. Benschop</span>
</p>

<p class="sessionid">E0684</p><span class="title">Low utility of parallel testing by multiplex and individual real-time PCR assays for the diagnosis of viral meningitis and encephalitis at a large public hospital in the United States. 
<span>A. Cuber* (Los Angeles, United States), S. Butler-Wu</span>
</p>

<p class="sessionid">E0685</p><span class="title">Plasma Separation Card as an alternative sampling method for quantitative HCV RNA testing with high comparability to EDTA plasma 
<span>F. Garcia* (Granada, Spain), A. Fuentes López, A. Rando Segura, R. Carracedo, A. Kessler, A. De Salazar González, S.Z. Gebreab, E. Molina, N. Parajó, S. Pereira, J. Romero Vico, E. Ruiz Escolano, M. Vila, L. Viñuela González,</span>
</p><p>A. Carrasco Durán, A. Aguilera, F. García, M. Buti Ferret <br/></p><p> 

</p><p> 



<p class="sessionid">KN130</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 1</span>
</p><p>Keynote Lecture</p><p> 
<span> Infectious disease challenges in an ever-changing environment</span>
</p><p class="presenters"></p><p>

<p class="sessionid">K0360</p>  13:30    
<span>Pamela Rendi Wagner (Stockholm, Sweden)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">PM3</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 12</span>
</p><p>Meet-the-Innovators</p><div><p>Future prospects of electronic clinical decision support systems in stewardship programs</p></div><p><table>
<tr><td>

<p class="sessionid">L007</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Opportunities for clinical decision support systems in infectious disease management </p><span class="presenter">Nathan Peiffer- Smadja (Paris, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">L008</p></p></td><td><p class="start">14:00</p></td><td><p class="title">CDSS and AMS programs: the Lumed example </p><span class="presenter">Valiquette Louis (Sherbrooke, Canada)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">SY132</p></p></td><td><p>13:30  
<span>-</span>
14:30</p></td><td><p>Hall 13</p></td></tr>
<tr><td></td><td><p> 

</p><p>1-hour Symposium</p></td><td></td></tr>
<tr><td><p>Predicting antibiotic susceptibility profiles from whole genome sequences: state-of-the-art</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Werner Ruppitsch (Vienna, Austria) Balaji Veeraraghavan (Vellore, India)</p></td></tr>
<tr><td>

<p class="sessionid">S0363</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Impact of the WHO’s developed catalogue of mutations on rapid TB diagnosis and treatment <span> </span>Thomas Schön (Kalmar, Sweden)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0364</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Antimicrobial resistance prediction using whole genome sequencing </p><span class="presenter">Patricia Simner (Rochester, United States)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), ESCMID Study Group for Epidemiological Markers (ESGEM), EUCAST Steering Committee</p><p> 

</p><p> 



<p class="sessionid">OS092</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 14<span> </span>
</p><p>1-hour Case Session</p><p> 
<span>      Mycobacterial            mayhem</span>
</p><p class="presenters"></p><p> 


<p class="sessionid">O0663</p></span>
Limitations of the Xpert 
<span>®</span>
 MTB/RIF assay: A series of four clinical cases 
<span>A. Haas* (Salt Lake City, United States), A. Ma, J. Pham, P. Verma, U. Malhotra, E.C. Church, M. Narita, V. Escuyer, S. Shakir</span>
</p>

<p class="sessionid">O0664</p><span class="title">Pharmacokinetic analysis of blood and cerebrospinal fluid contezolid concentrations in a patient with tuberculous meningoencephalitis 
<span>W. Nie* (Beijing, China), N. Chu</span>
</p>

<p class="sessionid">O0665</p><span class="title">Is this the first case of Mycobacterium stephanolepidis infection in humans? 
<span>S. Pérez-Recio* (Barcelona, Spain), M.D. Grijota-Camino, A. Lérida, A. Bauer, L. Fernández-Delgado, M.J. Luque, N. Sabé Fernández, F. Alcaide, M. Santin</span>
</p><p>

<p class="sessionid">O0666</p><span class="title"><span class="presenters"></span>
</p><p>S.G. Yoon, M.H. Nam, G.I. Lee, Y. Cho</p>

<p class="sessionid">O0667</p></p>
<span class="title">Mycobacterium abscessus: Is Shorter Antibiotic Therapy Combined with Surgery Sufficient?</span>
<span class="presenters">M.J. Lopes* (Amadora, Portugal), C. Paulo, D. Trigo, M. Caixeiro, M. Alves, R. Macedo, P. Pacheco</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY133</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 15<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Probiotics  in  infectious  diseases:  current  state-of-play</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0365</p><span class="start">13:30</span><span class="title">Probiotics  in infectious diseases: the perfect complement to antimicrobial therapies? 
<span>Lena Biehl (Cologne, Germany)</span>
</p><p>

<p class="sessionid">S0366</p><span class="start">14:00</span><span class="title">The  horizon of next generation probiotics for infectious diseases 
<span>Cormac Gahan (Cork, Ireland)</span>
</p><p>Co-organised with: ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI) <br/></p><p> 

</p><p> 



<p class="sessionid">OS091</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 5</span>

</p><p>1-hour Oral Session</p><p> 
<span> Genomic and molecular drivers of bacterial virulence and resistance</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0658</p><span class="title"><span class="presenters"></span>


<p class="sessionid">ST9</p> lineage. 
<span>Y. Chen* (Hangzhou, China), L. Sun</span>
</p><p>

<p class="sessionid">O0659</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0660</p><span class="title">Clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) strains carrying a mutH mutation are hypermutators that have heightened virulence and readily develop -lactam/-lactamase resistance 
<span>S. Cheng* (Pittsburgh, United States), C. Clancy, M.H. Nguyen, B. Hao, G. Liu</span>
</p>

<p class="sessionid">O0661</p><span class="title">Genomic insights into the new prophages of MDR  
<span>Pseudomonas aeruginosa</span>
: an example of phage- host-phage interaction 
<span>A. Uskudar Guclu* (Ankara,</span>
</p><p class="presenter">Türkiye), S. Unlu</p>

<p class="sessionid">O0662</p><span class="title">Genome-wide association study (GWAS) reveals importance of vaginal epithelium associated genes in case of recurrent vaginitis </span><span class="presenters">R. Mändar* (Tartu, Estonia), E. Mutli, K. Koort, A. Salumets, T. Laisk</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF099</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Infection Prevention in Action: Innovations, Insights, and Global Intervention</span>
</p><p class="presenter">Chair       Allison Mcgeer (Toronto, Canada) <br/></p>

<p class="sessionid">E0706</p><span class="title">A  </span><span class="presenters">Candida auris</span>
cgMLST Scheme for Enhanced Outbreak Surveillance and Global Epidemiological Tracking 
<span>C. Harless* (Silver Spring, United States), J. Stam, B. Corey, E. Horishny, A. Ong, Y. Kwak, J. Bennett, P. Mcgann, F. Lebreton</span>
</p>

<p class="sessionid">E0707</p><span class="title">Machine Learning-Augmented Clinical Scoring System for Predicting KPC Infections in Healthcare Crisis Scenarios 
<span>A. Rearte* (Buenos Aires, Argentina),</span>
</p><p class="presenter">F. Herrera, E. Temporiti, J. Smayevski, P. Bonvehi</p>

<p class="sessionid">E0708</p><span class="title">Incident infections with respiratory syncytial virus in a hospital-based healthcare worker cohort, 2023-2024 winter season </span><span class="presenters">C. Savulescu* (Paris, France), M. Rojas,
 K. Brolin, A. Uusküla, C. Bergin, C. Fleming, V. Zvirbulis, D. Zavadska, V. Gaio, C.P. Popescu, R.M. Hrisca, M. Cisneros, M. Latorre-Millán, J. Mcgrath, L. Lohur, L. Ferguson, I. Abolina, D. Gravele, A. Machado, S.A. Florescu, S.M. Pohrib, P. Subirats, L. Clusa Cuesta, J. Sui, C. Kenny, D. Krievins, E.A. Barzdina, C. Valadas Henriques, A.G. Kosa, M. Lazar,</p><p>C. Muñoz-Almagro, A.M. Milagro, S. Bacci, A. Nardone</span></p><p>

<p class="sessionid">E0709</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0711</p><span class="title">Emerging uncommon non-fermenters and their decreasing antibiotic susceptibility in patients with prolonged hospital stay 
<span>V. Khillan* (New Delhi, India),</span>
</p><p class="presenter">V.G. Nag P, P. Kale, A. Paul, A. Saran</p>

<p class="sessionid">E0712</p><span class="title">Air and surface sampling around mpox Clade 1b in hospitals in the UK </span><span class="presenters">S. Gould* (Liverpool, United Kingdom), B. Atkinson, B. Hack, T. Williams, J. Otter,</span>
</p><p>Y. Ceesay, A. Alsonso, G. Nebbia, S. Blundell, W. Newsholme, G. O'hara, M.G. Semple, T. Fletcher, J. Dunning</p>

<p class="sessionid">E0713</p></p>
<span>Utilization of a healthcare facilities rapid assessment tool to define infection prevention and control and Water, Sanitation and Hygiene baseline criterion met during Democratic Republic of Congo mpox outbreak from August to November 2024A. Baller* (Geneva, Switzerland), N.R. Okum, G. Nsambi, K. Kabamba,</span>
</p><p class="presenter">Y.L. Soro, L. Kabego, V. Willet, N. Usman, H. Hamilton Hurwitz, M. Moon</p>

<p class="sessionid">E0714</p><span class="title">The REACT study: Exploring the BSI Potential of KPC, NDM, VRE, and CRAB rectal colonization </span><span class="presenters">M. Colaneri* (Milano, Italy), P. Giordani, S. Lerta, A. Sangani, V.A. Villano, A. Gori, M. Rettani, S. Milanesi, G. De Nicolao,</span>
</p><p>R. Bruno <br/></p><p> 

</p><p> 



<p class="sessionid">EF100</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Cefiderocol:   an   efficient   Trojan   horse?</span>
</p><p class="presenter">Chair      Anna Sramkova (Pilsen, Czech Republic) <br/></p>

<p class="sessionid">E0715</p><span class="title">Acceleration of Emergence of Cefiderocol Resistance in Microfluidic Evolution System </span><span class="presenters">B. Li* (Beijing, China),</span>
</p><p class="presenter">S. Shen, Q. Wang, S. Wang, W. Wang, H. Wang</p>

<p class="sessionid">E0716</p><span class="title">The hidden link between cefiderocol resistance and increased virulence in  </span><span class="presenters">Klebsiella pneumoniae</span>
: Insights from a TraDIS-based investigation 
<span>E. Eger*</span>
</p><p class="presenter">(Greifswald, Germany), L. Guardabassi, K. Schaufler,</p><p class="presenter">J.U. Müller, B. Jana, M. Schwabe, Y. Ma, M. Pirolo</p>

<p class="sessionid">E0717</p><span class="title">Resistance profiles of Carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol? </span><span class="presenters">I. Baltas* (London, United Kingdom), T. Patel, A.L. Soares</span>
</p>

<p class="sessionid">E0718</p><span class="title">Impact of cefiderocol therapy on patient survival across different multi-drug resistant Gram-negative bacilli infections: insights from the SUSANA cohort. 
<span>N. Corti* (Monza, Italy), M. Faltoni, L. Mezzadri, E. Ricci,</span>
</p><p class="presenter">M. Fois, A. De Vito, A. Bandera, P. Maggi, D. Bavaro,</p><p class="presenter">S. Rusconi, A. Mastroianni, M.A. Carleo, G. Cenderello, L. Bisi, G. Madeddu, P. Bonfanti</p>

<p class="sessionid">E0719</p><span class="title">Decoding resistance: investigating cefiderocol's battle against carbapenem-resistant  </span><span class="presenters">Acinetobacter baumanniiY.T. Lee* (Taipei, Taiwan, China)</span>
</p>

<p class="sessionid">E0720</p></p>Long-read sequencing reveals novel genetic factors in cefiderocol resistance in  
<span>Pseudomonas aeruginosa</span>
ATCC 27853: A stepwise adaptive evolution study 
<span>M. Cardoso* (Groningen, Netherlands), B.B. Xavier, B. Sinha, J. W. A. Rossen, A. Kumar Bari, T. T. Severs</span>
</p>

<p class="sessionid">E0721</p><span class="title">Activity of cefiderocol against carbapenem-resistant and molecularly characterized Enterobacterales clinical isolates causing infection in hospitals in Europe and adjacent regions 
<span>R. Mendes* (North Liberty, United States), A. Scullin, D. Beekman, Z. Kockler, J.M. Maher, H.S. Sader, M. Castanheira</span>
</p>

<p class="sessionid">E0722</p><span class="title">Cefiderocol activity against planktonic and biofilm forms of -lactamase-producing  
<span>Pseudomonas aeruginosa</span>
from people with cystic fibrosis 
<span>G. Fabrizio* (Rome, Italy), M. Truglio, I. Cavallo, F. Sivori,</span>
</p><p class="presenter">M. Francalancia, R. Riveros Cabral J, S. Petrolo, L. Pamparau, M. Comar, D. Compagnino, M. Trancassini, G. Antonelli, F. Ascenzioni, G. Cimino, F. Pimpinelli, E.G. Di Domenico</p>

<p class="sessionid">E0723</p><span class="title">Activity of cefiderocol against clinical isolates of Pseudomonas aeruginosa collected from five European countries as part of SENTRY antimicrobial surveillance program 2020-2023<span class="presenters">C. Longshaw* (London, United Kingdom), J. Maher, R. Mendes, H. Yamashiro, Y. Yamano</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF101</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Immunology    of    bacterial    pathogens</span>
 <br/></p><p>

<p class="sessionid">E0724</p><span class="title"><span class="presenters"></span>
emerges as one of the dominant serotypes causing invasive pneumococcal disease in Germany and Poland, but not in the Netherlands 
<span>K. Hajji* (Bilthoven, Netherlands), I. Wróbel-Pawelczyk, J. Van Veldhuizen, K. Maruhn, W. Miellet, M. Rob, A. Steens,</span>
</p><p class="presenter">N. Van Sorge, K. Trzciński, M. Van Der Linden, A.</p><p class="presenter">Skoczyńska, L. Visser</p>

<p class="sessionid">E0725</p><span class="title">Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine <p class="sessionid" style="background-color: red;">V116</p>: a secondary analysis of five phase 3 studies </span><span class="presenters">M. Esteves Jaramillo* (Rahway, United States), J. Li, H. Platt, W. Hu, W. Xu,
 T. Chapman, K. Nolan, J. Hartzel, U. Buchwald</span></p><p>

<p class="sessionid">E0726</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0727</p><span class="title">Protection against invasive meningococcal disease and gonorrhoea, 5 years post introduction of a 4CMenB immunisation program in infants and adolescents in South Australia 
<span>H. Marshall* (Adelaide, Australia), B. Wang, L. Giles, P. Andraweera, M. Mcmillan, S. Almond, R. Beazley, J. Mitchell, J. Sisnowski, C. Bell, L. Flood, J. Ward</span>
</p><p>

<p class="sessionid">E0728</p><span class="title"><span class="presenters"></span>
from carriage and disease: assessing vaccine coverage in Brazil 
<span>T. Pinto* (Rio De Janeiro, Brazil), L. Oliveira, N. Costa, E. Bressan, A. Rio Tinto, S. Fracalanzza, L. Teixeira</span>
</p><p>

<p class="sessionid">E0729</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0730</p><span class="title">Immune signature against  
<span>Klebsiella pneumoniae</span>
proteins in a mother-baby cohort from Blantyre, Malawi 
<span>E. Heinz* (Glasgow, United Kingdom), J. Campo, O. Pearse, A. Zuza, A. Teng, J. Pablo, A. Oberai, J. Edgar, A. Shandling, K. Kawaza, N. Feasey</span>
</p><p>

<p class="sessionid">E0731</p><span class="title"><span class="presenters"></span>
porinome 
<span>S. Prieto Martin Gil* (Madrid, Spain), S. Prieto Martín Gil, E. Gato, A. Pérez, M.J. Mcconnell, A.J. Martín Galiano</span>
</p>

<p class="sessionid">E0732</p><span class="title">Chronic infection induces a broadly neutralizing antibody response to Elastase B of  
<span>Pseudomonas aeruginosaA. Albus* (Cologne, Germany), D. Kolling,</span>
</p><p>K. Rox, D. Holzmann, K. Mundry, M. Sánchez Agut, C. Meyer, R. Brock, J. Kutschera, K. Schmitt, J.A. Wilms,</p><p>L. Ullrich, C. Kreer, M. Meyer-Willerscheidt, M. Hallek,</p><p>E. Rietschel, S. Van Koningsbruggen-Rietschel, F. Klein, J. Koehnke, J. Rybniker, A. Simonis <br/></p><p> 

</p><p> 



<p class="sessionid">KN137</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture <br/></p><table>
<tr><td><p>Staphylococcus aureus  
<span>host-microbe interaction: ecology, disease, and vaccine development</span>
</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Werner Ruppitsch (Vienna, Austria) Annelies Zinkernagel (Zurich, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">K0376</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Juliane Bubeck Wardenburg (St. Louis, United States)</p></td></tr>
<tr><td>

<p class="sessionid">ME140</p></p></td><td><p>14:45  
<span>-</span>
15:45</p></td><td><p>Hall 11</p></td></tr>
<tr><td></td><td><p>Meet-the-Expert</p></td><td></td></tr></table><p> 

</p><p> 
<span>  Bioinformatic   tools   from   start   to   finish</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0381</p></p></td><td><p>14:45</p></td><td><p>Vítor Borges (Lisbon, Portugal)</p></td></tr>
<tr><td>

<p class="sessionid">M0382</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Clare Sloggett (Melbourne, Australia)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME141</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 13<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span>  AI    use    in    antimicrobial    stewardship</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0383</p></p></td><td><p class="start">14:45</p></td><td><p class="title">Shruti Gohil (Irvine, United States)</p></td></tr>
<tr><td>

<p class="sessionid">M0384</p></p></td><td><p class="start">14:57</p></td><td><p class="title">Jose Ramon Pano-Pardo (Zaragoza, Spain)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS097</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 14<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span> Update   on   zoonotic   and   enteric   infections</span>
</p><p class="presenter">Chairs      Steen Ethelberg</p><p class="presenter">Kavitha Saravu (Manipal, India) <br/></p>

<p class="sessionid">O0696</p><span class="title">A large-scale epidemiological study of  </span><span class="presenters">Campylobacter</span>
employing whole genome analysis reveals the evolution of highly virulent and multidrug- resistant clones in the UK. 
<span>B. Lopes* (Middlesbrough, United Kingdom), A.S. Boaitey-Biko</span>
</p>

<p class="sessionid">O0697</p><span class="title">Population dynamics and evolution of multidrug resistant clones of  
<span>Shigella sonnei</span>
in Metropolitan France 
<span>C. Silva Nodari* (Paris, France), I. Carle, M. Lejay-Collin, L. Philippot, C. Ruckly, L. Fabre, M. Pardos De La Gandara, F.X. Weill</span>
</p><p>

<p class="sessionid">O0698</p><span class="title"><span class="presenters"></span>


<p class="sessionid">O26</p> as an increasingly common cause of haemolytic uraemic syndrome in England: A fifteen-year analysis of national enhanced surveillance data 
<span>L. Mcgeoch* (London, United Kingdom), O. Quinn, C. Sawyer, A. Douglas, C. Jenkins, S. Balasegaram</span>
</p>

<p class="sessionid">O0699</p></p>Incidence, clinical presentation, and outcomes of Pasteurella infections: a population-based Danish study 
<span>L. Øbo Larsen* (8200, Denmark), L.Ø. Larsen,</span>
</p><p class="presenter">H.L. Nielsen, K.K. Søgaard</p>

<p class="sessionid">O0700</p><span class="title">Natural history of latent brucellosis and efficacy evaluation of B-spot in active and latent cases: A 12- month prospective cohort study </span><span class="presenters">H. Wang* (Shanghai, China), G. Yuan, D. Li, H. Liu, J. Ai, W. Zhang</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS098</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 15<span> </span>
</p><p>1-hour Case Session</p><p> 
<span> Opportunistic  infections  in  the  Immunocompromised</span>
</p><p class="presenter">Chairs      Aleksandra Barac (Belgrade, Serbia) Olivier Lortholary (Paris, France) <br/></p>

<p class="sessionid">O0701</p><span class="title">Dog scratch disease? A case of  </span><span class="presenters">Vibrio vulnificus</span>
in a liver transplant patient 
<span>E. Kim* (Galveston, United States), A. Covington</span>
</p>

<p class="sessionid">O0702</p><span class="title">Mpox infection among solid organ transplant recipients: a single center experience at a U.S. Tertiary Care Facility. 
<span>J. Bini Viotti* (Miami, United States), J. Bini</span>
</p><p>

<p class="sessionid">O0703</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">R. Kumar, Y. Dharmashaktu</p>

<p class="sessionid">O0704</p><span class="title">Nocardiosis in a kidney transplant recipient: pros &amp; cons of tedizolid </span><span class="presenters">M. Pellegrino* (Modena, Italy), V. Todisco, S. Generoso, L. Benassi, E. Franceschini, F. Damiano, G. Donati, C. Mussini, A. Cervo</span>
</p>

<p class="sessionid">O0705</p><span class="title">Mycobacterium genavense-Associated IRIS with Macrophage Activation Syndrome: A Case Report Highlighting Diagnostic Challenges 
<span>M. Meroi* (Verona, Italy), M. Morra, M.E. De Rui, E. Tacconelli, F. Soldani</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY139</p><span> </span><span class="start">14:45</span>-<span class="end">15:45<span class="location">Hall 16<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> How to manage bacterial meningitis in low resource settings</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0379</p><span class="start">14:45</span><span class="title">Bacterial  meningitis diagnosis and surveillance 
<span>Divya Deodhar (Muscat, Oman)</span>
</p><p>

<p class="sessionid">S0380</p><span class="start">15:05</span><span class="title">Clinical  presentation and management of CNS infections 
<span>Kartika Maharani (Jakarta, Indonesia)</span>
</p><p>Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR), Spanish Society of Forensic Pathologists (SEPAF) <br/></p><p> 

</p><p> 



<p class="sessionid">OS095</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 2</span>

</p><p>1-hour Oral Session</p><p> 
<span> Community respiratory tract infections: latest trends and approaches</span>
</p><p class="presenters"></p>

<p class="sessionid">O0686</p></p>
<span>Mycoplasma pneumoniae</span>
increase in 2023/24 causes disease in adults in Europe 
<span>B.M.M. Streng* (Utrecht, Netherlands), C. Prat Aymerich, L. Bont, P. Meyer Sauteur, M. Bonten, A. Van Rossum</span>
</p>

<p class="sessionid">O0687</p><span class="title">Serotype distribution of pneumococcal community-</p><p>acquired pneumonia in hospitalized adults in Germany 
<span>D. Karssen* (Utrecht, Netherlands), L. Hessels, G. Barten-Neiner, W. Bauer, S. Franch, T. Fühner, C. Hassiepen, D.F. Heigener, B. Hullegie, R. Jahja, K.D. Johnson, J. Kremling, C. Roberts, G.G.U. Rohde, M. Ruggieri, J. Scheider, D. Stolz, T.D. Swarthout, T. Weiss, H. Van Werkhoven, M. Bonten,</span>
</p><ol id="l9"><li data-list-text="C."><p class="presenter">Prat-Aymerich</p>

<p class="sessionid">O0688</p><span class="title">Community-acquired pneumonia identification from electronic health records in the absence of a gold standard: a Bayesian latent class analysis </span><span class="presenters">J. Wei* (Oxford, United Kingdom), K. Yuan, A. Luk, S. Walker,</span>
</p></li><li data-list-text="D."><p>Eyre</p></li></ol>

<p class="sessionid">O0689</p><span class="title">Causes of death and risk factors for 90-day mortality and readmission in community-acquired pneumonia. 
<span>F. Al-Zergani* (Hvidovre, Denmark), C. Lundetoft Clausen, P. Ravn, M. Sebastian Roldgaard,</span>
</p><ol id="l10"><li data-list-text="L."><p>Kolte, H. Sarac, M. Fally, S. Bastrup Israelsen, T. Benfield</p><p>

<p class="sessionid">O0690</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY138</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 4</span>

</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>Global clones and evolving resistance mechanisms towards newer beta- lactams: Where are we heading?</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Yesim Besli (Istanbul, Türkiye) Spyros Pournaras (Athens, Greece)</p></td></tr>
<tr><td><p class="presenter"><br/></p>

<p class="sessionid">S0377</p><span class="title"></td><td><p class="presenter">14:45</p></td><td><p>Carbapenemase </span><span class="presenters">-producing Enterobacterales: the not so good, the bad and the ugly.</span>
Arjana Tambic Andrasevic (Zagreb, Croatia)</p></td></tr>
<tr><td>


<p class="sessionid">S0378</p></p></td><td><p class="start">15:15</p></td><td><p class="title">The  <span> </span>P. aeruginosa</span>
frightening cocktail: high-risk clones, horizontally-acquired resistance and evolving mutational resistome <span> </span>Katy Jeannot (Besançon, France)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) <br/></p><p> 

</p><p> 



<p class="sessionid">OS096</p></span>
<span class="start">14:45</span>-<span class="end">15:45</span><span class="location">Hall 5</span>

</p><p>1-hour Oral Session</p><p> 
<span>  Trends     in     antifungal     resistance</span>
</p><p class="presenter">Chairs      Alexandre Alanio (Paris, France)</p><p class="presenter">Ana Alastruey-Izquierdo (Madrid, Spain) <br/></p>

<p class="sessionid">O0691</p><span class="title">Turning resistance into vulnerability: leveraging genetic insights to predict collateral sensitivity and synergism for effective multidrug therapies </span><span class="presenters">K. Schmidlin* (Tempe, United States), K. Geiler- Samerotte</span>
</p><p>

<p class="sessionid">O0692</p>      Role of the <p class="sessionid" style="background-color: red;">C2585</p>G substitution in the  


<p class="sessionid">MRR1</p></span>
gene in the development of azole resistance in  
<span>Candida parapsilosis sensu strictu</span>
. 
<span>I. Franconi* (Pisa, Italy), P. Noemi, A. Tavanti, A. Lupetti, R. Cosmeri, L. Maltinti,</span>
</p></li><li data-list-text="M."><p>Falcone</p></li></ol>

<p class="sessionid">O0693</p><span class="title">Fungaemia in a tertiary Madrid hospital from 2007 to 2024: changes in species epidemiology, increase in echinocandin resistance and low patient-to-patient transmission in recent years 
<span>J. Guinea* (Madrid, Spain), P. Escribano, G. Jesús, M. Machado, A. Burillo, P. Muñoz</span>
</p>

<p class="sessionid">O0694</p><span class="title">A multicentre study for determination of epidemiological cutoff values for rezafungin and four comparators against Candida auris with EUCAST broth microdilution reference methodology 
<span>J. Meletiadis* (Haidari, Greece), J. Guinea, S. Arikan- Akdagli, E.F.J. Meijer, J. Meis, M.C. Arendrup</span>
</p><p>

<p class="sessionid">O0695</p><span class="title"><span class="presenters"></span>
Resistance in Latin America: Candida.app vs. Pathogenwatch 
<span>J. Acosta España* (Quiro, Ecuador), P. Eduarda, J.D. Acosta-España, A.</span>
</p><p>Herrera-Yela <br/></p><p> 

</p><p> 



<p class="sessionid">SY144</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium <br/></p><table>
<tr><td><p>What's the role of infant and maternal immunisation for paediatric RSV prevention?</p></td></tr>
<tr><td><p class="presenters">Joanne M. Langley (Halifax, Canada)</p><p class="presenters">Peter Openshaw (London, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">S0391</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Pros and cons of passive infant immunisation with mAb before their first RSV season <span> </span>Federico Martinón- Torres (Santiago De Compostela, Spain)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0392</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Pros and cons of maternal vaccination in preventing severe RSV infections in infants. </p><span class="presenter">Anne Vergison (Luxembourg, Luxembourg)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">EF104</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Cutting-edge  technologies  to  improve  viral  diagnostics</span>
</p><p class="presenter">Chair      Patricia Alvarez (Rio De Janeiro, Brazil) <br/></p>

<p class="sessionid">E0743</p><span class="title">How straightforward is the switch from qPCR to dPCR in a routine lab setting for quantification of Varicella-zoster virus in CSF samples </span><span class="presenters">A. Baumhögger* (Bochum, Germany), T. Bähr, G. Geis,</span>
</p><p class="presenter">S. Gatermann</p>

<p class="sessionid">E0744</p><span class="title">A novel biosensor for the detection of RSV infection </span><span class="presenters">C. Zannella* (Naples, Italy), F. Passeggio, F. Napolitano,</span>
</p><p class="presenter">A. De Filippis, F. Arcadio, C. Marzano, I. Tavoletta, L. Zeni, M. Galdiero, G. Portella, N. Cennamo</p>

<p class="sessionid">E0745</p><span class="title">Insufficient sexual health bloods don't always need throwing away! </span><span class="presenters">S. Hutchings* (Bristol, United Kingdom), R. Hopes, P. North, W. Stoate, M. Murphy,</span>
</p><p class="presenter">G. Beckley, J. Gabb</p>

<p class="sessionid">E0746</p><span class="title">A comparison of 4 HAV serology assays: the value of consensus results as a reference standard </span><span class="presenters">T. Chin* (Ghent, Belgium), E. Padalko</span>
</p>

<p class="sessionid">E0747</p><span class="title">Advancing herpesvirus diagnostics: clinical evaluation of a high-performance real-time PCR assay 
<span>H. Alonso-Ezcurra* (Zaragoza, Spain), S. Lucea,
 C. Escolar, H. Alonso</span></p><p>

<p class="sessionid">E0748</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0749</p><span class="title">Development of Non-Cross-Reactive Monoclonal Antibodies Against West Nile Virus and Usutu Virus Non-Structural Protein 1 to Improve Early Diagnosis 
<span>M. Ceconi* (Antwerp, Belgium), K. Ariën, P. Delputte</span>
</p>

<p class="sessionid">E0750</p><span class="title">Enhancing Diagnostics and Global Standards through the QCMD Viral Metagenomics EQA 
<span>G. Sutton* (Glasgow, United Kingdom), D. Montgomery, E. Mcculloch, A. Ricketts</span>
</p><p>

<p class="sessionid">E0751</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF105</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> New  data  in  non-tuberculous  mycobacterial  disease</span>
</p><p class="presenter">Chair       Lorenzo Guglielmetti (Paris, France) <br/></p>

<p class="sessionid">E0752</p><span class="title">Deciphering genotypic resistance to amikacin in  </span><span class="presenters">Mycobacterium abscessus</span>
using whole genome sequencing and a specific pipeline (GenoMAB) 
<span>C.</span>
</p><p>Allam* (Paris, France), S. Agsous, P. Baylac, K. La,</p><p>N. Godron, F. Mougari, Z. Awad, E. Cambau</p>

<p class="sessionid">E0753</p></p>
<span>Pseudomonas aeruginosa</span>
rapidly kills  
<span>Mycobacterium abscessus</span>
in dual-species biofilms  
<span>in vitroM. Mcdaniel* (Nijmegen, Netherlands), J. Scoffield, J. Van Ingen</span>
</p>

<p class="sessionid">E0754</p><span class="title">Distribution of contezolid in different tissues of mice and human patients infected with  
<span>Mycobacterium abscessusW. Nie* (Beijing, China), N. Chu</span>
</p>

<p class="sessionid">E0755</p><span class="title">Exploration of clofazimine and bedaquiline activity against clinical strains of  
<span>Mycobacterium abscessus</span>
to advance innovative therapeutic strategies 
<span>C. Maria* (Madrid, Spain), M. Cano-Fernández, J. Esteban, P. López-Roa, A. Ruedas-López, J.J. Aguilera-Correa, M.C. Muñoz-Egea</span>
</p><p>

<p class="sessionid">E0756</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0757</p><span class="title">Recovery of Non-Tuberculous Mycobacteria and Detection of Dominant Circulating Clones in Indoor Water Samples from Germany 
<span>N. Wetzstein* (Frankfurt, Germany), M. Diricks, D. Frank, I. Friesen, S. Niemann, T. Wichelhaus</span>
</p>

<p class="sessionid">E0758</p><span class="title">Deciphering the Epidemiology of  
<span>Mycobacterium chimaera</span>
: Genetic Lineages, Environmental Sources, and Infection Prevention Insights 
<span>G. Lorenzin* (Trento, Italy), M. Sandei, P. Fassan, A. Casadei, C. Scarparo</span>
</p>

<p class="sessionid">E0759</p><span class="title">Evaluation of a novel media for susceptibility testing of  
<span>Mycobacterium avium-intracellulare</span>
complex isolates 
<span>T. Grams* (Salt Lake City, United States), S. Shakir</span>
</p>

<p class="sessionid">E0760</p><span class="title">Emerging cases of  
<span>Mycobacterium chelonae</span>
endocarditis associated with  
<span>BioIntegral</span>
bioprostheses 
<span>J. Kikhney* (Berlin, Germany), F. Pfäfflin, L. Kursawe, K. Sarbandi, I. Friesen, M. Stegemann, R. Schwarzer, D. Von Schöning, V. Falk,</span>
</p><p>A. Moter <br/></p><p> 

</p><p> 



<p class="sessionid">EF106</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Arena 3<span> 
 ePoster Flash Session <br/></p><div><p>The ABC (allergy, bloodstream infections and clinical decision support) in AMS</p></div><p><p>Chair      Céline Pulcini (Nancy, France) <br/></span></p><p>

<p class="sessionid">E0761</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0762</p><span class="title">Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record to assess safety, de-labelling and antibiotic prescribing: The ALABAMA randomised controlled trial. 
<span>J. Sandoe* (Leeds, United Kingdom),</span>
</p><p class="presenter">S. Ahmed, K. Armitage, C. Bates, R. Bestwick, B. Jenny, C. Butler, J. Cook, F. Joanne, U. Galal, P. Howard, D. Howdon, S. Mort, R. Mujica-Mota, A. Negut, C. Porter, N. Powell, M. Santillo, R. Sargur, S. Savic, S. Tonkin-Crine, M. Wanat, R. West, M. Yang,</p><p class="presenter">L.M. Yu, S. Pavitt</p>

<p class="sessionid">E0763</p><span class="title">Stewardship interventions reduced blood culture utilization by 40% during BD BACTEC™ Blood Culture media shortage </span><span class="presenters">X. Li* (Toronto, Canada), K. Katz, A. Ceentavida, R. Kozak, C. Vermeiren, P. Sheldrake, S. John, A. Belhaj, S. Hsieh, S. Patel, R. Lovinsky</span>
</p>

<p class="sessionid">E0764</p><span class="title">Prescriptive Impact of Rapid Microbiological Diagnostics in Bloodstream Infections Caused by  
<span>Escherichia coli</span>
,  
<span>Klebsiella pneumoniae</span>
, and  
<span>Staphylococcus aureus</span>
(PRIMEKA): A Retrospective Single-Center Cohort Study. 
<span>F. Salvati* (Rome, Italy),
 F. Giovannenze, G.M. Leanza, M. Chiuchiarelli, A. Frater, M.L. Colombo, F. Iannarelli, B. Fiori, T. D'inzeo,</p><p>R. Murri, C. Torti</span></p><p>

<p class="sessionid">E0765</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">X. Mulet, A. Oliver, J. Murillas</p>

<p class="sessionid">E0766</p><span class="title">Factors influencing meropenem prescription following the 2020 EUCAST « I » definition update : a multicentric observational study in Belgian hospitals </span><span class="presenters">L. Catteau* (Brussels, Belgium), L. Bonacini</span>
</p>

<p class="sessionid">E0767</p><span class="title">Impact of an Antimicrobial Stewardship Mobile Application on Antimicrobial Prescribing, Length of Hospital Stay, and Cost Savings 
<span>Z.O.E. Babiker* (Abu Dhabi, United Arab Emirates), L. Bukasa, A. Sadeq, J. Shamseddine, R. Ali</span>
</p>

<p class="sessionid">E0768</p><span class="title">Evaluation of a model-based clinical decision support system for empirical antimicrobial therapy 
<span>M.L. Mogensen* (Aalborg, Denmark), S.N. Søgaard, L. Ward, H. Skjøt-Arkil</span>
</p>

<p class="sessionid">E0769</p><span class="title">A rapid systematic review of criteria to facilitate prompt intravenous-to-oral antimicrobial switch in children and young people in England. 
<span>R. Oettle* (London, United Kingdom), S. Patel, A. Demirjian, M. Mcleod, C. Jamieson, G. Damant, K. Hand, D. Ashiru- Oredope</span>
 <br/></p><p> 

</p><p> 

<span>EA</span>
<span class="start">16:15</span><span>-</span>
17:30 </span><span class="location">Hall 1</span>

</p><p>Awards</p><p> 
<span>   Excellence       Award       Lectures</span>
</p><p class="presenters"></p><p>

<p class="sessionid">A006</p>   16:15   Towards pandemic prevention, moonshot or utopia?</p><p>Marion Koopmans (Rotterdam, Netherlands)</p><p><p class="sessionid" style="background-color: red;">A007</p><span class="start">16:50</span><span class="title">Can  global warming bring new infectious</p><p>diseases? 
<span>Arturo Casadevall (Baltimore, United States)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY143</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 11<span> 
 ESCMID guidelines for the vaccination of immunocompromised individuals: solid organ transplant recipients</p><p><p>1-hour Symposium <br/></p><p class="presenters"></span></p><p>

<p class="sessionid">S0389</p><span class="start">16:15</span><span class="title">Vaccination  against respiratory pathogens 
<span>Albert
 Vollaard (Bilthoven, Netherlands)</span></p><p>

<p class="sessionid">S0390</p><span class="start">16:45</span><span class="title">Other  vaccines 
<span>Olivier Epaulard (Grenoble, France)</span>
</p><p>Co-organised with: ESCMID Study Group for Infections in Compromised Hosts (ESGICH), ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">EW146</p><span> </span><span class="start">16:15</span>-<span class="end">18:15<span class="location">Hall 13<span> </span></p><p>Educational Session</p><p> 
<span> How to detect, manage and communicate hospital outbreaks</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Margaret Ip (Shatin, Hong-Kong SAR, China) Rossitza Vatcheva-Dobrevska (Sofia, Bulgaria)</p></td></tr>
<tr><td>

<p class="sessionid">W0395</p></p></td><td><p class="start">16:15</p></td><td><p class="title">How to detect hospital outbreaks <span> </span>David Fisman (Toronto, Canada)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0396</p></p></td><td><p class="start">16:35</p></td><td><p class="title">How to confirm hospital outbreaks using genomics </p><span class="presenter">John W. A. Rossen (Groningen, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0397</p></p></td><td><p class="start">16:55</p></td><td><p class="title">How to rapidly respond to an ongoing hospital outbreak </p><span class="presenter">Ermira Tartari (Msida, Malta)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0398</p></p></td><td><p class="start">17:15</p></td><td><p class="title">How to communicate hospital outbreaks via scientific publication </p><span class="presenter">Ines Steffens (Solna, Sweden)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">ME145</p><span> </span><span class="start">16:15</span>-<span class="end">17:15<span class="location">Hall 15<span> </span>
</p><p>Meet-the-Expert <br/></p><div><p>Fungal meningitis: recognition and current status of management</p></div><p><table>
<tr><td>

<p class="sessionid">M0393</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Olivier Lortholary (Paris, France)</p></td></tr>
<tr><td>

<p class="sessionid">M0394</p></p></td><td><p class="start">16:27</p></td><td><p class="title">Janis Blair (Phoenix, United States)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">JS2</p></span>
<span class="start">16:15</span>-<span class="end">17:15</span><span class="location">Hall 16</span>

</p><p>Journal Session <br/></p><table>
<tr><td><p>Late-breaker research from the Lancet group: new interventions for familiar and new infectious diseases</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Syeda Saleha Hassan (London, United Kingdom) Ursula Hofer (London, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">J011</p></p></td><td><p class="start">16:15</p></td><td><p class="title">TBA</p></td></tr>
<tr><td>


<p class="sessionid">J012</p></p></td><td><p class="start">16:30</p></td><td><p class="title">The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America </p><span class="presenter">Jan Felix Drexler (Berlin, Germany)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">J013</p></p></td><td><p class="start">16:45</p></td><td><p class="title">The WHO Bacterial Priority Pathogens List: guiding research and development, and informing innovative public health strategies to address antimicrobial resistance </p><span class="presenter">Hatim Sati (Geneva, Switzerland)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">J014</p></p></td><td><p class="start">17:00</p></td><td><p class="title">Efficacy, safety, and immunogenicity of the <p class="sessionid" style="background-color: red;">AS01</p>E- adjuvanted respiratory syncytial virus prefusion F protein vaccine (<p class="sessionid" style="background-color: red;">RSVPreF3</p> OA) in older adults over three RSV seasons: a randomized trial </p><span class="presenter">Alberto Papi (Ferrara, Italy)</span>
</p></td></tr></table><p>Co-organised with: The Lancet group <br/></p><p> 

</p><p> 



<p class="sessionid">OS102</p></span>
<span class="start">16:15</span>-<span class="end">17:15</span><span class="location">Hall 2</span>

</p><ol id="l11"><li data-list-text="1-"><p>hour Oral Session</p></li></ol><div><p>AI tools empowering AMR prediction in WGS and MALDI-TOF</p></div><p><p class="presenters"></p>


<p class="sessionid">O0733</p><span class="title">A scalable machine learning approach to predict antimicrobial susceptibility from whole genome sequencing data 
<span>Y. Zhong* (Liverpool, United Kingdom), A. Gerada, A. Howard, P. Green, W. Hope</span>
</p><p>

<p class="sessionid">O0734</p><span class="title"><span class="presenters"></span>
from Clinical NGS Data 
<span>J. Xinmiao* (Beijing, China), X. Jia, J. Zhang, J. Chen, Q. Yang</span>
</p><p>

<p class="sessionid">O0735</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0736</p></p>MALDI-TOF Prediction model based on machine learning algorithm for the detection of <p class="sessionid" style="background-color: red;">ST23</p> high- virulence  
<span>K. pneumoniaeL. Dortet* (Le Kremlin- Bicêtre, France), L. Mancera Pascual, M.J. Arroyo</span>
</p>

<p class="sessionid">O0737</p><span class="title">Predicting rifampicin resistance in  
<span>Mycobacterium tuberculosis complex</span>
with a machine learning based MALDI-TOF MS approche 
<span>Y.W. Sun* (Taichung, Taiwan, China), P. Huang, B. Tsou, S.C. Chang, C.W. Lu, C.C. Chen, J. Yu</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">LB005</p></span>
<span class="start">16:15</span><span>-</span>
17:15 </span><span class="location">Hall 3</span>
</p><ol id="l12"><li data-list-text="1-"><p>hour Oral Session</p><div><p>Emerging pathogens in humans, animals and vectors</p></div></li></ol><p>

<p class="sessionid">L0026</p></p>Genome-wide association study identifies  


<p class="sessionid">ABCG1</p></span>
as a susceptibility locus for tick-borne encephalitis 
<span>P. Gampawar* (Graz, Austria), M. Sagmeister, D. Ruzek,</span>
</p><p class="presenter">N. Schweintzger, E. Hofer, B. Kohlmaier, V. Švendová,</p><p>P. Bogovicˇ, J. Zajkowska, L. Krbková, V. Štruncová,</p><p>A. Mickiene, D. Kohlfürst, A. Sonnleitner, A. Fořtová,</p><p class="presenter">M. Berankova, M. Pychova, D. Zavadska, N. Sallah, A. Pichler, D. Sedlácek, A. Chrdle, C. Haudum, B. Obermayer-Pietsch, P. Hoffmann, M. Nöthen, M.L. Tammesoo, A. Metspalu, P. Husa, K. Stiasny, A. Binder, A. Berghold, F. Strle, M. Hibberd, W. Zenz</p>

<p class="sessionid">L0027</p><span class="title">First detection of tick-borne encephalitis virus in Belgian ticks, May 2024 </span><span class="presenters">E. Portell-Buj* (Stockholm, Sweden), C. Philippe, S. Van Gucht, F. Dufrasne</span>
</p>

<p class="sessionid">L0028</p><span class="title">Spread of a fusidic acid and methicillin-resistant  
<span>Staphylococcus aureus</span>
clone causing impetigo in Europe 
<span>A.R. Larsen* (Copenhagen, Denmark), A. Petersen, L. Roer, K. Vendrik, R. Zwittink, D. Notermans, N. Yin, M. Perrin, K. Khonyongwa, A. Tristan, B. Youenou, F. Layer-Nicolaou, G. Werner, H. Enger, E.C.H. Eikrem, J. Darenberg, B. Mäkitalo, M. Paulsson, H. Fang, E. Tång Hallbäck, L. Lindholm, K. Moganeradj, B.J. Holzknecht, H.B. Eriksen, M. Hoppe,</span>
</p><p class="presenter">M.D. Bartels, J.A. Samaniego Castruita</p>

<p class="sessionid">L0029</p><span class="title">Increase of PVL-positive livestock-associated MRSA in the Netherlands: a growing concern beyond livestock settings </span><span class="presenters">K. Vendrik* (Bilthoven, Netherlands), S. Witteveen, D.W. Notermans, S.C. De Greeff, C.C. Wielders, E. Van Duijkeren, A.S. Schoffelen, A.P. Hendrickx, R.D. Zwittink</span>
</p><p>

<p class="sessionid">L0030</p><span class="title"><span class="presenters"></span>
</p><p>K. Hoschler, N. Groves, D. Kumar, O. Olufon, W. Cook,</p><p>N. Watkins, D. Ready, S. Makki, K. Marston, S. Collins,</p><p>C. Arevalo, D. Blackman, L. Guiness, C. Chatt, M. Mcgivern, A. Edwards, A. Banyard, R. Jorquera, K. Saville, R. Benee, S. Van Helvoort, E. Brown, L. Leighton Mcteague, M. Chand, S. Rokadiya, S. Hopkins, H.I.M. Team, N. National Response Center Team <br/></p><p> 

</p><p> 



<p class="sessionid">SY142</p></span>
<span class="start">16:15</span>-<span class="end">18:15</span><span class="location">Hall 4</span>

</p><ol id="l13"><li data-list-text="2-"><p>hour Symposium</p></li></ol><p> 
<span> Precision genomics to improve infectious diseases management</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Jacob Moran-Gilad (Beer Sheva, Israel)</p></td></tr>
<tr><td>

<p class="sessionid">S0385</p></p></td><td><p class="start">16:15</p></td><td><p class="title">Human genomics approaches to infection immunity <span> </span>Fergus Hamilton (Bristol, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0386</p></p></td><td><p class="start">16:45</p></td><td><p class="title">Applying bacterial GWAS to uncover new mechanisms of antibiotic resistance </p><span class="presenter">Marco Galardini (Hannover, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0387</p></p></td><td><p class="start">17:15</p></td><td><p class="title">Evolution in action: large-scale within-host evolution analyses of persistent bacterial infections </p><span class="presenter">Stefano Giulieri (Melbourne, Australia)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0388</p></p></td><td><p class="start">17:45</p></td><td><p class="title">Machine learning in bacterial genomics and metagenomics </p><span class="presenter">Francesco Asnicar (Trento, Italy)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">OS103</p></p></td><td><p>16:15  
<span>-</span>
17:15</p></td><td><p>Hall 5</p></td></tr>
<tr><td></td><td><p>1-hour Oral Session</p></td><td></td></tr></table><p> 

</p><p> 
<span>  Polymicrobial    interactions    and    competition</span>
</p><p class="presenters"></p>


<p class="sessionid">O0738</p><span class="title">The  
<span>Klebsiella pneumoniae</span>
type VI secretion system effector 

<p class="sessionid">Tle4</p> facilitates adaptation survival by damaging the cell membrane of competing bacteria 
<span>W. Li* (Shanghai, China), J. Zhang</span>
</p>

<p class="sessionid">O0739</p></p>
<span>Candida albicans</span>
promotes TSST-1 production in  
<span>Staphylococcus aureus</span>
by depleting glucose and lifting carbon catabolite repression 
<span>M. Carriou* (Lyon, France), C. Badiou, A. Soulard, K. Chikh, O. Vitalis, A. Frugier, K. Dufresne, G. Lina</span>
</p>

<p class="sessionid">O0740</p><span class="title">Understanding polymicrobial biofilm dynamics: focus on  
<span>Pseudomonas aeruginosa</span>
and its molecular interactions 
<span>S. Kansal* (Chandigarh, India), U. Dutta,</span>
</p><p class="presenter">A. Angrup, P. Ray</p>

<p class="sessionid">O0741</p><span class="title">Intra- and interspecific antagonism inhibits growth of  </span><span class="presenters">Staphyloccous aureus</span>
in human nasal microbial communities 
<span>L. Brülisauer* (Zurich, Switzerland), M. Boumasmoud, S. Brugger, A.R. Hall</span>
</p><p>

<p class="sessionid">O0742</p><span class="title"><span class="presenters"></span>
and  
<span>Staphylococcus aureusP. Mojarrad* (Helsinki, Finland), P. Tammela,</span>
</p><p>T. Laaksonen, Z. Gounani <br/></p><p> 

</p><p> 



<p class="sessionid">EF110</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Advancing  diagnostics  and  treatment  of  endocarditis</span>
</p><p class="presenter">Chair       Benoît Guery (Lausanne, Switzerland) <br/></p>

<p class="sessionid">E0785</p><span class="title">18F-FDG-PET/CT improves source control of extra- cardiac complications in infective endocarditis </span><span class="presenters">J.M. Prins* (Amsterdam, Netherlands), S. Douiyeb, W. Van Gameren, D. Buis, T. Van Der Vaart, M. Boekholdt, J. Selder, D. Robbers-Visser, H. Verberne, H. Van Werkhoven, K. Sigaloff</span>
</p>

<p class="sessionid">E0786</p><span class="title">Comparing Duke criteria updates: Advancing IE diagnosis in patients with prosthetic intracardiac materials 
<span>M. Papadimitriou Olivgeris* (Sion, Switzerland), M. Papadimitriou-Olivgeris, B. Ledergerber, N. Fourré, V. Zimmermann, N. Ianculescu, P. Monney, M. Frank, G. Tzimas, G. Domenichini, P. Tozzi, M. Kirsch, M. Van Hemelrijck,</span>
</p><p>O. Dzemali, J. Epprecht, B. Guery, B. Hasse</p>

<p class="sessionid">E0787</p></p>
<span>In vivo</span>
Dalbavancin efficacy against methicillin- resistant  
<span>Staphylococcus aureus</span>
(MRSA) and high- level aminoglycoside resistant (HLAR)  
<span>Enterococcus faecalis</span>
(EFAE) experimental endocarditis model. 
<span>C. Garcia De La Maria* (Barcelona, Spain), C. García De La Mària, M.A. Cañas, M. Brunet, J. García-González, G. Cuervo, M. Espasa, M. Hernandez-Meneses, C. Falces, A. Perissinotti, B. Vidal, J.M. Tolosana, E. Sandoval, J. Llopis, A. Moreno, J.M. Miro</span>
</p>

<p class="sessionid">E0788</p><span class="title">Identification and validation of clinical phenotypes in Staphylococcus aureus blood stream infection and their association with mortality (FEN-AUREUS study) 
<span>J. Rodríguez-Baño* (Seville, Spain), B. Gutiérrez-Gutiérrez, B. Gallego, A.J. Kaasch, M. Riediger, S. Rieg, M. Trigo, S. Sonsoles, F. Anguita- Santos, Á. Cano, R. Palacios, S. López-Cárdenas,</span>
</p><p class="presenter">M.T. Pérez-Rodríguez, F.J. Martínez-Marcos, E. Merino-Lucas, B. Anaya-Baz, A. Aizcorreta, A. Plata- Ciézar, M. Piscaglia, A. Aceituno, E. Ruiz-Gutiérrez,</p><p class="presenter">L. Romero-Calderón, A. Alemán-Rodríguez, E. Recacha, J. Torre-Cisneros, N. Merchante, Á. Pascual, L.E. López-Cortés</p>

<p class="sessionid">E0789</p><span class="title">Enterococcal Infective Endocarditis: demographics, comorbidities, diagnostic evaluation and mortality outcomes </span><span class="presenters">M. Singh* (London, United Kingdom), C. Watkins, H. Bristowe, M. Gunning, J. Galloway, R. Dworakowski, M. Arias</span>
</p>

<p class="sessionid">E0790</p><span class="title">Health related quality of life of patients with infective endocarditis – preliminary data of the DERIVE cohort 
<span>C. Meyer-Schwickerath* (Cologne, Germany), K. Schmidt-Hellerau, J. Camp, K. Last, I. Joost, S. Rieg, N. Jung</span>
</p>

<p class="sessionid">E0791</p><span class="title">The optimal management of  
<span>Enterococcus faecium</span>
catheter-related bloodstream infections: a gap to bridge 
<span>I. Rancan* (Florence, Italy), M. Rinaldi, F. Malerba, B. Profiti, L. Ancillotti, M. Tumbarello, P. Viale, M. Giannella</span>
</p>

<p class="sessionid">E0792</p><span class="title">Ceftobiprole alone versus in combination with ampicillin against borderline penicillin-resistant, vancomycin-resistant  
<span>Enterococcus faecalisO. Funk* (Brooklyn, United States), I. Khan, J. Li, J. Cusumano</span>
</p>

<p class="sessionid">E0793</p><span class="title">Risk factors for in- hospital mortality in 500 cases of infective endocarditis 
<span>C. Lamas* (Rio De Janeiro, Brazil), G. Pompeo, T. De Almeida, M. De Carvalho,</span>
</p><p>N. Feijoó, R. Garrido, G. Barbosa, B. Zappa, C. Weksler, M. Correia, W. Golebiovski <br/></p><p> 

</p><p> 



<p class="sessionid">EF111</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Don't    blink:    STIs    are    everywhere</span>
</p><p class="presenter">Chair      Mathew Beale (Hinxton, United Kingdom) <br/></p>

<p class="sessionid">E0794</p><span class="title">Neurosyphillis and Mpox co-infection mimic HIV encephalitis </span><span class="presenters">L. Mejdoubi* (Vienna, Austria), A. Nader,
 L. Mautner, A. Bahrami, F. Hofer</span></p><p>

<p class="sessionid">E0796</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0798</p><span class="title">Ocular Syphilis, an uncommon presentation form of syphilis: two cases 
<span>R. Kardashi* (Dresden, Germany),</span>
</p><p class="presenter">A. Frenz, K. De With</p>

<p class="sessionid">E0799</p><span class="title">Case report of a severe skin infection in a young man on PrEP and DoxyPEP </span><span class="presenters">M. Zlámal* (Prague, Czech Republic), Z. Bartovská, B. Lacmanová, M. Holub</span>
</p><p>

<p class="sessionid">E0800</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0801</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0802</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF112</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Clinical   considerations   in   resistant   organisms</span>
</p><p class="presenter">Chair       Divya Deodhar (Muscat, Oman) <br/></p>

<p class="sessionid">E0803</p><span class="title">Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin- resistant enterococci: a multicenter clinical experience </span><span class="presenters">F. Serapide* (Catanzaro, Italy), R. Serraino, L. Spadafora, M. Bernardi, G. Brucci, G. Cattardico, S. Corcione, I. De Benedetto, M. Del Monte, A. Limongelli, D.R. Giacobbe, E. Graziano, M. Meschiari, S. Mornese Pinna, M. Peghin, G. Tiseo,</span>
</p><p class="presenter">A. Vena, F. Romeo, G. Sarto, M. Bassetti, G. Biondi- Zoccai, F.G. De Rosa, M. Falcone, P.A. Grossi, C. Mussini, A. Russo</p>

<p class="sessionid">E0804</p><span class="title">Clinical outcomes of MSSA bacteremia exhibiting the cefazolin inoculum effect and development of a novel diagnostic method </span><span class="presenters">S. Yoshizawa* (Ota-Ku, Japan), T. Sato, K. Komori, K. Yamada, T. Yamaguchi, K. Tateda</span>
</p>

<p class="sessionid">E0805</p></p>Third- and fourth-generation cephalosporins for the treatment of infections due to <p class="sessionid" style="background-color: red;">OXA48</p> carbapenemase-producing Enterobacterales 
<span>A. Blanco Arévalo* (Barcelona, Spain), A. Blanco- Arevalo, E. Sastre-Escolà, J. Camara Mas, F. Tubau Quintano, R. Costa, A. Padulles, E. Shaw, C. Gudiol,</span>
</p><p class="presenter">M. Puig-Asensio</p>

<p class="sessionid">E0806</p><span class="title">Are meropenem or imipenem-cilastatin effective therapies for patients with invasive ertapenem- resistant infections? </span><span class="presenters">A. Peters* (Santiago, Chile), S. Fiawoo, L. Diaz, J.R. Martínez, M. Spencer-Sandino,</span>
</p><p class="presenter">L. Rivas, M.P. Riquelme, P. Rojas, L. Rojas, M.L. Rioseco, J. Moreno, R. Araos, P. Garcia, P.D. Tamma, J.M. Munita</p>

<p class="sessionid">E0807</p><span class="title">Oral Fosfomycin after Carbapenems as de- escalating therapy in Complicated Urinary Tract</p><p>Infection: A randomized controlled trial </span><span class="presenters">K. Angkanavisan* (Bankgkok, Thailand), B. Sakboonyarat, C. Ungthammakhun</span>
</p>

<p class="sessionid">E0808</p><span class="title">Oral switch vs. intravenous antibiotics treatment for serious carbapenem-resistant Enterobacterales and  
<span>Pseudomonas aeruginosa</span>
infections on hospital discharge: the next frontier for oral switch? 
<span>C. Arena* (Detroit, United States), A. Abed, R. Kenney,</span>
</p><p>G. Suleyman, A. Shallal, S. Davis, M. Veve</p>

<p class="sessionid">E0809</p></p>
<span>Metallo--lactamase</span>
colonization and subsequent risk of infection: a retrospective study. 
<span>C. Lee Luna Fernandes* (Sao Paulo, Brazil), C. Vaiana, C. Amato,</span>
</p><p class="presenter">S. Castelbuono, G. Di Martino, F. Cardinale, F. Monaco, A. Cona, A. Mularoni</p>

<p class="sessionid">E0810</p><span class="title">Polymyxin including therapy versus colistin including therapy in the therapy of carbapenem- resistant Gram-negative infections: A retrospective matched cohort study </span><span class="presenters">M. Mert Vahabi* (Van, Türkiye), D. Akyol Seyhan, B. Kenanoğlu, Ş. Yeniyol,</span>
</p><p class="presenter">G. Şanlıdağ İşbilen, Ş. Dirik, D. Dağ, B. Özkara, M. Ceylan, C. Bulut Avşar, U. Önal, S. Ketentzi, A. Uyan Önal, A. Kaya, O. Acet, D. Kaya, N. Yalcin, G. Vatansever, C. Tol, Ş. Aydemir, D. Akdağ, H.A. Erdem, T. Yamazhan, H. Sipahi, B. Arda, O.R. Sipahi</p>

<p class="sessionid">E0811</p><span class="title">Prognostic factors and role of clinical management in carbapenem-resistant  </span><span class="presenters">Acinetobacter baumannii</span>
bacteraemia: results from a prospective, international, multicentre cohort (EURECA) 
<span>F. Cogliati Dezza* (Seville, Spain), J.M. Bravo-Ferrer Acosta, B. Gutiérrez-Gutiérrez, B. Carevic, G. Dragovac, G.L. Daikos, M. Akova, L. Raka, A. Hristea, P. Viale, E. Shaw, E. Roilides, M. Antonelli,</span>
</p><p>H. Akalin, A. Komnos, J.M. Reguera, A. Vince, M. Mašanovic, L. Radulović, C. Kirakli, C. Gogos, A. Bartoloni, C. Dan, P. Kapisyzi, M.E. Falagas, A. Vata,</p><p>S. Benea, D. Tomescu, A. Meda Vasiesiu, L. Bukarica, N. Lukic, A. Cano, V. Pintado, A. Azap, H. Goosens, M.J.M. Bonten, J. Rodríguez-Baño <br/></p><p> 

</p><p> 



<p class="sessionid">SY147</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 11<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Avian  influenza  in  mammals:  jumps  under  the  radar</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0399</p><span class="start">17:30</span><span class="title">Threat  of highly pathogenic avian influenza to non-</p><p>traditional hosts, including humans 
<span>Thijs Kuiken (Rotterdam, Netherlands)</span>
</p><p>

<p class="sessionid">S0400</p><span class="start">18:00</span><span class="title">Recent  changes in the epidemiology of avian influenza in relation to human health risks 
<span>Ron Fouchier (Rotterdam, Netherlands)</span>
</p><p>Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Veterinary Microbiology (ESGVM), ESCMID Study Group for Respiratory Viruses (ESGREV), European Scientific Working group on Influenza (ESWI) <br/></p><p> 

</p><p> 



<p class="sessionid">SY148</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 15<span> </span>
</p><p>1-hour Symposium</p><p> 
<span>  Echinococcosis:    neglected    but    expanding</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0401</p><span class="start">17:30</span><span class="title">Expansion  and diversity of cystic echinococcosis 
<span>Pedro Legua (Lima, Peru)</span>
</p><p>

<p class="sessionid">S0402</p><span class="start">18:00</span><span class="title">Management  of echinococcosis: evidence, eminence and new developments 
<span>Beate Grüner (Ulm, Germany)</span>
</p><p>Co-organised with: Österreichische Gesellschaft für Antimikrobielle Chemotherapie (ÖGACH), Österreichische Gesellschaft für Hygiene, Mikrobiologie und Präventivmedizin (ÖGHMP), Österreichische Gesellschaft für Infektionskrankheiten und Tropenmedizin (OEGIT), ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) <br/></p><p> 

</p><p> 



<p class="sessionid">OS109</p><span> </span><span class="start">17:30</span>-<span class="end">18:30<span class="location">Hall 16<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>  Training   CM/ID   -   a   global   view</span>
</p><p class="presenter">Chairs      Mihai Mares (Iasi, Romania)</p><p class="presenter">Priya Nori (New York, United States) <br/></p>

<p class="sessionid">O0780</p><span class="title">Specialist training in infectious diseases in Europe </span><span class="presenters">J. Salmanton-Garcia* (Cologne, Germany), J. Salmanton-García, A. Guerra Maio, J.P. Stahl, E. De Barra, S. Jensen-Fangel, C. Torti, C. Kraef, J.M. Miró,</span>
</p><p class="presenter">A. Verbon, O.A. Cornely, N. Beeching</p>

<p class="sessionid">O0781</p><span class="title">Infectious Diseases Residency Training over the World </span><span class="presenters">P. Irkören* (Zeytinburnu/istanbul, Türkiye), P. Irkoren, C. Cimen, S. Keske, Ö. Ergönül</span>
</p><p>

<p class="sessionid">O0782</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">C. Azzouz, S. Mehtar</p>

<p class="sessionid">O0783</p><span class="title">Combatting challenges in laboratory capacity through an innovative, longitudinal Gram stain training programme for blood culture specimens in Zimbabwe. </span><span class="presenters">T. Mwaturura* (Harare, Zimbabwe), D. Hettle, F. Makoga, A. Mudungwe, B. Sado, K. Kranzer</span>
</p>

<p class="sessionid">O0784</p><span class="title">Benefit of the implementation of Entrustable Professional Activities (EPA) as an assessment tool in the Laboratory of clinical bacteriology: a study focused on the improvement of residents' skills and feelings. 
<span>H. Pailhoriès* (Angers, France), H. Pailhories,</span>
</p><p>C. Zins, R. Chenouard, M. Kempf, M. Eveillard <br/></p><p> 

</p><p> 



<p class="sessionid">ME149</p></span>
<span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 2</span>

</p><p>Meet-the-Expert</p><p> 
<span> How to perform molecular surveillance of multidrug resistant bacteria</span>
 <br/></p><table>
<tr><td>

<p class="sessionid">M0403</p></p></td><td><p class="start">17:30</p></td><td><p class="title">Martina Lengerova (Brno, Czech Republic)</p></td></tr>
<tr><td>

<p class="sessionid">M0404</p></p></td><td><p class="start">17:42</p></td><td><p class="title">Henrik Hasman (Copenhagen, Denmark)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS107</p><span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 3</span>
<p>l-hour Oral Session</p><p> 
<span>  Novel   vaccines   in   clinical   development</span>


</p><p class="presenters"></p>




<p class="sessionid">O0770</p><span class="title">Safety and immunogenicity of a seasonal booster dose of the 6-valent, OspA-based Lyme borreliosis vaccine candidate <p class="sessionid" style="background-color: red;">VLA15</p> in a healthy population aged 5-65 years 
<span>M. Messier* (Vienna, France), L. Wagner,</span>
</p><p class="presenter">R. Hochreiter, J. Larcher-Senn, E. Lamberth, R. Simon, C. Clarkin, J. Stark, S. Eder-Lingelbach</p>

<p class="sessionid">O0771</p><span class="title">Safety and immunogenicity of mRNA mpox vaccine candidate mRNA-1769: Interim analysis results from a Phase 1/2 Trial </span><span class="presenters">H. Hiruy* (Cambridge, United States),</span>
</p><p class="presenter">R. Lazarus, K. Mccafferty, K. Cohen, R. Dhar, T. Rizk,</p><p class="presenter">A. Adeniji, X. Chang, L. Siquel, H. Bennett, B. Leav</p>

<p class="sessionid">O0772</p><span class="title">Development of a Rapid-Acting Oral Cholera Vaccine: Phase I Clinical Trial </span><span class="presenters">A. Hannaford* (Boston, United States), D. Leitner, M. Waldor, L. Baden, M. Desjardins, M. Suzuki, L. Carr, D. Slater, H. Levine, H. Kaul, J.B. Park Chang, A. Piermatti, N. Puri, B. Piantadosi, J. Harris, S. Piantadosi, A. Sherman, S. Walsh</span>
</p>

<p class="sessionid">O0773</p><span class="title">Safety and immunogenicity of a Group B Streptococcus vaccine in participants aged 55-75 years 
<span>L. Oostvogels* (Frederiksberg, Denmark), A. Alhatemi, S. De Gussem, E. Englev, B. Jacobs, B. Johansson-Lindbom, G. Kitson, G. Waerlop, I. Leroux- Roels</span>
</p><p>

<p class="sessionid">O0774</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS108</p></span>
<span class="start">17:30</span>-<span class="end">18:30</span><span class="location">Hall 5</span>

</p><ol id="l15"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Novel  approaches  to  preventing  device-related  infections</span>
</p><p class="presenter">Chairs      Natividad Benito (Barcelona, Spain) Preeti Malani (Ann Arbor, United States) <br/></p>

<p class="sessionid">O0775</p><span class="title">Clinical and microbiological impact of antibiotic- impregnated catheters in ventriculoperitoneal shunt infections in adults. </span><span class="presenters">M. Sanz De Mena* (Barcelona, Spain), I. Pelegrín Senent, J. Gómez Junyent, J. Poblet Florentin, C. Iglesias, A. Siverio Parés, S. Gómez Zorrilla, L. Sorlí Redó, M. Montero, J.P. Horcajada</span>
</p>

<p class="sessionid">O0776</p><span class="title">Reducing drainage-associated meningitis by using an antiseptic dressing: A randomized controlled trial AntiRedMen 
<span>S. Scheithauer* (Goettingen, Germany),</span>
</p><p class="presenter">O. Moerer, V. Rohde, N. Srivastava, T. Asendorf, K. Antweiler, D. Mielke, G. Uwe, N. Lennart, S. Friedrich,</p><p class="presenter">A. Beste, N. Kucheryava, M. Baehr</p>

<p class="sessionid">O0777</p><span class="title">Efficacy of antimicrobial envelopes in preventing cardiac implantable electronic device infections – systematic review and meta-analysis </span><span class="presenters">A. Mahajan* (Melbourne, Australia), C. Robson</span>
</p>

<p class="sessionid">O0778</p><span class="title">A bundled approach to reducing central line associated blood stream infections (CLABSI) in hemodialysis (HD) patients 
<span>J. Guerrero* (Scarborough, Canada), A. Garga, S. Paramalingam,</span>
</p><p class="presenter">R. Lovinsky, F. Go</p>

<p class="sessionid">O0779</p><span class="title">Increased long-term mortality in patients with prosthetic joint infection after primary total hip arthroplasty – a cohort study with 89'709 patients </span><span class="presenters">N. Imhasly* (Lucerne, Switzerland), A. Widmer, C. Brand, V. Zdravkovic, A. Spoerri, K. Schmidlin, M. Wicki, M. Beck, R. Sommerstein</span>
</p><p>Tuesday, 15 April 2025</p><p> 

</p><p> 



<p class="sessionid">SY152</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 12<span> </span>
</p></li><li data-list-text="2-"><p>hour Symposium</p></li></ol><p> 
<span> Out of the spotlight or out of reach? Vaccination of hard-to-reach groups</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0413</p><span class="start">08:30</span><span class="title">Ukrainian  war refugees and vaccination attitudes:</p><p>experience from Poland 
<span>Maria Ganczak (Zielona Gora, Poland)</span>
</p><p>

<p class="sessionid">S0414</p><span class="start">09:00</span><span class="title">Vaccination  in migrants in Latin America: The challenges of transit through Darien, Panama 
<span>Alfonso
 J. Rodriguez-Morales (Pereira, Colombia)</span></p><p>

<p class="sessionid">S0415</p><span class="start">09:30</span><span class="title">Are  penitentiary systems ready for introducing vaccination programmes? 
<span>Lara Tavoschi (Pisa, Italy)</span>
</p><p>

<p class="sessionid">S0416</p><span class="start">10:00</span><span class="title">HPV  and other essential vaccinations for sex workers 
<span>Debora Konopnicki (Brussels, Belgium)</span>
</p><p>Co-organised with: ESCMID Vaccine Study Group (EVASG) <br/></p><p> 

</p><p> 



<p class="sessionid">SY153</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 13<span> </span>
</p><p>2-hour Symposium</p><p> 
<span> Breaking  new  ground  in  febrile  neutropaenia  management</span>
</p><p>Chairs      Murat Akova (Ankara, Türkiye) Stefan Schwartz (Berlin, Germany)</p><table>
<tr><td>

<p class="sessionid">S0417</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Do we need to redefine the concept of febrile neutropaenia in the era of immunotherapy? </p><span class="presenter">Manuela</span>
</p></td></tr>
<tr><td></td><td></td><td><p>Aguilar-Guisado (Seville, Spain)</p></td></tr>
<tr><td>

<p class="sessionid">S0418</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Should some patients be empirically treated with combination therapy? </p><span class="presenter">Dina Averbuch (Jerusalem, Israel)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0419</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Role of new antibiotics in febrile neutropaenia </p><span class="presenter">Malgorzata Mikulska (Genoa, Italy)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0420</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Can treatment strategies be personalised using AI or new diagnostic tools? </p><span class="presenter">Carolina Garcia Vidal (Barcelona, Spain)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Infections in Compromised Hosts (ESGICH), European Conference on Infections in Leukemia (ECIL) <br/></p><p> 

</p><p> 



<p class="sessionid">EW156</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 5</span>

</p><p>Educational Session</p><p> 
<span> The rules of the game: how to tackle the peer-review and publication process</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0429</p><span class="start">08:30</span><span class="title">Communicating  with journals, editors and reviewers 
<span>Angela Huttner (Geneva, Switzerland)</span>
</p><p>

<p class="sessionid">W0430</p><span class="start">08:50</span><span class="title">The  Wild West of predatory journals 
<span>Ursula Hofer (London, United Kingdom)</span>
</p><p>

<p class="sessionid">W0431</p><span class="start">09:10</span><span class="title">Communicating  your publications on social media 
<span>Neil
 Stone (London, United Kingdom)</span></p><p>

<p class="sessionid">W0432</p>  09:30  Re-imagining peer review 
<span>Amelia Joseph</span>
</p><p>(Nottingham, United Kingdom)</p><p>Co-organised with: Deutsche Gesellschaft für Hygiene und Mikrobiologie, CMI Communications Board of Editors, ESCMID Parity Commission, CMI Board of Editors <br/></p><p> 

</p><p> 



<p class="sessionid">EF114</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 1<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Innovations  and  insights  in  diagnosing  parasitic  infections</span>
</p><p>Chair      Pikka Jokelainen (Copenhagen, Denmark) <br/></p>


<p class="sessionid">E0822</p><span class="title">Evaluation of a multiplex beads assay for the simultaneous detection of serum antibodies in neurocysticercosis patients. 
<span>A. Lopez Alva* (Lima, Peru), P.D.S. Nakazaki Aza, L.M. Toribio Salazar, H.H. Garcia Lescano</span>
</p>

<p class="sessionid">E0823</p></p>
<span>Development and evaluation of real-time loop mediated isothermal amplification assay for rapid detection of hookworm (Ancylostoma duodenale) in human fecal samplesM. Thakur* (Chandigarh, India),</span>
</p><p class="presenter">S. Khurana, A. Mewara, L. Pvm</p>

<p class="sessionid">E0824</p><span class="title">Exploring Genotypic Prevalence and Transmission of Cryptosporidium and Giardia in Immunocompromised Patients: A Dual Approach with Modern Molecular Methods: MLST &amp; nested real- time HRM </span><span class="presenters">P. Rani* (Chandigarh, India), P. Datta, S.L. Bhasin, P. Malhotra, S.S. Rana, R. Sehgal</span>
</p>

<p class="sessionid">E0825</p><span class="title">Prevalence and diagnostic accuracy of different diagnostic tests for Chagas disease in the Paraguayan Chaco 
<span>S. Ardiles Ruesjas* (Saarbruecken, Germany), S. Ardiles-Ruesjas, V. Lesmo, V. González-Romero, Z. Cubilla, L. Chena, C. Huber, M.J. Rivas, P. Saldaña, A. Carrascosa, S. Méndez, S. Sanz, S.L. Becker, J. Alonso-Padilla, I. Losada</span>
</p>

<p class="sessionid">E0826</p><span class="title">Development and validation of an artificial intelligence model for detection of gastrointestinal parasites from concentrated wet-mount stool examinations 
<span>M.R. Couturier* (Salt Lake City, Ut, United States), B. Mathison, K.A. Knight, J.R. Potts, F. Markow, A.E. Wood, K.W. Dixon, J.F. Walker, D.L. Bess, W. Hymas</span>
</p>

<p class="sessionid">E0827</p><span class="title">Evaluation of KU-<p class="sessionid" style="background-color: red;">F40</p> automated microscope for diagnosis of intestinal parasitic infections : will AI rescue old-time microscopy ? 
<span>A. Aupaix* (Hornu, Belgium), L. Filippin, I. Mansoor, M. Chemais, D. Martiny, V.Y. Miendje Deyi, M. Deffontaine, C. Deckers, V. Verbelen, J. Brauner</span>
</p>

<p class="sessionid">E0828</p><span class="title">Improving vector surveillance: evaluating a real-time PCR assay for  
<span>Leishmania</span>
DNA detection in sandflies 
<span>H. Alonso-Ezcurra* (Zaragoza, Spain), M.P. Peris, I. Ruiz-Arrondo, J.A. Castillo, D. Martínez- Durán, S. Delacour, I. Ruiz-Zarzuela, I. De Blas, C. Cervera-Acedo, J.A. Oteo, F. Collantes, B. Dehesa, H. Alonso</span>
</p>

<p class="sessionid">E0829</p><span class="title">Assessment of a new immunochromatographic assay for serological diagnosis of amoebic liver abscess 
<span>R. Fleury* (Besançon, France), M.P. Brenier-Pinchart, P. Tirard-Collet, F. Gabriel, E. Pretot, F. Touafek, A. Marteau, S. Houze, C. Amiot, T.G. Nguyen, D. Dupont,</span>
</p><p class="presenter">A. Moreno-Sabater, F. Grenouillet</p>

<p class="sessionid">E0830</p><span class="title">Human piroplasmosis: diagnostic lessons from a national parasitology reference laboratory in South Africa. </span><span class="presenters">C. Sriruttan-Nel* (Johannesburg, South Africa),</span>
</p><p>J. Frean <br/></p><p> 

</p><p> 



<p class="sessionid">EF115</p><span> </span><span class="start">08:30</span>-<span class="end">09:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> New  genomic  methods  in  clinical  microbiology</span>
</p><p class="presenter">Chair      Natacha Couto (Oxford, United Kingdom) <br/></p>

<p class="sessionid">E0831</p><span class="title">Prediction of antimicrobial minimum inhibitory concentration from  </span><span class="presenters">Escherichia coli</span>
whole genome sequence data using machine learning 
<span>A. Gerada* (Liverpool, United Kingdom), N. Harper, Y. Zhong, A. Howard, P.L. Green, W. Hope</span>
</p><p>

<p class="sessionid">E0832</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0833</p><span class="title"><span class="presenters"></span>
,  
<span>Escherichia coli</span>
and  
<span>Klebsiella pneumoniae</span>
from genomic data using machine learning and deep learning approaches 
<span>E. Denakpo* (Gif-Sur-Yvette, France), N. Dias, F. Jay, B. Iorga</span>
</p><p>

<p class="sessionid">E0834</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0835</p><span class="title">Reliable bacterial genomic genotyping from Oxford Nanopore Technologies data – the ONT cgMLST Polisher 
<span>N. Scherff* (Muenster, Germany), J. Rothgänger, D. Harmsen</span>
</p>

<p class="sessionid">E0836</p><span class="title">Developing a core genome MLST (cgMLST) for  
<span>Mycoplasma pneumoniaeC. Dixon* (Cardiff, United Kingdom), R. Mamede, M. Ramirez, H. Milton, P.M. Meyer Sauteur, G. Greub, N. Couto, M.L. Beeton</span>
</p>

<p class="sessionid">E0837</p></p>Voyager: real-time taxonomic characterization of long-read mixed-species sequencing samples in sorted motif distance space 
<span>S. Branders* (Hamar, Norway), M. Grabherr, R. Ahmad</span>
</p>

<p class="sessionid">E0838</p></p>VCP: a signature protein-based tool for accurate and rapid profiling of human gut virome 
<span>J. Li* (Shenzhen, China), F. Yang, L. Xiong, X. Feng, H. Zhong</span>
</p>

<p class="sessionid">E0839</p><span class="title">Genomic Data-Driven Machine Learning for Predicting Antimicrobial Resistance in ESCAPEE Pathogens 
<span>A. Skoulakis* (Lamia, Greece), K. Daniilidis, S. Digenis, A. Hatzigeorgiou</span>
 <br/></p><p> 

</p><p> 

<span>CGR</span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 1</span>

</p><p class="header">Special Session</p><p><span class="title">    Clinical       Grand       Round
 Experts     Nina Khanna (Basel, Switzerland)</p><p>Dimitrios P. Kontoyiannis (Houston, Tx, United States) Lior Nesher (Beersheba, Israel)</p><p>David L. Paterson (Singapore, Singapore)</p><p>Priscilla Rupali (Vellore, India) Monica Slavin (Melbourne, Australia)</span></p><p>

<p class="sessionid">CGR01</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR02</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR03</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR04</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR05</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR06</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">CGR07</p><span class="title"><span class="presenters"></span>
</p><p>Co-organised with: Infectious Diseases Society of America (IDSA) <br/></p><p> 

</p><p> 



<p class="sessionid">OS113</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 11<span> </span>
</p></li><li data-list-text="2-"><p>hour Oral Session</p></li></ol><p> 
<span> Knockin'  on  Science's  Door:  New  Antimicrobial  Solutions</span>
</p><p class="presenter">Chairs       Sandrine Marchand (Poitiers, France) Ursula Theuretzbacher (Vienna, Austria) <br/></p>

<p class="sessionid">O0812</p><span class="title">Chimerbactin: a hybrid antibiotic for persistent Gram-positive infections that overcomes resistance development </span><span class="presenters">R. Lee* (Memphis, United States), Y. Zhao, A. Arya, M. Lafleur, R. Conlin, G. Phelps, C. Dunn, E. Griffith, J. Portelinha, N. Chumbler, V. Loudon, I. Lister, S. Zia, K. Urish, K. Lewis</span>
</p>

<p class="sessionid">O0813</p><span class="title">A Novel Klebicin Cocktail to Treat Lung Infection Caused by  
<span>Klebsiella pneumoniaeV.D. Paul* (Bangalore, India), A. Ambady, U. Chopra</span>
</p>

<p class="sessionid">O0814</p><span class="title">Thiophene derivatives: A promising solution against MDR Gram-negative bacilli 
<span>Y. Smani* (Seville, Spain), I. Molina Panadero, Á. Rey Hidalgo, M. Morales-Tenorio, A. García-Rubia, T. Samernate, P. Nonejuie, A. Martínez, A. Hmadcha, A. De Alarcón,</span>
</p><p class="presenter">C. Gil</p>

<p class="sessionid">O0815</p><span class="title">Molecular insight into non-lytic polyproline peptide disruption of  </span><span class="presenters">Klebsiella pneumoniae</span>
biofilms 
<span>R. Fleeman* (Orlando, United States), R. Beckman Iv,</span>
</p><p class="presenter">B. Victoria, L. Suits, P. Eswara</p>

<p class="sessionid">O0816</p><span class="title">Reverting cefotaxime resistance in CTX-M-15- producing  </span><span class="presenters">Escherichia coli</span>
using Targeted- Antibacterial-Plasmids (TAPs): a CRISPR-

<p class="sessionid">Cas9</p> approach. 
<span>N. Roson Calero* (Barcelona, Spain), N. Roson-Calero, E. Derollez, P. Rouze, A. Dedieu- Berne, S. Bigot, C. Ballesté-Delpierre, J. Vila, P. Bogaerts, C. Lesterlin</span>
</p>

<p class="sessionid">O0817</p><span class="title">Structural and functional characterization of <p class="sessionid" style="background-color: red;">LysSM5</p>: An innovative endolysin from Salmonella Phage vB_SenA_<p class="sessionid" style="background-color: red;">SM5</p> 
<span>K. Sharma* (Chandigarh, India), H. Kaur, N. Chaudhary, S. Prajapati, B. Mohan, N. Taneja</span>
</p>

<p class="sessionid">O0818</p><span class="title">Rational step-by-step design of a two-phage cocktail against a contemporary  
<span>A. baumannii</span>
strain recovered from a burned patient at CHUV. 
<span>G. Resch* (Lausanne, Switzerland), H. De Villiers De La Noue, G. Golliard, X. Vuattoux</span>
</p>

<p class="sessionid">O0819</p><span class="title">A novel antibiotic class targeting the enolase of  
<span>Acinetobacter baumanniiI. Molina Panadero* (Seville, Spain), A. Moreno Rodríguez, Á. Rey Hidalgo, L. Tomás Gallardo, M. De La Cruz, P. Sánchez, T. Samernate, A.J. Pérez Pulido, S. Glisic,</span>
</p><p class="presenter">O. Genilloud, P. Nonejuie, A. Hmadcha, Y. Smani</p>

<p class="sessionid">O0820</p><span class="title">Reviving antibiotic potency: Pharmacological Assessment of <p class="sessionid" style="background-color: red;">JS238</p> a newly designed potentiator against  </span><span class="presenters">P. aeruginosaP. Rasouli* (Brussels, Belgium), J.M. Brunel, J.H. Lorent, F. Van Bambeke</span>
</p>

<p class="sessionid">O0821</p><span class="title">Advancements in combating tularemia: Novel therapeutic strategies targeting  
<span>Francisella tularensisS. Guillier* (Brétigny-Sur-Orge, France),</span>
</p><p>M. Gâchon, C. Lemoigne, C. Rougeaux, V. Lourde,</p><p>C. Demeure, J. Pizarro Cerda, G. Guichard, G. Compain, D. Burnouf, O. Gorgé, J. Wagner <br/></p><p> 

</p><p> 



<p class="sessionid">SY154</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 14<span> </span>
</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Using mathematical and epidemiological models to identify the drivers of AMR</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Marc J.M. Bonten (Utrecht, Netherlands) Sarah Tschudin Sutter (Basel, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">S0421</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Quantifying the drivers of antiviral resistance: what does it take to prevent resistance evolution? <span> </span>Roger Kouyos (Zürich, Switzerland)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0422</p></p></td><td><p class="start">09:00</p></td><td><p class="title">Inferring the determinants of AMR dynamics across bacterial pathogens </p><span class="presenter">Lulla Opatowski (Paris, France)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0423</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Modelling the evolution of resistance </p><span class="presenter">Erida Gjini (Lisbon, Portugal)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0424</p></p></td><td><p class="start">10:00</p></td><td><p class="title">Assessing the associations of microbiome and socio- demographic dynamics on AMR </p><span class="presenter">Katariina Pärnänen (Helsinki, Finland)</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">EW157</p><span> </span><span class="start">08:30</span>-<span class="end">10:30<span class="location">Hall 15<span> </span>
</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Endemic mycoses and mycetoma: underdiagnosed and underreported fungal diseases</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Ana Alastruey-Izquierdo (Madrid, Spain) Rita Oladele (Lagos, Nigeria)</p></td></tr>
<tr><td>

<p class="sessionid">W0433</p></p></td><td><p class="start">08:30</p></td><td><p class="title">Advances and gaps in the diagnosis and treatment of histoplasmosis <span> </span>Diego Rodrigues Falci (Porto Alegre, Brazil)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0434</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Paracoccidioidomycosis: an update on diagnostic challenges </p><span class="presenter">Beatriz L. Gomez (Bogota, Colombia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0435</p></p></td><td><p class="start">09:10</p></td><td><p class="title">What is new in Talaromycosis </p><span class="presenter">Brown Lottie (London, United Kingdom)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0436</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Mycetoma: treatment challenges of a unique neglected tropical disease </p><span class="presenter">Borna Nyaoke-Anoke (Nairobi, Kenya)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">EW155</p></p></td><td><p>08:30  
<span>-</span>
10:30</p></td><td><p>Hall 2</p></td></tr>
<tr><td></td><td><p> 

</p><p>Educational Session</p></td><td></td></tr>
<tr><td><p> 
<span> An   update   on   arboviral   disease   challenges</span>
</p></td></tr>
<tr><td><p class="presenters">Misa Korva (Ljubljana, Slovenia)</p><p class="presenters">Anna Papa-Konidari (Thessaloniki, Greece)</p></td></tr>
<tr><td>

<p class="sessionid">W0425</p></p></td><td><p class="start">08:30</p></td><td><p class="title">The global epidemiology of arboviral diseases <span> </span>Chantal</span>
</p><p>B.E.M. Reusken (Bilthoven, Netherlands)</p></td></tr>
<tr><td>


<p class="sessionid">W0426</p></p></td><td><p class="start">08:50</p></td><td><p class="title">Arboviral diseases transmitted by mosquitoes </p><span class="presenter">Luisa Barzon (Padua, Italy)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0427</p></p></td><td><p class="start">09:10</p></td><td><p class="title">Aboviral diseases transmitted by ticks </p><span class="presenter">Joanna Maria Zajkowska (Białystok, Poland)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">W0428</p></p></td><td><p class="start">09:30</p></td><td><p class="title">Arboviral diseases transmitted by sandflies </p><span class="presenter">Rémi Charrel (Marseille, France)</span>
</p></td></tr></table><p>Co-organised with: EURL-PH-VBV, Polish Association of Epidemiologists and Infectiologists <br/></p><p> 

</p><p> 



<p class="sessionid">SY150</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 3</span>

</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Faecal microbiota transplantation and live biotherapeutic products: scientific and regulatory challenges</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Lindsey Ann Edwards (London, United Kingdom) Ed J. Kuijper (Leiden, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0405</p></p></td><td><p class="start">08:30</p></td><td><p class="title">How can we recognise and deal with adverse events of Faecal Microbiota Transplantation? <span> </span>Serena Porcari (Roma, Italy)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0406</p></p></td><td><p class="start">09:00</p></td><td><p class="title">What to check? – An attempt at evidence-based donor screening </p><span class="presenter">Elisabeth Terveer (Leiden,</span>
</p></td></tr></table><table>
<tr><td></td><td></td><td><p>Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">S0407</p></p></td><td><p class="start">09:30</p></td><td><p class="title">What are the right bugs – Developing LBPs out of FMTs </p><span class="presenter">Lena Biehl (Cologne, Germany)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0408</p></p></td><td><p class="start">10:00</p></td><td><p class="title">What’s up next? – Hot LBP candidates </p><span class="presenter">Ilan Youngster (Beer Yaakov, Israel)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI), The European Faecal Microbiota Transplantation Network of academics (EurFMT), European Helicobacter &amp; Microbiota Study Group (EHMSG) <br/></p><p> 

</p><p> 



<p class="sessionid">SY151</p></span>
<span class="start">08:30</span>-<span class="end">10:30</span><span class="location">Hall 4</span>

</p><p>2-hour Symposium</p><p> 
<span>   News     in     endocarditis     care</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0409</p><span class="start">08:30</span><span class="title">Endocarditis  guidelines: what is new? 
<span>Siegbert Rieg
 (Freiburg, Germany)</span></p><p>

<p class="sessionid">S0410</p><span class="start">09:00</span><span class="title">Oral  therapy and outpatient care 
<span>Laura Escolà-Vergé
 (Barcelona, Spain)</span></p><p>

<p class="sessionid">S0411</p>   09:30   PK/PD aspects of endocarditis antibiotic therapy 
<span>Fekade Bruck Sime (Brisbane, Australia)</span>
</p><p>

<p class="sessionid">S0412</p><span class="start">10:00</span><span class="title">The  Endocarditis Team: there is no way to work alone 
<span>Barbara Hasse (Zurich, Switzerland)</span>
</p><p>Co-organised with: ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), ESCMID Study Group for Antimicrobial stewardship (ESGAP), Sociedad Espanola de Infecciones Cardiovasculares (SEICAV) <br/></p><p> 

</p><p> 



<p class="sessionid">EF116</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Sepsis  revolutions:  from  machines  to  molecules</span>
</p><p class="presenter">Chair       Pierluigi Del Vecchio (Roma, Italy) <br/></p>

<p class="sessionid">E0840</p><span class="title">Machine learning enabled prediction of blood stream infection in emergency department attendees. </span><span class="presenters">C. Rosato* (Liverpool, United Kingdom),</span>
</p><p class="presenter">S. Aston, A. Velluva, A. Howard, W. Hope</p>

<p class="sessionid">E0841</p><span class="title">Utilizing Automation to Streamline the Blood Culture Process: Enhancing Efficiency and Patient Outcomes </span><span class="presenters">J. Qin* (Shanghai, China), M. Li, Z. Shen</span>
</p><p>

<p class="sessionid">E0842</p><span class="title"><span class="presenters"></span>
</p><p class="presenter">A. Amicucci, C. Campoli, Z. Pasquini, F. Calo', P. Viale, M. Giannella</p>

<p class="sessionid">E0843</p><span class="title">A matter of time: impact of time to first follow-up blood cultures in patients with candidemia and  </span><span class="presenters">Staphylococcus aureus</span>
bacteremia from a retrospective cohort 
<span>P. Valsecchi* (Pavia, Italy), E. Bono, A. Valeretto, S. Resuli, M. Corbella, P. Cambieri, E. Seminari, R. Bruno</span>
</p>

<p class="sessionid">E0844</p><span class="title">Characteristics of infections and outcomes in patients with left ventricular assist devices 
<span>N. Sarı* (Ankara, Türkiye), E. Ateş, Ç. Sarıkaş, Ö. Kurt Azap, Ç. Erol, A. Sezgin</span>
</p><p> 


<p class="sessionid">E0845</p></span>
Nb 
<span>2</span>
(Sn 
<span>0.7</span>
Cu 
<span>0.3</span>
)C MAX phase for anti-Infection therapy via hyperthermia-mediated bacterial metabolic interference 
<span>M. Yang* (Chengdu, China)</span>
</p><p>

<p class="sessionid">E0846</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0847</p><span class="title">Aberrant integrin activation causes transmigration defects in <p class="sessionid" style="background-color: red;">S100</p><p class="sessionid" style="background-color: red;">A9</p> 
<span>-/-</span>
 neutrophils during sepsis 
<span>S. Mülder* (Münster, Germany), N. Ludwig, J.</span>
</p><p class="presenter">Rossaint, T. Vogl</p>

<p class="sessionid">E0848</p><span class="title">Efficacy of dimercaptosuccinic acid in combination with imipenem in a murine model of experimental sepsis due to metallo-ß-lactamase-producing  </span><span class="presenters">Pseudomonas aeruginosa</span>
. 
<span>S. Herrera-Espejo* (Seville, Spain), M. Bouvier, J. Findlay, L. Ceballos- Romero, J. Pachón, J.M. Cisneros, M.E. Pachón- Ibáñez, P. Nordmann</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF117</p><span> </span><span class="start">09:30</span>-<span class="end">10:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session <br/></p><div><p>C. diff  
<span>challenges: insights into treatment, monitoring, and infection prevention</span>
</p></div><p class="presenter"><p>Chair      Kerrie Davies (Leeds, United Kingdom) <br/></p>

<p class="sessionid">E0849</p><span class="title">Epidemiology, risk factors, and outcomes of nosocomial  </span><span class="presenters">Clostridioides difficile</span>
infections: a cohort study in a tertiary hospital. 
<span>L. Ruiz Salazar* (Madrid, Spain), T. Mata Forte</span>
</p><p>

<p class="sessionid">E0850</p><span class="title"><span class="presenters"></span>
infection surveillance? 
<span>M. Brajerová* (Prague, Czech Republic), M. Brajerova, P. Kinross, P. Drevinek, M. Krutova</span>
</p><p>

<p class="sessionid">E0851</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0853</p><span class="title">Comparison of bezlotoxumab versus no- bezlotoxumab on recurrence in high-risk patients with  
<span>Clostridioides difficile</span>
infection 
<span>C. Arena* (Detroit, United States), A. Abed, R. Kenney, A. Shallal, S. Davis, M. Veve</span>
</p>

<p class="sessionid">E0854</p><span class="title">Exploring bacterial contributors to  
<span>C. difficile</span>
colonization resistance: comparative effects of vancomycin and fidaxomicin in humanised mice 
<span>E. Montenegro-Borbolla* (Lausanne, Switzerland), L. Beldi, S. Hapfelmeier, G. Greub, C. Bertelli, B. Guery</span>
</p><p>

<p class="sessionid">E0855</p><span class="title"><span class="presenters"></span>
, reduces gut microbiota impact and prevents recurrent  
<span>C. difficile</span>
infection in a human in vitro gut model. 
<span>J. Freeman* (Leeds, United Kingdom), C. Normington, E. Clark, K. Bentley, J. Altringham, A. Berry, W. Spittle, D. Ewin, A. Kirby, M. Wilcox, K. Davies</span>
</p>

<p class="sessionid">E0856</p><span class="title">Cost and resource utilization of fidaxomicin in risk patients with recurrent or refractory Clostridioides difficile infection 
<span>M. Engelhard* (Cologne, Germany),
 I. Alram, S.M. Wingen-Heimann, N. Pfeiffer, J.J. Vehreschild, M.J.G.T. Vehreschild, S.M. Hopff</span></p><p>

<p class="sessionid">E0857</p><span class="title"><span class="presenters"></span>
</p><p>D. Kavatha <br/></p><p> 

</p><p> 



<p class="sessionid">ME165</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 12<span> </span>
</p><p>Meet-the-Expert</p><p> 
<span> How  to  use  citizen  science  for  public  health</span>
 <br/></p><p>

<p class="sessionid">M0450</p>  11:00    
<span>Anna Noel-Storr (Leamington Spa, United Kingdom)</span>
</p><p>

<p class="sessionid">M0451</p>  11:12    
<span>Jani Sormunen (Turku, Finland)</span>
</p><p>Co-organised with: European Centre for Disease Prevention and Control (ECDC) <br/></p><p> 

</p><p> 



<p class="sessionid">SY164</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 15<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> dsDNA  virus  infections  in  immunocompromised  patients</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Lior Nesher (Beersheba, Israel) Michelle Yong (Melbourne, Australia)</p></td></tr>
<tr><td>

<p class="sessionid">S0448</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Challenges of diagnosis: do we need to treat all patients with detectable dsDNA virus PCR? <span> </span>Hans H. Hirsch (Basel, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0449</p></p></td><td><p class="start">11:30</p></td><td><p class="title">The role of CRISPR-<p class="sessionid" style="background-color: red;">Cas9</p>-edited antiviral T cells against dsDNA virus infections </p><span class="presenter">Tba</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">FO167</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 1<span> </span>
</p><p>Open Forum</p><p> 
<span>  Vaccine   rollout   in   low   resource   settings
 Chair      Asma Nasim (Karachi, Pakistan) <br/></span></p><p>

<p class="sessionid">F0454</p><span class="start">11:00</span><span class="title">Typhoid  vaccine roll out 
<span>Nginache Nampota
 (Baltimore, United States)</span></p><p>

<p class="sessionid">F0455</p><span class="start">11:10</span><span class="title">Introduction  of malaria vaccines to countries in sub-</p><p>Saharan Africa: acceptance and barriers 
<span>Bernhards Ogutu Ragama (Nairobi, Kenya)</span>
</p><p>

<p class="sessionid">F0456</p><span class="start">11:20</span><span class="title">The  story of COVID-19 vaccines in LMIC 
<span>Paul Adepoju</span>
</p><p>(Perton, United Kingdom)</p><p>Co-organised with: ESCMID Ethics Advisory Committee (EEAC) <br/></p><p> 

</p><p> 



<p class="sessionid">EF123</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Advancing antimicrobials: trials and therapies for resistant infections</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Ursula Theuretzbacher (Vienna, Austria)</p></td></tr>
<tr><td>

<p class="sessionid">E0888</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Efficacy of High Dose Tigecycline-Containing Regimens for the Combination Treatment of Carbapenem Resistance  <span> </span>Enterobacterales</span>
Bacteremia: a propensity score-matched study <span> </span>V. Vasikasin* (Bangkok, Thailand), W. Nasomsong, P. Wanloptaree</span>
</p></td></tr>
<tr><td>

<p class="sessionid">E0883</p></p></td><td><p class="start">11:06</p></td><td><p class="title">Evaluation of <p class="sessionid" style="background-color: red;">CRS3123</p> compared to vancomycin for the treatment of  <span> </span>Clostridioides difficile</span>
infection (CDI) <span> </span>J. Bruss* (Pagosa Springs Co, United States),</span>
</p><p>M.A. Degroote, L. Boccumini, W. Ribble, J. Day, C. Mason, X. Sun, J. Freeman, N. Seema, N. Janjic, T. Jarvis, U. Ochsner, M. Wilcox, T. Louie</p></td></tr>
<tr><td>

<p class="sessionid">E0884</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Phase 2/3, open-label, randomized, active-controlled clinical trial evaluating the safety and efficacy of imipenem/cilastatin/relebactam (IMI/REL) in paediatric patients with gram-negative bacterial infection <span> </span>J. Bradley* (San Diego, United States), C.T. Norice, E. Roilides, A. Shevelev, B. Jurkiewicz, J.A. Piedrahita, S. Koseoglu, I. Masih, P. Nair, K. Young,</span>
</p><p>D.W. Hilbert, G.T. Nieddu, J.A. Huntington, C.J. Bruno</p></td></tr>
<tr><td>

<p class="sessionid">E0885</p></p></td><td><p class="start">11:18</p></td><td><p class="title">A Phase I, Randomized, Double-Blind, Placebo- Controlled, Dose Escalation Study to Evaluate the Safety and Tolerability of Intravenous Ertapenem (ERT) with Zidebactam (ZID) in Combination (WCK 6777) in Healthy Adult Subjects <span> </span>T. Lodise* (Albany, United States), R. Chavan, A. Patel, R. Yeole, S. Bhagwat, M. Patel, G. Saviolakis, K. Gu, V. Ghazaryan,</span>
</p><p>M. Kankam, A. Jaunarajs, E. Hammett, H. Howell, R.A. Bonomo</p></td></tr>
<tr><td>

<p class="sessionid">E0886</p></p></td><td><p>11:24</p></td><td><p>Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC- producing  <span> </span>K. pneumoniae</span>
infections – Results from a retrospective multicentre study <span> </span>A. Marino* (Catania, Italy), A.E. Maraolo, M. Mazzitelli, A. Oliva, N. Geremia, A. De Vito, C. Gullotta, V. Scaglione, E. Vania, S. Lo Menzo, P. Navalesi, L. Volpicelli, A. Fiori,</span>
</p><p>P. Prestifilippo, A. Cattelan, C.M. Mastroianni, G. Madeddu, B. Cacopardo, G. Nunnari</p></td></tr>
<tr><td>

<p class="sessionid">E0887</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Phase 3 study of oral gepotidacin for the treatment of uncomplicated urinary tract infection in Japanese</p></td></tr></table><table>
<tr><td></td><td><p>female participants (EAGLE-J) <span> </span>Y. Kayama* (Tokyo, Japan), S. Yamamoto, K. Fujii, A. Nimura, T. Maenaka,</span>
</p><p>M. Ramirez, R. Banerjee, N.E. Scangarella-Oman, S. Mozzicato, S. Ura</p></td></tr>
<tr><td>

<p class="sessionid">E0889</p></p></td><td><p class="start">11:36</p></td><td><p class="title">Efficacy of Ceftolozane/Tazobactam vs. Ceftazidime/Avibactam in the Treatment of Nosocomial Pneumonia Caused by  <span> </span>Pseudomonas aeruginosa</span>
: a multicentric retrospective study from the SUSANA cohort. <span> </span>A. Bitti* (Sassari, Italy), A. De Vito, M. Fois, E. Ricci, A. Bandera, A. Maccaro, S. Piconi, P. Maggi, G. Cenderello, M. Merli, G.V. De Socio, P. Morelli, P. Bonfanti, G. Madeddu</span>
</p></td></tr>
<tr><td>

<p class="sessionid">E0890</p></p></td><td><p class="start">11:42</p></td><td><p class="title">Experience of dalbavancin use for unlicensed indications in a UK tertiary infectious diseases setting </p><span class="presenter">C. Darlow* (Liverpool, United Kingdom), J. Parsons, D. Lucy, N. Wong</span>
</p></td></tr>
<tr><td>

<p class="sessionid">E0891</p></p></td><td><p>11:48</p></td><td><p>Investigator-driven randomised controlled trial of cefiderocol versus standard therapy for healthcare- associated and hospital-acquired gram-negative bacterial bloodstream Infections (BSI) : Hierarchical composite endpoint analysis with DOOR and generalised pairwise comparisons <span> </span>M. Hardy* (Maroochydore, Australia), D.L. Paterson, M. Chatfield, H. Bin Sulaiman, L. Po-Yu, M. Yilmaz, Z.N. Salmuna, M.Z. Mazlan, S. Anunnatsiri, R. Sirijatuphat,</span>
</p><p>D. Chotiprasitsakul, D. Lye, J. Somani, S. Kalimuddin,</p><p>V. Thamlikitkul, Y.T. Lee, Y.T. Lin, W.N.W. Ramli, H.C. Ong, P. Mootsikapun, A. Meesing, C.H. Tseng, T.K. Yeh, A.M.B. Hashim, P. Puangpatra, A. Aslan, P. Santanirand, T.T. Chiang, S. Archuleta, Y.F.Z. Chan,</p><p>P.Y. Chia, B. Forde, H. Wright, A. Stewart, K. Ramsay,</p><p>W.P. Ling, V. Rossi, T. Harris-Brown, P.N.A. Harris</p></td></tr>
<tr><td>

<p class="sessionid">EF124</p></p></td><td><p>11:00  
<span>-</span>
12:00</p></td><td><p>Arena 3</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><p> 

</p><p> 
<span> Thinking  outside  the  box  in  urinary  tract  infection
 Chair      Özlem Kurt Azap (Ankara, Türkiye) <br/></span></p><p>

<p class="sessionid">E0892</p><span class="title"><span class="presenters"></span>
</p><p>

<p class="sessionid">E0893</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0894</p><span class="title">Identification of Microorganism Types in Urinary Tract Infections Using Machine Learning and Flow Cytometry 
<span>E. Flores* (Alicante, Spain), I. Gutierrez, R. Torrreblanca, A. Blasco, R. Carbonell, M. Lopez- Garrigós</span>
</p>

<p class="sessionid">E0895</p><span class="title">A New Approach In Diagnosis Of Urinary Tract Infections 
<span>B. Dinc* (Ankara, Türkiye), F. Kırca, S. Kazcı, Ö. Uslu, N. Çöplü</span>
</p>

<p class="sessionid">E0896</p><span class="title">Diagnosis of urinary tract infections: from machine learning to clinical practice 
<span>E. Flores* (Alicante, Spain), R. Torrreblanca, I. Gutierrez, R. Carbonell, L.G. Maite, A. Blasco</span>
</p>

<p class="sessionid">E0897</p><span class="title">Strategic testing optimisation practices for urinary tract infections (STOP-UTI): findings from LMIC hospital setting 
<span>S. Sarika* (Tamil Nadu, India), B. Rithik Dharan</span>
</p>

<p class="sessionid">E0898</p><span class="title">Rapid culture-independent mass spectrometry based proteomics methods for improving urinary tract infection diagnostics 
<span>S. El-Ali* (Gothenburg, Sweden),</span>
</p><p class="presenter">L. Acha Alarcon, G. Alves, Y.K. Yu, R. Karlsson, E. Moore</p>

<p class="sessionid">E0899</p><span class="title">Unraveling the complexity: Corynebacterium diversity and antimicrobial resistance hub in the urinary tract ecosystem </span><span class="presenters">E. Cappelli* (Porto, Portugal),</span>
</p><p class="presenter">A. Morais, T. Ribeiro, L. Peixe</p>

<p class="sessionid">E0900</p><span class="title">Active surveillance in the diagnosis of sexually transmitted infections: performing PCR in negative urine cultures </span><span class="presenters">A. Castellano Verdasco* (Lleida, Spain),</span>
</p><p>E. Sánchez Báscones, E. López González, A. Blanquero-Porras, M. Riesgo Magaña, A. Bernet Sánchez, S. Mormeneo Bayo, I. Prats Sánchez, A. Bellés-Bellés, M. García González <br/></p><p> 

</p><p> 



<p class="sessionid">EF125</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Bugs   breaking   the   blood-brain   barrier</span>
</p><p class="presenter">Chair       Markus Zeitlinger (Vienna, Austria) <br/></p>

<p class="sessionid">E0901</p><span class="title">Pharmacologic depletion of meningeal macrophages worsens disease in a mouse model of meningitis </span><span class="presenters">U. Koedel* (Munich, Germany), S. Dyckhoff-Shen, I. Masouris, H.W. Pfister, M. Klein</span>
</p>

<p class="sessionid">E0902</p></p>


<p class="sessionid">Pgm1</p></span>
modulates the inflammatory response of macrophages in experimental pneumococcal meningitis 
<span>D. Bakker* (Amsterdam, Netherlands), R. Koning, M. Van Roon, V. Jaspers, M. Brouwer, D. Van De Beek</span>
</p><p>

<p class="sessionid">E0903</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0904</p><span class="title">Efficacy Analysis of Intraventricular/Intrathecal Polymyxin B sulphate Injections in the Treatment of Post-neurosurgical CNS Infections in Neurocritical Ill Patients:a prospective observational study 
<span>L. Yang* (Shanghai, China), J. Song, M. Wang, H. Yuan, Q. Yuan, Z. Du, G. Wu, J. Hu, W. Chen</span>
</p>

<p class="sessionid">E0905</p><span class="title">Ventriculitis characteristics and outcomes (VELCRO): an international retrospective cohort study 
<span>D. Luque Paz* (Rennes, France), B. Díaz Pollán, M. Boyer- Besseyre, F. Djanikian, A.L. Munier, F. Cunha, L. Escaut, G. Martin-Blondel, B. Sarton, P. Jaquet, F. Arrivé, R. Wolf, V. Legros, M. Willig, O.R. Sipahi, L. Flurin, A. Bianchi, B. Balança, J. Puel, R. Lino, B. Soyer, T. Leveque, A. Salomon, A. Serris, R. Larcher,
 F. Bruneel, N. Mongardon, A. Mazeraud, M. Wolff, R. Sonneville, F. Valour, P. Tattevin</span></p><p>

<p class="sessionid">E0906</p><span class="title"><span class="presenters"></span>
Brain Abscess 
<span>E. Eriksen* (Aalborg, Denmark),</span>
</p><p class="presenter">M. Bijlsma, S. Olie, L. Larsen, M. Storgaard, H. Mens,</p><p>L. Wiese, M.P.G. Jepsen, B.R. Hansen, H.R. Lüttichau,</p><p class="presenter">H. Nielsen, M. Brouwer, J. Bodilsen</p>

<p class="sessionid">E0907</p><span class="title">Epidemiology of Adult Intracranial Bacterial Abscess in the Republic of Ireland (2010-2021) </span><span class="presenters">S. Kilgarriff* (Cork, Ireland), E. Glynn, D. Murray, C. Lim, C. Hickey,</span>
</p><p class="presenter">S. O Donnell, B. Dinesh, C. O Connor, A. Doherty</p>

<p class="sessionid">E0908</p><span class="title">Corticospinal tract involvement in Neuromelioidosis: A Retrospective cohort Study from South India and a Systematic Review of Literature </span><span class="presenters">P.K. Tirlangi* (Manipal, India), N. Gupta, V. Muralidhar, C. Mukhopadhyay</span>
</p><p>

<p class="sessionid">E0909</p><span class="title"><span class="presenters"></span>
</p><p>S.V. Sajjan, K. Mallesh, R.S. Mani, T. Solomon, V.K. Gowda, R. Vasanthapuram, R. Yadav <br/></p><p> 

</p><p> 



<p class="sessionid">KN158</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 1</span>

</p><p>Keynote Lecture <br/></p><table>
<tr><td><p>What genomics brought to the knowledge of tuberculosis, leprosy and buruli ulcer</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Emmanuelle Cambau (Paris, France) Kathryn Holt (London, United Kingdom)</p></td></tr>
<tr><td>

<p class="sessionid">K0437</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Stewart T. Cole (Paris, France)</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">SY162</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 11<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> Antimicrobial stewardship across the lifespan from paediatrics to geriatrics</span>
</p><table>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Lucy Catteau (Brussels, Belgium) Priya Nori (New York, United States)</p></td></tr>
<tr><td>

<p class="sessionid">S0444</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Antimicrobial Stewardship in paediatrics across different settings <span> </span>Taylor Morrisette (Charleston, United States)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0445</p></p></td><td><p class="start">11:30</p></td><td><p class="title">Stewardship in geriatrics: an exceedingly important target </p><span class="presenter">Dafna Yahav (Ramat-Gan, Israel)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">ME166</p></p></td><td><p>11:00  
<span>-</span>
12:00</p></td><td><p>Hall 13</p></td></tr>
<tr><td></td><td><p>Meet-the-Expert</p></td><td></td></tr></table><div><p>Implementing AI in microbiological diagnostics: practical steps and quality control</p></div><p><table>
<tr><td>

<p class="sessionid">M0452</p></p></td><td><p class="start">11:00</p></td><td><p class="title">Oliver Nolte (Zürich, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">M0453</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Jennifer Dien Bard (Los Angeles, United States)</p></td></tr></table><p> 

</p><p>Co-organised with: ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), Swiss Society for Microbiology (SSM) <br/></p><p> 

</p><p> 



<p class="sessionid">SY163</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 14<span> </span>
</p><p>1-hour Symposium</p><p> 
<span> People-centred approach to strengthening the AMR response at primary care</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0446</p><span class="start">11:00</span><span class="title">Implementation  of WHO’s people-centred</p><p>interventions 
<span>Nienke Van De sanDe Bruinsma (Geneva, Switzerland)</span>
</p><p>

<p class="sessionid">S0447</p><span class="start">11:30</span><span class="title">Opportunities  for strengthening AMR interventions in primary healthcare 
<span>Sholpan Kaliyeva (Karaganda City, Kazakhstan)</span>
</p><p>Co-organised with: World Health Organisation (WHO) <br/></p><p> 

</p><p> 



<p class="sessionid">OS122</p><span> </span><span class="start">11:00</span>-<span class="end">12:00<span class="location">Hall 16<span> </span>
</p><p>1-hour Oral Session</p><p> 
<span>  Serious   games   -   a   serious   business</span>
</p><p class="presenters"></p>
<p>

<p class="sessionid">O0878</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0879</p><span class="title">Impact of Professional Background on Performance in ToREIMC: A Gamified Medical Knowledge Platform 
<span>A. Blanco-Di Matteo* (Pamplona, Spain), M. Morante Ruiz, M. Riesgo Magaña, M. Martín García</span>
</p><p>

<p class="sessionid">O0880</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0881</p></p>‘The Sepsis Olympics': Raising awareness of the Sepsis 6 care bundle in an Irish Hospital through a clinical challenge game. 
<span>C. Uhomoibhi* (Dublin, Ireland), K. Costelloe, J. Harte, N. Power, E. De Barra</span>
</p>

<p class="sessionid">O0882</p><span class="title">Improvement of learners' confidence in antibiotic management by an interdisciplinary annual multi- centred webinar 
<span>A. Friedrichs* (Kiel, Germany), E. Kramme, T. Koch, J. Jochum, A. Van Der Linde, H. Gerth, F. Jahn, A. Neubert</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY159</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 2</span>

</p><p>1-hour Symposium</p><p> 
<span> Beat  the  cancer  by  beating  the  infections</span>
</p><p class="presenters"></p><p>

<p class="sessionid">S0438</p><span class="start">11:00</span><span class="title">Prevention  of infection-associated cancer: learning from each other 
<span>Catharina Alberts (Amsterdam, Netherlands)</span>
</p><p>

<p class="sessionid">S0439</p><span class="start">11:30</span><span class="title">Test  and treat early to prevent cancer: hepatitis B and hepatitis C 
<span>Francesco Negro (Geneva, Switzerland)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY160</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 4</span>

</p><p>Personalised patient management and infection prevention: Current evidence and future perspectives</p><p><p>1-hour Symposium <br/></p><p class="presenters"></p><p>

<p class="sessionid">S0440</p><span class="start">11:00</span><span class="title">The  dosing perspective: towards individualised treatment strategies 
<span>Thomas Tängdén (Uppsala, Sweden)</span>
</p><p>

<p class="sessionid">S0441</p><span class="start">11:30</span><span class="title">The  infection control perspective: advancing patient-</p><p>centred approaches 
<span>Alessia Savoldi (Verona, Italy)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">SY161</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 5</span>

</p><p>Emerging fungal diseases in children: Global challenges and approach to management</p><p><p>1-hour Symposium <br/></p><p class="presenters"></p><p>

<p class="sessionid">S0442</p><span class="start">11:00</span><span class="title">Emerging  fungal infections in immunocompromised and geographically exposed children 
<span>Laura Ferreras- Antolin (London, United Kingdom)</span>
</p><p>

<p class="sessionid">S0443</p><span class="start">11:30</span><span class="title">Best  available treatments and options for children in</p><p>resource-limited settings 
<span>Fabianne Carlesse (Sao Paulo, Brazil)</span>
</p><p>Co-organised with: ESCMID Fungal Infection Study Group (EFISG), German- Speaking Mycological Society (DMykG) <br/></p><p> 

</p><p> 



<p class="sessionid">OS118</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 6</span>

</p><p>1-hour Oral Session</p><p> 
<span> Plasmids as a powerful tool of antibiotic resistance spread</span>
</p><p class="presenter">Chair      Monika Dolejska (Pilsen, Czech Republic) <br/></p>

<p class="sessionid">O0858</p><span class="title">Co-anchorage of antibiotic resistance genes and mobile genetic elements on bacterial plasmids boosts horizontal gene transfer across sewage interfaces </span><span class="presenters">M. Shafiq* (Shantou, China)</span>
</p><p>

<p class="sessionid">O0859</p><span class="title"><span class="presenters"></span>
(

<p class="sessionid">X4</p>) and  
<span>mcr</span>
co-harbored on the same plasmid and its clinical significance 
<span>N. Rakhi* (Oxford, United Kingdom), A. Lankapalli, T. Lanyon-Hogg, P. Niumsup, K. Thomson, K. Sands, T. Walsh</span>
</p>

<p class="sessionid">O0860</p><span class="title">The plasmidome of a global collection of convergent</p><p class="presenter">K. pneumoniae  and its impact on virulence<span> </span>F. Lebreton* (Silver Spring, United States), M. Martin,</p><p>A.P. Sapre, T. Luo, U. Carolino-Macdonald, E. Mills, B.</p><p class="presenter">Corey, R. Maybank, A. Ong, Y. Kwak, J. Bennett, T. Russo, P. Mc Gann</p><p class="sessionid" style="background-color: red;">O0861</p><span class="title">Factors that affect plasmid transfer in multispecies biofilms </span><span class="presenters">H.Y. Liu* (Norwich, United Kingdom), M. Yasir, E. Trampari, G. Langridge, M. Webber</span>
</p>

<p class="sessionid">O0862</p><span class="title">Identification of the  
<span>czc</span>
metal efflux operon on a new plasmid type in a  
<span>Pseudomonas aeruginosa</span>
clinical isolate belonging to 

<p class="sessionid">ST357</p> <p class="sessionid" style="background-color: red;">O11</p> 
<span>A. Valcek* (Brussels, Belgium), D.I. Costescu Strachinaru, P. Soentjens, A. Stoefs, C. Van Der Henst</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS119</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 7</span>

</p><p>1-hour Case Session</p><p> 
<span>  Looking    inside    endovascular    infections</span>
</p><p class="presenters"></p><p>

<p class="sessionid">O0863</p><span class="title"><span class="presenters"></span>
Aortitis with Endocarditis: Diagnostic and Therapeutic Challenges 
<span>V. Zwart* (Breda, Netherlands), E. Kayabasi, H. De Groot, R. Bentvelsen</span>
</p><p>

<p class="sessionid">O0864</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0865</p><span class="title">Fungal frenzy: handling an uncommon etiology in prosthetic valve endocarditis 
<span>I. Cafarella* (Naples, Italy), R. Gallo, F. Patauner, F. Luciano, L. Bertolino,</span>
</p><p class="presenter">A.M.C. Peluso, F. Boccia, R. Zampino, E. Durante- Mangoni</p>

<p class="sessionid">O0866</p><span class="title">Successful Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by  </span><span class="presenters">Enterococcus</span>
spp.: Experience from Seven Cases in a Referral Center 
<span>F. Frondizi* (Rome, Italy), G.M. Leanza, F. Catania, F. Sangiorgi, M. Chiuchiarelli, B. Andriolo, L. Vahedi, B. Liguoro, F. Giovannenze, E. Taddei, G. Scoppettuolo, C. Torti</span>
</p>

<p class="sessionid">O0867</p><span class="title">Clinical Features and Outcomes of Gram-Negative Bacterial Endocarditis: A Case Series from a University Hospital 
<span>G. Oliva* (Rome, Italy), F. Giovannenze, G.M. Leanza, F. Frondizi, M. Chiuchiarelli, B. Liguoro, B. Andriolo, E. Taddei, G. Scoppettuolo, C. Torti</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS120</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 8</span>

</p><p class="presenter">1-hour Oral Session <br/></p><div><p>Exploring Host-Pathogen Interactions and Immune Dynamics in Bacterial Virulence</p></div><p><p class="presenters"></p>

<p class="sessionid">O0868</p><span class="title">Bacteria and host responses in both mice and human lung organoid model revealed the role of a novel plasmid <p class="sessionid" style="background-color: red;">pvirhs1</p> in hypervirulent Carbapenem- resistant Klebsiella pneumoniae </span><span class="presenters">Y. Zhang* (Shanghai, China), W. Liu, K. Lin, L. Chen, J. Wu, N. Jiang</span>
</p>

<p class="sessionid">O0869</p><span class="title">Presence and role of hypervirulence-associated markers in  
<span>Klebsiella pneumoniae</span>
groups based on 

<p class="sessionid">LD50</p> value in mouse septic model 
<span>A. Avdeeva* (Saint-Petersburg, Russian Federation), D. Kandina,
 E. Podvysotskaia, P. Chulkova, M. Velizhanina, J. Sopova, V. Lomonosova, V. Galushka, A. Afinogenova, V. Shapovalova, O. Sulian, I. Ageevets,</p><p>V. Ageevets, S. Sidorenko</span></p><p>

<p class="sessionid">O0870</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0871</p><span class="title">Unveiling the hidden virulence of  
<span>Acinetobacter baumannii</span>
: how the lipooligosaccharide core modulates immune responses and enhances interferon- production 
<span>Y.T. Lee* (Taipei, Taiwan,</span>
</p><p class="presenter">China), Y.C. Wang</p>

<p class="sessionid">O0872</p><span class="title">Platelets drive neutrophil-mediated neuroinflammation in tuberculous meningitis </span><span class="presenters">K. Skolimowska* (London, United Kingdom), R. Wilkinson, J.S. Friedland, D. Kirwan, T. Reid, D. De Swardt, D.L.W. Chong, J. Kutschenreuter, M. Saeed,</span>
</p><p>A. Davis, S. Wasserman, R. Goliath, Q. Kakana, P. Renner, M. Panchoo, C. Stek, R. Johnson, M. Maxebengula <br/></p><p> 

</p><p> 



<p class="sessionid">OS121</p></span>
<span class="start">11:00</span>-<span class="end">12:00</span><span class="location">Hall 9</span>

</p><ol id="l16"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span> Shaping the future of IPC - digitalisation of surveillance</span>
</p><table>
<tr><td><p class="presenters">Diamantis Plachouras (Solna, Sweden)</p><p class="presenters">Maaike S.M. Van Mourik (Utrecht, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">O0873</p></p></td><td><p class="start">11:00</p></td><td><p class="title">PRAISE hospital-onset bacteraemia and fungaemia algorithm as novel automated surveillance indicator: results from four European university hospitals <span> </span>S. Van Der Werff* (Stockholm, Sweden), S.J.S. Aghdassi, M. Behnke, M.S.M. Van Mourik, G. Catho, M. Brekelmans, L.A. Peña Diaz, N. Buetti, F.D. Rüther, D. Dinis Teixeira, D. Sjöholm, P. Nauclér</span>
</p></td></tr>
<tr><td>

<p class="sessionid">O0874</p></p></td><td><p class="start">11:12</p></td><td><p class="title">Transforming hospital-onset bacteremia and fungemia data to the OMOP common data model </p><span class="presenter">H. Düsseldorf* (Vienna, Austria), G. Duftschmid, E. Presterl</span>
</p></td></tr>
<tr><td>

<p class="sessionid">O0876</p></p></td><td><p class="start">11:24</p></td><td><p class="title">Dutch Electronic Health Records in primary care: the Nivel general practisioners database </p><span class="presenter">F.F. Stelma* (Utrecht, Netherlands), J. Van Summeren, M. Hooiveld, C. Baliatsas, V. Sankatsing, J. Schmitz, S. Van Beusekom</span>
</p></td></tr>
<tr><td>

<p class="sessionid">O0877</p></p></td><td><p class="start">11:36</p></td><td><p class="title">Local signs at catheter insertion sites: Insights from the multicenter DeepCath cohort study with 4,256 pictures <span> </span>N. Buetti* (Geneva, Switzerland), S. Ruckly,</span>
</p><p>A. Byczko, L. Gallay, A. Nguyen, H. Slimani, J.R. Zahar,</p><p>J.F. Timsit</p></td></tr>
<tr><td>

<p class="sessionid">O0875</p></p></td><td><p class="start">11:48</p></td><td><p class="title">Prospective evaluation of a machine learning-based real-time multidrug-resistant organism prediction system <span> </span>V. Vasikasin* (Bangkok, Thailand), W. Nasomsong, A. Holmes, R.L. Peach, K. Bhangananda,</span>
</p><p>A. Myall, C.H. Yoon, D. Changpradub, S. Mookerjee,</p><p>J. Price, B. Mauricio, T.M. Rawson</p></td></tr>
<tr><td>

<p class="sessionid">EF131</p></p></td><td><p>13:30  
<span>-</span>
14:30</p></td><td><p>Arena 1</p></td></tr>
<tr><td></td><td><p>ePoster Flash Session</p></td><td></td></tr></table><div><p>The current landscape of carbapenem resistance: from genotype to phenotype and virulence determinants</p></div></li></ol><p><p> 

</p><p class="presenter">Chair      Amy Mathers (Charlottesville, United States) <br/></p>

<p class="sessionid">E0940</p><span class="title">Molecular Insights into the Growing Threat Carbapenem-Resistant Hypervirulent  </span><span class="presenters">Klebsiella pneumoniae</span>
and the Rising Challenge of Ceftazidime- Avibactam Resistance 
<span>C. Vatansever* (Istanbul, Türkiye), A. Akpinar, J. Boral, S. Belge, N. Kardan, B. Tanyolaç, G. Shahrokhi, G. Ekinci, E. Ural, B. İşler, Ö. Ergönül, F. Can</span>
</p>

<p class="sessionid">E0941</p><span class="title">Global large-scale genomic snapshot on the diversity of carbapenem-resistant and hypervirulent  
<span>Klebsiella pneumoniae</span>
strains 
<span>R. Elias* (Lisboa, Portugal), T. Clark, I. Portugal, J. Perdigao</span>
</p><p>

<p class="sessionid">E0942</p><span class="title"><span class="presenters"></span>
complex: genetic determinants of resistance and molecular epidemiology 
<span>D. Pinheiro De Sousa Santos* (Lisbon, Portugal), D. Santos, A. Bruschy-Fonseca, E. Gonçalves, D. Ranhel, C. Conceição, A. Pedrosa, A.C. Silva, A. Duarte, L. Méndez, C. Toscano, J. Melo- Cristino, C. Caneiras</span>
</p><p>

<p class="sessionid">E0943</p><span class="title"><span class="presenters"></span>
in Hungary 
<span>A. Hanczvikkel* (Budapest, Hungary), D. Göbhardter, E. Ungvári, N. Derzsy, A. Darab, L. Jánvári, L. Buzgó, L. Holub, K. Papp, K. Kristóf, L. Majoros, K. Kamotsay, M. Käfer, G.</span>
</p><p class="presenter">Jakab, Á. Sonnevend, Á. Tóth</p>

<p class="sessionid">E0944</p><span class="title">Genomic multicentre surveillance of VIM-producing  </span><span class="presenters">Enterobacterales</span>
shows spread driven by bacterial clones and plasmids in Germany from 2015 to 2021 
<span>A. Wendel* (Cologne, Germany), J. Sattler, B. Bader, J. Müller, A. Hamprecht, S. Peter</span>
</p><p>

<p class="sessionid">E0945</p><span class="title"><span class="presenters"></span>
from Eastern Europe over the last decade. 
<span>A. Sapre* (Silver Spring, United States), E. Nguyen, T. Luo, E. Mills, B. Corey, R. Maybank, A. Ong, V. Kondratiuk, V. Kovalchuk, M. Metreveli, N. Trapaidze, Y. Kwak, T. Musich, J. Bennett, P. Mc Gann, M. Martin, F. Lebreton</span>
</p>

<p class="sessionid">E0946</p><span class="title">Carbapenemases in Germany in 2024: Report of the German National Reference Centre for Multidrug- resistant Gram-negative Bacteria 
<span>N. Pfennigwerth* (Bochum, Germany), S. Möller, J. Eisfeld, F. Pankok,
 A. Anders, S. Gatermann</span></p><p>

<p class="sessionid">E0947</p><span class="title"><span class="presenters">
 P.Y. Hon, X. Huan, Z.L. Kyaw, A.Y. Lin, P. Rao, P.P. De,</p><p>S. Vasoo, K. Marimuthu, O.T. Ng</span></p><p>

<p class="sessionid">E0948</p><span class="title"><span class="presenters"></span>
,  
<span>Acinetobacter baumannii</span>
and  
<span>Pseudomonas aeruginosa</span>
isolates from Greek hospitals: data from the Electronic System for the AMR surveillance-WHONET-Greece 
<span>M. Polemis* (Vari, Greece), A. Vatopoulos, K. Tryfinopoulou</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF132</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 2<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span> Difficult-to-treat  cases  in  the  immunocompromised
 Chair       Nicolas Mueller (Zurich, Switzerland) <br/></span></p><p>

<p class="sessionid">E0949</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0951</p><span class="title">Concurrent invasive disseminated Nocardia farcinica and Candida infections in a patient undergoing long- term glucocorticoid therapy for autoimmune thrombocytopenia: A case report 
<span>N. Zhang* (Bengbu, China)</span>
</p>

<p class="sessionid">E0952</p><span class="title">Subcutaneous paeohyphomycosis due to  
<span>Alternaria infectoria</span>
in an immunosuppressed renal transplant recipient: successful multidisciplinary management 
<span>E. Vetsiou* (London, United Kingdom), E. Rudd, S. Rai,</span>
</p><p class="presenter">K. Ahmed, S. Rao-Merugumala, A. Wasif, C. Shaw, A. Abdolrasouli, M. Arias</p>

<p class="sessionid">E0953</p><span class="title">Lung nodules in a patient with breast cancer history… Not everything is cancer. </span><span class="presenters">E. Muñoa Hernández* (Chiapas, Mexico), E. Muñoa</span>
</p>

<p class="sessionid">E0954</p><span class="title">Treatment of fulminant  
<span>Clostridioides difficile</span>
infection using bacteria-free stool supernatant in adult hematological patients during chemotherapy- induced aplasia 
<span>B.G. Szabo* (Budapest, Hungary), D. Korozs, A. Hardi, K. Jeszenszky, P. Remenyi, J. Sinko</span>
</p>

<p class="sessionid">E0955</p><span class="title">Eradication of multidrug resistant Pseudomonas aeruginosa pneumonia in acute lymphoblastic leukemia patient with broad host-range phage 
<span>P. Gadea* (Montevideo, Uruguay), J. Puig, M. Gómez, I. Ferrés, A. Galiana, F. Grill, G. Iraola</span>
</p>

<p class="sessionid">E0956</p><span class="title">An Emerging fungal pathogen in immunocompromised hosts: A rare case of subcutaneous abscess caused by  
<span>Chondrostereum purpureumP. Kitjacharoenchai* (Bangkok, Thailand),</span>
</p><p class="presenter">A. Thammahong, J. Vanichanan</p>

<p class="sessionid">E0957</p><span class="title">Unveiling a Rare Simultaneous Central Nervous System infection in an Immunocompromised Patient from Mexico </span><span class="presenters">E. Sienra Iracheta* (Tlalpan, Mexico), A. Magallanes Lopez, J.P. Venzor Castellanos, M.J. Corredor Nassar, A.P. Rodriguez Zulueta</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">EF133</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 3<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>  Viral   infections   in   special   populations</span>
</p><p class="presenter">Chair       Federico Garcia (Granada, Spain) <br/></p>

<p class="sessionid">E0958</p><span class="title">ORCHESTRA Delphi Consensus: Therapeutic and Diagnostic Management of SARS-CoV-2 Infection in Rheumatological Patients </span><span class="presenters">M.G. Caponcello* (Seville, Spain), P. Olivares Navarro, J. Rodríguez Baño, Z.R. Palacios Baena, C. Bonazzetti, C. Campoli, A. Savoldi, E. Gentilotti, G. Marchetti, S. Lo Caputo, L. Otero-Varela, I. Castrejón, E. Tacconelli</span>
</p>

<p class="sessionid">E0959</p></p>Immunogenicity, reactogenicity and safety of booster vaccinations with <p class="sessionid" style="background-color: red;">BNT162</p><p class="sessionid" style="background-color: red;">b2</p> or full-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1- AGED) – final report 
<span>J. Stemler* (Cologne, Germany), L. Yeghiazaryan, C. Stephan, R. Cox, K. Greve-Isdahl Mohn, A.J. Carcas-Sansuan, E. Romero Rodriguez, J. Moltó, I. Vergara Mitxeltorena, T. Welte, B. Zablockienė, M. Akova, U. Bethe, S. Grimm, J. Salmanton-García, J. Jakobs, L. Tischmann, M. Zarrouk, A. Cüppers, L.M. Biehl, J. Grothe, S.C. Mellinghoff, J.A. Nacov, J.M. Neuhann,</span>
</p><p class="presenter">R. Sprute, J. Frías-Iniesta, R. Negi, C. Gaillard, G. Saini, A. García León, P.W.G. Mallon, C. Lammens,</p><p class="presenter">A. Hotterbeekx, L. Katherine, S. Malhotra-Kumar, H. Goossens, S. Kumar-Singh, F. König, M. Posch, P. Koehler, O.A. Cornely</p>

<p class="sessionid">E0960</p><span class="title">Effectiveness of adjuvanted recombinant zoster vaccine in adults aged ≥50 years in the United States </span><span class="presenters">L. Qian* (Pasadena, United States), L.S. Sy,</span>
</p><p class="presenter">B.K. Ackerson, E. Rayens, J. Wu, Y. Luo, Y. Cheng,</p><p class="presenter">J.H. Ku, L.I. Vega Daily, H.S. Takhar, J. Song, R.A. Cohen, H. Yun, D. Oraichi, H. Seifert, H.F. Tseng</p>

<p class="sessionid">E0961</p><span class="title">Differential SARS-CoV-2 RNAemia features and humoral immune response analysis of acute COVID- 19 in solid organ transplant recipients and patients with hematological malignancies. </span><span class="presenters">A. Ruiz-Molina* (Seville, Spain), J. Martín-Escolano, C. Infante- Domínguez, Z.R. Palacios-Baena, I. Tallón-Ruiz, F. Martín-Dominguez, G. Bernal-Blanco, B. Villacorta- Linaza, G. Suárez-Artacho, C. Cepeda-Franco, D. Rangel-Sousa, C. Rodríguez-Urbistondo, B. Gutiérrez-Gutiérrez, M. Carretero-Ledesma, N. Maldonado, S. Salto-Alejandre, B. Gallego, L. Merino, J. Rodríguez-Baño, J.M. Cisneros, J.A. Pérez-Simón, E. Cordero, J. Pachón, M. Aguilar- Guisado, R. Álvarez-Marín, J. Sánchez-Céspedes</span>
</p>

<p class="sessionid">E0962</p><span class="title">Prevalence of and risk factors for persisting COVID- 19 in patients with B-cell malignancies 
<span>A. Toschi* (Bologna, Italy), Z. Pasquini, A. Amicucci, N. Caroccia, M. Di Chiara, F. Simone, B. Casadei, C. Pellegrini, A. D'abramo, P. De Marco, L. Bussini, M. Ciccone, A. Visentin, G. Caponcello, M. Bartoletti, E. Nicastri, M. Krampera, P.L. Zinzani, J. Rodriguez Baño, E. Tacconelli, M. Giannella</span>
</p>

<p class="sessionid">E0963</p><span class="title">Clinical characteristics and predictors of severe outcome among older adults hospitalized with respiratory syncytial virus (RSV) infection– a retrospective study from Israel 
<span>M. Jurkowicz* (Tel Aviv, Israel), I. Margalit, I. Harris, D. Mazar, A. Teper,</span>
</p><p class="presenter">I. Royzman, S. Uppal, C. Liang, E. Begier, I. Ganiel,</p><p class="presenter">M. Mandelboim, D. Yahav</p>

<p class="sessionid">E0964</p><span class="title">RSV and bronchiolitis associated primary care and emergency department visit rates in children under 5 years: Estimates for Europe and other high- income countries. </span><span class="presenters">F.F. Stelma* (Utrecht, Netherlands), S. Heemskerk, L. Van Heuvel, P. Spreeuwenberg, L. Bont, J. Van Summeren</span>
</p>

<p class="sessionid">E0965</p><span class="title">Higher incidence of post-transplant EBV infection in pediatric liver transplant recipients compared to pediatric kidney transplants: a retrospective analysis from a tertiary pediatric transplant center 
<span>S. Mercadante* (Rome, Italy), L. Romani, A. Pietrobattista, I. Guzzo, R. Labbadia, A. Cappoli, A. Mosca, L. Lancella, M. De Luca</span>
</p>

<p class="sessionid">E0966</p><span class="title">Insights from a single center's experience in hepatitis C treatment across four prisons in Slovakia 
<span>I. Hockickova* (Košice, Slovakia), I. Hockicková, J. Hockicko, M. Novotný, Z. Paraličová,</span>
</p><p>P. Kristian <br/></p><p> 

</p><p> 



<p class="sessionid">EF134</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Arena 4<span> </span>
</p><p>ePoster Flash Session</p><p> 
<span>   Infection       Controller's       Daily</span>
</p><p class="presenter">Chair       Cansu Cimen (Oldenburg, Germany) <br/></p>

<p class="sessionid">E0967</p><span class="title">Mortality and length of stay associated with antimicrobial-susceptible and resistant hospital- onset bloodstream infections at a tertiary referral hospital in Melbourne, Australia </span><span class="presenters">A. Stewardson* (Melbourne, Victoria, Australia), S.J. Curtis, S.L. Lee, B.S. Cooper, J.M. Bell, G.W. Coombs, D. Daley,</span>
</p><p class="presenter">A.C. Cheng, D.W. Spelman, A.Y. Peleg</p>

<p class="sessionid">E0968</p><span class="title">MRSA on the rise in neonatal care departments </span><span class="presenters">E. Herkes* (Amsterdam, Netherlands), A. Schoffelen,</span>
</p><p class="presenter">R. Zwittink, J. Kluytmans, D. Notermans</p>

<p class="sessionid">E0969</p><span class="title">Risk factors for OXA-carbapenemase-producing  </span><span class="presenters">Enterobacteriaceae</span>
acquisition in Israel: a retrospective case control study 
<span>M. Amar* (Haifa, Israel), R. Najjar-Debbiny, G. Weber, R. Yasin, A. Arbel, S. Shehade, I. Greenfeld, O. Salah, P. Shaked- Mishan, O. Barnett-Griness</span>
</p>

<p class="sessionid">E0970</p><span class="title">Experience providing a rapid, reactive nanopore isolate sequencing service for bacterial outbreak investigation for hospitals in London, UK 
<span>S. Raharison* (Nice, France), A. Alcolea-Medina, L.B. Snell, M. Tan, G. Humayun, R. Chang, D. Ward, V. Enne, V. Patel, C. Alder, L. Sowole, R. Batra, S. Goldenberg, J. Edgeworth, J. Otter</span>
</p>

<p class="sessionid">E0971</p><span class="title">Duration of colonization and time to de-isolation in patients with extended-spectrum beta-lactamase producing non- 
<span>Escherichia coli</span>
Enterobacterales 
<span>J. Männer* (St.Gallen, Switzerland), V. Steinacher, T. Dörr, M. Schlegel, P. Kohler</span>
</p><p>

<p class="sessionid">E0972</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">E0973</p><span class="title">Molecular epidemiology and transmission dynamics of vancomycin-resistant  
<span>Enterococcus faecium</span>
in Belgian hospitals (2022-2023) 
<span>S. De Koster* (Edegem, Belgium), S. Van Kleef-Van Koeveringe, H. Jansens, S. Vandamme, T. Demuyser, M. Vanden Driessche, Y. Glupczynski, S. Malhotra-Kumar, V. Matheeussen</span>
</p>

<p class="sessionid">E0974</p><span class="title">Increasing Prevalence of Linezolid-resistant Enterococci: Outbreak or Overuse? 
<span>R. Traynor* (Cork, Ireland), G. Brennan, I. O Callaghan, E. Keily,</span>
</p><p class="presenter">E. Skelton, E. Kennedy, B. O Connell, J. Walsh, A. Doherty, C. Hickey</p>

<p class="sessionid">E0975</p><span class="title">Continuous 2-year surveillance for airborne fungi at hospitals in the same city: Impact of season, construction, a construction accident and HEPA- filtered/positive pressure rooms </span><span class="presenters">M.H. Nguyen* (Pittsburgh, United States), C. Clancy, Z. Wilkins, Y. Cho, B. Hao, E. Driscoll, S. Cheng, A. Sundermann,</span>
</p><p>A. Ayres, S. Graham <br/></p><p> 

</p><p> 



<p class="sessionid">EW174</p><span> </span><span class="start">13:30</span>-<span class="end">15:30<span class="location">Hall 11<span> </span>
</p><p class="heading">Educational Session <br/></p><table>
<tr><td><p class="title">Best practices and emerging strategies in the management of ventilator- and healthcare-associated pneumonia</p></td></tr>
<tr><td><p class="presenters">Fusun Can (Istanbul, Türkiye)</p><p class="presenters">Jeroen Schouten (Nijmegen, Netherlands)</p></td></tr>
<tr><td>

<p class="sessionid">W0481</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Artificial Intelligence to predict VAP <span> </span>Miia Jansson (Oulu, Finland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0482</p></p></td><td><p class="start">13:50</p></td><td><p class="title">Metagenomic approach to VAP diagnosis </p><span class="presenter">Jacques</span>
</p></td></tr></table><table>
<tr><td>

<p class="sessionid">W0483</p></p></td><td><p class="start">14:10</p></td><td><p class="title">Viruses in VAP and HAP: should we worry about them? </p><span class="presenter">Catia Cilloniz (Barcelona, Spain)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0484</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Optimising antibiotic therapy in VAP </p><span class="presenter">Pinyo Rattanaumpawan (Bangkok, Thailand)</span>
</p></td></tr></table><table>
<tr><td>

<p class="sessionid">SY170</p></p></td><td><p>13:30  
<span>-</span>
15:30</p></td><td><p>Hall 13</p></td></tr>
<tr><td></td><td><p> 

</p><p>2-hour Symposium</p></td><td></td></tr>
<tr><td><p> 
<span> Novel  strategies  for  eliminating  the  ‘worst  films  ever’</span>
</p></td></tr>
<tr><td><p class="presenters">Elisa Borghi (Milan, Italy)</p><p class="presenters">Markus Zeitlinger (Vienna, Austria)</p></td></tr>
<tr><td>

<p class="sessionid">S0465</p></p></td><td><p class="start">13:30</p></td><td><p class="title">What answers can biofilm PK/PD modelling provide? <span> </span>Coen Van Hasselt (Leiden, Netherlands)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0466</p></p></td><td><p class="start">14:00</p></td><td><p class="title">subMIC antibiotic effects to improve biofilm PK/PD parameters – still relevant? </p><span class="presenter">Francoise Van Bambeke (Brussels, Belgium)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0467</p></p></td><td><p class="start">14:30</p></td><td><p class="title">PK/PD-based optimisation of antibiotic treatments to suppress resistance in dynamic biofilm models </p><span class="presenter">Maria Dolores Macia Romero (Palma De Mallorca, Spain)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0468</p></p></td><td><p class="start">15:00</p></td><td><p class="title">Giving antibiotics an upper hand in the treatment of biofilm infections – antibiotic augmenting strategies </p><span class="presenter">Claus Moser (Copenhagen, Denmark)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Biofilms (ESGB), ESCMID Scientific Affairs Subcommittee <br/></p><p> 

</p><p> 



<p class="sessionid">SY171</p><span> </span><span class="start">13:30</span>-<span class="end">15:30<span class="location">Hall 14<span> </span>
</p><ol id="l17"><li data-list-text="2-"><p>hour Symposium</p></li></ol><table>
<tr><td><p>Enhancing efficiency and reducing cost in microbiological diagnostics using pool testing</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Mauricio Farfan (Santiago, Chile) Chiara Minotti (Basel, Switzerland)</p></td></tr>
<tr><td>

<p class="sessionid">S0469</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Congenital cytomegalovirus detection by pool testing in saliva <span> </span>Giannina Izquierdo (Santiago, Chile)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0470</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Detection of blood-corne pathogens in asymptomatic blood donors by pool testing </p><span class="presenter">Patricia Alvarez (Rio De Janeiro, Brazil)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0471</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis </p><span class="presenter">Melissa Sander (Bamenda, Cameroon)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0472</p></p></td><td><p class="start">15:00</p></td><td><p class="title">Pool testing for screening of bacterial sexually transmitted infections </p><span class="presenter">Tba</span>
</p></td></tr></table><p> 

</p><p> 



<p class="sessionid">OS130</p><span> </span><span class="start">13:30</span>-<span class="end">14:30<span class="location">Hall 16<span> </span>
</p><ol id="l18"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span>  Advances     in     fungal     diagnostics</span>
</p><p class="presenter">Chair      Sarah Delliere (Paris, France) <br/></p>

<p class="sessionid">O0935</p><span class="title">BAL galactomannan dynamics predict survival in critically ill patients with virus-associated pulmonary aspergillosis </span><span class="presenters">V. Delanote* (Leuven, Belgium), J. Wauters, S. Feys, J. Heylen, H.M. Lauwers, C. Jacobs,</span>
</p><p class="presenter">L. Maessen, Y. Debaveye, P. Frederiks, G. Hermans,</p><p>P. Meersseman, M. Peetermans, E. Van Wijngaerden,</p><p class="presenter">A. Wilmer, K. Lagrou</p>

<p class="sessionid">O0936</p><span class="title">Retrospective Assessment of a New Chemiluminescence Immunoassay for Serum (1, 3)-</p><p>-D-Glucan Levels in Patient with Invasive Fungal Infections </span><span class="presenters">Z. Zhou* (Tianjin, China), K. Yuan, L. Ye, S. Liu, A. Huang, Z. Chen, W. Yan, S. Niu, K. Hua, Q. Wang, G. Zhang, H. Wang, Y. Zhao, G. Li</span>
</p>

<p class="sessionid">O0937</p><span class="title">Evaluation of a multiplex PCR assay using barcoded magnetic bead technology for detection of fungal pathogens in bronchoalveolar lavage fluid: a diagnostic aid for invasive fungal infections 
<span>S. Zhang* (Baltimore, United States)</span>
</p><p>

<p class="sessionid">O0938</p><span class="title"><span class="presenters"></span>
pneumonia diagnosis in non-HIV population 
<span>A. Falcó Roget* (Mataró, Spain), A. Falcó-Roget, A. Albasanz-Puig, A.B. Pérez,</span>
</p><p class="presenter">S. Serradell, A. Guillén, E. Revilla, I. Los-Arcos, O. Len,</p><p class="presenter">I. Ruiz-Camps, M.T. Martín-Gómez</p>

<p class="sessionid">O0939</p><span class="title">Iron levels in bronchoalveolar lavage fluid of hematological patients with suspected invasive pulmonary aspergillosis and their association with 12- week mortality: a retrospective cohort study </span><span class="presenters">H. Lamberink* (Amsterdam, Netherlands), J. Heijmans,</span>
</p><ol id="l19"><li data-list-text="A."><p>Wagemakers, K. Van Dijk</p></li></ol><p> 

</p><p> 



<p class="sessionid">SY168</p></span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 2</span>

</p></li><li data-list-text="2-"><p>hour Symposium</p></li></ol><p> 
<span> Staphylococcus aureus</span>
 
<span>: its expansion dynamics and interactions with its pals</span>
</p><table>
<tr><td><p>Chair</p></td><td></td><td><p>Barbara C. Kahl (Münster, Germany)</p></td></tr>
<tr><td><p class="presenter"><br/></p>

<p class="sessionid">S0457</p><span class="title"></td><td><p class="presenter">13:30</p></td><td><p>S. aureus  </span><span class="presenters">and its special relationship to</span>
S. epidermidis Andreas Peschel (Tübingen, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">S0458</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Computational and in  <span> </span>vitro</span>
evaluation of probiotic treatments for nasal  <span> </span>S. aureus</span>
decolonization <span> </span>Silvio Daniel Brugger (Zurich, Switzerland)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0459</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Clonal population expansion of  <span> </span>S. aureus</span>
occurs due to escape from a finite number of intraphagocyte niches <span> </span>Simon Foster (Sheffield, United Kingdom)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">S0460</p></p></td><td><p class="start">15:00</p></td><td><p class="title">How bacteriophages and pathogenicity islands drive the evolution of  </p><span class="presenter">S. aureus John Chen (Singapore, Singapore)</span>
</p></td></tr></table><p>Co-organised with: ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) <br/></p><p> 

</p><p> 



<p class="sessionid">EW172</p></span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 3</span>

</p><p>Educational Session</p><p> 
<span> Beyond  the  gift  of  life:  viral  infection  during  pregnancy</span>
</p><p class="presenters"></p><p>

<p class="sessionid">W0473</p><span class="start">13:30</span><span class="title">Hepatitis  B during pregnancy: diagnosis,</p><p>management and outcome 
<span>Tba</span>
</p><p>

<p class="sessionid">W0474</p><span class="start">13:50</span><span class="title">RSV  and Influenza during pregnancy: management and outcome 
<span>Monika Redlberger-Fritz (Vienna, Austria)</span>
</p><p>

<p class="sessionid">W0475</p><span class="start">14:10</span><span class="title">Prenatal  screening and prevention of congenital</p><p>CMV: shifting concepts and consensus guideline 
<span>Marianne Leruez-Ville (Paris, France)</span>
</p><p>

<p class="sessionid">W0476</p><span class="start">14:30</span><span class="title">Novel  methods of vaccine administration to newborns 
<span>Tba</span>
</p><p>Co-organised with: ESCMID Study Group for Viral Hepatitis (ESGVH), European Society for Infectious Diseases in Obstetrics and Gynaecology (ESIDOG), Society on Liver Diseases in Africa (SOLDA), Gastroenterology and Hepatology Association of SubSaharan Africa (GHASSA) <br/></p><p> 

</p><p> 



<p class="sessionid">SY169</p></span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 4</span>

</p><p>2-hour Symposium <br/></p><table>
<tr><td><p>Molecular epidemiology, resistance mechanisms and management of Gram- negative bacteria</p></td></tr>
<tr><td><p class="presenters"></p></td><td><p class="presenters">Agnes Maria Sonnevend (Pécs, Hungary) Kyriaki Xanthopoulou (Cologne, Germany)</p></td></tr>
<tr><td>

<p class="sessionid">S0461</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Globally emerging resistance patterns of Enterobacterales <span> </span>Sasheela Ponnampalavanar (Kuala Lumpur, Malaysia)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0462</p></p></td><td><p class="start">14:00</p></td><td><p class="title">Non-fermenters still important globally: a review of spread and resistance </p><span class="presenter">Anupa Thampy (Vellore, India)</span>
</p></td></tr>
<tr><td>


<p class="sessionid">S0463</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Innovative rapid diagnostic methodologies for Gram- negative pathogens </p><span class="presenter">Laurent Dortet (Le Kremlin-</span>
</p></td></tr></table><p>

<p class="sessionid">S0464</p><span class="start">15:00</span><span class="title">Tailoring  treatment to resistant Gram-negative bacteria: newer therapeutic approaches 
<span class="presenter">Juan P. Horcajada (Barcelona, Spain)</span>
</p><p>Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS) <br/></p><p> 

</p><p> 



<p class="sessionid">EW173</p></span>
<span class="start">13:30</span>-<span class="end">15:30</span><span class="location">Hall 5</span>

</p><p class="header">Educational Session</p><p> 
<span class="title">  Tropical dermatology: a case-based approach</span>
</p><table>
<tr><td><p class="presenters">Pedro Legua (Lima, Peru)</p><p class="presenters">Bobbi Pritt (Rochester, United States)</p></td></tr>
<tr><td>

<p class="sessionid">W0477</p></p></td><td><p class="start">13:30</p></td><td><p class="title">Parasitic diseases: dermatological manifestations in the tropics <span> </span>Kirti Sabnis (India)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0478</p></p></td><td><p class="start">13:50</p></td><td><p class="title">Madura foot and other implantation mycoses </p><span class="presenter">M Ramam (New Delhi, India)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0479</p></p></td><td><p class="start">14:10</p></td><td><p class="title">Mycobacteria </p><span class="presenter">Francisco Bravo (Lima, Peru)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">W0480</p></p></td><td><p class="start">14:30</p></td><td><p class="title">Approach to rash in the returning traveller </p><span class="presenter">Frank O. D. Pettersen (Oslo, Norway)</span>
</p></td></tr>
<tr><td>

<p class="sessionid">OS127</p></p></td><td><p>13:30  
<span>-</span>
14:30</p></td><td><p>Hall 6</p></td></tr>
<tr><td></td><td><p>1-hour Oral Session</p></td><td></td></tr></table><p> 

</p><p> 
<span> The  good,  the  bad  and  the  itchy:  update  on  STIs</span>
</p><p class="presenter">Chair       Tatum Mortimer (Athens, United States) <br/></p>

<p class="sessionid">O0920</p><span class="title">High frequency of Nichols-like strains of  </span><span class="presenters">Treponema pallidum</span>
subsp 
<span>. pallidum</span>
circulating in Barcelona, Spain 
<span>P. Nadal-Baron* (Barcelona, Spain), P. Nadal- Barón, J. Trejo-Zahinos, M. Arando, A. Barberan- Masegosa, M. Bernat-Sole, A. Perez-Ugarte, M. Valverde Espinal, A. Canals Quintana, J.J. González- López, A. Antón, M. Alberny, O. Mitjà, N. Larrosa, Y. Hoyos-Mallecot</span>
</p>

<p class="sessionid">O0921</p><span class="title">Doxycycline post-exposure prophylaxis (doxy-PEP) use and outcomes in metropolitan Detroit 
<span>C. Arena* (Detroit, United States), N. Everson, R. Kenney, I. Brar,</span>
</p><p class="presenter">S. Gudipati, N. Yared, S. Davis, M. Veve</p>

<p class="sessionid">O0922</p><span class="title">The Gonococcus Bacterial Load Measured by the Cycle Threshold (Ct) in Urinary Samples Correlates with Symptomatology </span><span class="presenters">G. Beraud* (Orleans, France),
 T. Prazuck, L. Barhoum, H. Meyjonnade, J. Effa, L. Hocqueloux, A. Seve, J. Guinard, K. Kochbati, E. Carbonelle, C. Guillaume</span></p><p>

<p class="sessionid">O0923</p><span class="title"><span class="presenters"></span>
</p>

<p class="sessionid">O0924</p><span class="title">Epidemiology of bacterial genitourinary infections among women with recurrent vulvovaginal Candidiasis (RVVC) in Nigeria. 
<span>S. Fayemiwo* (Ibadan, Nigeria), L. Novak-Frazer, I. Adewole, R. Rautemaa- Richardson</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS129</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 7</span>

</p><ol id="l20"><li data-list-text="1-"><p>hour Oral Session</p><p> 
<span>   Biofilm     biology     and     control</span>
</p><p class="presenter">Chairs      Margherita Cacaci (Rome, Italy)</p><p class="presenter">Laura Escolà-Vergé (Barcelona, Spain) <br/></p>

<p class="sessionid">O0930</p><span class="title">Influence of non-coding small <p class="sessionid" style="background-color: red;">RNA00203</p> in biofilm cells of  </span><span class="presenters">Acinetobacter baumannii</span>
: Transcriptomic and phenotypic 
<span>D. Gebrelibanos* (Hong Kong, China), P. Leung, A.M. Shenkutie, F. Chow</span>
</p><p>

<p class="sessionid">O0931</p><span class="title"><span class="presenters"></span>
biofilm streamer formation 
<span>A. Di Claudio* (Pieve Emanuele, Italy), R. Rusconi, E. Secchi, G. Savorana</span>
</p>

<p class="sessionid">O0932</p><span class="title">Regulation of Novel Genes and Their Downstream Functions in the AI-2-Mediated Quorum Sensing System of Klebsiella pneumoniae 
<span>X. Chu* (Beijing, China), Q. Yang</span>
</p><p>

<p class="sessionid">O0933</p><span class="title"><span class="presenters"></span>
clinical strains through confocal laser scanning microscopy 
<span>C. Maria* (Madrid, Spain), M. Cano-Fernández, J. Esteban, P. López-Roa, A. Ruedas-López, M.C. Muñoz-Egea</span>
</p><p>

<p class="sessionid">O0934</p><span class="title"><span class="presenters"></span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS126</p></span>
<span class="start">13:30</span><span>-</span>
<span class="start">15:30</span><span class="location">Hall 8</span>

</p></li><li data-list-text="2-"><p>hour Oral Session</p></li></ol><p> 
<span>  Emerging    viruses,    diverse    threats</span>
</p><p class="presenter">Chairs       Luisa Barzon (Padua, Italy) Karin Stiasny (Vienna, Austria) <br/></p>

<p class="sessionid">O0910</p><span class="title">Epidemiological and clinical features of mpox during the clade Ib outbreak in South-Kivu, Democratic Republic of the Congo: a prospective cohort study </span><span class="presenters">I. Brosius* (Antwerp, Belgium), E. Hasivirwe Vakaniaki, S. Sabiti Nundu, L. Liesenborghs, P. Mbala-Kingebeni, G. Mukari, P. Munganga, J.C. Tshomba, E. De Vos, E. Bangwen,</span>
</p><p class="presenter">Y. Mujula, A. Tsoumanis, C. Van Dijck, A. Alengo, L. Mutimba-Mambo, F. Mweshi Kumbana, J. Babingwa Muunga, D. Mazambi Mambo, J. Wakilongo Zangilwa, S. Bilembo Kitwanda, S. Houben, N. Hoff, J.C. Makangara-Cigolo, E. Kinganda-Lusamaki, M. Peeters, A. Rimoin, J. Kindrachuck, N. Low, P. Katoto, E. Bwenge Malembaka, J.H. Amuasi, O. Tshiani, R. Kojan, D. Muamba Kambaj, C. Kacita, D. Mukadi-Bamuleka,</p><p class="presenter">S. Ahuka-Mundeke, K. Vercauteren, T. Wawina- Bokalanga, J.J. Muyembe-Tamfum</p>

<p class="sessionid">O0911</p><span class="title">Tracing the origin, spread and molecular evolution of Dengue type 1 cases occurred in Northern Italy in 2023 </span><span class="presenters">G. Romano* (Pavia, Italy), G. Ferrari, A.M.G. Pitrolo, F. Rovida, A. Piralla, F. Baldanti</span>
</p>

<p class="sessionid">O0912</p><span class="title">Dengue Country Risk Estimation: Vector Suitability and Imported Activity 2024. 
<span>M. Torres Portillo* (Toronto, Canada), K. Williams, R. Lababidi, A. Thomas, K. Khan</span>
</p>

<p class="sessionid">O0913</p><span class="title">Rat HEV in humans in Germany: presence but low detection rate, a screening study 2022 - 2023 
<span>L. Mueller* (Berlin, Germany), M.L. Schmidt, T. Schwarz, T.D. Best, T. Bleicker, J. Panajotov, J. Jansen, J. Melchert, T. Mauno, C. Drosten, R. Johne, V.M. Corman</span>
</p>

<p class="sessionid">O0914</p>
<p class="title">Emergence of new enterovirus D68 lineage in Europe in 2023 associated with distinct amino acid substitutions in VP1 protein</p> 
<span class="presenters">A. Hirvonen* (Vantaa, Finland), C.K. Johannesen, P. Simmonds, T.K. Fischer, H. Harvala, K.S.M. Benschop</span>



<p class="sessionid">O0915</p></p>Health-economic impacts of chikungunya vaccination in 34 countries 
<span>J. Zhou* (Oxford, United Kingdom), N. Salant, D. Smith, D. Hollingsworth, K. Pouwels, S. Radoykova, J. Lord, K. French</span>
</p>

<p class="sessionid">O0916</p><span class="title">Clinical importance of a new tick-borne  
<span>flaviviridae</span>
virus, Alongshan Virus: retrospective serologic and molecular study in Switzerland 
<span>F. Tagini* (Lausanne, Switzerland), O. Opota, A. Eggermann, A. Coste, G. Greub</span>
</p>

<p class="sessionid">O0917</p><span class="title">From Trade Routes to Transmission Routes: Risk Assessment of Japanese Encephalitis Outbreak in Pakistan under China-Pakistan Economic Corridor Using One Health Approach 
<span>S. Ahmad* (Tampere, Finland)</span>
</p>

<p class="sessionid">O0918</p><span class="title">Building a screening protocol for the detection of Orthobunyavirus oropoucheense infection 
<span>G. Gagliardi* (Milan, Italy), D. Mileto, A. Mancon, L. Morelli, M. Cutrera, A. Cavallo, A. Rizzo, V. Micheli,</span>
</p><p class="presenter">A. Lombardi, A. Dolci</p>

<p class="sessionid">O0919</p><span class="title">Substantial viral diversity in bats and rodents from East Africa: insights into conservation, recombination, and co-circulation </span><span class="presenters">D. Wang* (Shenzhen, China)</span>
 <br/></p><p> 

</p><p> 



<p class="sessionid">OS128</p></span>
<span class="start">13:30</span>-<span class="end">14:30</span><span class="location">Hall 9</span>

</p><p>1-hour Oral Session</p><p> 
<span>    AI        Aiding        AMS</span>
</p><p class="presenter">Chairs      Marlieke De Kraker (Geneva, Switzerland) Bhanu Sinha (Groningen, Netherlands) <br/></p>

<p class="sessionid">O0925</p><span class="title">Using natural language processing to understand free-text antibiotic prescriptions </span><span class="presenters">A. Martin* (Middlesbrough, United Kingdom), L. Christopher</span>
</p><p>

<p class="sessionid">O0926</p><span class="title"><span class="presenters"></span>
</p><p> 


<p class="sessionid">O0927</p></span>
Augmented Intelligence in Infectious Diseases (AI 
<span>2</span>
D) as an antimicrobial stewardship tool for early antibiotic discontinuation in suspected lower respiratory tract infections 
<span>J.L. Lim* (Singapore, Singapore), P.Z.B. Cherng, P.M. Chlebicki, L.S.C. Gan,</span>
</p><p class="presenter">S.Y. Thien, S.L.S. Tang, L.X.T. Lee, Y.C.D. Yii, P.Y.</p><p class="presenter">Zhou, Y. Wang, S.J. Chung, L.H.A. Kwa</p>

<p class="sessionid">O0928</p><span class="title">Virtual antimicrobial stewardship ward rounds: predicting antibiotic course stopping decisions in hospitals using machine learning </span><span class="presenters">K. Yuan* (Oxford, United Kingdom), J. Wei, C.H. Yoon, Q. Gu, W. Walker,</span>
</p><p class="presenter">T. Zhu, D. Eyre</p>

<p class="sessionid">O0929</p><span class="title">Prospective evaluation of a machine learning-based decision support system for intravenous-to-oral antibiotic switching. </span><span class="presenters">W. Bolton* (London, United Kingdom), R. Wilson, P. Georgiou, A. Holmes, T.M. Rawson, M. Gilchrist</span>
</p>
</body></html>